{"title": "las vacunas brucella: Topics by WorldWideScience.org", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2013-11-12", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[El estado actual de las vacunas contra las drogas](http://riiad.org/index.php/riiad/article/view/riiad.2017.2.05) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaura Epifan\u00eda Matus Ortega\n2017-12-01\nFull Text Available Introducci\u00f3n: por lo com\u00fan, la adicci\u00f3n a las drogas se trata con psicoterapia y farmacolog\u00eda que evita la uni\u00f3n de las sustancias psicoactivas a receptores espec\u00edficos en el cerebro. El resultado de estos tratamientos no ha sido del todo satisfactorio, por lo que el desarrollo de terapias m\u00e1s eficaces representa un reto constante para tratar las adicciones. Una alternativa a la farmacolog\u00eda antiadictiva es la vacunaci\u00f3n activa dirigida contra las sustancias de abuso. Objetivo: esta revisi\u00f3n re\u00fane la informaci\u00f3n disponible sobre los fundamentos y avances cient\u00edficos en la generaci\u00f3n de una terapia inmunol\u00f3gica, que coadyuve al tratamiento de la adicci\u00f3n a sustancias como la hero\u00edna-morfina, la coca\u00edna, la nicotina y la anfetamina. M\u00e9todo: se consideraron los reportes cient\u00edficos disponibles en PubMed \u2013de 2005 a abril de 2017\u2013, sobre los fundamentos, la metodolog\u00eda empleada, los estudios precl\u00ednicos y cl\u00ednicos, y los resultados obtenidos en dichas investigaciones para generar vacunas contra las drogas. Resultados: las vacunas lograron mitigar los efectos producidos por las sustancias en los estudios precl\u00ednicos en modelos de estudio en animales; sin embargo, con pacientes humanos los resultados no han sido del todo satisfactorios. Discusi\u00f3n y conclusiones: a pesar de los esfuerzos realizados por diferentes grupos de investigaci\u00f3n y compa\u00f1\u00edas farmac\u00e9uticas para generar vacunas terap\u00e9uticas contra el uso de diferentes drogas, ninguna ha alcanzado la fase III de estudios cl\u00ednicos. En la actualidad, se contin\u00faa con los esfuerzos para lograr que las vacunas contra las adicciones alcancen su m\u00e1xima eficiencia y eficacia, y contribuyan al tratamiento de la adicci\u00f3n a las drogas.\n[Efectividad comunitaria de las vacunas frente a la Parotiditis Infecciosa. Estudio de casos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271999000400003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLim\u00f3n Mora Juan\n1999-01-01\nFull Text Available FUNDAMENTO: En nuestro pa\u00eds existen dos tipos de vacunas disponibles frente a la parotiditis infecciosa. En los \u00faltimos tiempos se han planteado dudas sobre la eficacia global de estas vacunas y de la eficacia comparada entre ambas (cepa Rubini y cepa Jeryl Lynn. En el distrito sanitario de A.P. \"Sevilla Este\" se registraron 256 casos durante 1997 (90,1 casos por 100.000 habitantes. Con este estudio se pretende aprovechar la aparici\u00f3n de casos de parotiditis para evaluar poblaciones afectadas e incidencia comparada seg\u00fan tipo de vacuna recibida durante la infancia. M\u00c9TODOS: An\u00e1lisis descriptivo de los casos (edad, distribuci\u00f3n territorial, antecedentes vacunales,... y an\u00e1lisis evolutivo (tasas de incidencia anuales en el distrito sanitario y su entorno. Se eval\u00faa la efectividad global de las vacunas frente a la parotiditis. Igualmente se estiman las tasas de incidencia de casos entre los vacunados con cepa Rubini y Jeryl Lynn. RESULTADOS: Se observan las tasas de incidencias m\u00e1s elevadas en ni\u00f1os entre 1 y 4 a\u00f1os. Se han estimado niveles de efectividad global para estas vacunas. Adem\u00e1s se observa una incidencia de casos significativamente m\u00e1s elevada entre los ni\u00f1os vacunados con cepa Rubini que en los que lo hicieron con Jeryl Lynn (riesgo relativo de 6,5 con Intervalo de confianza 95% 3,6-11,8. CONCLUSIONES: La efectividad que se desprende de este estudio no parece ser tan buena como la eficacia te\u00f3rica preconizada para las vacunas frente a la parotiditis. Se plantea la conveniencia de realizar otros estudios de casos seg\u00fan tipos de vacunas utilizadas. Igualmente son de gran inter\u00e9s los datos a suministrar por estudios seroepidemiol\u00f3gicos.\n[Vaccines against dengue: a review of current candidate vaccines at advanced development stages Vacunas contra el dengue: una revisi\u00f3n de las vacunas candidatas en etapas avanzadas de desarrollo](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007000300011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJoachim Hombach\n2007-04-01\nFull Text Available Los esfuerzos sistem\u00e1ticos para desarrollar una vacuna contra el dengue comenzaron durante la Segunda Guerra Mundial, inspirados en el desarrollo exitoso de una vacuna contra la fiebre amarilla. Sin embargo, la falta de modelos adecuados de la enfermedad, la informaci\u00f3n incompleta acerca de los mecanismos patog\u00e9nicos y los insuficientes incentivos econ\u00f3micos han dificultado los avances. Debido al impacto actual del dengue en todo el mundo y su explosiva diseminaci\u00f3n, ha aumentado el inter\u00e9s en el desarrollo de vacunas contra el dengue y se ha avanzado considerablemente en el camino hacia la evaluaci\u00f3n cl\u00ednica de vacunas candidatas. La Iniciativa para la Investigaci\u00f3n en Vacunas, de la Organizaci\u00f3n Mundial de la Salud, est\u00e1 facilitando el desarrollo de y los ensayos con las vacunas candidatas. Las vacunas contra el dengue que se encuentran actualmente en etapas avanzadas de desarrollo son de tres tipos fundamentales: 1 vivas atenuadas; 2 vivas recombinantes; y 3 de subunidades e inactivadas. La mayor\u00eda de las vacunas en cartera son vivas atenuadas, siguiendo el camino exitoso de otras vacunas vivas contra flavivirus, especialmente de la desarrollada contra la fiebre amarilla. En general, las vacunas contra el dengue que se encuentran actualmente en desarrollo est\u00e1n bastante avanzadas y son muy diversas. Muy pronto comenzar\u00e1 la evaluaci\u00f3n de estas vacuna candidatas en ensayos de eficacia basados en poblaciones expuestas, lo que requerir\u00e1 resolver varios problemas t\u00e9cnicos, operacionales y regulatorios.\n[Las vacunas nos protegen (Vaccines Help Protect Us)](https://www2c.cdc.gov/podcasts/player.asp?f=8630647) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2013-04-23\nEn este podcast, los ni\u00c3\u00b1os de Kidtastics hablan sobre la importancia de las vacunas y c\u00c3\u00b3mo funcionan. Created: 4/23/2013 by Centers for Disease Control and Prevention (CDC). Date Released: 12/11/2013.\n[El legado de la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1810: las juntas de vacuna](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/71/74) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRam\u00edrez Mart\u00edn, Susana Mar\u00eda\n2004-06-01\nFull Text Available The Royal Vaccination Expedition, directed by the physicians Francisco Xavier Balmis and Jos\u00e9 Salvany, was the most important scientific and medical achievement of the Spanish colonial era. It took place at a time of political restlessness, and its achievements were thus conditioned by each of the cultures into which the vaccine was introduced. As its legacy, the philantropic expedition left the Vaccination Boards, established in the Americas as centers of medical expertise to sustain the expedition\u00b4s principal objetive: the battle against the smallpox epidemics in pursuit of public health.\nLa Expedici\u00f3n de la Vacuna, dirigida por los m\u00e9dicos Francisco Xavier Balmis y Jos\u00e9 Salvany, es la gesta cient\u00edfica y sanitaria m\u00e1s importante de \u00e9poca colonial. Su desarrollo tuvo lugar en un momento pol\u00edtico convulso y los resultados estuvieron condicionados por las sociedades donde la vacuna se estableci\u00f3. El legado de esta expedici\u00f3n filantr\u00f3pica fue la creaci\u00f3n de las Juntas de Vacuna. Estas instituciones se erigieron como centros creadores de saber m\u00e9dico en Am\u00e9rica y consolidaron el objetivo primario de la expedici\u00f3n: la b\u00fasqueda de la salud p\u00fablica luchando contra las epidemias de viruela.\n[VARIABILIDAD EN LA NOTIFICACI\u00d3N DE REACCIONES ADVERSAS A LAS VACUNAS DE LA GRIPE PAND\u00c9MICA Y ESTACIONAL. TEMPORADAS 2009-2010 Y 2010-2011, COMUNITAT VALENCIANA](http://www.redalyc.org/articulo.oa?id=17023106004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Mar\u00eda Alguacil Ramos\n2012-01-01\nFull Text Available Fundamentos: La p\u00e9rdida de confianza en la seguridad de las vacunas derivada de situaciones de alarma, como en el caso de la gripe pand\u00e9mica, puede afectar tanto a las coberturas vacunales como a la sensibilidad frente a la notificaci\u00f3n de las sospechas de reacciones adversas asociadas a vacunas (SRAAV. El objetivo del trabajo es describir los efectos adversos a la vacuna frente a la gripe pand\u00e9mica notificados en la temporada 2009-2010 y comparar si existen diferencias con los descritos con la vacuna de la gripe estacional en las temporadas 2009-2010 y 2010-2011 en la Comunitat Valenciana (CV. M\u00e9todos: Se realiz\u00f3 un estudio descriptivo de los individuos vacunados frente a la gripe que presentaron alguna SRAAV a la vacuna antigripal y que fue notificada a trav\u00e9s del Sistema de Informaci\u00f3n Vacunal, durante las temporadas 2009-2010 (incluyendo la vacunaci\u00f3n pand\u00e9mica y 2010-2011 en CV. se calcularon las tasas de notificaci\u00f3n de sospechas de reacciones adversas asociadas a vacunas por cada mil dosis de vacunas administradas y sus intervalos de confianza al 95%. Resultados: Durante el periodo 2009-2010 la tasa de notificaci\u00f3n de SRAAV para la vacuna de la gripe estacional fue de 0,02 por mil dosis administradas, para la vacuna pand\u00e9mica de 0,95. En el periodo 2010-2011 la tasa para la vacuna de la gripe estacional fue de 0,04 por mil. Conclusiones: Durante las temporadas analizadas se increment\u00f3 el n\u00famero de notificaciones de SRAAV para las vacunas pand\u00e9micas en comparaci\u00f3n con el resto de vacunas antigripales. La mayor tasa de notificaci\u00f3n de SRAAV correspondi\u00f3 al grupo de profesionales sociosanitarios, tanto para las vacunas frente a la gripe estacional como pand\u00e9- mica.\n[Evaluaci\u00f3n de un modelo de infecci\u00f3n murino para la evaluaci\u00f3n de vacunas hom\u00f3logas y heter\u00f3logas contra Brucella canis Evaluation of a mouse infection model to evaluate homologue and heterologue vaccines against Brucella canis in mouse model](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::ece01fbd6d31d8575f7f4ae84e6b72a6)\nM Clausse; S.M. Estein\n2011-01-01\nLa brucelosis canina es una enfermedad zoon\u00f3tica que afecta a los caninos y provoca importantes p\u00e9rdidas econ\u00f3micas en criaderos. En la actualidad, no existe una vacuna para la prevenci\u00f3n de esta enfermedad. Una limitante en el desarrollo de una vacuna eficaz es la falta de un modelo experimental que permita evaluar la infecci\u00f3n con Brucella canis. En este trabajo, se desarroll\u00f3 un modelo rat\u00f3n para evaluar la infecci\u00f3n espl\u00e9nica por B. canis empleando distintas dosis, tiempos de sacrificio y...\n[An\u00e1lisis econ\u00f3mico de las vacunas 10-valente y 13-valente contra neumococo: revisi\u00f3n sistem\u00e1tica](https://www.openaire.eu/search/publication?articleId=od______1325::3699ed70c8821c924c79160abcf4fcaf)\nTorres Garrido, Alba Luz; Vargas-Zambrano, Juan-Camilo\n2014-01-01\nIntroducci\u00f3n: Las vacunas cl\u00e1sicamente han representado un m\u00e9todo econ\u00f3mico y eficaz para el control y prevenci\u00f3n de m\u00faltiples enfermedades infecciosas. En los \u00faltimos a\u00f1os se han introducido nuevas vacunas contra neumococo a precios elevados, y los diferentes an\u00e1lisis econ\u00f3micos a nivel mundial de estas vacunas no muestran tendencias. El objetivo de este trabajo era resumir la evidencia existente a trav\u00e9s de los diferentes estudios econ\u00f3micos evaluando las dos vacunas de segunda generaci\u00f3n c...\n[Streptococcus pneumoniae aislados durante 2002-2006: serotipos y resistencia antibi\u00f3tica. Correlaci\u00f3n con las vacunas existentes](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832008000100006&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Mar\u00eda Guevara-Duncan\n2008-03-01\nFull Text Available Objetivos: Identificar los serotipos de S. pneumoniae aislados, correlacion\u00e1ndolos con los incluidos en las vacunas existentes y su resistencia antimicrobiana. Dise\u00f1o: Estudio descriptivo, observacional y longitudinal. Lugar: Instituto de Medicina Tropical Daniel A. Carri\u00f3n, Facultad de Medicina, UNMSM. Material biol\u00f3gico: Cepas de Streptococcus pneumoniae. Intervenciones: Cuarenta Streptococcus pneumoniae de nuestro cepario, aislados entre el 2002 y 2006, fueron serotipificados en el Instituto de Salud Carlos III en Madrid -Espa\u00f1a; 15 fueron invasivos, 11 aislados de infecciones localizadas, 6 de portadores y 8 eran multiresistentes. Principales medidas de resultados: Protecci\u00f3n de las vacunas existentes en nuestro medio a las infecciones causadas por Streptococcus pneumoniae. Resultados: Hubo 14 serotipos diferentes y los serogrupos m\u00e1s identificados fueron 23, 19 y 6. El 28,6% estaba contenido en la vacuna 7-valente, 42,9% en la 9-valente, 50% en la 11-valente y el 71,4% en la 23-valente; 57,5% fue resistente a la penicilina y 30% a eritromicina. El grupo de Streptococcus invasivo result\u00f3 m\u00e1s sensible a los antibi\u00f3ticos que los otros grupos. Los serotipos asociados a multirresistencia fueron 19F y 23F. Conclusiones: Ninguna de las vacunas protege a todas las infecciones causadas por Streptococcus pneumoniae, en nuestro medio.\nLlor Vila, Carles\n2005-01-01\nLa vacunaci\u00f3n antigripal, con m\u00e1s de 50 a\u00f1os de existencia, tiene una eficacia, una efectividad y una seguridad contrastadas, pero la respuesta inmunitaria oscila entre el 60 y el 90%, siendo algo menor en la poblaci\u00f3n anciana. Cl\u00e1sicamente se han utilizado las vacunas inactivadas trivalentes en las campa\u00f1as de vacunaci\u00f3n antigripal pero se considera que su aceptabilidad no es \u00f3ptima. Desde hace unos a\u00f1os se est\u00e1n investigando otros tipos de vacunas antigripales con el objetivo de mejorar su ...\n[Registro de ensayos con vacunas del Programa Mundial de Vacunas e Inmunizaci\u00f3n de la OMS](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRobertson S. E.\n1998-01-01\nFull Text Available En 1995, el Programa Mundial de Vacunas e Inmunizaci\u00f3n de la OMS estableci\u00f3 un registro para ensayos con vacunas. En septiembre de 1996, este registro conten\u00eda 50 ensayos de vacunaci\u00f3n patrocinados por la OMS, de los cuales 25 (50% eran estudios ya terminados. Las vacunas que se hab\u00edan estudiado con mayor frecuencia fueron las de sarampi\u00f3n (9 ensayos, poliovirus (8 ensayos, c\u00f3lera (8 ensayos, Escherichia coli enterotox\u00edgena (4 ensayos y neumococo (4 ensayos. Casi 80% de estos ensayos se llevaron a cabo en pa\u00edses en desarrollo, principalmente en el \u00c1frica. En los 25 ensayos ya terminados, los resultados investigados fueron la respuesta inmunitaria (24 ensayos, las reacciones adversas (13 ensayos, la morbilidad (4 ensayos y la mortalidad (1 ensayo. La OMS contribuy\u00f3 a estos ensayos con el aporte indirecto de fondos, ayuda con el dise\u00f1o metodol\u00f3gico, visitas a las localidades, el an\u00e1lisis de los datos, la adquisici\u00f3n de vacunas y la investigaci\u00f3n de su potencia.\n[Vacunas de bacterias recombinantes vivas](https://www.openaire.eu/search/publication?articleId=od______3272::e04c2a8ca070b76a97f8c299cefc6434)\nBlanco Le\u00f3n, Marina\n2016-01-01\nLa vacunaci\u00f3n es uno de los logros m\u00e1s importantes en la historia de la medicina, que ha ido evolucionando a lo largo de los a\u00f1os permitiendo una reducci\u00f3n significativa de la mortalidad infantil, una disminuci\u00f3n de la incidencia de enfermedades e incluso la erradicaci\u00f3n de algunas de ellas en pa\u00edses enteros. Las vacunas de nueva generaci\u00f3n surgen para reducir o eliminar las carencias de las vacunas \u201ctradicionales\u201d. T\u00e9cnicas biotecnol\u00f3gicas basadas en el ADN recombinante han dado lugar, entre...\n[La evidencia acerca de la controversia de las vacunas que contienen timerosal y su asociaci\u00f3n con el autismo](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342013000200018&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLisset Garc\u00eda-Fern\u00e1ndez\n2013-06-01\nFull Text Available La vacunaci\u00f3n es una de las medidas de mayor impacto en la salud p\u00fablica para la reducci\u00f3n de la morbimortalidad infantil. El timerosal es un compuesto org\u00e1nico del mercurio utilizado como preservante de los frascos multidosis. Eventualmente, en el Per\u00fa, surgen olas de controversia acerca de la seguridad de estas vacunas, asoci\u00e1ndolas especialmente con el autismo. Como resultado de estas controversias, se han propuesto, incluso, leyes que proh\u00edben este tipo de vacunas, lo que tendr\u00eda un importante impacto en los costos y en los aspectos log\u00edsticos de la estrategia nacional de vacunaci\u00f3n. En este art\u00edculo se revisa la literatura sobre las principales controversias acerca de las vacunas que contienen timerosal y su supuesta asociaci\u00f3n con el autismo. Se realiza una aproximaci\u00f3n hist\u00f3rica sobre estas controversias, se hace una actualizaci\u00f3n de la evidencia cient\u00edfica disponible al momento, y se revisa la posici\u00f3n de los organismos internacionales m\u00e1s importantes con respecto a este tema. Se concluye que la evidencia cient\u00edfica no apoya la noci\u00f3n que exista una asociaci\u00f3n entre el uso del timerosal en las vacunas con los trastornos del espectro autista en ni\u00f1os.\n[VARIABILIDAD EN LA NOTIFICACI\u00d3N DE REACCIONES ADVERSAS A LAS VACUNAS DE LA GRIPE PAND\u00c9MICA Y ESTACIONAL. TEMPORADAS 2009-2010 Y 2010-2011, COMUNITAT VALENCIANA](https://www.openaire.eu/search/publication?articleId=doajarticles::6f322a77ce0bd5fd88c95f861a1a0782)\nAna Mar\u00eda Alguacil Ramos; Jos\u00e9 Antonio Lluch Rodrigo; Antonio Portero Alonso; Rosa Mart\u00edn Ivorra; Eliseo Pastor Villalba\n2012-01-01\nFundamentos: La p\u00e9rdida de confianza en la seguridad de las vacunas derivada de situaciones de alarma, como en el caso de la gripe pand\u00e9mica, puede afectar tanto a las coberturas vacunales como a la sensibilidad frente a la notificaci\u00f3n de las sospechas de reacciones adversas asociadas a vacunas (SRAAV). El objetivo del trabajo es describir los efectos adversos a la vacuna frente a la gripe pand\u00e9mica notificados en la temporada 2009-2010 y comparar si existen diferencias con los descritos con...\n[Influenza. Vacunas cl\u00e1sicas y novedosas a las puertas de otra pandemia](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200005&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRaiza Mart\u00ednez\n2006-08-01\nFull Text Available Los virus de la influenza A, adem\u00e1s del hombre, infectan otros mam\u00edferos y una gran variedad de especies de aves. Desde 1997 se sabe que cepas aviares son capaces de infectar al hombre provocando una enfermedad generalmente leve. El brote actual de gripe aviar H5N1 en humanos ha puesto en alerta a la comunidad cient\u00edfica internacional, no solo por su elevada mortalidad sino por su potencialidad en la generaci\u00f3n de una nueva pandemia. Las autoridades sanitarias han puesto en marcha un amplio programa para la preparaci\u00f3n ante esta contingencia, que abarca diferentes campos, desde el diagn\u00f3stico y la detecci\u00f3n precoz de los brotes tanto en animales como en humanos, la caracterizaci\u00f3n sistem\u00e1tica de las cepas circulantes, el sacrificio de aves infectadas, la producci\u00f3n masiva de antivirales y por supuesto el desarrollo y producci\u00f3n a gran escala de vacunas eficaces. En este \u00faltimo tema se trabaja intensamente tanto en el mejoramiento de las vacunas ya existentes como en la b\u00fasqueda de alternativas basadas en tecnolog\u00edas de nueva generaci\u00f3n.\n[Tipificaci\u00f3n molecular de Brucella abortus cepa 19 y su aplicaci\u00f3n al control de biol\u00f3gicos Molecular characterization of Brucella abortus strain 19 and its application for controlling biologics](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412005000300002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nM.E. Pavan\n2005-09-01\nFull Text Available Brucella abortus es el agente etiol\u00f3gico de la brucelosis bovina. La cepa 19, utilizada en la elaboraci\u00f3n de vacunas, puede ser identificada a trav\u00e9s de una deleci\u00f3n en la regi\u00f3n eri asociada con la sensibilidad al eritritol. Se optimiz\u00f3 un ensayo de PCR para caracterizar espec\u00edficamente esta cepa. El m\u00e9todo que describimos es un procedimiento r\u00e1pido para identificar B. abortus y simult\u00e1neamente diferenciar la cepa 19 de otras cepas de B. abortus biovar 1. Hemos aplicado este ensayo para la detecci\u00f3n de la cepa 19 en vacunas contra la brucelosis bovina elaboradas en Argentina. Los resultados indican que este m\u00e9todo podr\u00eda ser \u00fatil para el seguimiento de las cepas madres y semillas utilizadas en la producci\u00f3n industrial de esta vacuna. Esta metodolog\u00eda tambi\u00e9n contribuir\u00eda a la reducci\u00f3n del riesgo de la infecci\u00f3n adquirida en el laboratorio y podr\u00eda aplicarse como prueba de rutina para confirmar la presencia de B. abortus en vacunas no relacionadas.Brucella abortus is the etiological agent of bovine brucellosis. The strain 19 used in vaccine elaboration can be identified through a deletion in the eri region associated with its susceptibility to erythritol. We optimized a PCR assay for specific characterization of this strain. The method described here is a rapid procedure that enables identification of B. abortus, and simultaneous differentiation of the strain 19 from other B. abortus biovar 1 strains. We applied the assay to detect the strain 19 in vaccines against B. abortus produced in Argentina. The results show this method could be used to follow vaccine seed cultures of this strain. The methodology could also contribute to reduce the risk of a laboratory-acquired infection and could be of great help as a routine test for confirmation of B. abortus in non related vaccines.\n[Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlejandro Roque Vald\u00e9s\n2004-04-01\nFull Text Available El presente trabajo es un art\u00edculo de revisi\u00f3n que pretende abordar un tema tan controvertido como actual: la posible asociaci\u00f3n causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la \u00faltima d\u00e9cada del siglo XX se producen una serie de cambios en la clasificaci\u00f3n, nomenclatura y criterios diagn\u00f3sticos del autismo. Los hallazgos de estudios epidemiol\u00f3gicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo son en la actualidad muy superiores a las de hace 15 a\u00f1os. Entre los factores que se esgrimen para explicar este fen\u00f3meno est\u00e1n las vacunas, y entre los mecanismos que se invocan para tratar de inculpar a las vacunas en la etiolog\u00eda del autismo est\u00e1n el exceso de mercurio derivado del tiomersal que se emplea como conservante de las mismas y procesos autoinmunes que de forma directa o indirectamente act\u00faan sobre el SNC, induciendo lesiones a nivel de la mucosa intestinal, lo cual favorecer\u00e1 la absorci\u00f3n de macromol\u00e9culas, ant\u00edgenos y toxinas que una vez en el torrente sangu\u00edneo llegar\u00edan al SNC produciendo all\u00ed las lesiones responsables de la g\u00e9nesis del autismo.\n[Los laboratorios p\u00fablicos productores de vacunas: el nuevo paradigma](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAkira Homma\nFull Text Available Los laboratorios p\u00fablicos productores de vacunas de Am\u00e9rica Latina y el Caribe han contribuido en diferente grado al control y a la erradicaci\u00f3n de las enfermedades prevenibles por vacunaci\u00f3n y varios est\u00e1n produciendo las vacunas que se aplican rutinariamente en los programas nacionales de inmunizaci\u00f3n, como la vacuna antituberculosa (a base del bacilo de Calmette-Gu\u00e9rin, BCG, la vacuna contra difteria-t\u00e9tanos-pertussis (DTP, el toxoide tet\u00e1nico (TT, la vacuna antisarampionosa y la vacuna antipoliomiel\u00edtica oral. Gracias a los adelantos cient\u00edficos recientes, se prev\u00e9 un aumento importante del n\u00famero de vacunas seguras y eficaces que estar\u00e1n disponibles en un futuro cercano para uso en los programas normales de vacunaci\u00f3n. Sin embargo, los gastos asociados con el desarrollo de estas vacunas y con los derechos de propiedad intelectual que las protegen son cuantiosos. Adem\u00e1s, pocos laboratorios en Am\u00e9rica Latina poseen la capacidad t\u00e9cnica para investigar y elaborar estas vacunas. Tales factores tendr\u00e1n un impacto en la celeridad con que se incorporar\u00e1n en los esquemas de vacunaci\u00f3n de los pa\u00edses de la Regi\u00f3n. En la actualidad, los laboratorios p\u00fablicos productores de vacunas de la Regi\u00f3n no est\u00e1n capacitados para competir en este nuevo contexto y corren el riesgo de ser desplazados del mercado por completo. De ah\u00ed la necesidad de que cambien radicalmente su manejo gerencial y su capacidad cientificot\u00e9cnica, lo cual exige que los gobiernos se comprometan a mejorar y fortalecer aquellos aspectos pol\u00edticos y financieros que garanticen la participaci\u00f3n de los laboratorios nacionales en el suministro sostenible de vacunas a los programas de vacunaci\u00f3n, as\u00ed como en la investigaci\u00f3n, desarrollo y producci\u00f3n de vacunas nuevas\n[Informaci\u00f3n sobre las vacunas y el tiomersal en la internet](https://www.openaire.eu/search/publication?articleId=od______3056::90581237738de503aa4b6681ae4c01e3)\nVargas, Javier\n2005-01-01\nLa informaci\u00f3n inexacta sobre la asociaci\u00f3n entre las vacunas y el autismo propagada en las \u00faltimas semanas por los medios de comunicaci\u00f3n, impacta de manera desfavorable en la salud p\u00fablica del pa\u00eds, restando m\u00e9rito a los logros alcanzados por la inmunizaci\u00f3n en la erradicaci\u00f3n de la viruela en el mundo y la erradicaci\u00f3n de la viruela en el mundo y la erradicaci\u00f3n en marcha de la poliomelitis y la eliminaci\u00f3n del sarampi\u00f3n en el Per\u00fa; confundiendo con la poblaci\u00f3n sobre los beneficios holgad...\n[Vacuna fenol-insoluble contra la brucelosis humana: evaluacion del poder inmunogenico en cobayos Phenol insoluble extract vaccine for the prevention of brucellosis in humans: evaluation in guinea pigs](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651991000100005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJ. Bolpe\n1991-02-01\nFull Text Available Se examin\u00f3 una vacuna dise\u00f1ada para inmunizar al hombre, preparada con extracto de fenol insoluble, para determinar si proteg\u00eda a cobayos contra el desaf\u00edo con la cepa virulenta B. abortus 2308. Se incluyeron en el experimento las vacunas vivas atenuadas B. abortus cepa 19 y B. melitensis Rev. 1, para comparar los resultados. Se vacunaron 93 animales en cada grupo, que fueron subdivididos en subgrupos de 31 y se los desafi\u00f3 con 10(4, 10\u00b3 y 10\u00b2 unidades formadoras de colonias de la cepa B. abortus 2308 virulenta. El an\u00e1lisis global de los resultados demostr\u00f3 una protecci\u00f3n del 11.9% en animales vacunados con el extracto de fenol insoluble, 65% en los vacunados con B. abortus cepa 19 y 95% en el grupo que recibi\u00f3 vacuna B. melitensis Rev. 1.A phenol insoluble extract vaccine proposed to immunize men against brucellosis was tested for its ability in protecting guinea pigs against challenge with virulent Brucella abortus strain 2308. Living attenuated Brucella abortus strain 19 and B. melitensis Rev. 1 were included in the experiment for comparison. Ninety three animals were vaccinated in each group and subdivided in subgroups of 31 for challenge with 10(4,10\u00b3 and 10\u00b2 colony forming units of virulent B. abortus 2308. A global analysis of the results showed protection of 11.9%, 65% and 95% in animals vaccinated with phenol insoluble extract, strain 19 and Rev. 1, respectively.\n[La evidencia acerca de la controversia de las vacunas que contienen timerosal y su asociaci\u00f3n con el autismo](https://www.openaire.eu/search/publication?articleId=doajarticles::9f083d9cb2b9e06dbceeb1cf2c0fabe3)\nLisset Garc\u00eda-Fern\u00e1ndez; Adri\u00e1n V Hern\u00e1ndez; V\u00edctor Su\u00e1rez Moreno; Fabi\u00e1n Fiestas\n2013-01-01\nLa vacunaci\u00f3n es una de las medidas de mayor impacto en la salud p\u00fablica para la reducci\u00f3n de la morbimortalidad infantil. El timerosal es un compuesto org\u00e1nico del mercurio utilizado como preservante de los frascos multidosis. Eventualmente, en el Per\u00fa, surgen olas de controversia acerca de la seguridad de estas vacunas, asoci\u00e1ndolas especialmente con el autismo. Como resultado de estas controversias, se han propuesto, incluso, leyes que proh\u00edben este tipo de vacunas, lo que tendr\u00eda un impor...\n[La vacuna contra el virus del papiloma humano](https://www.openaire.eu/search/publication?articleId=od______3040::cc271e44d67bb301b8673ae704eb1321)\nTobar Ruiz, Mar\u00eda\n2015-01-01\nLa carciog\u00e9nesis est\u00e1 condicionada por factores dependientes del virus como de los h\u00e1bitos del hu\u00e9sped. En cuanto a la vacunaci\u00f3n se han descubierto vacunas seguras y eficaces, siendo las dos vacunas destacadas la tetravalente o Gardasil y la bivalente o Cervarix. E nfermer\u00eda es la profesional que administra la vacuna y conoce los efectos adversos posibl es a causa de su administraci\u00f3n, y es por esa raz\u00f3n por la que mi inter\u00e9s se centr\u00f3 en la vacunaci\u00f3n.\n[PRACTICAS MEDICAS, PRACTICAS POLITICAS. ROSAS Y LA \u00abVACUNA INDIGENA\u00bb](http://www.revistas.usach.cl/ojs/index.php/historiasocial/article/view/319) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMAR\u00cdA SILVIA DI LISCIA\n2011-10-01\nFull Text Available BUENOS AIRES, 1830. Se declara una epidemia de viruela entre los indios \u00abpampas\u00bb que est\u00e1n en la ciudad para honrar al Restaurador de las Leyes. Los caciques no disimulan su admiraci\u00f3n ante la valent\u00eda de Rosas, quien los visita sin alarma ante el contagio y los estimula a vacunarse para eliminar el temible mal. Un n\u00famero estimado en m\u00e1s de cien indios acepta, entonces, inmunizarse, coloc\u00e1ndose, seg\u00fan el testimonio de Parish, la \u00abvacuna a ind\u00edgenas \u00bb. Buenos Aires, 1833. Francisco X. Mu\u00f1iz, m\u00e9dico de la campa\u00f1a bonaerense, inicia las investigaciones con las que diez a\u00f1os despu\u00e9s se logra el redescubrimiento del cow pox, es decir, la viruela vacuna, llamada por Sarmiento \u00abla vacuna ind\u00edgena\u00bb.\n[Vacunas en situaciones especiales. Embarazo, inmunodepresi\u00f3n, transplante](https://www.openaire.eu/search/publication?articleId=od______1404::05502ca26081377cb9ac9b967d7e66d8)\nFarjas Abad\u00eda, M\u00aa Pilar\n2005-01-01\nEn las recomendaciones de vacunaci\u00f3n de grupos de poblaci\u00f3n que por su situaci\u00f3n de salud requieren medidas espec\u00edficas deben conjugarse: Las limitaciones en la aplicaci\u00f3n de determinadas vacunas por la mayor probabilidad de efectos secundarios en estos pacientes (por ejemplo la aplicaci\u00f3n de vacunas de virus vivos en pacientes inmunodeprimidos). El mayor riesgo de infecci\u00f3n frente a determinados agentes que genera la patolog\u00eda o situaci\u00f3n inmunitaria del paciente, y que determina un mayor in...\n[Vacunas, biotecnolog\u00eda y su relaci\u00f3n con el aborto provocado](https://www.openaire.eu/search/publication?articleId=doajarticles::4639710bd8874709386dd27339826e1d)\nJos\u00e9 Luis Redondo Calder\u00f3n\n2008-01-01\nLas vacunas de c\u00e9lulas diploides humanas (WI-38, MRC-5) tienen un origen \u00e9ticamente objetable, dado que dichas c\u00e9lulas proceden de abortos provocados. Entre ellas destacan vacunas empleadas contra rub\u00e9ola, sarampi\u00f3n, parotiditis, rabia, poliomielitis, viruela, hepatitis A, varicela y herpes z\u00f3ster. Actualmente se encuentran en desarrollo otras vacunas cultivadas en c\u00e9lulas (293, PER.C6) transformadas mediante virus, procedentes de abortos. Entre ellas hay vacunas contra la gripe, virus respi...\n[Vacuna Sint\u00e9tica contra la Malaria](http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/903) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nManuel Elkin Patarroyo\n1993-12-01\nFull Text Available\nEl doctor Manuel Elkin Patarroyo hace un recuento de lo que fueron sus primeros a\u00f1os de estudio y los primeros pasos que se dieron para fundar el Instituto de Inmunolog\u00eda, ayudado por muchos de los Acad\u00e9micos. Siempre ha querido representar al pueblo colombiano en sus valores de trabajo, disciplina, estudio, pensamiento y generosidad, en aras de un pueblo que sufre, que en definitiva es el objetivo del M\u00e9dico, el paciente.\nPosteriormente comenta qu\u00e9 es lo que se ha hecho con toda la profundidad que se merece pero con simpleza de palabras y en t\u00e9rminos sencillos, c\u00f3mo se desarroll\u00f3 la Vacuna Sint\u00e9tica contra la malaria: \u00bfPor qu\u00e9 malaria?, porque esta es una enfermedad de gran trascendencia; aclara que \u00e9l no le teme ni le molesta el cuestionamiento cient\u00edfico sobre el desarrollo de esta investigaci\u00f3n, por el contrario lo acepta y lo goza porque es el ejercicio intelectual; lo que s\u00ed le molesta es el morbo alrededor de ello, por esto pidi\u00f3 al doctor Mu\u00f1oz que al final se adelante un debate al respecto.\nDice a continuaci\u00f3n que las vacunas tradicionales son biol\u00f3gicas como todo el mundo lo sabe, es el microorganismo causal mismo que se muta ose mata, pero que descomponiendo la estructura qu\u00edmica de sus mol\u00e9culas, con el concepto de la s\u00edntesis qu\u00edmica se podr\u00edan rehacer qu\u00edmicamente y ser utilizadas como vacuna.\nDecidieron entonces atacar el problema de la vacuna a trav\u00e9s de esta metodolog\u00eda creando la vacuna contra la malaria de la cual se conoce su estructura qu\u00edmica, y aclara que las vacunas qu\u00edmicas tienen otra ventaja, que son puras, con menos reacciones adversas que las tradicionales.\nDice el doctor Patarroyo que decidieron aislar, e identificar m\u00e1s de la mitad de las prote\u00ednas del par\u00e1sito y dividiendo la muestra en dos fracciones, una de ellas se seleccion\u00f3 para averiguar su composici\u00f3n qu\u00edmica y la otra para saber cu\u00e1l podr\u00eda ser \u00fatil como vacuna. As\u00ed, fueron al Amazonas y all\n[Estrategia y resultados de la farmacovigilancia de vacunas desde el Instituto Finlay, 2009](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000200006&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIv\u00e1n E. Cuevas-Valdespino\n2010-08-01\nFull Text Available El objetivo de este trabajo fue mostrar la estrategia y los resultados de la farmacovigilancia desde el Instituto Finlay, como titular de registros sanitarios. Se concret\u00f3 la biograf\u00eda de los productos en la etapa de poscomercializaci\u00f3n y se examin\u00f3 el balance riesgo/beneficio. Esto fue posible gracias a convenios con instituciones que permitieron el acceso a bases de datos digitales y auditables, donde se encontr\u00f3 la notificaci\u00f3n espont\u00e1nea de eventos adversos y el cumplimiento de las buenas pr\u00e1cticas, reglamentos y regulaciones de la autoridad reguladora. La miner\u00eda de datos para la b\u00fasqueda de la agrupaci\u00f3n de eventos raros e inesperados para un mismo lote o de accidentes, la confecci\u00f3n de los informes peri\u00f3dicos de seguridad y la pr\u00e1ctica sistem\u00e1tica para completar la informaci\u00f3n de seguridad solicitada en subpoblaciones y grupos especiales permiti\u00f3 actualizar el perfil de seguridad de las vacunas. Se confirm\u00f3 que la vacuna antileptospir\u00f3sica trivalente, la antitifo\u00eddica Vi y el toxoide tet\u00e1nico, presentaron una frecuencia de eventos adversos menor de 0,1 reporte por cada 100.000 dosis administradas, mientras las dem\u00e1s vacunas tuvieron valores entre 1 y 10 por cada 10.000 vacunados. Entre el 80% y 95% de las notificaciones fueron relacionadas causalmente con la vacuna, y solo el 0,89% fueron de severidad grave, casi todas en ni\u00f1os menores de un a\u00f1o. Las manifestaciones generales fueron las que predominaron. Los resultados presentados muestran la importancia que tiene la farmacovigilancia desde la industria para obtener una valiosa informaci\u00f3n de la seguridad en la aplicaci\u00f3n de las vacunas.\n[Cadena del fr\u00edo para la conservaci\u00f3n de las vacunas en los centros de atenci\u00f3n primaria de un \u00e1rea de Madrid: mantenimiento y nivel de conocimientos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272002000400008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOrtega Molina Paloma\n2002-01-01\nFull Text Available Fundamento. Las vacunas son medicamentos termol\u00e1biles y para garantizar su inmunogenicidad y eficacia protectora, dentro de los programas de inmunizaci\u00f3n, es imprescindible mantener la cadena de fr\u00edo. El elemento fundamental en esta cadena es el personal responsable de las vacunas, que debe conocer las caracter\u00edsticas de estabilidad de cada preparado con el fin de evitar errores durante su manipulaci\u00f3n. El objetivo de este trabajo fue conocer c\u00f3mo se realiza el mantenimiento de la cadena del fr\u00edo en equipos de atenci\u00f3n primaria de un \u00e1rea sanitaria de la Comunidad Aut\u00f3noma de Madrid, as\u00ed como establecer el grado de informaci\u00f3n que poseen los responsables de las vacunas con respecto a la termoestabilidad de las mismas. M\u00e9todos. Se ha realizado un estudio transversal en 46 puntos de vacunaci\u00f3n en atenci\u00f3n primaria. La recogida de los datos se realiz\u00f3 mediante entrevista personal por un \u00fanico investigador. Resultados. La tasa de participaci\u00f3n fue del 93,5% (43/46. En todos los casos exist\u00eda term\u00f3metro de m\u00e1xima y m\u00ednima y registro mensual de la temperatura. Se observ\u00f3 una temperatura inadecuada en tres ocasiones (6,97%. El porcentaje de profesionales que conoc\u00eda el efecto que la congelaci\u00f3n produc\u00eda sobre las vacunas fue muy diverso: 53.5%, 51.2%, 44.2% y 53.5% para difteria-t\u00e9tanos-pertussis (DTP, hepatitis B (VHB, polio oral (VPO y rub\u00e9ola-sarampi\u00f3n-paperas (RSP respectivamente. Y s\u00f3lo el 32% conoc\u00eda el test de agitaci\u00f3n. Conclusi\u00f3n. La formaci\u00f3n de los profesionales sobre el efecto que las altas temperaturas ocasionan en las vacunas era correcta, pero es necesario reforzar su formaci\u00f3n sobre la inestabilidad que presentan los preparados adsorbidos cuando se someten a congelaci\u00f3n.\n[Vacunas para la prevenci\u00f3n de la gripe en personas de edad avanzada](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9f9342f04c4ecfc6206eb357ddd593ea)\nJefferson, Tom; Di Pietrantonj, Carlo; Al-Ansary, Lubna A.; Ferroni, Eliana; Thorning, Sarah; Thomas, Roger E.\n2010-01-01\nAntecedentes: Durante las \u00faltimas cuatro d\u00e9cadas, las vacunas han sido la principal arma global para disminuir la repercusi\u00f3n de la gripe en las personas de edad avanzada, y a nivel mundial se recomiendan para los individuos de 65 a\u00f1os o m\u00e1s de edad. El objetivo principal de la vacunaci\u00f3n contra la gripe en las personas de edad avanzada es reducir el riesgo de complicaciones en quienes son m\u00e1s vulnerables. Objetivos: Evaluar la efectividad de las vacunas sobre la prevenci\u00f3n de la gripe, la...\n[VACUNAS E INFECCIONES RESPIRATORIAS](http://www.sciencedirect.com/science/article/pii/S0716864017300160) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDr. Rodolfo Villena\n2017-01-01\nFull Text Available Las vacunas han demostrado ser una excelente estrategia para reducir la morbimortalidad en infecciones respiratorias, con un perfil de seguridad adecuado. Nuestro PNI incorpora varias de ellas con este objetivo, logrando resultados de alto impacto a nivel de salud p\u00fablica. Para que esto prosiga se requiere de nuestro compromiso y conocimiento para estimular, difundir y obtener altas tasas de cobertura, de manera de lograr efectos de protecci\u00f3n indirecta, conocidos como inmunidad comunitaria. Por otro lado, se debe mantener la vigilancia epidemiol\u00f3gica de los agentes inmunoprevenibles para conocer su oscilaci\u00f3n temporal, serogrupos, sero y/o genotipos, de manera de establecer directrices adecuadas de edad y esquemas de vacunaci\u00f3n para la poblaci\u00f3n. Debemos avanzar en estos temas y realizar estudios de efectividad de las vacunas que hemos introducido, para conocer su aporte en la prevenci\u00f3n de infecciones respiratorias, de manera de objetivar sus beneficios, conocer el impacto en poblaciones de riesgo y avanzar en la vacunaci\u00f3n de embarazadas, para otorgar mejores estrategias de prevenci\u00f3n a nuestra poblaci\u00f3n.\n[Enfermedad meningoc\u00f3cica: epidemiolog\u00eda y vacunas, un enfoque pr\u00e1ctico](http://www.sciencedirect.com/science/article/pii/S0716864014700689) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nC. Giannina Izquierdo, Dra.\n2014-05-01\nLas principales estrategias para la prevenci\u00f3n de la enfermedad son el uso de vacunas (prevenci\u00f3n primaria y el uso de quimioprofilaxis a los contactos de un caso \u00edndice (prevenci\u00f3n secundaria. A la fecha existen numerosas vacunas contra Nmen, todas ellas con adecuados perfiles de seguridad e inmunogenicidad, por lo que la elecci\u00f3n de la vacuna a utilizar depender\u00e1 del serogrupo prevalente en cada pa\u00eds; de las caracter\u00edsticas de la poblaci\u00f3n m\u00e1s afectada y de la factibilidad de disponer de ella e insertarla dentro de los programas nacionales o campa\u00f1as respectivas de vacunaci\u00f3n.\n[Los laboratorios p\u00fablicos productores de vacunas: el nuevo paradigma](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAkira Homma\n1998-10-01\nFull Text Available Los laboratorios p\u00fablicos productores de vacunas de Am\u00e9rica Latina y el Caribe han contribuido en diferente grado al control y a la erradicaci\u00f3n de las enfermedades prevenibles por vacunaci\u00f3n y varios est\u00e1n produciendo las vacunas que se aplican rutinariamente en los programas nacionales de inmunizaci\u00f3n, como la vacuna antituberculosa (a base del bacilo de Calmette-Gu\u00e9rin, BCG, la vacuna contra difteria-t\u00e9tanos-pertussis (DTP, el toxoide tet\u00e1nico (TT, la vacuna antisarampionosa y la vacuna antipoliomiel\u00edtica oral. Gracias a los adelantos cient\u00edficos recientes, se prev\u00e9 un aumento importante del n\u00famero de vacunas seguras y eficaces que estar\u00e1n disponibles en un futuro cercano para uso en los programas normales de vacunaci\u00f3n. Sin embargo, los gastos asociados con el desarrollo de estas vacunas y con los derechos de propiedad intelectual que las protegen son cuantiosos. Adem\u00e1s, pocos laboratorios en Am\u00e9rica Latina poseen la capacidad t\u00e9cnica para investigar y elaborar estas vacunas. Tales factores tendr\u00e1n un impacto en la celeridad con que se incorporar\u00e1n en los esquemas de vacunaci\u00f3n de los pa\u00edses de la Regi\u00f3n. En la actualidad, los laboratorios p\u00fablicos productores de vacunas de la Regi\u00f3n no est\u00e1n capacitados para competir en este nuevo contexto y corren el riesgo de ser desplazados del mercado por completo. De ah\u00ed la necesidad de que cambien radicalmente su manejo gerencial y su capacidad cientificot\u00e9cnica, lo cual exige que los gobiernos se comprometan a mejorar y fortalecer aquellos aspectos pol\u00edticos y financieros que garanticen la participaci\u00f3n de los laboratorios nacionales en el suministro sostenible de vacunas a los programas de vacunaci\u00f3n, as\u00ed como en la investigaci\u00f3n, desarrollo y producci\u00f3n de vacunas nuevasIn Latin America and the Caribbean, public laboratories that produce vaccines have contributed in varying degrees to the control and eradication of vaccine-preventable diseases, and several of them\n[Dot Blot para determinar la identidad antig\u00e9nica en vacunas conjugadas contra Streptococcus pneumoniae serotipo 19F](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOsmir Cabrera-Blanco\n2017-04-01\nFull Text Available Las autoridades regulatorias recomiendan el uso de t\u00e9cnicas de Resonancia Magn\u00e9tica Nuclear o t\u00e9cnicas serol\u00f3gicas para la determinaci\u00f3n de la identidad de los ant\u00edgenos presentes en las vacunas conjugadas. Con la aparici\u00f3n de las vacunas conjugadas multivalentes, se ha hecho necesario recurrir a t\u00e9cnicas inmunoqu\u00edmicas con la utilizaci\u00f3n de anticuerpos monoclonales para aumentar la sensibilidad en la determinaci\u00f3n de la identidad de los ant\u00edgenos en dichas vacunas conjugadas. El objetivo del presente trabajo fue establecer las condiciones \u00f3ptimas de trabajo que permitieran utilizar la t\u00e9cnica del Dot Blot para determinar la identidad de los ant\u00edgenos en vacunas conjugadas de Streptococcus pneumoniae serotipo 19F. Para ello se estudiaron los tiempos de incubaci\u00f3n, la influencia del reactivo en la soluci\u00f3n de bloqueo; tambi\u00e9n las concentraciones \u00f3ptimas del anticuerpo monoclonal y de los ingredientes farmac\u00e9uticos activos, as\u00ed como los vol\u00famenes de aplicaci\u00f3n \u00f3ptimos para estos y vacunas. Se utiliz\u00f3 un anticuerpo monoclonal contra el polisac\u00e1rido capsular del serotipo 19F de neumococo. Las muestras empleadas en este trabajo fueron lotes de ingredientes farmac\u00e9uticos activos de conjugados de polisac\u00e1rido capsular 19F y lotes de un candidato vacunal cubano conjugado heptavalente contra neumococos. Los resultados mostraron que para la determinaci\u00f3n de la identidad antig\u00e9nica fueron suficientes 10 \u00b5L de muestras de los principios activos a una concentraci\u00f3n de 125 \u00b5g/mL e igual volumen para las vacunas heptavalentes. Qued\u00f3 demostrado que una concentraci\u00f3n de 1 \u00b5g/mL para el anticuerpo monoclonal y tiempos de incubaci\u00f3n de 30 min a 37 \u00b0C fueron suficientes para la determinaci\u00f3n. Estos resultados permiten concluir que quedaron establecidas las condiciones \u00f3ptimas de trabajo para determinar la identidad antig\u00e9nica por Dot Blot del polisac\u00e1rido capsular de S. pneumoniae serotipo 19F presente en las vacunas\n[Prevenci\u00f3n de las neumon\u00edas mediante vacunas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312014000200012&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRoberto Raz\u00f3n Behar\nFull Text Available La neumon\u00eda es una infecci\u00f3n respiratoria aguda que afecta a los pulmones. La neumon\u00eda adquirida en la comunidad, es la principal causa individual de mortalidad infantil en todo el mundo. Se calcula que cada a\u00f1o mueren por su causa m\u00e1s de 1,5 millones de ni\u00f1os menores de 5 a\u00f1os, lo que supone el 18 % de todas las defunciones de este grupo etario en todo el mundo. Diversos agentes infecciosos, particularmente los virus y bacterias, causan neumon\u00eda, y son los m\u00e1s comunes el Streptococcus pneumoniae -la causa m\u00e1s com\u00fan de neumon\u00eda bacteriana en ni\u00f1os-; el Haemophilus influenzae de tipo b -la segunda causa m\u00e1s com\u00fan de neumon\u00eda bacteriana-; as\u00ed como el virus sincitial respiratorio. La prevenci\u00f3n de la neumon\u00eda infantil es un componente fundamental de toda estrategia para reducir la mortalidad infantil. La inmunizaci\u00f3n, particularmente contra el Haemophilus influenzae de tipo b, los neumococos, el sarampi\u00f3n y la tos ferina, es la forma m\u00e1s eficaz de prevenirla. Por tal motivo se considera importante una revisi\u00f3n y actualizaci\u00f3n de las principales vacunas existentes hoy en d\u00eda.\n[VACUNAS E INFECCIONES RESPIRATORIAS](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::61ee14b25b56c72855596bb426219d56)\nDr. Rodolfo Villena\n2017-01-01\nLas vacunas han demostrado ser una excelente estrategia para reducir la morbimortalidad en infecciones respiratorias, con un perfil de seguridad adecuado. Nuestro PNI incorpora varias de ellas con este objetivo, logrando resultados de alto impacto a nivel de salud p\u00fablica. Para que esto prosiga se requiere de nuestro compromiso y conocimiento para estimular, difundir y obtener altas tasas de cobertura, de manera de lograr efectos de protecci\u00f3n indirecta, conocidos como inmunidad comunitaria. ...\n[Conocimientos de los pediatras de Salvador, Brasil, sobre la vacuna antisarampionosa](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMoreira Luiza A. Cabus\n1997-01-01\nFull Text Available El \u00e9xito de las iniciativas internacionales para la erradicaci\u00f3n del sarampi\u00f3n depende en gran medida del grado de conocimiento sobre la vacunaci\u00f3n. En 1992 se evaluaron mediante un estudio transversal los conocimientos sobre la vacuna antisarampionosa de los pediatras de la ciudad brasile\u00f1a de Salvador, Bahia. Del total de 506 pediatras residentes en la ciudad, 299 (59% pudieron ser localizados y respondieron a un cuestionario de 15 preguntas en las que se planteaban situaciones hipot\u00e9ticas sobre indicaciones y contraindicaciones de esta vacuna. El promedio de aciertos fue de 9,3 preguntas de las 15, lo que muestra el poco conocimiento de los pediatras sobre la vacunaci\u00f3n antisarampiososa. Situaciones comunes en la pr\u00e1ctica pedi\u00e1trica brasile\u00f1a -desnutrici\u00f3n, infecci\u00f3n de v\u00edas respiratorias altas, diarrea y estado prematuro- fueron a menudo err\u00f3neamente consideradas como contraindicaciones para la inmunizaci\u00f3n. M\u00e1s de la mitad (62% de los pediatras no conoc\u00edan la v\u00eda correcta de administraci\u00f3n de la vacuna. Los conocimientos sobre la vacuna no variaron en funci\u00f3n del tiempo transcurrido desde la formaci\u00f3n universitaria del pediatra o de su trabajo en centros sanitarios de la Secretar\u00eda Estatal de Salud. Los profesores universitarios, los pediatras con maestr\u00eda y los que cursaban estudios de posgrado tuvieron una media de aciertos ligeramente superior a la del resto. Estos resultados indican la necesidad de reforzar la ense\u00f1anza sobre la vacunaci\u00f3n antisarampionosa en las facultades de medicina y en los programas de formaci\u00f3n continuada para pediatras.\n[Conocimientos de los pediatras de Salvador, Brasil, sobre la vacuna antisarampionosa](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuiza A. Cabus Moreira\n1997-12-01\nFull Text Available El \u00e9xito de las iniciativas internacionales para la erradicaci\u00f3n del sarampi\u00f3n depende en gran medida del grado de conocimiento sobre la vacunaci\u00f3n. En 1992 se evaluaron mediante un estudio transversal los conocimientos sobre la vacuna antisarampionosa de los pediatras de la ciudad brasile\u00f1a de Salvador, Bahia. Del total de 506 pediatras residentes en la ciudad, 299 (59% pudieron ser localizados y respondieron a un cuestionario de 15 preguntas en las que se planteaban situaciones hipot\u00e9ticas sobre indicaciones y contraindicaciones de esta vacuna. El promedio de aciertos fue de 9,3 preguntas de las 15, lo que muestra el poco conocimiento de los pediatras sobre la vacunaci\u00f3n antisarampiososa. Situaciones comunes en la pr\u00e1ctica pedi\u00e1trica brasile\u00f1a -desnutrici\u00f3n, infecci\u00f3n de v\u00edas respiratorias altas, diarrea y estado prematuro- fueron a menudo err\u00f3neamente consideradas como contraindicaciones para la inmunizaci\u00f3n. M\u00e1s de la mitad (62% de los pediatras no conoc\u00edan la v\u00eda correcta de administraci\u00f3n de la vacuna. Los conocimientos sobre la vacuna no variaron en funci\u00f3n del tiempo transcurrido desde la formaci\u00f3n universitaria del pediatra o de su trabajo en centros sanitarios de la Secretar\u00eda Estatal de Salud. Los profesores universitarios, los pediatras con maestr\u00eda y los que cursaban estudios de posgrado tuvieron una media de aciertos ligeramente superior a la del resto. Estos resultados indican la necesidad de reforzar la ense\u00f1anza sobre la vacunaci\u00f3n antisarampionosa en las facultades de medicina y en los programas de formaci\u00f3n continuada para pediatras.\n[Prescripci\u00f3n de vacunas no incluidas en el calendario vacunal en la Comunitat Valenciana durante el per\u00edodo 2004-2009](http://www.redalyc.org/articulo.oa?id=17020115007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Ruiz Palacio\n2011-01-01\nFull Text Available Fundamentos, En el marco de las pol\u00edticas de uso racional del medicamento, y al objeto de conseguir una gesti\u00f3n eficiente de los programas de vacunaciones, el objetivo de este trabajo es conocer el n\u00famero de envases de las vacunas prescritas no incluidas en los programas de vacunaci\u00f3n en la Comunitat Valenciana y en sus departamentos de salud, as\u00ed como el gasto que produjeron en 2009, y analizar la evoluci\u00f3n desde 2004, centrando el an\u00e1lisis en la vacuna heptavalente conjugada frente al Streptococcus pneumoniae en menores de dos a\u00f1os. M\u00e9todo, Estudio descriptivo retrospectivo de las vacunas prescritas mediante receta en la Comunitat Valenciana durante el a\u00f1o 2009 y su evoluci\u00f3n desde 2004. Variables, n\u00famero de envases, tipo de beneficiario (activo/pensionista, departamento y gasto generado. Fuentes, Gestor de Prestaci\u00f3n Farmac\u00e9utica (GAIA y Sistema Informaci\u00f3n Poblacional (SIP. Resultados: En 2009 la prescripci\u00f3n mediante receta de vacunas no incluidas en los programas de vacunaci\u00f3n gener\u00f3 un gasto de 683.445,71 ] correspondiente a 17.353 envases, lo que supuso el 87! del total del gasto en vacunas recetadas. La vacuna frente al S. pneumoniae gener\u00f3 el 72! del gasto total de las vacunas no incluidas en el calendario. La evoluci\u00f3n 2004-2009 muestra un aumento del gasto de 735.334 ] (24,66! en 2005 a partir del cual se produjo un descenso acusado y paulatino que alcanz\u00f3 los 1.562.650,67 ] (-228.64!. El gasto por departamentos para la vacuna del neumococo conjugada heptavalente por mil ni\u00f1os/as menores de dos a\u00f1os oscil\u00f3 entre 17.377 y 324 ]. Conclusiones: La tendencia descendente del gasto en recetas prescritas se mantuvo durante 2009, fundamentalmente de vacunas conjugadas frente a neumococo. No obstante, se observ\u00f3 gran variabilidad interdepartamental en las tasas de prescripci\u00f3n que debe ser corregida.\n[Perspectivas para nuevas vacunas antituberculosas en la era posgen\u00f3mica.](http://www.revistabiomedica.org/index.php/biomedica/article/view/1320) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuis F. Garc\u00eda\n2004-06-01\nFull Text Available A pesar de que la vacunaci\u00f3n con Mycobacterium bovis BCG es el procedimiento m\u00e1s utilizado a nivel mundial para prevenir la tuberculosis, su eficicacia es muy cuestionable, lo cual ha motivado la b\u00fasqueda de nuevas opciones inmunoprofil\u00e1cticas. El conocimiento generado con el secuenciamiento completo de una cepa de Mycobacterium tuberculosis H37Rv y la aplicaci\u00f3n de nuevas tecnolog\u00edas inmunol\u00f3gicas, bioqu\u00edmicas y gen\u00e9ticas han permitido realizar una disecci\u00f3n fina del transcriptoma y el proteoma de M. tuberculosis, lo cual ha generado una gran cantidad de conocimiento sobre la biolog\u00eda de este microorganismo. Dado que alrededor de una tercera parte de la poblaci\u00f3n mundial puede estar infectada con M. tuberculosis y que \u00e9ste s\u00f3lo se detecta cuando se inicia la enfermedad, la mayor parte de los esfuerzos se han dedicado al dise\u00f1o de vacunas posinfecci\u00f3n que induzcan un aumento selectivo de la inmunidad celular espec\u00edfica del hospedero a largo plazo, no generen reacciones adversas y sean de bajo costo. Dentro de las nuevas estrategias que est\u00e1n siendo utilizadas para el desarrollo de vacunas, se destaca la utilizaci\u00f3n de mezclas de prote\u00ednas con una alta inmunogenicidad, cepas de M. bovis BCG recombinantes y de M. tuberculosis gen\u00e9ticamente atenuadas o modificadas para inducir una mayor respuesta inmune, y las vacunas de ADN desnudo. Los candidatos con m\u00e1s potencial incluyen las vacunas de subunidades micobacterianas, las cuales expresan mol\u00e9culas ampliamente reconocidas por el sistema inmune y cuyo reconocimiento resulta en el incremento de la respuesta Th1 y aqu\u00e9llas que utilizan vectores virales dise\u00f1ados para expresar mol\u00e9culas micobacterianas antig\u00e9nicas. Aunque los modelos animales son de valor limitado, puesto que la patolog\u00eda observada en ellos s\u00f3lo reproduce parcialmente la observada en humanos, los resultados obtenidos con estas vacunas son muy prometedores y algunas est\u00e1n siendo actualmente evaluadas en\nAlejandro Roque Vald\u00e9s\n2004-01-01\nEl presente trabajo es un art\u00edculo de revisi\u00f3n que pretende abordar un tema tan controvertido como actual: la posible asociaci\u00f3n causal que se ha querido establecer entre el autismo y las vacunas infantiles. A partir de la \u00faltima d\u00e9cada del siglo XX se producen una serie de cambios en la clasificaci\u00f3n, nomenclatura y criterios diagn\u00f3sticos del autismo. Los hallazgos de estudios epidemiol\u00f3gicos llevados a cabo bajo estos nuevos ponderados han revelado que las tasas de prevalencia del autismo s...\n[La vacuna en Cuba durante el gobierno de Someruelos](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9c7220297c636745e06628ec37f2b47e)\nV\u00e1zquez Cienfuegos, Sigfrido\n2004-01-01\nLa Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1806), dirigida por Francisco Javier de Balmis, se dirigi\u00f3 al Nuevo Mundo para paliar las epidemias de viruelas que hab\u00edan venido asolando Am\u00e9rica desde casi el mismo momento del Descubrimiento. Para entonces en la isla de Cuba ya se hab\u00eda iniciado una labor con el mismo objetivo por el m\u00e9dico cubano Tom\u00e1s Romay, apoyado en el fomento de la introducci\u00f3n y aplicaci\u00f3n de la vacuna por el marqu\u00e9s de Someruelos gobernador y capit\u00e1n general de la ...\n[Efectividad de la vacuna VA-MENGOC-BC\u00ae contra cepas heter\u00f3logas de meningococo B](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRolando Ochoa-Azze\n2016-08-01\nFull Text Available La efectividad de las vacunas de ves\u00edculas de membrana externa de Neisseria meningitidis serogrupo B ha sido cuestionada por algunos investigadores, limit\u00e1ndola a la cepa vacunal. VA-MENGOC-BC\u00ae es una vacuna antimeningoc\u00f3cica basada en dicha tecnolog\u00eda. Presentamos un metaan\u00e1lisis de estudios realizados en diferentes contextos epidemiol\u00f3gicos, evaluando su efectividad contra cepas heter\u00f3logas de meningococo B en varios grupos de edades. Se demuestra que la vacuna es efectiva contra cepas hom\u00f3logas, heter\u00f3logas y de diferentes complejos clonales.\n[Evaluaci\u00f3n de la toxicidad por dosis \u00fanica y tolerancia local de la vacuna vax-SPIRAL\u00ae en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan F. Infante\n2004-04-01\nFull Text Available Las pruebas precl\u00ednicas de toxicidad en dosis \u00fanica y en dosis repetidas brindan una valiosa informaci\u00f3n sobre la seguridad del producto, al incluir el estudio macrosc\u00f3pico e histopatol\u00f3gico de \u00f3rganos importantes, as\u00ed como evaluaciones de las v\u00edas de administraci\u00f3n y el r\u00e9gimen de dosificaci\u00f3n. Cuba desarroll\u00f3 una vacuna polivalente de c\u00e9lulas inactivadas qu\u00edmicamente adyuvadas con hidr\u00f3xido de aluminio, vax-SPIRAL\u00ae. Esta vacuna presenta ventajas en relaci\u00f3n con otras vacunas como la procedente de la antigua URSS. El esquema de vacunaci\u00f3n para humanos consiste en dos dosis de 0,5 mL, separadas por un intervalo \u00f3ptimo de seis semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley fue determinar la toxicidad potencial, letalidad, \u00f3rganos y sistemas susceptibles y otros eventos adversos, as\u00ed como la toxicidad en el sitio de inoculaci\u00f3n despu\u00e9s de la administraci\u00f3n de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones en estudio y seg\u00fan los criterios establecidos para evaluar los datos obtenidos, la vacuna antileptospir\u00f3sica trivalente no produce efectos t\u00f3xicos en el modelo animal usado. Las \u00fanicas alteraciones encontradas fueron formaciones granulomatosas a nivel del sitio de inoculaci\u00f3n. Estas formaciones han sido reportadas como pertenecientes al adyuvante de dep\u00f3sito (hidr\u00f3xido de aluminio, tambi\u00e9n usado en otras vacunas de aplicaci\u00f3n parenteral.\n[Desarrollo de una vacuna profil\u00e1ctica de segunda generaci\u00f3n contra el papilomavirus humano](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlonso Leonardo\n2011-06-01\nFull Text Available Los papilomavirus humanos (HPV son el agente etiol\u00f3gico del c\u00e1ncer cervical (CC, la segunda causa de muerte por c\u00e1ncer en mujeres. Se estima que medio mill\u00f3n de nuevos c\u00e1nceres se diagnostica cada a\u00f1o, ocurriendo la mayor\u00eda de ellos en pa\u00edses en v\u00edas de desarrollo debido a la ausencia o ineficiencia de los programas masivos de detecci\u00f3n temprana. Recientemente se han introducido en el mercado dos vacunas profil\u00e1cticas contra las principales cepas oncog\u00e9nicas de HPV, la cepa 16 y 18, responsables por el 80% de todos los CC. Estas vacunas se obtienen en forma recombinante y han demostrado ser extremadamente seguras y eficaces. Sin embargo, su impacto inmediato en la incidencia de la infecci\u00f3n por HPV en pa\u00edses en v\u00edas de desarrollo ser\u00e1 m\u00ednimo, debido principalmente al alto costo de las mismas. Existe la necesidad de contar con vacunas de segunda generaci\u00f3n, de bajo costo y de aplicaci\u00f3n masiva que permitan disminuir sensiblemente el n\u00famero de CC en la poblaci\u00f3n. Con este objetivo hemos desarrollado una plataforma de expresi\u00f3n recombinante que permite obtener part\u00edculas tipo virus (VLPs con las cuales es posible formular vacunas efectivas y accesibles contra la infecci\u00f3n por HPV.\n[Vacuna atenuada de Salmonella como vector de ant\u00edgenos heter\u00f3logos](http://www.revistabiomedica.org/index.php/biomedica/article/view/1056) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nOscar G. G\u00f3mez\n2000-06-01\nFull Text Available Salmonella enterica, serotipo Typhi, es el agente etiol\u00f3gico de la fiebre tifoidea de los habitantes de las regiones m\u00e1s pobres del mundo y es, adem\u00e1s. el centro de atenci\u00f3n de muchos investigadores dados sus fascinantes mecanismos de invasi\u00f3n, multiplicaci\u00f3n intracelular y diseminaci\u00f3n intercelular que expresa in vivo e in vitro. Aunque estos mecanismos se asocian directamente con la patogenicidad y la severidad de la enfermedad, las mutaciones definidas en el cromosoma de Salmonella han permitido que estos mecanismos de virulencia se puedan utilizar en beneficio del hospedero. Las mutantes atenuadas de Salmonella son capaces de invadir las c\u00e9lulas M de la mucosa intestinal y de migrar a las c\u00e9lulas linfoides del sistema reticuloendotelial donde, en lugar de causar enfermedad, activan eficazmente las respuestas inmunes humoral y celular no s\u00f3lo contra el microorganismo mismo sino tambi\u00e9n contra aquellos antigenos heter\u00f3logos recombinantes que la bacteria pueda expresar y transportar. En la presente revisi\u00f3n, se discutir\u00e1n los avances m\u00e1s recientes en el campo de las vacunas vivas atenuadas de Salmonella, su evaluaci\u00f3n preclinica y clinica y, tambi\u00e9n, su aplicaci\u00f3n como vector de antigenos. Se dar\u00e1n a conocer las t\u00e9cnicas biomoleculares de clonaci\u00f3n y expresi\u00f3n procari\u00f3tica de las toxinas dift\u00e9rica, tet\u00e1nica y de pertusis. as\u00ed como de los ant\u00edgenos de Helicobacterpylori y de Plasmodium falciparum. Finalmente, se propone el uso de Salmonella atenuada como vector de vacunas de ADN para expresi\u00f3n eucari\u00f3tica de los ant\u00edgenos recombinantes. Los continuos esfuerzos cientificos y tecnol\u00f3gicos en el campo de la vacunaci\u00f3n con vectores vivos atenuados sugieren que Salmonella es una herramienta potencialmente \u00fatil para enfrentar el constante reto de la fiebre tifoidea. Igualmente, los estudios precl\u00ednicos y cl\u00ednicos de fase I demuestran la eficacia de la vacuna de Salmonella viva atenuada como vector de ant\u00edgenos heter\n[Inmunoterapia en melanoma: vacunas de c\u00e9lulas dendr\u00edticas](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342015000300021&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIvan Lozada-Requena\nFull Text Available La presente es una revisi\u00f3n narrativa que muestra la informaci\u00f3n accesible a la comunidad cient\u00edfica sobre melanoma e inmunoterapia. Las c\u00e9lulas dendr\u00edticas tienen la capacidad de participar en la inmunidad innata y adaptativa, pero no son ajenas a la evasi\u00f3n inmune de los tumores. Conocer su biolog\u00eda y rol ha llevado a generar in vitro varios prospectos de vacunas celulares aut\u00f3logas contra diversos tipos de c\u00e1ncer en humanos y modelos animales; sin embargo, en vista de la poca eficiencia que han mostrado, se deben implementar estrategias para potenciar su capacidad natural ya sea a trav\u00e9s de la coexpresi\u00f3n de mol\u00e9culas clave para activar o reactivar al sistema inmune, en combinaci\u00f3n con biosimilares o drogas quimioterape\u00faticas y no se debe descartar la acci\u00f3n de productos naturales como alternativa inmunoestimulante o adyuvante. Todos los tipos de inmunoterap\u00eda deber\u00edan medir el impacto de las c\u00e9lulas supresoras de origen mieloide, las que pueden atacar al sistema inmune y ayudar a la progresi\u00f3n tumoral, respectivamente. Esto puede reducir la actividad de las vacunas celulares y/o sus combinaciones pudiendo ser la diferencia entre el \u00e9xito o no de la inmunoterapia. Aunque en melanoma existen biosimilares aprobados por la Food and Drug Administration (FDA no todos tienen el \u00e9xito esperado por lo que es necesario evaluar otras estrategias que incluyan vacunas celulares cargadas con p\u00e9ptidos antig\u00e9nicos tumorales expresados exclusivamente o ant\u00edgenos provenientes de extractos tumorales y sus respectivos adyuvantes.\n[Un caso de osteocondritis costal t\u00edfica tratado con vacunas y antivirus](https://www.openaire.eu/search/publication?articleId=od______1326::8fd162326a4cf806bef07884700a3945)\nLleras Acosta, F.; Rueda H., Alfonso\n2011-01-01\nPor considerala de importancia pr\u00e1ctica, presentamos la historiacl\u00ednica de una enferma afectada de osteocondritis costal de origen Eberthiano, tratada con \u00e9xito completo por las autovacunas y antivirus, Debemos esta interesante observaci\u00f3n al Dr. Juan N. Carpas y al interno de su servicio de mujeres, Sr. Azuero, quienes galantemente nos suministraron los datos cl\u00ednicos y las observaciones relativas a los efectos producidos por las vacunas.\n[Un caso de Osteocondritis costal t\u00edfica tratado con vacunas y antivirus](https://revistas.unal.edu.co/index.php/revfacmed/article/view/22140) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nF. Lleras Acosta\n1932-05-01\nFull Text Available Por considerala de importancia pr\u00e1ctica, presentamos la historia cl\u00ednica de una enferma afectada de osteocondritis costal de origen Eberthiano, tratada con \u00e9xito completo por las autovacunas y antivirus, Debemos esta interesante observaci\u00f3n al Dr. Juan N. Carpas y al interno de su servicio de mujeres, Sr. Azuero, quienes galantemente nos suministraron los datos cl\u00ednicos y las observaciones relativas a los efectos producidos por las vacunas.\n[Vacunas de ADN: inducci\u00f3n de la respuesta inmunitaria DNA Vaccines: Induction of the immune response](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJavier Mota-S\u00e1nchez\n2009-01-01\nFull Text Available La efectividad de las vacunas y la inmunizaci\u00f3n en la prevenci\u00f3n de las enfermedades infecciosas es uno de los grandes avances de la medicina. En la actualidad, el acceso a la tecnolog\u00eda de punta en el \u00e1rea de la gen\u00f3mica y la prote\u00f3mica ha hecho posible acelerar el desarrollo de nuevos modelos de vacunas con caracter\u00edsticas mejoradas en aspectos fundamentales, como la inmunogenicidad y la seguridad. A casi dos d\u00e9cadas del primer informe, en el cual se demostr\u00f3 que un gen puede expresarse mediante la inyecci\u00f3n directa de ADN desnudo, las vacunas de ADN han probado ser eficientes para inducir una respuesta inmunitaria protectora contra par\u00e1sitos, virus y bacterias en diversos modelos animales. Esta revisi\u00f3n tiene por objetivo presentar un panorama general de las vacunas de ADN y los mecanismos mediante los cuales la inmunizaci\u00f3n con ant\u00edgenos insertados en vectores de ADN (pl\u00e1smidos inducen una respuesta inmunitaria.The effectiveness of vaccines and immunization in the prevention of infectious diseases is one of the greatest successes in medicine. In recent years, with access to cutting edge genomic and proteomic technology, it is possible to accelerate the development of new and improved vaccines with better immunogenicity and safety characteristics. Since the first report almost two decades ago, where it was demonstrated that gene expression is possible by directed injection of naked DNA, DNA vaccines have been proven to induce protective immune responses against parasites, virus and bacterium in diverse animal disease models. This review aims to present an overview about DNA vaccines and the mechanisms by which immune responses are induced after immunization with plasmid DNA-encoded antigens.\n[Vacunas para la prevenci\u00f3n de la gripe en personas de edad avanzada](http://www.sciencedirect.com/science/article/pii/S0716864010706088) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTom Jefferson\n2010-09-01\nConclusiones de los autores: Las pruebas disponibles son de calidad deficiente y no proporcionan orientaci\u00f3n con respecto a la seguridad, la eficacia o la efectividad de las vacunas contra la gripe en las personas de 65 a\u00f1os de edad o m\u00e1s. Para resolver la incertidumbre se debe realizar un ensayo aleatorio controlado con placebo, con financiamiento p\u00fablico y con poder estad\u00edstico adecuado, durante varias estaciones.\n[La Real Expedici\u00f3n Filantr\u00f3pica de la vacuna (1803 - 1810](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2007000400010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJorge Veiga de Cabo\n2007-12-01\nFull Text Available La Expedici\u00f3n Filantr\u00f3pica de la vacuna supuso una de las empresas sanitarias realizadas en el Siglo XVIII de mayor envergadura, por su complejidad, dificultad y sobre todo, por constituir una de las misiones de Salud P\u00fablica m\u00e1s importantes realizadas en la Historia. Supone el resultado de un proceso en el que una serie de acontecimientos hist\u00f3ricos, sanitarios y sociales confluyen para generar uno de los primeros programas de intervenci\u00f3n en salud p\u00fablica a escala internacional y de expansi\u00f3n de la vacuna de la viruela. Se crean Centros de producci\u00f3n, almacenamiento y distribuci\u00f3n de la vacuna, y programas de capacitaci\u00f3n t\u00e9cnica enfocados a mantener campa\u00f1as de vacunaci\u00f3n poblacional.One of the most important medical achievements made in the eighteenth century was the Philanthropic Expedition of the Vaccine. Due to its complexity and difficulty it was one of the most important Public Health undertakings in history. It was the outcome of a series of historical, social and health advances that converged in creating one of the earliest international programs for the expansion of the smallpox vaccine, creating centres for the production, storage and distribution of the vaccine together with technical training programs aimed at maintaining population vaccination campaigns.\n[Estudio de toxicidad por dosis \u00fanica y tolerancia local de una vacuna antimeningoc\u00f3cica tipo B en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan F. N\u00fa\u00f1ez\n2006-08-01\nFull Text Available La vacuna antimeningoc\u00f3cica tipo B, objetivo de este estudio, contiene ves\u00edculas purificadas de la membrana externa del meningococo del serogrupo B de la cepa (Cu- 385 - 83 B:4:P1.19,15. El esquema de vacunaci\u00f3n propuesto en humanos consiste en tres dosis de 0,5 mL, separadas por un intervalo \u00f3ptimo de ocho semanas. El objetivo de este estudio de toxicidad en ratas Sprague Dawley (SD fue determinar la toxicidad potencial, letalidad, \u00f3rganos, sistemas susceptibles y otros eventos adversos, as\u00ed como la toxicidad en el sitio de inoculaci\u00f3n despu\u00e9s de la administraci\u00f3n de una dosis de la vacuna en estudio. Los resultados indicaron que, bajo las condiciones del estudio y seg\u00fan los criterios establecidos para evaluar los resultados, la vacuna antimeningoc\u00f3cica tipo B, no produce efectos t\u00f3xicos en el modelo animal usado. Todo lo que se observ\u00f3 fueron formaciones granulomatosas a nivel del punto de inoculaci\u00f3n. Estas formaciones han sido reportadas como pertenecientes a los adyuvantes de dep\u00f3sito, como el hidr\u00f3xido de aluminio, usado en otras vacunas parenterales. Se concluye que la vacuna antimeningoc\u00f3cica tipo B result\u00f3 satisfactoria en las pruebas de toxicidad por dosis\u00fanica y tolerancia local realizadas en la especie rata.\n[Estudio histopatol\u00f3gico entre ratones infectados con Salmonella typhi sin vacunar y vacunados por diferentes v\u00edas con las vacunas polisacar\u00eddica y de c\u00e9lulas enteras](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2000000400004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan F. Infante\n2000-12-01\nFull Text Available La fiebre tifoidea constituye una enfermedad propia del hombre. La misma es causada por Salmonella typhi y produce una respuesta inflamatoria en el tracto intestinal. Con el fin de establecer su control por vacunaci\u00f3n el Instituto Finlay ha desarrollado una vacuna a partir del polisac\u00e1rido capsular Vi. Para su estudio experimental no existe un modelo animal que reproduzca los s\u00edntomas y la patogenia de la enfermedad. El desarrollo de modelos experimentales y los estudios histopatol\u00f3gicos aportan informaciones al conocimiento de la enfermedad y a la interpretaci\u00f3n de los procesos inmunol\u00f3gicos. Nos propusimos caracterizar el cuadro histopatol\u00f3gico en los ratones utilizados en las pruebas de potencia de la vacuna antitifo\u00eddica basada en polisac\u00e1rido Vi purificado y su comparaci\u00f3n con la vacuna de c\u00e9lulas enteras. Se utilizaron 240 ratones de ambos sexos pertenecientes a la l\u00ednea C57BL/6 procedentes del Centro Nacional para la Producci\u00f3n de Animales de Laboratorio (CENPALAB, con un peso comprendido entre 18 y 22 g. Se evalu\u00f3 la protecci\u00f3n comparativa entre las v\u00edas intraperitoneal y subcut\u00e1nea utilizando dos inmun\u00f3genos, a partir del polisac\u00e1rido Vi y con la variante de c\u00e9lulas enteras. Se logr\u00f3 una considerable eficacia en rat\u00f3n C57BL/6 para reproducir las lesiones compatibles con Salmonella typhi en h\u00edgado y bazo. La sobrevivencia del grupo no vacunado fue de un 15%. La sobrevivencia de los ratones correspondientes al grupo vacunado con polisac\u00e1rido Vi oscil\u00f3 entre 90% y 100% para ambas v\u00edas, mientras que los vacunados con c\u00e9lulas enteras variaron entre 50% y 100% para la v\u00eda subcut\u00e1nea y entre 60% y 100% para la v\u00eda intraperitoneal todo lo cual evidencia la superioridad de la vacuna a partir del polisac\u00e1rido capsular Vi sobre la variante de c\u00e9lulas enteras en la especie rat\u00f3n C57BL/6\n[INTRODUCCI\u00d3N DE NUEVAS VACUNAS: PROCESOS POL\u00cdTICOS, ADMINISTRATIVOS Y FINANCIEROS EN LA TOMA DE DECISIONES DEL PAI-BRASIL](http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/92) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarla Magda A.S. Domingues\n2012-07-01\nFull Text Available Se presentan los antecedentes del PAI en el Brasil remont\u00e1ndose al a\u00f1o de 1804 en que se inicia el programa de vacunaci\u00f3n en Brasil aplicando la vacuna contra la viruela hasta llegar a 1973 cuando se crea el Programa Nacional de Inmunizaciones en Brasil, y a partir de ah\u00ed se mantiene un esquema b\u00e1sico de vacunaci\u00f3n hasta llegar al 2012 cuando se introducen las vacunas VIP y pentavalentes. Muestra las alteraciones sufridas en el Calendario de Vacunaci\u00f3n del 2012, para llegar a la reformulaci\u00f3n de un Nuevo Calendario de Vacunaci\u00f3n a partir del 2012. Se\u00f1ala las estrategias nacionales de vacunaci\u00f3n enmarcadas en acciones de rutina, campa\u00f1as y control de brotes. Hace referencia a los criterios de inclusi\u00f3n de nuevas vacunas referidos a aspectos: epidemiol\u00f3gicos, inmunol\u00f3gicos, tecnol\u00f3gicos, log\u00edstica, socio-econ\u00f3micos, aprobaci\u00f3n por los Comit\u00e9s y presupuesto. Registra las novedades ocurridas en el Sistema de Informaciones del Programa Nacional de Inmunizaciones, relacionadas con la situaci\u00f3n actual, propuesta y Resoluci\u00f3n Ministerial. Por \u00faltimo se\u00f1ala los desaf\u00edos que debe enfrentar el Sistema enmarcados principalmente en la capacidad para mantener altas coberturas de vacunaci\u00f3n.\n[Vaccines against dengue: a review of current candidate vaccines at advanced development stages Vacunas contra el dengue: una revisi\u00f3n de las vacunas candidatas en etapas avanzadas de desarrollo](https://www.openaire.eu/search/publication?articleId=doajarticles::d1c5d56abb3c55f6f0d140a1ec694442)\nJoachim Hombach\n2007-01-01\nLos esfuerzos sistem\u00e1ticos para desarrollar una vacuna contra el dengue comenzaron durante la Segunda Guerra Mundial, inspirados en el desarrollo exitoso de una vacuna contra la fiebre amarilla. Sin embargo, la falta de modelos adecuados de la enfermedad, la informaci\u00f3n incompleta acerca de los mecanismos patog\u00e9nicos y los insuficientes incentivos econ\u00f3micos han dificultado los avances. Debido al impacto actual del dengue en todo el mundo y su explosiva diseminaci\u00f3n, ha aumentado el inter\u00e9s e...\n[Perfil de seguridad de la vacuna antileptospir\u00f3sica trivalente vax-SPIRAL\u00ae](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000300001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGiset Jim\u00e9nez\n2010-12-01\nFull Text Available Con el objetivo de mostrar el perfil de seguridad de la vacuna antileptospir\u00f3sica cubana, vax-SPIRAL\u00ae, se realiz\u00f3 un estudio observacional descriptivo y transversal, a partir de la base de datos de la red nacional de farmacovigilancia a medicamentos. Se estim\u00f3 la frecuencia de reportes por dosis de vacunas administradas, la valoraci\u00f3n de causalidad, severidad, localizaci\u00f3n y los eventos adversos con mayor asociaci\u00f3n estad\u00edstica, a partir del c\u00e1lculo de disproporcionalidad de las combinaciones de eventos adversos a vacunas de todos los diagn\u00f3sticos en los reportes de eventos del grupo farmacol\u00f3gico de vacunas y el c\u00e1lculo de la Raz\u00f3n de Riesgo Proporcional (PRR y la Raz\u00f3n Diferencial de Riesgo (ROR. Hubo 1,62 reportes por 100 000 dosis administradas y 1,9 diagn\u00f3sticos por reporte en personas entre 18 y 77 a\u00f1os de edad y una media \u00b1DE de 40 \u00b1 13 a\u00f1os, con predominio del sexo femenino (65,54%. No se reportaron casos graves; el 74,17% fueron con severidad leve y el 66,96% fueron manifestaciones adversas sist\u00e9micas. El 94,17% de los reportes estuvieron relacionados con la vacuna. Los eventos adversos m\u00e1s frecuentes fueron: fiebre/hipertermia (18,75%, cefalea (14,73%, dolor local (13,84%, enrojecimiento/eritema/rubor en el sitio de inyecci\u00f3n (12,05%, malestar general (8,48% y manifestaciones de hipersensibilidad m\u00ednimas, s\u00f3lo a nivel cut\u00e1neo. Entre los que mostraron mayor asociaci\u00f3n: cefalea, malestar general y rubor. Los resultados obtenidos son similares y con mejor perfil de seguridad que los de la vacuna francesa SPIROLEPT, por lo cual se recomienda para la protecci\u00f3n en grupos de riesgo de leptospirosis.\n[Dengue, zika, chikungunya y el desarrollo de vacunas](https://www.openaire.eu/search/publication?articleId=od_______617::72f63e3faddc26d37afb5bec15e160d2)\nKantor, Isabel N\n2018-01-01\nDengue (DENV), zika (ZIKV) y chikungunya (CHIKV), tres arbovirosis transmitidas por mosquitos Aedes, se han propagado en las \u00faltimas d\u00e9cadas en zonas tropicales y subtropicales h\u00famedas. El dengue es epid\u00e9mico en \u00e1reas subtropicales de la Argentina. Despu\u00e9s de la infecci\u00f3n por DENV hay inmunidad duradera contra el serotipo infectante, pero aumenta el riesgo de enfermedad grave por los otros tres. La vacuna recombinante tetravalente, Dengvaxia\u00ae previene el dengue grave y la hospitalizaci\u00f3n en s...\n[Que hay en el horizonte sobre el virus del papiloma humano, vacunas y el control del c\u00e1ncer](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000300011&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPatricia J. Garc\u00eda\n2007-07-01\nFull Text Available Esta revisi\u00f3n provee una visi\u00f3n general sobre las infecciones genitales producidas por el virus del papiloma humano (VPH y de las neoplasias relacionadas con \u00e9ste y la informaci\u00f3n sobre las expectativas crecientes de la vacunaci\u00f3n como medio de prevenci\u00f3n. Se explora como se han desarrollado las vacunas contra el VPH y que aspectos hay que tener en cuenta para una posible implementaci\u00f3n de un programa de vacunaci\u00f3n para prevenir el c\u00e1ncer cervical, como los costos, el p\u00fablico objetivo (varones, mujeres o ambos, grupos de riesgo, a que edad vacunarlos, consideraciones que debemos tener en cuenta en la promoci\u00f3n de la vacuna, que pasar\u00eda con los programas de detecci\u00f3n precoz de c\u00e1ncer cervical y cuales son los potenciales problemas que tendr\u00eda en pa\u00edses en desarrollo.\n[Evaluaci\u00f3n de la toxicidad por dosis \u00fanica de la vacuna antitet\u00e1nica vax-TET en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2007000300004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYulie\u00e9 L\u00f3pez.\n2007-12-01\nFull Text Available La vacuna vax-TET\u00ae est\u00e1 indicada en la prevenci\u00f3n del t\u00e9tanos y es efectiva si se logra un completo y apropiado esquema de inmunizaci\u00f3n. Para investigar el potencial t\u00f3xico de este producto se realiz\u00f3 una prueba toxicol\u00f3gica con una dosis \u00fanica, por v\u00eda intramuscular, en un volumen de 0,2 mL en ratas Sprague Dawley. La composici\u00f3n de la vacuna de ensayo probada fue la misma de la vacuna comercial. Los animales fueron observados diariamente en busca de s\u00edntomas locales y sist\u00e9micos de toxicidad. Se realizaron mediciones del consumo de agua y alimento, as\u00ed como del peso corporal. Dos semanas despu\u00e9s de la inoculaci\u00f3n las ratas fueron sacrificadas por m\u00e9todos de eutanasia sin dolor y sometidas a necropsia. No se observaron muertes ni s\u00edntomas de toxicidad en los animales estudiados. Tampoco se encontraron diferencias de inter\u00e9s toxicol\u00f3gico entre los grupos experimentales en cuanto a las variables medidas. El estudio anatomopatol\u00f3gico revel\u00f3 la presencia de formaciones granulomatosas de tipo macrof\u00e1gico asociadas, fundamentalmente, al hidr\u00f3xido de aluminio. Estos resultados permitieron concluir que, bajo las condiciones del estudio y seg\u00fan los criterios establecidos, esta vacuna no produce efectos adversos en el modelo animal usado, por lo que se considera potencialmente no t\u00f3xica para humanos.\n[Vacuna contra la fiebre hemorr\u00e1gica argentina Candid#1 producida en la Argentina: Inmunogenicidad y seguridad](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDelia A. Enria\n2010-06-01\nFull Text Available Se realiz\u00f3 un estudio cl\u00ednico en 946 voluntarios humanos sanos, donde se compar\u00f3 la vacuna Candid#1 producida en Argentina con la elaborada en EE.UU., que hab\u00eda sido utilizada en estudios previos. Como objetivo primario se evalu\u00f3 la equivalencia en la eficacia utilizando como marcador subrogante a la inmunogenicidad medida por detecci\u00f3n de anticuerpos neutralizantes. Como objetivo secundario se evalu\u00f3 la equivalencia en inocuidad comparando las tasas de reacciones adversas. Ambas vacunas mostraron una tasa equivalente de inmunogenicidad ligeramente superior al 95.5%, que es la eficacia estimada para Candid #1 en estudios previos. No se observaron eventos adversos graves relacionados con la vacuna. Los eventos adversos generales considerados relacionados fueron de escasa significaci\u00f3n cl\u00ednica y de resoluci\u00f3n espont\u00e1nea o con tratamiento sintom\u00e1tico; se presentaron en los receptores de ambas vacunas en tasas equivalentes (29.9% para la vacuna fabricada en la Argentina y 35.0% para la fabricada en EE.UU., e incluyeron: cefalea, decaimiento, mialgias, plaquetopenia leve (< 150 000 plaquetas/mm\u00b3, n\u00e1useas y/o v\u00f3mitos, leucopenia leve (< 4 000 blancos/mm\u00b3, fiebre, dolor retroocular, mareos, microhematuria, lumbalgia y exantema. Estos resultados indican que la vacuna Candid #1 elaborada en la Argentina es equivalente a la elaborada en los EE.UU. Este estudio permiti\u00f3 el registro del biol\u00f3gico producido en la Argentina ante la autoridad regulatoria del pa\u00eds (ANMAT.\n[El timerosal y las enfermedades del neurodesarrollo infantil: Comentarios y respuestas](https://www.openaire.eu/search/publication?articleId=od______3056::b5aead9f580b681052141b2e3d723c77)\nCabezas, Cesar; Whittembury Vl\u00e1sica, Alvaro; Maya, Luis\n2013-01-01\nQuiero comentarle sobre las versiones period\u00edsticas sobre el art\u00edculo del Dr. Maya publicado en la Revista de la Facultad, sobre el timerosal y vacunas. Desde el a\u00f1o 1991, venimos trabajando con vacunas en reci\u00e9n nacidos y menores de 5 a\u00f1os, sin haber documentado los efectos que mencionan en dicho tema de debate. Por otro lado, hay estudios serios, en pa\u00edses en donde se retir\u00f3 las vacunas con timerosal y los casos de autismo siguen en igual o en mayor n\u00famero. Siendo este tema controversial, l...\n[Administraci\u00f3n de vacunas y casos de muerte s\u00fabita del lactante en el Per\u00fa, 2001: \u00bfasociaci\u00f3n o coincidencia temporal?](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342006000100007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJavier Vargas H\nFull Text Available Objetivos: Describir las caracter\u00edsticas cl\u00ednicas, socioecon\u00f3micas, y patol\u00f3gicas de nueve casos de lactantes que fallecieron horas despu\u00e9s de administr\u00e1rseles vacunas antipolio y DPT junto con anti Haemophilus influenzae b o asociada con antihepatitis B o BCG. Materiales y m\u00e9todos: Revisi\u00f3n de la historia cl\u00ednica, entrevista con el equipo de salud a cargo de la vacunaci\u00f3n y con los padres del lactante fallecido. Revisi\u00f3n de los informes del protocolo de autopsia e informes de anatom\u00eda patol\u00f3gica y entrevista con los m\u00e9dicos legistas y pat\u00f3logos. Evaluaci\u00f3n de control de calidad de las vacunas administradas. Realizaci\u00f3n de ex\u00e1menes de inmunohistoqu\u00edmica de tejidos pulmonares para el diagn\u00f3stico de virus. Resultados: Entre agosto y diciembre de 2001 se notificaron en el Per\u00fa, nueve casos de fallecimiento de lactantes entre ocho horas y tres d\u00edas despu\u00e9s de la aplicaci\u00f3n de vacunas DPT y antipolio. Despu\u00e9s de la vacunaci\u00f3n, los s\u00edntomas iniciaron entre 30 minutos a tres horas y la muerte se produjo entre ocho a 78 horas. Los s\u00edntomas m\u00e1s frecuentes fueron irritabilidad 8/9, llanto persistente 6/9, somnolencia 5/9, sangrado por nariz y boca 5/9. Todos los casos procedieron de familias pobres o muy pobres. El control de calidad se corrobor\u00f3 que las vacunas cumplieron con los est\u00e1ndares establecidos por la OMS. Las causas de la muerte reportadas en las necropsias fueron neumon\u00eda en dos casos y edema pulmonar en cinco casos, los informes de anatom\u00eda patol\u00f3gica mostraron una neumonitis intersticial y meningitis linfocitaria. No se observaron efectos citop\u00e1ticos virales en los tejidos pulmonares y los estudios toxicol\u00f3gicos fueron negativos. Conclusiones: No existe evidencia de una asociaci\u00f3n causal entre los eventos fatales y la administraci\u00f3n de las vacunas.\n[El timerosal y las enfermedades del neurodesarrollo infantil](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832006000300009&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuis Maya\n2006-09-01\nFull Text Available Se eval\u00faa la relaci\u00f3n causal entre el timerosal (etilmercurio, como preservante en las vacunas pedi\u00e1tricas, y el incremento de casos de enfermedades del neurodesarrollo infantil, como consecuencia de la ampliaci\u00f3n de los esquemas de inmunizaci\u00f3n. Se revis\u00f3 la informaci\u00f3n cient\u00edfica, relacionando el timerosal y las evidencias que permitan evaluar una posible asociaci\u00f3n causal, con estudios epidemiol\u00f3gicos, ecol\u00f3gicos, biomoleculares y toxicol\u00f3gicos, de bioseguridad, toxicol\u00f3gicos fetales y sobre salud reproductiva. Se encontr\u00f3 m\u00faltiples asociaciones entre la exposici\u00f3n a timerosal y las enfermedades del neurodesarrollo infantil. Tal neurotoxicidad ocurre en los infantes y fetos de gestantes vacunadas por dosis acumulativa de mercurio. Las diversas evidencias implican al timerosal como el agente causante, agravante o disparador de las enfermedades del neurodesarrollo infantil. La toxicidad del mercurio oblig\u00f3 al retiro progresivo del timerosal de los medicamentos. Lamentablemente, en las vacunas, ha habido una sustancial demora en la demostraci\u00f3n de su impacto negativo. Actualmente, existen vacunas sin timerosal, cuyo uso est\u00e1 ocasionando la disminuci\u00f3n de la incidencia de las enfermedades del neurodesarrollo infantil.\n[Identidad de la vacuna contra Streptococcus pneumoniae \u201cQuimi-Vio\u201d mediante la t\u00e9cnica Dot Blot empleando los anticuerpos monoclonales contra los polisac\u00e1ridos capsulares 1,5, 6B, 14 y 19F de la bacteria](http://revistabionatura.com/2017.02.01.7.html) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nElizabeth Gonz\u00e1lez Aznar\n2017-02-01\nFull Text Available Streptococcus pneumoniae (neumococo constituye una de las principales causas de enfermedades infecciosas bacterianas, particularmente en ni\u00f1os menores de 2 a\u00f1os de edad. Basadas en el polisac\u00e1rido capsular (PsC, su principal factor de virulencia, existen dos tipos de vacunas aprobadas para uso en humanos: las vacunas polisacar\u00eddicas planas y las vacunas polisacar\u00eddicas conjugadas. Quimi-Vio, la vacuna antineumoc\u00f3cica cubana, pertenece al segundo grupo y est\u00e1 compuesta por los PsC de los siete serotipos de mayor incidencia y circulaci\u00f3n en Cuba (1, 5, 6B, 14, 18C, 19F y 23F. El objetivo de este trabajo fue realizar el ensayo de identidad de la vacuna cubana Quimi-Vio empleando los AcM contra los PsC 1, 5, 6B, 14, y 19F de Sp obtenidos recientemente en el Instituto Finlay de Vacunas, teniendo en cuenta que los Ensayos de identidad de las vacunas son requisito indispensable para la liberaci\u00f3n final de los lotes. La t\u00e9cnica empleada para la realizaci\u00f3n del ensayo de identidad de Quimi-Vio fue el Dot Blot, donde empleando membrana de Nitrocelulosa se realiz\u00f3 la captura de tres lotes de vacuna Quimi-Vio y como control positivo de la t\u00e9cnica los respectivos PsC de los serotipos 1, 5, 6B, 14, y 19F sin conjugar y una vacuna comercial Prevenar-13. Para la identidad de los PsC de neumococo se emplearon los respectivos AcM a una concentraci\u00f3n de 10\u00b5g/mL y como segundo anticuerpo anti IgG de rat\u00f3n conjugado a peroxidasa teniendo en cuenta que los AcMs empleados son murinos. Cada AcM fue capaz de identificar de forma altamente especifica al PsC homologo (mismo serotipo, tanto en su forma no conjugada y monovalente como en el contexto de las vacunas Quimi-Vio y Prevenar 13V, donde adem\u00e1s de estar conjugado al TT se encuentra mezclado con otros PsC de forma multivalente. La t\u00e9cnica Dot Blot empleando los AcMs contra los PsC serotipos 1, 5,6B, 14 y 19F permite identificar de forma espec\u00edfica cada PsC en la formulaci\u00f3n multivalente, por lo\n[Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction Enfermedad neumoc\u00f3cica y vacunaci\u00f3n antineumoc\u00f3cica en las Am\u00e9ricas: programa de acci\u00f3n para la introducci\u00f3n acelerada de una vacuna](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000500007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSalvador Garcia\n2006-05-01\nOrganizaci\u00f3n Panamericana de la Salud (OPS y el Plan para el Desarrollo Acelerado y la Introducci\u00f3n de Vacunas Antineumoc\u00f3cicas (PneumoADIP, por Pneumococcal Vaccines and Accelerated Development and Introduction Plan de la Alianza Mundial para Vacunas e Inmunizaci\u00f3n (GAVI, por Global Alliance for Vaccines and Immunization. Las personas que participaron en la reuni\u00f3n revisaron el estado de la vigilancia de las enfermedades neumoc\u00f3cicas en la Regi\u00f3n de las Am\u00e9ricas, as\u00ed como c\u00e1lculos de la carga de enfermedades neumoc\u00f3cicas, la distribuci\u00f3n de serotipos de Streptococcus pneumoniae que provocan enfermedad invasora, el estado de la introducci\u00f3n de vacunas antineumoc\u00f3cicas, an\u00e1lisis econ\u00f3micos sanitarios, y aspectos econ\u00f3micos de la introducci\u00f3n de la vacuna. Los participantes de la reuni\u00f3n tambi\u00e9n se dedicaron a identificar los pr\u00f3ximos pasos necesarios para generar la informaci\u00f3n esencial que hace falta para facilitar la toma de decisiones en torno a la introducci\u00f3n de una vacuna antineumoc\u00f3cica. La vigilancia coordinada de las enfermedades neumoc\u00f3cicas en la Regi\u00f3n de las Am\u00e9ricas se remonta a 1993, cuando la OPS estableci\u00f3 el proyecto conocido por Sistema Regional de Vacunas (SRV, dedicado a la vigilancia de la meningitis y la neumon\u00eda por bacterias, incluido el neumococo. Los datos obtenidos mediante las actividades de vigilancia del SRV indican que la distribuci\u00f3n de los principales serotipos en las Am\u00e9ricas ha sido estable a lo largo del tiempo (pero que la resistencia a los antibi\u00f3ticos va en aumento, siendo el serotipo 14 el que m\u00e1s se a\u00edsla en la mayor\u00eda de los pa\u00edses que participan en el SRV. Seg\u00fan se deduce de los datos sobre serotipos procedentes de seis de los pa\u00edses abarcados por el SRV (Argentina, Brasil, Chile, Colombia, M\u00e9xico y Uruguay, la vacuna septavalente cubrir\u00eda a alrededor de 65% de los serotipos, la nonavalente cubrir\u00eda a m\u00e1s de 77% y la undecavalente cubrir\u00eda a m\u00e1s de 83%.\n[Aproximaci\u00f3n al uso de hongos entomopat\u00f3genos y vacunas para el control sostenible de garrapatas en sistemas ganaderos: revisi\u00f3n](http://www.redalyc.org/articulo.oa?id=83743886006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Carolina Moncada Gonz\u00e1lez\n2015-01-01\nFull Text Available La resistencia desarrollada por las garrapatas frente a los acaricidas de s\u00edntesis, hace necesario replantear las estrategias utilizadas actualmen - te para su control. Los programas de manejo integrado de par\u00e1sitos se presentan como una alternativa que, al promover estrategias de con - trol basadas en la ecolog\u00eda y la epidemiolog\u00eda de cada especie de par\u00e1sito, reducen el riesgo de desarrollo de resistencia. Dichas estrategias incluyen la aplicaci\u00f3n de vacunas antigarrapata y hongos entomopat\u00f3genos que afectan la viabi - lidad y la reproducci\u00f3n en las garrapatas. Sin embargo, la informaci\u00f3n obtenida entre estudios sobre hongos y vacunas ha sido inconsistente, por lo que hoy en d\u00eda ambas representan \u00e1reas de investigaci\u00f3n bastante activas. El prop\u00f3sito de este trabajo consisti\u00f3 en realizar una revisi\u00f3n descriptiva sobre los mecanismos de acci\u00f3n de la vacuna antigarrapata y los hongos entomopat\u00f3genos, en la b\u00fasqueda de una po - sible complementariedad que permita el dise\u00f1o de planes de aplicaci\u00f3n conjunta, con miras a mejorar los resultados de control en sistemas ganaderos. En la primera parte del documento se revisa la actual problem\u00e1tica asociada al uso y abuso de los acaricidas de s\u00edntesis, haciendo un \u00e9nfasis particular en el tema de resistencia; posteriormente, se describen los mecanismos de acci\u00f3n de hongos y vacunas que afectan la re - producci\u00f3n y supervivencia en garrapatas, y se incluye informaci\u00f3n relevante sobre su eficacia. Se espera que la informaci\u00f3n aqu\u00ed recolectada, sirva como base para elaborar estudios que permitan identificar la utilidad de los hongos entomopat\u00f3genos y las vacunas antigarrapata al interior de los programas de manejo integrado de par\u00e1sitos en ganader\u00eda.\n[Vacuna contra el VPH (HPV Vaccine)](https://www2c.cdc.gov/podcasts/player.asp?f=8630175) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2013-07-25\nDesde el 2006, hay una vacuna que protege contra los tipos de VPH que causan c\u00c3\u00a1ncer con mayor frecuencia. Este podcast habla sobre la importancia de que los padres hablen con los proveedores de atenci\u00c3\u00b3n m\u00c3\u00a9dica de sus hijos sobre ponerles la vacuna contra el VPH. Created: 7/25/2013 by MMWR. Date Released: 11/4/2013.\n[Vacunas y autoinmunidad: una rara asociaci\u00f3n bajo debate Vaccines and autoimmunity: a strange association under debate](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342012000200017) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlexander Batista-Duharte\n2012-06-01\nFull Text Available La posible asociaci\u00f3n entre vacunas y enfermedades autoinmunes es un tema controversial. Existen elementos a favor de esta relaci\u00f3n basados en modelos te\u00f3ricos, ensayos de laboratorio y varios casos cl\u00ednicos publicados. En cambio, los estudios epidemiol\u00f3gicos no han confirmado esta asociaci\u00f3n y, de ellos, puede inferirse que las vacunas no constituyen una causa demostrada de enfermedades autoinmunes. En este trabajo se analizan las evidencias a favor y en contra de esta controversial asociaci\u00f3n, adem\u00e1s, se aborda un nuevo s\u00edndrome asociado con la administraci\u00f3n continuada de adyuvantes vacunales. Se concluye que debido al gran impacto en beneficio de la salud logrado con las vacunas, es necesario continuar desarrollando esta tecnolog\u00eda, pero tambi\u00e9n se debe seguir perfeccionando los dise\u00f1os de las nuevas formulaciones y profundizando estudios b\u00e1sicos, precl\u00ednicos, ensayos cl\u00ednicos y farmacovigilancia de los nuevos candidatos vacunales para establecer el riesgo real de desarrollo de un evento autoinmune posvacunaci\u00f3n.The occurrence and significance of autoimmune manifestations after administration of vaccines remain controversial. Evidence for immunization triggered autoimmunity come from several sources including theoretical models, animal studies, single and multiple case reports. In contrast, several epidemiological studies don\u2019t report this association, which is reassuring and at least indicates that vaccines are not a major cause of autoimmune diseases. We analyzed current scientific data concluded that vaccines bring a positive impact on public health, so it is necessary to continue developing this technology. Evaluation methods should be improved to avoid or anticipate the possible autoimmune side effects that can be presented.\n[Estandarizaci\u00f3n de una prueba de PCR para la detecci\u00f3n de Brucella sp.](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342003000200007&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarlos Padilla R\n2003-04-01\nFull Text Available Objetivo: Estandarizar una prueba de PCR para la detecci\u00f3n de Brucella spp. Materiales y m\u00e9todos: Se us\u00f3 oligonucle\u00f3tidos reportados que amplifican la secuencia de 16S rRNA de Brucella spp. Fueron evaluados dos m\u00e9todos de extracci\u00f3n de ADN: fenol-cloroformo-alcohol isoam\u00edlico y un kit comercial basado en columnas con afinidad. Para determinar la sensibilidad de la prueba se us\u00f3 8 cepas peruanas de Brucella y para determinar la especificidad de la prueba se us\u00f3 otras cepas bacterianas peruanas de E. coli, Shigella, Proteus mirabilis, Salmonella aratyphi, Salmonella typhi, Citrobacter freundii y Vibrio cholerae. Resultados: Los 2 m\u00e9todos de extracci\u00f3n de ADN evaluados fueron efectivos. La sensibilidad anal\u00edtica de la prueba es alta, logr\u00e1ndose detectar 80 femtogramos de ADN de Brucella spp. purificado. Todas las cepas peruanas de Brucella spp. fueron detectadas por la prueba. Adem\u00e1s, la prueba es negativa para cepas peruanas de otras especies bacterianas. Conclusi\u00f3n: Se ha estandarizado las condiciones de una prueba de PCR para la detecci\u00f3n de cepas peruanas de Brucella spp., la cual es muy sensible y espec\u00edfica en el laboratorio.\n[Caracter\u00edsticas de los v\u00eddeos en espa\u00f1ol publicados en YouTube sobre la vacuna contra el virus del papiloma humano](http://www.redalyc.org/articulo.oa?id=17033372012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Tuells\n2015-01-01\nFull Text Available Fundamentos: Internet constituye un recurso de b\u00fasqueda de informaci\u00f3n relacionada con la salud. El objetivo de este trabajo fue conocer las caracter\u00edsticas de los v\u00eddeos en idioma espa\u00f1ol de YouTube relacionados con la vacuna contra el virus del papiloma humano (VPH. M\u00e9todos: Se realiz\u00f3 un estudio observacional a partir de una b\u00fasqueda en YouTube el 26 de julio de 2013, con las palabras claves: \u201cvacuna virus papiloma humano\u201d, \u201cvacuna VPH\u201d, \u201cvacuna Gardasil\u201d, \u201cvacuna Cervarix\u201d. Se establecieron categor\u00edas por tipo, fuente de publicaci\u00f3n y predisposici\u00f3n favorable o no hacia la vacuna. Se registr\u00f3 el n\u00famero de visitas, tiempo de duraci\u00f3n de los videos y origen de los 20 v\u00eddeos m\u00e1s visitados. Resultados. Se encontraron 1.080 videos registrados, 170 fueron seleccionados y clasificados como: noticias locales (n=39; 37 favorables, 2 desfavorables; 2:06:29; 42972 visitas, noticias nacionales (n=32; 30/2; 1:49:27; 50138 visitas, creados por subscritores de YouTube (n=21; 13/8; 2:50:35; 144655 visitas, entrevistas (n=21; 20/1; 1:44:39; 10991 visitas, anuncios (n=21; 19/2; 0:27:05; 28435 visitas, conferencias (n=17; 15/2; 3:25:39; 27206 visitas, documentales (n=16; 12/4; 2:11:31; 30629 visitas, y noticias internacionales (n=3; 3/0; 0:11:33; 1667 visitas. De los 20 videos m\u00e1s reproducidos predominan los favorables a la vacunaci\u00f3n (n=12; 0:43:43; 161.789 visitas frente a los desfavorables (n=8; 2:44:14; 86.583 visitas. Conclusiones. Predominan los videos que tiene una opini\u00f3n favorable hacia la vacuna contra el VPH, aunque los videos de contenido negativo son los m\u00e1s extensos y reproducidos-\n[VIGILANCIA DE LA GRIPE PAND\u00c9MICA EN LA COMUNIDAD VALENCIANA Y VACUNA ANTIGRIPAL ESTACIONAL](http://www.redalyc.org/articulo.oa?id=17015304012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRosa Mar\u00eda Carb\u00f3 Malonda\n2010-01-01\nFull Text Available Fundamento: En la Comunidad Valenciana se ha llevado a cabo la vigilancia de la Gripe pand\u00e9mica. Algunos estudios sobre efectividad de la vacuna estacional para Gripe AnH1N1 han presentado resultados no consistentes. El objetivo del trabajo es describir los resultados de la vigilancia epidemiol\u00f3gica y la efectividad de la vacuna estacional para Gripe pand\u00e9mica en las semanas 28 a 51 de 2009. M\u00e9todos: Se estudiaron los casos en atenci\u00f3n primaria, hospitalizados confirmados, aislamientos virales y prote\u00edna C reactiva (PCR y coberturas vacunales. Se calcul\u00f3 la efectividad vacunal por el m\u00e9todo de screening de Farrington, en tres grupos de edad y dos periodos: vacunados de las temporadas 2008-9 y 2009-10. Resultados: En el primer periodo (semanas 28 a 40 los casos se concentraron en el grupo de 15 a 64 a\u00f1os (7.207 casos, seguido de los menores de 15 a\u00f1os (1.596 casos. En el segundo periodo (semanas 45 a 47 afect\u00f3 m\u00e1s a menores de 15 a\u00f1os (28.218 casos. En ambos periodos las tasas de incidencia en mayores de 65 a\u00f1os fue de 56,3 y 125,1 respectivamente. En el periodo estudiado (semanas 28 a 51 se confirmaron 5.481 casos de los que 1.746 (31,8% fueron hospitalizados. La curva de personas hospitalizadas presentaba un perfil similar al de atenci\u00f3n primaria, y tambi\u00e9n el seguimiento microbiol\u00f3gico del virus. La efectividad vacunal en el segundo periodo fue del 25% en adultos entre 15 y 64 a\u00f1os y del 51% en mayores de 64 a\u00f1os. Conclusiones: Se observ\u00f3 una protecci\u00f3n edad dependiente con efectividad vacunal positiva en los mayores de 64 a\u00f1os, aunque puede estar confundida por exposici\u00f3n natural al virus, vacunas previas y o respuesta inmunitaria.\n[Estudio de inmunogenicidad para dos vacunas recombinantes contra hepatitis B](http://www.revistabiomedica.org/index.php/biomedica/article/view/2011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nO. Juliao\n1991-12-01\nFull Text Available Este estudio compara la inmunogenicidad (seroconversi\u00f3n, seroprotecci\u00f3n e Hiperrespuesta, producida por dos vacunas recombinantes contra la hepatitis B (Engerix-B de B\u00e9lgica y Cubana, en dos esquemas (012 y 016 meses, empleando los m\u00e9todos de cuantificaci\u00f3n para Anti-HBsAg (Abbott y Organ\u00f3n, los cuales fueron tambi\u00e9n comparados. En el estudio participaron 257 voluntarios, divididos al azar en 4 grupos (dos vacunas, dos esquemas. Resultados: los dos m\u00e9todos de Abbon y Organon, no presentan diferencias estad\u00edsticas significativas. La vacuna cubana muestra una mayor respuesta inmunog\u00e9nica para dos dosis de vacuna y para el esquema 012. No hay diferencia entre los esquemas 012 y 016 y en el esquema 016 no se ven diferencias estad\u00edsticamente significativas con la vacuna Engerix-B. En esta \u00daltima el esquema 016 muestra mejores resultados que el 012.\n[ESTRUCTURA MOLECULAR Y ANTIG\u00c9NICA DE LA VACUNA](https://revistas.unal.edu.co/index.php/actabiol/article/view/11338) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nV\u00cdCTOR ANDR\u00c9S VANEGAS\n2008-09-01\nFull Text Available La prote\u00edna L1 del Virus del Papiloma Humano (VPH constituye el 80% de la c\u00e1pside viral. Las vacunas profil\u00e1cticas contra el VPH son sintetizadas a partir de la prote\u00edna L1 ensamblada en Part\u00edculas similares al Virus (del ingl\u00e9s VLP, las cuales son altamente inmunog\u00e9nicas generando anticuerpos espec\u00edficos de tipo y en algunos casos pueden presentar reacci\u00f3n cruzada entre tipos de VPH filogen\u00e9ticamente pr\u00f3ximos. La estructura de la prote\u00edna L1 del VPH es importante porque confiere estabilidad a la c\u00e1pside mediante el establecimiento de interacciones intra e intercapsom\u00e9ricas lo que asegura la integridad viral y antig\u00e9nicamente porque contiene los ep\u00edtopes que inducen la respuesta inmune protectora. En estudios en los que se evalu\u00f3 la antigenicidad de la prote\u00edna L1 se determin\u00f3 que los ep\u00edtopes inmunodominantes de la c\u00e1pside viral se encuentran en los bucles B-C, D-E, F-G, H-I y en el extremo C-terminal. Estos bucles son poco conservados entre los diferentes genotipos y se encuentran en segmentos de la prote\u00edna expuestos en la superficie de la c\u00e1pside. Los amino\u00e1cidos situados en los bucles B-C, F-G y H-I son primordiales para el reconocimiento por los anticuerpos neutralizantes. Los diferentes subtipos y variantes presentan cambios en estos amino\u00e1cidos o en residuos que conforman otros ep\u00edtopes. En esta revisi\u00f3n se presentar\u00e1 un estado del arte de la prote\u00edna L1 del VPH genotipo 16, la estructura y su importancia en el desarrollo de vacunas contra la infecci\u00f3n producida por este virus.\n[Seguridad, reactogenicidad e inmunogenicidad de una nueva vacuna de polisac\u00e1ridos meningoc\u00f3cicos en adultos j\u00f3venes cubanos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRossana Estruch\u2013de la Guardia\n2017-04-01\nFull Text Available Se realiz\u00f3 un estudio aleatorizado, controlado y a doble ciegas, en 352 adultos j\u00f3venes cubanos entre 18 y 35 a\u00f1os de edad, con el objetivo de evaluar la seguridad, reactogenicidad y la inmunogenicidad de una nueva vacuna de polisac\u00e1ridos de Neisseria meningitidis serogrupos A, C y W135, producida por el Instituto Finlay de Vacunas (La Habana, Cuba, con respecto a su similar comercial Mencevax\u00ae ACW de Glaxo Smith Kline. Se tomaron muestras de suero antes y 28 d\u00edas despu\u00e9s de la vacunaci\u00f3n. La reactogenicidad de ambas vacunas fue similar. Los s\u00edntomas y signos, tanto locales como generales fueron leves y aparecieron principalmente durante las primeras 48 h despu\u00e9s de la vacunaci\u00f3n. Ning\u00fan sujeto present\u00f3 eventos adversos graves durante los 28 d\u00edas del per\u00edodo de vigilancia. La vacuna en estudio mostr\u00f3 ser segura y poco reactog\u00e9nica; sus porcentajes de seroconversi\u00f3n a los 28 d\u00edas posteriores a la vacunaci\u00f3n fueron de: 92,19 % para el serogrupo A, 88,89 % para C y 90,06 % para W135. No se detectaron diferencias con respecto a la seroconversi\u00f3n. La seroprotecci\u00f3n alcanzada con la vacuna en estudio fue de 98,44 %, 91,81 % y 95,32 % para los serogrupos A, C y W135 respectivamente y no fue inferior con respecto a la vacuna control para los tres serogrupos estudiados.\n[Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Mar\u00eda Rodr\u00edguez\n2010-12-01\nFull Text Available Han pasado casi 30 a\u00f1os de la detecci\u00f3n de los primeros casos de infecci\u00f3n con HIV-1 y a\u00fan no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV, el HIV/sida sigue constituyendo un grave problema para la salud p\u00fablica, especialmente en los pa\u00edses en desarrollo, donde es dif\u00edcil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus del sida, mientras que en la Argentina se calcula que habr\u00eda unos 120 000 infectados. Uno de los desaf\u00edos para lograr una vacuna contra el HIV es la variabilidad viral. El grupo M, responsable de la pandemia, se encuentra dividido en 10 subtipos y varios sub-subtipos, adem\u00e1s de las 48 formas recombinantes circulantes y m\u00e1s de cien formas recombinantes \u00fanicas. La epidemia de HIV en nuestro pa\u00eds es tan compleja como en el resto del mundo, con la co-circulaci\u00f3n principalmente de virus pertenecientes al subtipo B y recombinantes BF (CRF12_BF y derivadas. A pesar de la cantidad de trabajos dedicados a la caracterizaci\u00f3n de la respuesta inmune y al desarrollo de vacunas, no queda claro cu\u00e1l es el impacto de la variabilidad en la elecci\u00f3n del ant\u00edgeno. Trabajos realizados en nuestro laboratorio demuestran el papel que juega la inmunidad celular con respecto a las variantes recombinantes BF, tanto en humanos como en modelos animales. Estos resultados son de importancia en el desarrollo de futuras vacunas para nuestra regi\u00f3n.\n[Reacciones adversas a la vacuna contra influenza A (H1N1 en trabajadores de salud de una instituci\u00f3n p\u00fablica peruana](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832011000300003&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPedro P. \u00c1lvarez-Falcon\u00ed\n2011-07-01\nFull Text Available Introducci\u00f3n: En abril de 2009 se produjo un brote de influenza en la frontera de M\u00e9xico y EE UU por el nuevo virus A(H1N1 2009. La pandemia no fue severa y la vacuna aplicada en diversos pa\u00edses produjo diversas reacciones adversas a medicamentos (RAM. Objetivos: Evaluar la posible relaci\u00f3n entre las RAM notificadas espont\u00e1neamente y la vacunaci\u00f3n en trabajadores de salud de un instituto. As\u00ed mismo, identificar t\u00f3picos afines a las RAM por dicha vacuna. Dise\u00f1o: Estudio prospectivo y descriptivo basado en la notificaci\u00f3n espont\u00e1nea. Instituci\u00f3n: Local central del Instituto Nacional de Salud en Lima. Participantes: Trabajadores de salud. Metodolog\u00eda: Las RAM notificadas espont\u00e1neamente fueron registradas en Hojas RAM. Se aplic\u00f3 un algoritmo para buscar una relaci\u00f3n causa-efecto. Principales medidas de resultados: Reacciones adversas a la vacuna influenza A(H1N1. Resultados: Hubo tres notificaciones espont\u00e1neas entre 148 trabajadores de salud vacunados (2% contra la influenza A(H1N1 2009. La relaci\u00f3n causa-efecto fue \u2018cierta\u2019 para fiebre y fatiga y \u2018posible\u2019 para afecciones respiratorias en tres mujeres (faringitis aguda, catarro nasal agudo, bronquitis catarral. Conclusiones: Entre los pocos trabajadores de salud que presentaron RAM, las afecciones respiratorias con una relaci\u00f3n considerada \u2018posible\u2019 podr\u00eda interpretarse que las mujeres ser\u00edan m\u00e1s sensibles para esa RAM comparadas con los varones. Las RAM fiebre y fatiga alcanzaron una relaci\u00f3n considerada \u2018cierta\u2019. La menor cantidad de infectados en personas de tercera edad en el pa\u00eds y en otros podr\u00eda explicarse por la presencia de \u2018anticuerpos protectores\u2019 en ellos.\n[Entre controversias cient\u00edfico-m\u00e9dicas y movilizaciones populares. Poblaci\u00f3n epid\u00e9mica y vacunas contra la fiebre hemorr\u00e1gica argentina 1958-1990](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/546/568) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAgnese, Graciela\n2013-06-01\nFull Text Available The emergence and gradual extension of a new epidemic disease, as it has been the Haemorrhagic Fever Argentina, from the Decade of the \u2018 50s, prompted the medical scientific research with the aim of finding a vaccine. In the period 1959-1990 developed three projects of vaccines with different results. This article aims to consider the behavior assumed by the epidemic population around the three vaccines in response to the tensions that exist between population and physicians and researchers in charge of vaccination campaigns; the struggles between the various scientific groups; the role of the press and the State.La irrupci\u00f3n y la progresiva extensi\u00f3n de una nueva enfermedad epid\u00e9mica, como ha sido la Fiebre Hemorr\u00e1gica Argentina, a partir de la d\u00e9cada del \u201950, impuls\u00f3 la investigaci\u00f3n cient\u00edfica m\u00e9dica con el objetivo fundamental de encontrar una vacuna. En el per\u00edodo 1959-1990 se desarrollaron tres proyectos de vacunas con distintos resultados. El objetivo de este art\u00edculo es considerar las conductas asumidas por la poblaci\u00f3n epid\u00e9mica en torno a las tres vacunas atendiendo a las tensiones existentes entre la poblaci\u00f3n y los m\u00e9dicos e investigadores a cargo de las campa\u00f1as de vacunaci\u00f3n; las pugnas entre los distintos grupos cient\u00edficos; el rol de la prensa y del estado.\n[Obtenci\u00f3n y evaluaci\u00f3n preliminar de un virus canarypox recombinante como candidato a vacuna antirr\u00e1bica Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate](https://www.openaire.eu/search/publication?articleId=doajarticles::0f1a7e9d964b5b4dd7e2026d0f5f7623)\nFlavia Zanetti; Liliana Rudak; Mat\u00edas Micucci; Daniela Conte Grand; Andrea Luque; Susana Russo; Oscar Taboga; Oscar P\u00e9rez; Gabriela Calamante\n2012-01-01\nEn la Argentina, la rabia est\u00e1 circunscripta a algunas provincias del norte. La disponibilidad de nuevas vacunas que eliminen la manipulaci\u00f3n del virus r\u00e1bico y que permitan el control de la enfermedad es de importancia estrat\u00e9gica nacional y regional. Las vacunas basadas en poxvirus recombinantes se han utilizado con \u00e9xito como vacunas antirr\u00e1bicas a nivel mundial. SI bien estos sistemas no est\u00e1n disponibles comercialmente, la plataforma de obtenci\u00f3n de virus canarypox (CNPV) recombinantes y...\n[Estudio de inmunogenicidad de la vacuna antitifo\u00eddica cubana de polisac\u00e1rido Vi vax-TyVi\u00ae en ratones](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Carlos Ram\u00edrez\n2006-08-01\nFull Text Available Salmonella enterica serovar Typhi es un microorganismo que provoca m\u00e1s de 16 millones de casos de fiebre tifoidea con aproximadamente 600 000 muertes al a\u00f1o en todo el mundo. Dentro de las vacunas antitifo\u00eddicas la de polisac\u00e1rido capsular Vi ha encontrado, gracias a sus incuestionables ventajas, una gran aceptaci\u00f3n entre productores y consumidores. El presente trabajo aborda el estudio de inmunogenicidad de la vacuna antitifo\u00eddica cubana de polisac\u00e1rido Vi vax-TyVi\u00e2 en ratones. El estudio estuvo conformado por un grupo control no inoculado y un segundo grupo que recibi\u00f3 0,05 mL de la vacuna por v\u00eda intramuscular. Se tomaron muestras de sangre a los -3, 7, 14, 21, 28, 42, 56 y 84 d\u00edas. La actividad de anticuerpos IgG antipolisac\u00e1rido Vi de los sueros individuales fue determinada por ELISA. Los datos fueron analizados por grupo y por sexo y se calcul\u00f3 el porcentaje de seroconversi\u00f3n, consider\u00e1ndose respondedor aquel animal que al menos aumentara en cuatro veces su t\u00edtulo inicial. La respuesta de anticuerpos inducida por la vacuna mostr\u00f3 un aumento notable de los t\u00edtulos de IgG antipolisac\u00e1rido Vi en el grupo vacunado (100% de seroconversi\u00f3n, mientras que el grupo control no increment\u00f3 sus niveles m\u00ednimos iniciales (0% de respondedores. Aunque m\u00e1s dispersa, la respuesta de anticuerpos antiVi fue significativamente mayor en las hembras que en los machos.\n[Avances en el desarrollo de vacunas contra la neosporosis bovina Advances in the development of vaccines for bovine neosporosis](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000300014) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYanina P. Hecker\n2012-09-01\nFull Text Available La neosporosis es una enfermedad que ocasiona abortos en bovinos y est\u00e1 causada por un protozoo intracelular obligado denominado Neospora caninum. Las graves p\u00e9rdidas econ\u00f3micas que provoca en los sistemas de producci\u00f3n de bovinos justifica la necesidad de avanzar en el desarrollo de vacunas. La resistencia a par\u00e1sitos Apicomplexa est\u00e1 asociada a una respuesta inmune T helper 1 mediada por linfocitos T CD4 citot\u00f3xicos y a la producci\u00f3n de interfer\u00f3n-gamma, interleuquina-12, factor de necrosis tumoral e inmunoglobulina G2. La disminuci\u00f3n de la transmisi\u00f3n vertical en las sucesivas pre\u00f1eces y el bajo nivel de repetici\u00f3n de abortos en animales infectados sugieren la existencia de mecanismos inmunitarios de protecci\u00f3n. Hasta el momento se conoce que la inoculaci\u00f3n pre-servicio con taquizo\u00edtos vivos protege contra la infecci\u00f3n y el aborto. Los antecedentes de desarrollo de vacunas vivas contra otros protozoos estimulan a los investigadores a continuar en la b\u00fasqueda de una vacuna de este tipo contra N. caninum de buena eficacia. Por otra parte, una vacuna inactivada, aun con una baja eficacia, es \u00fatil en la prevenci\u00f3n del aborto en aquellos establecimientos donde la enfermedad es epizo\u00f3tica. Una vacuna contra la neosporosis deber\u00eda evitar el aborto, la transmisi\u00f3n transplacental y la persistencia de la infecci\u00f3n. Este trabajo menciona los diversos tipos de vacunas que han sido evaluados hasta el momento, incluyendo inmun\u00f3genos inactivos, taquizo\u00edtos vivos, ant\u00edgenos recombinantes y vacunas en vectores.Neosporosis, a disease caused by the obligate intracellular protozoan Neospora caninum, produces abortions in cattle. The severe economic losses in cattle industry justify the need to develop control measures for preventing bovine abortion. Apicomplexan parasitic resistance is associated with T helper 1 immune response mediated by CD4 cytotoxic T lymphocytes, the production of interferon-gamma, interleukin-12, tumor necrosis\n[Realidad y nuevos horizontes de la vacuna del virus del papiloma humano](https://www.openaire.eu/search/publication?articleId=od______1472::a09ac4cf255ae73a6b4363b1bbc0a6ad)\nGarc\u00eda G\u00f3mez, Nuria\n2014-01-01\nLa vacuna frente al VPH es la primera vacuna destinada a la prevenci\u00f3n del c\u00e1ncer inducido por un virus, el CCU (problema de salud p\u00fablica mundial), y de lesiones precursoras. Disponemos de 2 vacunas profil\u00e1cticas: Gardasil\u00ae (frente a VPH 6, 11, 16 y 18) y Cervarix\u00ae (frente a VPH 16 y 18). El trabajo consiste en una revisi\u00f3n bibliogr\u00e1fica que tiene como objetivo conocer la situaci\u00f3n que vive actualmente la vacuna del VPH en Espa\u00f1a, utilizando como palabras clave virus, vacun...\n[Brucella lipopolysaccharide reinforced Salmonella delivering Brucella immunogens protects mice against virulent challenge.](https://www.ncbi.nlm.nih.gov/pubmed/28622869)\nLalsiamthara, Jonathan; Lee, John Hwa\n2017-06-01\nIntracellular pathogen Salmonella exhibits natural infection broadly analogous to Brucella, this phenomenon makes Salmonella a pragmatic choice for an anti-Brucella vaccine delivery platform. In this study we developed and formulated a combination of four attenuated Salmonella Typhimurium live vector strains delivering heterologous Brucella antigens (rBs), namely lumazine synthase, proline racemase subunit A, lipoprotein outer membrane protein-19, and Cu-Zn superoxide dismutase. With an aim to develop a cross-protecting vaccine, Brucella pan-species conserved rBs were selected. The present study compared the efficacy of smooth and rough variants of Salmonella delivery vector and also evaluated the inclusion of purified Brucella lipopolysaccharide (LPS) in the formulation. Immunization of SPF-BALB/c mice with the vaccine combinations significantly (P\u22640.05) reduced splenic wild-type Brucella abortus 544 colonization as compared to non-immunized mice as well as Salmonella only immunized mice. Increased induction of Brucella specific-IgG, sIgA production, and antigen-specific splenocyte proliferative responses were observed in the mice immunized with the formulations as compared to na\u00efve or vector only immunized mice. Modulatory effects of rB and LPS on production of interleukin (IL)-4, IL-12, and interferon-\u03b3 were detected in splenocytes of mice immunized with the formulation. Rough Salmonella variant in combination with LPS could further enhance the efficacy of the delivery when applied intraperitoneally. Taken together, it is compelling that Brucella LPS-augmented Salmonella vector delivering immunogenic Brucella proteins may be more suitable than the current non-ideal live Brucella abortus vaccine. The vaccine system also provides a basis for the development of cross-protecting vaccine capable of preventing multispecies brucellosis. Copyright \u00a9 2017 Elsevier B.V. All rights reserved.\n[Identifikasi Brucella abortus Isolat Lokal dengan Brucella abortus Strain Specific-Polymerase Chain Reaction (IDENTIFICATION OF LOCAL ISOLATES OF BRUCELLA ABORTUS USING BRUCELLA ABORTUS STRAIN SPECIFIC-POLYMERASE CHAIN REACTION ASSAY)](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::6c224d812f75e411561938046626731c)\nSusan Maphilindawati Noor; Pratiwi Pujilestari Sudarmono; Asmarani Kusumawati; Anis Karuniawati\n2014-01-01\nBrucella abortus Strain Specific-Polymerase Chain Reaction (BaSS-PCR) is a single multiplex PCRtechnique which able to identify and differentiate between Brucella abortus field strains (biovar 1, 2, and4), B. abortus vaccine strains, Brucella species, and non-Brucella species. In this study, BaSS-PCR wasapplied to identify local isolates of B. abortus in order to investigate the B. abortus strains that infectedcattle in Indonesia. Fifty local strains of B.abortus isolated from infected cattle...\n[Pseudomonas aeruginosa. Vacunas: un reto a la investigaci\u00f3n](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000100001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSara C. Esnard\n2004-04-01\nFull Text Available Pseudomonas aeruginosa, pat\u00f3geno gramnegativo vers\u00e1til y oportunista debido a su gran adaptabilidad fisiol\u00f3gica, potencial metab\u00f3lico y mecanismos de virulencia, es causa frecuente a escala mundial de severas o letales infecciones en pacientes hospitalizados. El empe\u00f1o por lograr terapias alternativas para prevenir o combatir las infecciones producidas por P. aeruginosa ha ocupado a investigadores de todo el mundo desde la segunda mitad del pasado siglo y actualmente se contin\u00faan reportando trabajos que respaldan los ensayos de candidatos vacunales, fundamentalmente a partir de ant\u00edgenos proteicos, mayoritariamente basados en la construcci\u00f3n de vacunas recombinantes. En este art\u00edculo se presenta una revisi\u00f3n de trabajos publicados sobre las investigaciones desarrolladas en diferentes pa\u00edses, con el objetivo de obtener candidatos vacunales para la prevenci\u00f3n o tratamiento de las infecciones causadas por Pseudomonas aeruginosa, a partir de la d\u00e9cada de los a\u00f1os 50 del siglo XX hasta el 2003.\n[Evaluaci\u00f3n de los programas de vacunaci\u00f3n mediante estudios serol\u00f3gicos y vacunas distribuidas Evaluation of vaccination programs through serological studies and distributed vaccines](http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112005000600006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPedro Plans\n2005-12-01\nFull Text Available Antecedentes: El objetivo del estudio fue comparar las coberturas vacunales en escolares para la vacuna triple v\u00edrica (sarampi\u00f3n-rub\u00e9ola-parotiditis, DTP (difteria-t\u00e9tanos-tos ferina y poliomielitis, obtenidas a partir de las vacunas distribuidas a los centros de vacunaci\u00f3n, las vacunaciones declaradas y el an\u00e1lisis serol\u00f3gico de anticuerpos. M\u00e9todos: La cobertura vacunal se obtuvo a partir de los antecedentes de vacunaci\u00f3n recogidos en un cuestionario y mediante el an\u00e1lisis serol\u00f3gico de anticuerpos frente al sarampi\u00f3n para la vacuna triple v\u00edrica, y el t\u00e9tanos para la vacuna DTP en una muestra representativa de escolares en 2001. La cobertura vacunal por registros se obtuvo dividiendo el n\u00famero de individuos que pod\u00edan haber completado la vacunaci\u00f3n por la poblaci\u00f3n objetivo. Se evalu\u00f3 la concordancia entre los antecedentes de vacunaci\u00f3n y los resultados serol\u00f3gicos mediante el \u00edndice kappa. Resultados: En los escolares de 6-8 y 9-11 a\u00f1os de edad se obtuvo una cobertura vacunal por cuestionario del 85,5 y el 87,6% para la vacuna DTP, del 89,9 y el 89,6% para la vacuna triple v\u00edrica, y del 90,4 y el 89,4% para la vacuna poliomiel\u00edtica, respectivamente, mientras la cobertura vacunal por an\u00e1lisis serol\u00f3gico fue del 100 y el 99,6% para la vacuna DTP, y del 85,5 y el 93,3% para la vacuna triple v\u00edrica, respectivamente. La cobertura vacunal por registros fue significativamente mayor que la obtenida mediante estos 2 m\u00e9todos: un 93,5 y un 100% para la vacuna DTP, un 96,3 y un 98,8% para la vacuna triple v\u00edrica, y un 100% para la vacuna poliomiel\u00edtica. La concordancia obtenida entre los antecedentes de vacunaci\u00f3n y los resultados serol\u00f3gicos fue muy baja (\u03ba Background: The objective of this study was to compare vaccination coverage in schoolchildren for the measles-mumps-rubella (MMR and diphtheria-tetanus-pertussis (DTP triple vaccines, and the poliomyelitis vaccine based on: a vaccines distributed to vaccination\n[La segunda expedici\u00f3n de Balmis, revoluci\u00f3n y vacuna](https://www.openaire.eu/search/publication?articleId=od_______935::d513a40dc09e50440853f4ad3258003a)\nTuells Hern\u00e1ndez, Jos\u00e9; Duro Torrijos, Jos\u00e9 Luis\n2013-01-01\nCuatro a\u00f1os despu\u00e9s de concluir la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (REFV) (1803-1806) en calidad de director, Francisco Xavier Balmis emprendi\u00f3 una nueva comisi\u00f3n con destino a M\u00e9xico que le mantuvo all\u00ed desde 1810 a 1813. El objetivo inicial para el que fue comisionado pasaba por verificar si la estrategia de vacunaci\u00f3n implantada a trav\u00e9s de las Juntas era eficaz y, asimismo, encontrar una fuente de fluido vacuno aut\u00f3ctona que permitiera continuar la acci\u00f3n vacunadora. Balmis ejer...\n[Activaci\u00f3n del polisac\u00e1rido capsular de Streptococcus pneumoniae serotipo 23F para la obtenci\u00f3n de vacunas conjugadas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJanoi Chang-Calder\u00f3n\n2017-04-01\nFull Text Available En la actualidad, las vacunas conjugadas constituyen un gran hito en el desarrollo de f\u00e1rmacos que protegen contra las enfermedades infecciosas. Estas vacunas no solo disminuyen dr\u00e1sticamente la mortalidad y morbilidad de diferentes enfermedades causadas por bacterias en la poblaci\u00f3n infantil; sino que tambi\u00e9n repercuten sobre la poblaci\u00f3n no vacunada. Las vacunas conjugadas se basan en establecer una uni\u00f3n covalente entre un polisac\u00e1rido y una prote\u00edna portadora para lo cual existen diferentes procedimientos qu\u00edmicos. Todos los procedimientos de conjugaci\u00f3n requieren la presencia de grupos reactivos complementarios que muchas veces son generados en ambas macromol\u00e9culas. Este trabajo se enfoca en el estudio de la reacci\u00f3n de fragmentaci\u00f3n y de la oxidaci\u00f3n pery\u00f3dica sobre el polisac\u00e1rido capsular serotipo 23F de Streptococcus pneumoniae para su uso como ant\u00edgeno vacunal. Se estableci\u00f3 la fragmentaci\u00f3n del polisac\u00e1rido mediante hidr\u00f3lisis con \u00e1cido ac\u00e9tico y trifluoro\u00e1cetico. En el caso de la reacci\u00f3n de oxidaci\u00f3n se encontr\u00f3 que la cantidad de moles de peryodato de sodio y la temperatura influyen de manera directamente proporcional sobre la generaci\u00f3n de grupos carbonilos. Adicionalmente se demostr\u00f3 que el sustituyente glicerol-fosfatos presente en la estructura del serotipo 23F es relevante para conservar la antigenicidad. El procedimiento descrito permite obtener conjugados inmunog\u00e9nicos a partir del polisac\u00e1rido capsular de Streptococcus pneumoniae serotipo 23F en el modelo de conejos.\n[IMPLICACIONES \u00c9TICAS Y SOCIALES DE LA INTRODUCCI\u00d3N DE LA VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO EN M\u00c9XICO: REFLEXIONES SOBRE UNA PROPUESTA DE INTERVENCI\u00d3N](https://www.openaire.eu/search/publication?articleId=od______3056::d4191acb1173d7dbea934cb8c961809f)\nPrieto de la Rosa,Alejandra; Guti\u00e9rrez Delgado,Cristina; Feinholz Klip,Dafna; Morales Gonz\u00e1lez,Gisela; Witlen,Renee\n2008-01-01\nEl objetivo de este trabajo es identificar aspectos \u00e9ticos y sociales relacionados con la introducci\u00f3n de la vacuna contra el virus del papiloma humano (VPH) en M\u00e9xico para una decisi\u00f3n informada y justa que considere no s\u00f3lo los aspectos financieros. De acuerdo con la informaci\u00f3n sobre eficiencia y costo de la vacuna, su introducci\u00f3n al sistema p\u00fablico mexicano puede acarrear consecuencias no previstas para las participantes y para toda la sociedad, por lo que debe examinarse en el contexto ...\n[ATP-Binding Cassette Systems of Brucella](http://dx.doi.org/10.1155/2009/354649) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDominic C. Jenner\n2009-01-01\nFull Text Available Brucellosis is a prevalent zoonotic disease and is endemic in the Middle East, South America, and other areas of the world. In this study, complete inventories of putative functional ABC systems of five Brucella species have been compiled and compared. ABC systems of Brucella melitensis 16M, Brucella abortus 9-941, Brucella canis RM6/66, Brucella suis 1330, and Brucella ovis 63/290 were identified and aligned. High numbers of ABC systems, particularly nutrient importers, were found in all Brucella species. However, differences in the total numbers of ABC systems were identified (B. melitensis, 79; B. suis, 72; B. abortus 64; B. canis, 74; B. ovis, 59 as well as specific differences in the functional ABC systems of the Brucella species. Since B. ovis is not known to cause human brucellosis, functional ABC systems absent in the B. ovis genome may represent virulence factors in human brucellosis.\n[Activation of bovine neutrophils by Brucella spp.](https://www.ncbi.nlm.nih.gov/pubmed/27436438)\nKeleher, Lauren L; Skyberg, Jerod A\n2016-09-01\nBrucellosis is a globally important zoonotic infectious disease caused by gram negative bacteria of the genus Brucella. While many species of Brucella exist, Brucella melitensis, Brucella abortus, and Brucella suis are the most common pathogens of humans and livestock. The virulence of Brucella is largely influenced by its ability to evade host factors, including phagocytic killing mechanisms, which are critical for the host response to infection. The aim of this study was to characterize the bovine neutrophil response to virulent Brucella spp. Here, we found that virulent strains of smooth B. abortus, B. melitensis, B. suis, and virulent, rough, strains of Brucella canis possess similar abilities to resist killing by resting, or IFN-\u03b3-activated, bovine neutrophils. Bovine neutrophils responded to infection with a time-dependent oxidative burst that varied little between Brucella spp. Inhibition of TAK1, or SYK kinase blunted the oxidative burst of neutrophils in response to Brucella infection. Interestingly, Brucella spp. did not induce robust death of bovine neutrophils. These results indicate that bovine neutrophils respond similarly to virulent Brucella spp. In addition, virulent Brucella spp., including naturally rough strains of B. canis, have a conserved ability to resist killing by bovine neutrophils. Copyright \u00a9 2016 Elsevier B.V. All rights reserved.\n[MLVA-16 typing of 295 marine mammal Brucella isolates from different animal and geographic origins identifies 7 major groups within Brucella ceti and Brucella pinnipedialis](http://www.biomedcentral.com/1471-2180/9/145) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJacques Isabelle\n2009-07-01\nFull Text Available Abstract Background Since 1994, Brucella strains have been isolated from a wide range of marine mammals. They are currently recognized as two new Brucella species, B. pinnipedialis for the pinniped isolates and B. ceti for the cetacean isolates in agreement with host preference and specific phenotypic and molecular markers. In order to investigate the genetic relationships within the marine mammal Brucella isolates and with reference to terrestrial mammal Brucella isolates, we applied in this study the Multiple Loci VNTR (Variable Number of Tandem Repeats Analysis (MLVA approach. A previously published assay comprising 16 loci (MLVA-16 that has been shown to be highly relevant and efficient for typing and clustering Brucella strains from animal and human origin was used. Results 294 marine mammal Brucella strains collected in European waters from 173 animals and a human isolate from New Zealand presumably from marine origin were investigated by MLVA-16. Marine mammal Brucella isolates were shown to be different from the recognized terrestrial mammal Brucella species and biovars and corresponded to 3 major related groups, one specific of the B. ceti strains, one of the B. pinnipedialis strains and the last composed of the human isolate. In the B. ceti group, 3 subclusters were identified, distinguishing a cluster of dolphin, minke whale and porpoise isolates and two clusters mostly composed of dolphin isolates. These results were in accordance with published analyses using other phenotypic or molecular approaches, or different panels of VNTR loci. The B. pinnipedialis group could be similarly subdivided in 3 subclusters, one composed exclusively of isolates from hooded seals (Cystophora cristata and the two others comprising other seal species isolates. Conclusion The clustering analysis of a large collection of marine mammal Brucella isolates from European waters significantly strengthens the current view of the population structure of these two\n[Una vacuna contra la tuberculosi, provada en cabres](https://www.openaire.eu/search/publication?articleId=od______1404::6574285bd1662fef225103ab5f2fa6f1)\nP\u00e9rez del Val, Bernat\n2012-01-01\nInvestigadors del CReSA han dut a terme el primer estudi de vacunaci\u00f3 contra la tuberculosi utilitzant com a model experimental la cabra dom\u00e8stica, que reprodueix amb molta similitud la resposta a la tuberculosi en humans. La vacuna, anomenada AdAg85A, ha estat dissenyada per investigadors de McMaster University (Canad\u00e0) per prevenir la tuberculosi en humans, i actualment es troba en fase I d\u2019assajos cl\u00ednics. De moment, aquest estudi mostra que la inoculaci\u00f3 d\u2019aquesta nova vacuna, com a refor...\n[Francisco Xavier Balmis y las Juntas de Vacuna, un ejemplo pionero para implementar la vacunaci\u00f3n Francisco Xavier Balmis and the vaccine network, a pioneering example of vaccination implementation](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342011000200010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Tuells\n2011-04-01\nFull Text Available La primera campa\u00f1a mundial de vacunaci\u00f3n organizada fue efectuada en Am\u00e9rica y las Filipinas por la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1810. La labor de Balmis como director y de Salvany, subdirector, no se limit\u00f3 al mero transporte del fluido vacunal a trav\u00e9s de los ni\u00f1os vacun\u00edferos sino tambi\u00e9n al sistema organizativo que aplicaron. Las Juntas de Vacuna fueron una red de centros creados para preservar y transportar el fluido vacuno en buenas condiciones hasta los lugares de vacunaci\u00f3n. Dispon\u00edan de un Reglamento con instrucciones sobre las caracter\u00edsticas del puesto de vacunaci\u00f3n o c\u00f3mo efectuar el censo de vacunados. Para mejorar la aceptabilidad vacunal integraron a los sanitarios locales y utilizaron la prensa para difundir noticias. La estrategia desarrollada constituye un antecedente que, transcurridos doscientos a\u00f1os, guarda una indudable similitud con modelos de planificaci\u00f3n sanitaria como el de Pineault y Daveluy utilizados en los modernos programas de inmunizaci\u00f3n.The first organised global immunization campaign was undertaken in America and the Philippines by the 'Royal Philanthropic Expedition of the Vaccine' (1803-1810. The work of Balmis as director of the Expedition and Salvany, his Assistant Director, not only included vaccinating children but also the development of an organised model for its application. The model was based on a network of centres created to protect and transport the vaccine fluids in good condition until they reached their vaccination sites and how to conduct a census of vaccinated people. In order to improve vaccine acceptability, local health workers were incorporated and the press was used to disseminate news. The strategy developed served as an antecedent that, two hundred years later, is unquestionably similar to health planning models such as Pineault and Daveluy, used in modern vaccination campaigns.\n[A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America Nueva vacuna combinada DTPw-HB/Hib para la vacunaci\u00f3n primaria y de refuerzo de menores de un a\u00f1o en Am\u00e9rica Latina](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000300006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMiguel Tregnaghi\n2006-03-01\n, la Organizaci\u00f3n Mundial de la Salud (OMS recomend\u00f3 que se incluyeran vacunas conjugadas contra Haemophilus influenzae tipo B (Hib en los programas de vacunaci\u00f3n de ni\u00f1os menores de un a\u00f1o, siempre que ello estuviera en consonancia con las prioridades nacionales. La compa\u00f1\u00eda GlaxoSmithKline Biologicals ha creado una nueva vacuna pentavalente que es una combinaci\u00f3n de la vacuna contra la difteria (D, el t\u00e9tanos (T y la tos ferina (P (con ant\u00edgeno tosfer\u00ednico a base de c\u00e9lulas completas y las vacunas contra la hepatitis B (HB y contra Haemophilus influenzae tipo B (Hib (DTPw-HB/Hib, con un total de 5 \u00b5g de fosfato de polirribosilrribitol (FPR. Hemos evaluado la inmunogenia y reactogenia observadas al aplicarse las dosis primaria y de refuerzo de esta nueva vacuna a ni\u00f1os sanos y las hemos comparado con las observadas al aplicar un r\u00e9gimen de referencia a base de las vacunas autorizadas DTPw-HB (Tritanrix y antiHib (Hiberix en forma de inyecciones simult\u00e1neas. M\u00c9TODOS: Llevamos a cabo un estudio aleatorizado y con doble enmascaramiento de septiembre de 1998 a agosto de 1999 para establecer la inmunogenia y reactogenia observadas al administrarles a ni\u00f1os sanos la nueva vacuna combinada pentavalente (DTPw-HB/Hib en una sola inyecci\u00f3n, y compararlas con las observadas con el r\u00e9gimen de referencia. RESULTADOS: Se obtuvieron excelentes respuestas inmunitarias con ambos reg\u00edmenes. Todos los ni\u00f1os vacunados en ambos grupos alcanzaron concentraciones s\u00e9ricas protectoras de anticuerpos antiFPR > 0,15 \u00b5g un mes despu\u00e9s de recibir la dosis primaria. La vacuna combinada DTPw-HB/Hib no dio resultados inferiores a los obtenidos con las vacunas autorizadas en t\u00e9rminos de los porcentajes de seroprotecci\u00f3n, seropositividad y respuesta frente a todos los componentes antig\u00e9nicos de la vacuna. La persistencia de anticuerpos contra todos los ant\u00edgenos contenidos en ella hasta el momento en que se administr\u00f3 la dosis de refuerzo fue parecida en ambos grupos, y\n[A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.](https://www.ncbi.nlm.nih.gov/pubmed/24941369)\nWang, Jing-Yu; Wu, Ning; Liu, Wan-Hua; Ren, Juan-Juan; Tang, Pan; Qiu, Yuan-Hao; Wang, Chi-Young; Chang, Ching-Dong; Liu, Hung-Jen\n2014-01-01\nThe commonest ways of diagnosing brucellosis in animals include the Rose-Bengal plate agglutination test, the buffered plate agglutination test (BPA), the slide agglutination test, the complement fixation test, and the indirect enzyme linked immunosorbent assay (I-ELISA). However, these methods cannot discriminate the Brucella vaccine strain (Brucella suis strain 2; B. suis S2) from naturally acquired virulent strains. Of the six common Brucella species, Brucella melitensis, Brucella abortus, and B. suis are the commonest species occurring in China. To develop an ELISA assay that can differentiate between cows inoculated with B. suis S2 and naturally infected with B. abortus and B. melitensis, genomic sequences from six Brucella spp. (B. melitensis, B. abortus, B. suis, Brucella canis, Brucella neotomae and Brucella ovis) were compared using Basic Local Alignment Search Tool software. One particular gene, the repA-related gene, was found to be a marker that can differentiate B. suis from B. abortus and B. melitensis. The repA-related gene of B. suis was PCR amplified and subcloned into the pET-32a vector. Expressed repA-related protein was purified and used as an antigen. The repA-based ELISA was optimized and used as specific tests. In the present study, serum from animals inoculated with the B. suis S2 vaccine strain had positive repA-based ELISA results. In contrast, the test-positive reference sera against B. abortus and B. melitensis had negative repA-based ELISA results. The concordance rate between B. abortus antibody-negative (based on the repA-based ELISA) and the Brucella gene-positive (based on the 'Bruce ladder' multiplex PCR) was 100%. Therefore, the findings suggest that the repA-based ELISA is a useful tool for differentiating cows vaccinated with the B. suis S2 and naturally infected with B. abortus and B. melitensis. Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.\n[A Novel PCR Assay for Detecting Brucella abortus and Brucella melitensis.](https://www.ncbi.nlm.nih.gov/pubmed/28443226)\nAlamian, Saeed; Esmaelizad, Majid; Zahraei, Taghi; Etemadi, Afshar; Mohammadi, Mohsen; Afshar, Davoud; Ghaderi, Soheila\n2017-02-01\nBrucellosis is a major zoonotic disease that poses a significant public health threat worldwide. The classical bacteriological detection process used to identify Brucella spp. is difficult and time-consuming. This study aimed to develop a novel molecular assay for detecting brucellosis. All complete sequences of chromosome 1 with 2.1-Mbp lengths were compared among all available Brucella sequences. A unique repeat sequence (URS) locus on chromosome 1 could differentiate Brucella abortus from Brucella melitensis . A primer set was designed to flank the unique locus. A total of 136 lymph nodes and blood samples were evaluated and classified by the URS-polymerase chain reaction (PCR) method in 2013-2014. Biochemical tests and bacteriophage typing as the golden standard indicated that all Brucella spp. isolates were B. melitensis biovar 1 and B. abortus biovar 3. The PCR results were the same as the bacteriological method for detecting Brucella spp. The sensitivity and specificity of the URS-PCR method make it suitable for detecting B. abortus and B. melitensis . Quick detection of B. abortus and B. melitensis can provide the most effective strategies for control of these bacteria. The advantage of this method over other presented methods is that both B. abortus and B. melitensis are detectable in a single test tube. Furthermore, this method covered 100% of all B. melitensis and B. abortus biotypes. The development of this URS-PCR method is the first step toward the development of a novel kit for the molecular identification of B. abortus and B. melitensis .\n[Estimaci\u00f3n de la cobertura de las vacunaciones sistem\u00e1ticas en la poblaci\u00f3n infantil de las Islas Baleares](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272002000400005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGalm\u00e9s Truyols Ant\u00f2nia\n2002-01-01\nFull Text Available Fundamentos: Para un buen desarrollo de los programas de vacunaci\u00f3n es primordial conocer la cobertura de vacunaci\u00f3n. En las Islas Baleares la cobertura notificada era muy inferior a la del resto de Espa\u00f1a. El objetivo de este trabajo es la estimaci\u00f3n de la cobertura de las vacunas incluidas en el calendario recomendado hasta los 18 meses de edad (4 dosis de polio oral, t\u00e9tanos y difteria; 3 de tosferina; 1 de sarampi\u00f3n, rubeola y parotiditis. M\u00e9todos: Estudio descriptivo, transversal, de base poblacional. Se calcularon los estimadores puntuales de distribuci\u00f3n de frecuencias y los intervalos de confianza al 95% (IC95% correspondientes, sobre una muestra de la poblaci\u00f3n residente en Baleares de dos a\u00f1os de edad (nacida en 1995, seleccionada por muestreo aleatorio por conglomerados en una sola etapa a partir de las secciones censales. Se consultan los registros de vacunas de Sanidad y de los centros de salud del Insalud, se pide telef\u00f3nicamente a las familias los datos del documento de vacunaci\u00f3n y a los pediatras privados los de la historia cl\u00ednica. Resultados: La muestra inclu\u00eda 606 ni\u00f1os. Pudo obtenerse la informaci\u00f3n completa de 532. Se consigui\u00f3 la informaci\u00f3n completa de 377 casos (62% a partir de los registros del sector p\u00fablico. La cobertura m\u00e1s baja fue la de la vacuna antidift\u00e9rica, 518 ni\u00f1os complentamente vacunados, el 96,8% (IC95% = 94,8 - 98,1 y la m\u00e1s alta la de la vacuna antipertussis, 537 ni\u00f1os, el 98,9% (IC95% = 97,5 - 99,5. Conclusiones: En las Islas Baleares existe una buena cobertura de la vacunaci\u00f3n, similar a lo que se viene estimando en Espa\u00f1a en su totalidad. Se cumple el objetivo incluido en el Plan de Erradicaci\u00f3n de la Polio. La informaci\u00f3n recogida desde el sector p\u00fablico es escasa.\n[La real expedici\u00f3n filantr\u00f3pica de la vacuna en Canarias (9 de diciembre de 1803 - 6 de enero de 1804](http://asclepio.revistas.csic.es/index.php/asclepio/article/view/62/64) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGarc\u00eda Nieto, V\u00edctor\n2005-12-01\nFull Text Available The conditions, circumstances and aftermath of the stay of the Balmis\u2019 Royal Vaccinal Expedition (1803-1806 in the Canary Islands have been studied in this paper. We have focused on reports from canary witnesses rather than official and administrative data. We have records of the spreading of the vaccine out to the isles. Finally, the decisive and determinant part played by the Roman Catholic Church to achieve the objectives of the Royal Expedition has been remarked.\nSe han estudiado las circunstancias y consecuencias de la escala de la Real Expedici\u00f3n Filantr\u00f3pica de la Vacuna (1803-1806 en el Archipi\u00e9lago Canario. Nos hemos centrado en los relatos de testigos canarios m\u00e1s que en los datos burocr\u00e1ticos y administrativos. Tenemos constancia de la difusi\u00f3n de la vacuna en las islas. Finalmente, hemos puesto de relieve el papel determinante y decisivo de la Iglesia en la consecuci\u00f3n de los objetivos de la Real Expedici\u00f3n.\n[Formative research to shape HPV vaccine introduction strategies in Peru Investigaci\u00f3n formativa relacionada con el dise\u00f1o de estrategias para introducir la vacuna contra el VPH en Per\u00fa](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342010000300007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRosario M Bartolini\n2010-06-01\nFull Text Available OBJECTIVE: To understand the sociocultural environment, health systems' capacities, and policy processes related to cervical cancer and HPV vaccines in order to inform HPV vaccine introduction. MATERIAL AND METHODS: Mixed-method formative research using qualitative and quantitative data collection techniques. Participants included girls, parents, community leaders, health and education officials, and policymakers. RESULTS: Respondents, including policymakers, generally supported HPV vaccine introduction, due partly to appreciation for the benefits of vaccination and the desire to prevent cancer. Community-level concerns regarding safety and quality of services will need to be addressed. The immunization system in Peru is strong and has capacity for including the HPV vaccine. CONCLUSION: Formative research provides key insights to help shape an effective program for HPV vaccine introduction.OBJETIVO: Comprender el contexto sociocultural, las capacidades del sistema de salud y las condiciones pol\u00edticas vinculadas al c\u00e1ncer cervical y a la vacuna contra el VPH para dise\u00f1ar una estrategia apropiada de introducci\u00f3n de la vacuna contra el VPH. MATERIAL Y M\u00c9TODOS: Investigaci\u00f3n formativa usando t\u00e9cnicas cualitativas y cuantitativas. Los participantes incluyeron ni\u00f1os, padres, l\u00edderes, funcionarios del sector salud y educaci\u00f3n, y dise\u00f1adores de pol\u00edticas. RESULTADOS: Generalmente se apoya la introducci\u00f3n de la vacuna contra el VPH, dado que se aprecian los beneficios de la vacunaci\u00f3n y se desea prevenir el c\u00e1ncer. En la comunidad se encontraron preocupaciones sobre seguridad, confianza y calidad de atenci\u00f3n. El sistema de inmunizaciones en el Per\u00fa es eficiente y tiene la capacidad para incluir la vacuna contra el VPH. CONCLUSIONES: La investigaci\u00f3n formativa permite comprender elementos clave que ayudan a dise\u00f1ar un programa efectivo para la introducci\u00f3n de la vacuna contra el VPH.\n[Evaluaci\u00f3n del impacto de la vacuna contra rotavirus en Colombia usando m\u00e9todos r\u00e1pidos de evaluaci\u00f3n](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892013001000002&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nKarol Cotes\n2013-10-01\nFull Text Available OBJETIVO: Estimar la efectividad de la vacuna monovalente antirrotav\u00edrica para prevenir la hospitalizaci\u00f3n por enfermedad diarreica aguda en ni\u00f1os menores de 2 a\u00f1os en cinco ciudades de Colombia. M\u00c9TODOS: Se realiz\u00f3 una encuesta poblacional sobre una muestra probabil\u00edstica de ni\u00f1os mayores de 2 meses y menores de 24 meses de edad en cinco ciudades de Colombia (Barranquilla, Bogot\u00e1, Cali, Cartagena y Riohacha en el per\u00edodo de agosto a octubre de 2010. La vacuna fue introducida en el Programa Ampliado de Inmunizaciones en enero de 2009. Se estimaron las coberturas de vacunaci\u00f3n contra rotavirus por grupos de edad y la incidencia acumulada de hospitalizaci\u00f3n por diarrea severa, y se evalu\u00f3 la magnitud de la asociaci\u00f3n entre la vacunaci\u00f3n con una o dos dosis de vacuna antirrotav\u00edrica y la hospitalizaci\u00f3n por diarrea, utilizando la raz\u00f3n de probabilidades (RP ajustada por edad y otros factores de importancia epidemiol\u00f3gica. La efectividad de la vacunaci\u00f3n se estim\u00f3 usando la expresi\u00f3n 1 - RP. RESULTADOS: La cobertura de vacunaci\u00f3n con una dosis de vacuna fue de 87,3%. En los 12 meses previos a la encuesta 43,2% (1 453 ni\u00f1os de menores de 24 meses presentaron diarrea, y de ellos, 5,2% (174 ni\u00f1os fueron hospitalizados por esta causa. La efectividad de dos dosis de vacuna antirrotav\u00edrica para prevenir la hospitalizaci\u00f3n por diarrea severa fue de 68% (intervalo de confianza de 95%: 55%-77%. CONCLUSIONES: La vacunaci\u00f3n contra rotavirus en Colombia protege contra la hospitalizaci\u00f3n por diarrea por cualquier causa. El uso de encuestas transversales se mostr\u00f3 adecuado para evaluar r\u00e1pidamente la efectividad de un programa de vacunaci\u00f3n con una nueva vacuna.\n[PREVALENCIA DE BACTERIAS ASOCIADAS A LA INFERTILIDAD INFECCIOSA EN BOVINOS DE MONTER\u00cdA, COLOMBIA](http://apps.unicordoba.edu.co/revistas/revistamvz/mvz-122/122-7.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarco Gonz\u00e1lez T\n2007-12-01\nFull Text Available Objetivo. Establecer la prevalencia de algunos g\u00e9rmenes asociados con infertilidad infecciosa de bovinos del municipio de Monter\u00eda. Materiales y m\u00e9todos. Se recolectaron 384 muestras sangu\u00edneas e igual n\u00famero de hisopados cervicales de hembras que cumplieron con alguno de los siguientes criterios de inclusi\u00f3n: m\u00e1s de tres servicios sin concepci\u00f3n, vaginitis, cervicitis, metritis, endometritis, \u00fatero con contenido, momificaci\u00f3n fetal, natimortos, reabsorciones embrionarias, antecedentes de abortos y/o hembras positivas a brucelosis. Las muestras cervicales se sembraron en agar Mc conkey, agar sangre, agar brucella y agar campylobacter. A las colonias sospechosas se le realizaron pruebas bioqu\u00edmicas y la confirmaci\u00f3n se llev\u00f3 a cabo con pruebas serol\u00f3gicas. Para el serodiagn\u00f3stico de Brucella, los sueros fueron analizados por Rosa de Bengala y los positivos fueron confirmados con ELISA indirecta. Resultados. De las 384 muestras procesadas, hubo crecimiento en 281 (73,2%, las bacterias prevalentes fueron Escherichia coli, Bacilos Gram Negativos Oxidantes, Klepsiella spp y Pseudomonas spp, que correspondieron a 194 (69.1% aislamientos y cinco muestras equivalentes al 1.8% resultaron positivas para Campylobacter spp. Las pruebas serol\u00f3gicas para Brucella arrojaron como resultado 22 muestras positivas por ELISA (6.3%. Conclusiones. Los resultados de este trabajo describen de forma preliminar la posible asociaci\u00f3n bacteriana en la infertilidad infecciosa en hembras vacunas, demostrando la presencia de una gran variedad de microorganismos.\n[9 CFR 113.65 - Brucella Abortus Vaccine.](https://www.gpo.gov/fdsys/pkg/CFR-2010-title9-vol1/pdf/CFR-2010-title9-vol1-sec113-65.pdf)\n2010-01-01\n... 9 Animals and Animal Products 1 2010-01-01 2010-01-01 false Brucella Abortus Vaccine. 113.65... Bacterial Vaccines \u00a7 113.65 Brucella Abortus Vaccine. Brucella Abortus Vaccine shall be prepared as a desiccated live culture bacterial vaccine from smooth colonial forms of the Brucella abortus organism...\n[Brucella, nitrogen and virulence.](https://www.ncbi.nlm.nih.gov/pubmed/25471320)\nRonneau, Severin; Moussa, Simon; Barbier, Thibault; Conde-\u00c1lvarez, Raquel; Zuniga-Ripa, Amaia; Moriyon, Ignacio; Letesson, Jean-Jacques\n2016-08-01\nThe brucellae are \u03b1-Proteobacteria causing brucellosis, an important zoonosis. Although multiplying in endoplasmic reticulum-derived vacuoles, they cause no cell death, suggesting subtle but efficient use of host resources. Brucellae are amino-acid prototrophs able to grow with ammonium or use glutamate as the sole carbon-nitrogen source in vitro. They contain more than twice amino acid/peptide/polyamine uptake genes than the amino-acid auxotroph Legionella pneumophila, which multiplies in a similar vacuole, suggesting a different nutritional strategy. During these two last decades, many mutants of key actors in nitrogen metabolism (transporters, enzymes, regulators, etc.) have been described to be essential for full virulence of brucellae. Here, we review the genomic and experimental data on Brucella nitrogen metabolism and its connection with virulence. An analysis of various aspects of this metabolism (transport, assimilation, biosynthesis, catabolism, respiration and regulation) has highlighted differences and similarities in nitrogen metabolism with other \u03b1-Proteobacteria. Together, these data suggest that, during their intracellular life cycle, the brucellae use various nitrogen sources for biosynthesis, catabolism and respiration following a strategy that requires prototrophy and a tight regulation of nitrogen use.\n[Impacto del neumococo y de los virus influenza en ni\u00f1os y adultos : su prevenci\u00f3n con vacunas](http://www.anfamed.edu.uy/index.php/rev/article/view/123) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Hortal\n2015-07-01\nFull Text Available Durante siglos las enfermedades infecciosas han diezmado a poblaciones enteras, por lo que se ha procurado descubrir su causa y as\u00ed lograr su prevenci\u00f3n. Actualmente, la vacunaci\u00f3n es una de las intervenciones en salud m\u00e1s costo-efectivas para reducir la morbilidad y mortalidad por enfermedades infecciosas. La historia as\u00ed lo confirma con la erradicaci\u00f3n de la viruela, y el control de la poliomielitis y del sarampi\u00f3n a nivel mundial. En Uruguay, el inicio de la vacunaci\u00f3n obligatoria contra la viruela se remonta a 1911, en tanto que la vacunaci\u00f3n contra la poliomielitis y el sarampi\u00f3n, se implementaron en 1957 y 1966 respectivamente. Dentro de las enfermedades inmunoprevenibles, las infecciones respiratorias agudas son notoriamente las m\u00e1s frecuentes. Su impacto urgi\u00f3 la necesidad de contar con medidas de control. La neumon\u00eda, aunque se observa en todas las edades, predomina en los extremos de la vida. En la infancia, en menores de cinco a\u00f1os, es una de las causas m\u00e1s frecuentes de hospitalizaci\u00f3n y en las poblaciones m\u00e1s desfavorecidas provoca elevada mortalidad. En los adultos con comorbilidades ocurre en todas las edades, pero es m\u00e1s frecuente en los mayores de 65 a\u00f1os, en los que patolog\u00edas asociadas aumentan el riesgo vital, que es mayor cuanto mayor es la persona. Una vez controladas las neumon\u00edas por la vacuna conjugada de Haemophilus influenzae tipo b, el agente bacteriano de mayor frecuencia es Streptococcus pneumoniae y, entre los virus respiratorios, los brotes anuales y las pandemias por virus influenza contribuyen al aumento de hospitalizaciones y decesos por neumon\u00eda. Cuando ambos agentes se asocian en un paciente, sus efectos se potencian mutuamente y sus resultados pueden ser fatales. En consecuencia, la prevenci\u00f3n de esas infecciones con las vacunas disponibles, neumoc\u00f3ccica y de influenza, es una prioridad de Salud P\u00fablica para asegurar la supervivencia infantil y disminuir costos sociales y econ\u00f3micos.\n[Eficacia y seguridad de una vacuna contra la leptospirosis humana en Cuba Efficacy and safety of a vaccine against human leptospirosis in Cuba](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000400005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRaydel Mart\u00ednez\n2004-04-01\nFull Text Available OBJETIVOS: Evaluar la eficacia de la vacuna cubana contra la leptospirosis vax-SPIRAL y aportar informaci\u00f3n adicional acerca de la seguridad de esta vacuna. M\u00c9TODOS: Ensayo de eficacia (fase III controlado, aleatorizado y con doble enmascaramiento de la vacuna cubana contra la leptospirosis vax-SPIRAL (Instituto Finlay, Cuba. Como control se utiliz\u00f3 la vacuna recombinante contra la hepatitis B Heberbiovac-HB (Heber Biotec, Cuba. Como unidad de aleatorizaci\u00f3n para la asignaci\u00f3n al grupo de estudio o al grupo testigo se emplearon los 523 consultorios de los m\u00e9dicos de familia existentes en los municipios seleccionados. El estudio abarc\u00f3 a toda persona de 20 a 64 a\u00f1os de edad de uno u otro sexo que resid\u00eda en los municipios de Ranchuelo, Quemado, Santo Domingo, Encrucijada, Corralillo, Cifuentes y Camajuan\u00ed, en la provincia de Villa Clara, ubicada en la regi\u00f3n central de Cuba, que acept\u00f3 participar voluntariamente en el ensayo. La vacunaci\u00f3n se efectu\u00f3 en los consultorios de los m\u00e9dicos de familia entre febrero y julio de 1998, con un intervalo de 6 semanas entre las dos dosis. El per\u00edodo de seguimiento fue de 12 meses. Se consider\u00f3 positivo un caso si hab\u00eda recibido las dos dosis de la vacuna asignada y hab\u00eda enfermado de leptospirosis, con diagn\u00f3stico confirmado mediante m\u00e9todos serol\u00f3gicos y microbiol\u00f3gicos, despu\u00e9s de 21 d\u00edas de aplicada la segunda dosis. Se calcularon la eficacia de la vacuna y el riesgo relativo (RR de enfermar de leptospirosis despu\u00e9s de la vacunaci\u00f3n. Para el estudio de seguridad se escogi\u00f3 a dos personas al azar entre las personas vacunadas en cada uno de los consultorios que participaron en el estudio de eficacia. El seguimiento de las reacciones adversas locales y sist\u00e9micas lo realizaron los m\u00e9dicos de familia durante los siete d\u00edas posteriores a la aplicaci\u00f3n de cada dosis. El nivel de significaci\u00f3n se fij\u00f3 en 0,05. RESULTADOS: En total se vacun\u00f3 a 101 832 personas, de las cuales 50\n[Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic Impacto de la vacuna conjugada contra Haemophilus influenzae tipo b sobre la meningitis bacteriana en la Rep\u00fablica Dominicana](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000900002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEllen H. Lee\n2008-09-01\nFull Text Available OBJECTIVES: Widespread use of Haemophilus influenzae type b (Hib vaccines has dramatically reduced the burden of Hib disease throughout the Americas. Few studies have evaluated the impact of Hib vaccination on non-culture-confirmed disease. This study analyzed trends in probable bacterial meningitis before and after the introduction of Hib vaccine in the Dominican Republic and estimated vaccine effectiveness against Hib meningitis. METHODS: Meningitis cases among children OBJETIVOS: El uso generalizado de la vacuna contra Haemophilus influenzae tipo b (Hib ha permitido reducir radicalmente la carga de enfermedad por Hib en las Am\u00e9ricas. Pocos estudios han evaluado el impacto de la vacunaci\u00f3n contra Hib sobre los casos no confirmados mediante cultivo. En este estudio se analizaron las tendencias en el n\u00famero de casos probables de meningitis bacteriana antes y despu\u00e9s de la introducci\u00f3n de la vacuna contra Hib en la Rep\u00fablica Dominicana y se estim\u00f3 la eficacia de la vacuna contra la meningitis. M\u00c9TODOS: Se identificaron los casos de meningitis en ni\u00f1os menores de 5 a\u00f1os a partir de los registros de ingreso del principal hospital pedi\u00e1trico de Santo Domingo entre 1998 y 2004. Los casos de meningitis con probable etiolog\u00eda bacteriana se clasificaron seg\u00fan criterios de laboratorio; los casos confirmados contaban con cultivo bacteriano positivo o detecci\u00f3n de ant\u00edgenos espec\u00edficos en el l\u00edquido cefalorraqu\u00eddeo. Se calcularon las tasas de incidencia acumulada de casos confirmados y probables de meningitis en los ni\u00f1os que viv\u00edan en el Distrito Nacional. Los casos confirmados de meningitis por Hib se incorporaron a un estudio de casos y controles -pareados seg\u00fan la edad y el barrio de residencia- para calcular la eficacia de la vacuna. RESULTADOS: Antes de la introducci\u00f3n de la vacuna, la tasa anual de meningitis de posible etiolog\u00eda bacteriana era de 49 casos por 100 000 ni\u00f1os menores de 5 a\u00f1os; de los casos confirmados de\n[Problemas bio\u00e9ticos en la investigaci\u00f3n de nuevas vacunas: \u00bfobedecen a razones de salud p\u00fablica?](http://www.redalyc.org/articulo.oa?id=73138582007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Carlos Tealdi\n2015-01-01\nFull Text Available Los problemas \u00e9ticos de las investigaciones sobre vacunas han crecido en las \u00faltimas d\u00e9cadas en frecuencia y magnitud debido a la posici\u00f3n dominante de la industria farmac\u00e9utica en el desarrollo de esos estudios. Las tradicionales cuestiones de seguridad y eficacia se han visto agravadas por el conflicto de intereses introducido por la competencia comercial en un mercado a escala global de miles de millones de d\u00f3lares. La integridad profesional de los investigadores, la responsabilidad moral de los patrocinadores, y la regulaci\u00f3n y control por parte de los Estados nacionales, se muestra cuestionada en varios ejemplos. Los resultados de estos cambios son las amenazas a la protecci\u00f3n de los derechos de las personas incluidas en estas investigaciones y el discutible progreso que resulta para la salud p\u00fablica.\n[Characterization of ribonuclease III from Brucella.](https://www.ncbi.nlm.nih.gov/pubmed/26778206)\nWu, Chang-Xian; Xu, Xian-Jin; Zheng, Ke; Liu, Fang; Yang, Xu-Dong; Chen, Chuang-Fu; Chen, Huan-Chun; Liu, Zheng-Fei\n2016-04-01\nBacterial ribonuclease III (RNase III) is a highly conserved endonuclease, which plays pivotal roles in RNA maturation and decay pathways by cleaving double-stranded structure of RNAs. Here we cloned rncS gene from the genomic DNA of Brucella melitensis, and analyzed the cleavage properties of RNase III from Brucella. We identified Brucella-encoding small RNA (sRNA) by high-throughput sequencing and northern blot, and found that sRNA of Brucella and Homo miRNA precursor (pre-miRNA) can be bound and cleaved by B.melitensis ribonuclease III (Bm-RNase III). Cleavage activity of Bm-RNase III is bivalent metal cations- and alkaline buffer-dependent. We constructed several point mutations in Bm-RNase III, whose cleavage activity indicated that the 133th Glutamic acid residue was required for catalytic activity. Western blot revealed that Bm-RNase III was differently expressed in Brucella virulence strain 027 and vaccine strain M5-90. Collectively, our data suggest that Brucella RNase III can efficiently bind and cleave stem-loop structure of small RNA, and might participate in regulation of virulence in Brucella. Copyright \u00a9 2016 Elsevier B.V. All rights reserved.\n[The new strains Brucella inopinata BO1 and Brucella species 83-210 behave biologically like classic infectious Brucella species and cause death in murine models of infection.](https://www.ncbi.nlm.nih.gov/pubmed/24558120)\nJim\u00e9nez de Bag\u00fc\u00e9s, Mar\u00eda P; Iturralde, Mar\u00eda; Arias, Maykel A; Pardo, Juli\u00e1n; Cloeckaert, Axel; Zygmunt, Michel S\n2014-08-01\nRecently, novel atypical Brucella strains isolated from humans and wild rodents have been reported. They are phenotypically close to Ochrobactrum species but belong to the genus Brucella, based on genetic relatedness, although genetic diversity is higher among the atypical Brucella strains than between the classic species. They were classified within or close to the novel species Brucella inopinata. However, with the exception of Brucella microti, the virulence of these novel strains has not been investigated in experimental models of infection. The type species B. inopinata strain BO1 (isolated from a human) and Brucella species strain 83-210 (isolated from a wild Australian rodent) were investigated. A classic infectious Brucella reference strain, B. suis 1330, was also used. BALB/c, C57BL/6, and CD1 mice models and C57BL/6 mouse bone-marrow-derived macrophages (BMDMs) were used as infection models. Strains BO1 and 83-210 behaved similarly to reference strain 1330 in all mouse infection models: there were similar growth curves in spleens and livers of mice and similar intracellular replication rates in BMDMs. However, unlike strain 1330, strains BO1 and 83-210 showed lethality in the 3 mouse models. The novel atypical Brucella strains of this study behave like classic intracellular Brucella pathogens. In addition, they cause death in murine models of infection, as previously published for B. microti, another recently described environmental and wildlife species. \u00a9 The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.\n[Identifikasi Brucella abortus Isolat Lokal dengan Brucella abortus Strain Specific-Polymerase Chain Reaction (IDENTIFICATION OF LOCAL ISOLATES OF BRUCELLA ABORTUS USING BRUCELLA ABORTUS STRAIN SPECIFIC-POLYMERASE CHAIN REACTION ASSAY](https://ojs.unud.ac.id/index.php/jvet/article/view/9979) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSusan Maphilindawati Noor\n2014-10-01\nFull Text Available Brucella abortus Strain Specific-Polymerase Chain Reaction (BaSS-PCR is a single multiplex PCRtechnique which able to identify and differentiate between Brucella abortus field strains (biovar 1, 2, and4, B. abortus vaccine strains, Brucella species, and non-Brucella species. In this study, BaSS-PCR wasapplied to identify local isolates of B. abortus in order to investigate the B. abortus strains that infectedcattle in Indonesia. Fifty local strains of B.abortus isolated from infected cattle in Java (Jakarta andBandung, South Sulawesi (Maros, East Nusa Tenggara (Kupang and Belu were used in this study. TheDNA bands were observed by agarose gel in the presence of ethidium bromide. Identification was performedbased on the size and number of DNA products amplified by PCR from each isolates. The results showedthat the 50 isolates were of B. abortus field strains. This finding showed that the cause of bovine brucellosisin Indonesia is B. abortus field strains.\n[Ontology-based representation and analysis of host-Brucella interactions.](https://www.ncbi.nlm.nih.gov/pubmed/26445639)\nLin, Yu; Xiang, Zuoshuang; He, Yongqun\n2015-01-01\nBiomedical ontologies are representations of classes of entities in the biomedical domain and how these classes are related in computer- and human-interpretable formats. Ontologies support data standardization and exchange and provide a basis for computer-assisted automated reasoning. IDOBRU is an ontology in the domain of Brucella and brucellosis. Brucella is a Gram-negative intracellular bacterium that causes brucellosis, the most common zoonotic disease in the world. In this study, IDOBRU is used as a platform to model and analyze how the hosts, especially host macrophages, interact with virulent Brucella strains or live attenuated Brucella vaccine strains. Such a study allows us to better integrate and understand intricate Brucella pathogenesis and host immunity mechanisms. Different levels of host-Brucella interactions based on different host cell types and Brucella strains were first defined ontologically. Three important processes of virulent Brucella interacting with host macrophages were represented: Brucella entry into macrophage, intracellular trafficking, and intracellular replication. Two Brucella pathogenesis mechanisms were ontologically represented: Brucella Type IV secretion system that supports intracellular trafficking and replication, and Brucella erythritol metabolism that participates in Brucella intracellular survival and pathogenesis. The host cell death pathway is critical to the outcome of host-Brucella interactions. For better survival and replication, virulent Brucella prevents macrophage cell death. However, live attenuated B. abortus vaccine strain RB51 induces caspase-2-mediated proinflammatory cell death. Brucella-associated cell death processes are represented in IDOBRU. The gene and protein information of 432 manually annotated Brucella virulence factors were represented using the Ontology of Genes and Genomes (OGG) and Protein Ontology (PRO), respectively. Seven inference rules were defined to capture the knowledge of host-Brucella\n[M\u00c9TODOS MULTIVARIADOS PARA ENCAUZAR LA MEJORA DE LA CALIDAD DE UNA VACUNA CONTRA EL C\u00c1NCER](http://rii.cujae.edu.cu/index.php/revistaind/article/view/80) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAida Rodr\u00edguez Hern\u00e1ndez\n2007-09-01\nFull Text Available\nEste trabajo se realiz\u00f3 con el objetivo de encontrar las relaciones entre las variables del proceso productivo y el patr\u00f3n cromatogr\u00e1fico de una vacuna terap\u00e9utica contra el c\u00e1ncer, caracter\u00edstica esta indicativa de la reproducibilidad del producto. Primeramente se emple\u00f3 el an\u00e1lisis de conglomerados (an\u00e1lisis de cluster para agrupar lotes de producci\u00f3n y posteriormente se emple\u00f3 el an\u00e1lisis discriminante para encontrar la explicaci\u00f3n de estas agrupaciones seg\u00fan las variables del proceso. La determinaci\u00f3n de estas relaciones, unida a la b\u00fasqueda en la literatura, permiti\u00f3 se\u00f1alar un camino para mejorar el proceso, dirigiendo el control hacia las variables m\u00e1s influyentes en la variabilidad del producto.\n[The genome sequence of Brucella pinnipedialis B2/94 sheds light on the evolutionary history of the genus Brucella](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3146883)\n2011-01-01\nBackground Since the discovery of the Malta fever agent, Brucella melitensis, in the 19th century, six terrestrial mammal-associated Brucella species were recognized over the next century. More recently the number of novel Brucella species has increased and among them, isolation of species B. pinnipedialis and B. ceti from marine mammals raised many questions about their origin as well as on the evolutionary history of the whole genus. Results We report here on the first complete genome sequence of a Brucella strain isolated from marine mammals, Brucella pinnipedialis strain B2/94. A whole gene-based phylogenetic analysis shows that five main groups of host-associated Brucella species rapidly diverged from a likely free-living ancestor close to the recently isolated B. microti. However, this tree lacks the resolution required to resolve the order of divergence of those groups. Comparative analyses focusing on a) genome segments unshared between B. microti and B. pinnipedialis, b) gene deletion/fusion events and c) positions and numbers of Brucella specific IS711 elements in the available Brucella genomes provided enough information to propose a branching order for those five groups. Conclusions In this study, it appears that the closest relatives of marine mammal Brucella sp. are B. ovis and Brucella sp. NVSL 07-0026 isolated from a baboon, followed by B. melitensis and B. abortus strains, and finally the group consisting of B. suis strains, including B. canis and the group consisting of the single B. neotomae species. We were not able, however, to resolve the order of divergence of the two latter groups. PMID:21745361\n[No se ha demostrado asociaci\u00f3n entre la presencia del timerosal en las vacunas y el autismo](https://www.openaire.eu/search/publication?articleId=od______3056::5d7a8a9d35638166a4e7ccabd8678667)\nCabezas S\u00e1nchez, C\u00e9sar\n2007-01-01\nEl timerosal es un compuesto org\u00e1nico que contiene etilmercurio, el cual ha sido usado como preservante de algunas vacunas, sobre todo en la presentaci\u00f3n de multidosis desde los a\u00f1os 30. El etilmercurio es diferente del metilmercurio, este \u00faltimo s\u00ed se conoce que es neurot\u00f3xico; sin embargo, el metabolismo del etilmercurio es diferente del metilmercurio. En realidad se quiso inferir que la toxicidad del metilmercurio era similar al etilmercurio presente en el timerosal.\n[Advancement of knowledge of Brucella over the past 50 years.](https://www.ncbi.nlm.nih.gov/pubmed/24981716)\nOlsen, S C; Palmer, M V\n2014-11-01\nFifty years ago, bacteria in the genus Brucella were known to cause infertility and reproductive losses. At that time, the genus was considered to contain only 3 species: Brucella abortus, Brucella melitensis, and Brucella suis. Since the early 1960s, at least 7 new species have been identified as belonging to the Brucella genus (Brucella canis, Brucella ceti, Brucella inopinata, Brucella microti, Brucella neotomae, Brucella ovis, and Brucella pinnipedialis) with several additional new species under consideration for inclusion. Although molecular studies have found such high homology that some authors have proposed that all Brucella are actually 1 species, the epidemiologic and diagnostic benefits for separating the genus based on phenotypic characteristics are more compelling. Although pathogenic Brucella spp have preferred reservoir hosts, their ability to infect numerous mammalian hosts has been increasingly documented. The maintenance of infection in new reservoir hosts, such as wildlife, has become an issue for both public health and animal health regulatory personnel. Since the 1960s, new information on how Brucella enters host cells and modifies their intracellular environment has been gained. Although the pathogenesis and histologic lesions of B. abortus, B. melitensis, and B. suis in their preferred hosts have not changed, additional knowledge on the pathology of these brucellae in new hosts, or of new species of Brucella in their preferred hosts, has been obtained. To this day, brucellosis remains a significant human zoonosis that is emerging or reemerging in many parts of the world. \u00a9 The Author(s) 2014.\n[A Brucella spp. Isolate from a Pac-Man Frog (Ceratophrys ornata) Reveals Characteristics Departing from Classical Brucellae.](https://www.ncbi.nlm.nih.gov/pubmed/27734009)\nSoler-Llor\u00e9ns, Pedro F; Quance, Chris R; Lawhon, Sara D; Stuber, Tod P; Edwards, John F; Ficht, Thomas A; Robbe-Austerman, Suelee; O'Callaghan, David; Keriel, Anne\n2016-01-01\nBrucella are highly infectious bacterial pathogens responsible for brucellosis, a frequent worldwide zoonosis. The Brucella genus has recently expanded from 6 to 11 species, all of which were associated with mammals; The natural host range recently expanded to amphibians after some reports of atypical strains from frogs. Here we describe the first in depth phenotypic and genetic characterization of a Brucella strains isolated from a frog. Strain B13-0095 was isolated from a Pac-Man frog ( Ceratophyrus ornate ) at a veterinary hospital in Texas and was initially misidentified as Ochrobactrum anthropi . We found that B13-0095 belongs to a group of early-diverging brucellae that includes Brucella inopinata strain BO1 and the B. inopinata -like strain BO2, with traits that depart significantly from those of the \"classical\" Brucella spp. Analysis of B13-0095 genome sequence revealed several specific features that suggest that this isolate represents an intermediate between a soil associated ancestor and the host adapted \"classical\" species. Like strain BO2, B13-0095 does not possess the genes required to produce the perosamine based LPS found in classical Brucella , but has a set of genes that could encode a rhamnose based O-antigen. Despite this, B13-0095 has a very fast intracellular replication rate in both epithelial cells and macrophages. Finally, another major finding in this study is the bacterial motility observed for strains B13-0095, BO1, and BO2, which is remarkable for this bacterial genus. This study thus highlights several novel characteristics in strains belonging to an emerging group within the Brucella genus. Accurate identification tools for such atypical Brucella isolates and careful evaluation of their zoonotic potential, are urgently required.\n[Validaci\u00f3n de un ELISA para la cuantificaci\u00f3n de las impurezas proteicas de la cepa hospedera en el principio activo de la vacuna recombinante cubana contra la hepatitis B](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000100003&lng=es&nrm=iso) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEliana P\u00e9rez\n2014-04-01\nFull Text Available Se valid\u00f3 un inmunoensayo tipo sandwich de doble anticuerpo para cuantificar las impurezas proteicas de la cepa hospedera que pueden estar presentes en el principio activo de la vacuna cubana contra la hepatitis B. Se prepararon los reactivos biol\u00f3gicos empleados en el ELISA. Las prote\u00ednas de la cepa hospedera se obtuvieron bajo las mismas condiciones que el proceso de producci\u00f3n de la prote\u00edna recombinante hasta un paso de semipurificaci\u00f3n o purificaci\u00f3n primaria. Los antisueros dirigidos contra las prote\u00ednas de la cepa hospedera se generaron en conejos por un proceso de inmunizaci\u00f3n en cascada. Para la validaci\u00f3n se analizaron los siguientes par\u00e1metros: linealidad, l\u00edmite de detecci\u00f3n y cuantificaci\u00f3n, exactitud, rango y precisi\u00f3n. El ensayo establecido result\u00f3 espec\u00edfico, con una exactitud entre 89% y 109% para todos los tampones estudiados; se demostr\u00f3 un ajuste parab\u00f3lico y un rango de trabajo entre 0,63 y 1,25 ng/mL, la repetibilidad y la precisi\u00f3n intermedia mostraron coeficientes de variaci\u00f3n inferiores al 10 y 20% respectivamente.\n[B\u00fasqueda e identificaci\u00f3n de nuevos candidatos a vacuna contra la malaria producida por Plasmodium vivax](https://revistas.unal.edu.co/index.php/actabiol/article/view/27394) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAndr\u00e9s Mauricio Pinz\u00f3n Velasco\n2004-07-01\nbioinform\u00e1ticas, estableciendo diversos patrones de alineamiento, as\u00ed como niveles de similitud no menores al 40%. A pesar de un riguroso enmascaramiento tanto de las secuencias prot\u00e9icas de P. falciparum, como del genoma de P. vivax, en este \u00faltimo fue evidente una alta presencia de regiones repetitivas que no fueron enmascaradas por ninguna de las fuentes de ADN repetitivo presente en la base de datos de REPBASE, lo cual lleva a pensar que dichas regiones pueden ser espec\u00edficas de este tipo de organismos. Finalmente se encontraron coincidencias entre 76 secuencias proteicas con actividad antig\u00e9nica de P. falciparum y el genoma hasta ahora secuenciado de P. vivax, que cumpl\u00edan con los requisitos m\u00ednimos para establecer los niveles de coincidencia, entre las cuales se determin\u00f3 que cuatro constituyen importantes candidatos a una vacuna contra la malaria producida por P. vivax.\n[The genome sequence of Brucella pinnipedialis B2/94 sheds light on the evolutionary history of the genus Brucella](http://www.biomedcentral.com/1471-2148/11/200) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nClaverie Jean-Michel\n2011-07-01\nFull Text Available Abstract Background Since the discovery of the Malta fever agent, Brucella melitensis, in the 19th century, six terrestrial mammal-associated Brucella species were recognized over the next century. More recently the number of novel Brucella species has increased and among them, isolation of species B. pinnipedialis and B. ceti from marine mammals raised many questions about their origin as well as on the evolutionary history of the whole genus. Results We report here on the first complete genome sequence of a Brucella strain isolated from marine mammals, Brucella pinnipedialis strain B2/94. A whole gene-based phylogenetic analysis shows that five main groups of host-associated Brucella species rapidly diverged from a likely free-living ancestor close to the recently isolated B. microti. However, this tree lacks the resolution required to resolve the order of divergence of those groups. Comparative analyses focusing on a genome segments unshared between B. microti and B. pinnipedialis, b gene deletion/fusion events and c positions and numbers of Brucella specific IS711 elements in the available Brucella genomes provided enough information to propose a branching order for those five groups. Conclusions In this study, it appears that the closest relatives of marine mammal Brucella sp. are B. ovis and Brucella sp. NVSL 07-0026 isolated from a baboon, followed by B. melitensis and B. abortus strains, and finally the group consisting of B. suis strains, including B. canis and the group consisting of the single B. neotomae species. We were not able, however, to resolve the order of divergence of the two latter groups.\n[Evaluation of experimental vaccines for bovine viral diarrhea in bovines, ovines and guinea pigs Evaluaci\u00f3n de vacunas experimentales para la diarrea viral bovina en bovinos, ovinos y cobayos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412009000200005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nF. Fern\u00e1ndez\n2009-06-01\nFull Text Available The bovine viral diarrhea virus (BVDV infection control should be based on elimination of persistently infected animals and on immunization through vaccination, to prevent fetal infection. However, the efficacy of inactivated BVDV vaccines is variable due to its low immunogenicity. This study evaluated the humoral immune response against homologous and heterologous strains of 7 inactivated BVDV vaccines, in bovines and two experimental models (ovine and guinea pig which might be used to test candidate vaccines. Vaccines formulated with BVDV Singer, Oregon, NADL, and multivalent, induced seroconversion in the three animal models studied, reaching antibody titres higher than 2. Vaccine containing 125C -genotype 2- only induced a low antibody response in ovine, while VS-115 NCP vaccine was not immunogenic. Furthermore, bovine sera at 60 dpv presented homologous as well as heterologous antibody response, indicating a high degree of cross-reactivity among the strains studied. However, when bovine sera were tested against the Argentine field strain 00-693, they showed the lowest levels of cross-reactivity, suggesting the need of continued surveillance to identify and characterize emerging field BVDV strains. Finally, optimal correlations between bovine-ovine and bovine-guinea pig models were observed, indicating that two alternative species could replace bovines when testing the immunogenicity of BVDV candidate vaccines.El control del virus de la diarrea viral bovina (VDVB se basa en la eliminaci\u00f3n de animales persistentemente infectados, y la inmunizaci\u00f3n de hembras para prevenir infecciones fetales. La eficiencia de estas vacunas es variable por su baja inmunogenicidad. Se evalu\u00f3 la respuesta inmune humoral contra virus hom\u00f3logos y heter\u00f3logos de 7 vacunas experimentales inactivadas del VDVB en bovinos y en dos modelos experimentales (ovinos y cobayos. Las vacunas conteniendo VDVB Singer, Oregon, NADL y polivalentes indujeron seroconversi\u00f3n en\n[Reactogenicidad de la vacuna cubana trivalente contra la leptospirosis humana en un ensayo cl\u00ednico de fase II](https://www.openaire.eu/search/publication?articleId=doajarticles::71daec30452063189f5b50ff40cbc04d)\nRaydel Mart\u00ednez,; Alberto P\u00e9rez; Alberto Baly; Morelia Bar\u00f3; Reynaldo Men\u00e9ndez; Aroldo Ru\u00edz; Amelia Urbino L\u00f3pez; Manuel D\u00edaz; Marlene Armesto\n2001-01-01\nCon el objetivo de evaluar la reactogenicidad de la vacuna cubana trivalente contra la leptospirosis humana (vax- SPIRAL) en grupos de voluntarios sanos utilizando diferentes dosis, se realiz\u00f3 un ensayo cl\u00ednico controlado, aleatorio y a doble ciego. Los voluntarios fueron distribuidos en dos grupos (vacunados y placebos) para evaluar las reacciones adversas en diferentes concentraciones de dosis (0,25 y 0,5 mL). Los s\u00edntomas y signos locales evaluados fueron: dolor, rubor, infiltraci\u00f3n local,...\n[Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.](https://www.ncbi.nlm.nih.gov/pubmed/26626213)\nZhu, Liangquan; Feng, Yu; Zhang, Ge; Jiang, Hui; Zhang, Zhen; Wang, Nan; Ding, Jiabo; Suo, Xun\n2016-01-12\nBrucellosis is a wide spread zoonotic disease that causes abortion and infertility in mammals and leads to debilitating, febrile illness in humans. Brucella abortus, Brucella melitensis and Brucella suis are the major pathogenic species to humans. Vaccination with live attenuated B. suis strain 2 (S2) vaccine is an essential and critical component in the control of brucellosis in China. The S2 vaccine is very effective in preventing brucellosis in goats, sheep, cattle and swine. However, there are still debates outside of China whether the S2 vaccine is able to provide protection against heterologous virulent Brucella species. We investigated the residual virulence, immunogenicity and protective efficacy of the S2 vaccine in BALB/c mice by determining bacteria persistence in spleen, serum antibody response, cellular immune response and protection against a heterologous virulent challenge. The S2 vaccine was of low virulence as there were no bacteria recovered in spleen four weeks post vaccination. The vaccinated mice developed Brucella-specific IgG in 2-3 weeks, and a burst production of IFN-\u03b3 at one week as well as a two-fold increase in TNF-\u03b1 production. The S2 vaccine protected mice from a virulent challenge by B. melitensis M28, B. abortus 2308 and B. suis S1330, and the S2 vaccinated mice did not develop any clinical signs or tissue damage. Our study demonstrated that the S2 vaccine is of low virulence, stimulates good humoral and cellular immunity and protects animals against infection by heterologous, virulent Brucella species. Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.\n[Laboratory exposure to Brucella melitensis in Denmark](http://www.forskningsdatabasen.dk/en/catalog/250070116) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nKnudsen, A; Kronborg, G; Knudsen, Inge Jenny Dahl\n2013-01-01\nBrucella species are a frequent cause of laboratory-acquired infections. This report describes the handling of a laboratory exposure of 17 laboratory staff members exposed to Brucella melitensis in a large microbiology laboratory in a brucella-non-endemic area. We followed the US Centers...\n[Aceptabilidad de la vacuna contra el virus papiloma humano en padres de adolescentes, en colombia](https://www.openaire.eu/search/publication?articleId=od______1326::8ba7ba7cedd44552d4d60ca52f50c9aa)\nWiesner, Carolina; Pi\u00f1eros, Marion; Cort\u00e9s, Claudia; Jaime Ardila, Jaime Ardila\n2012-01-01\nObjetivo La vacuna contra el VPH es una nueva tecnolog\u00eda disponible para el control del c\u00e1ncer de cuello uterino. Se espera, que en el menor tiempo posible esta vacuna pueda tener cobertura universal. Este art\u00edculo presenta la aceptabilidad que tiene los padres de adolescentes en Colombia hacia la vacuna contra el VPH y hace una aproximaci\u00f3n a sus determinantes. M\u00e9todos Estudio cualitativo en cuatro regiones en Colombia. Se realizaron 17 grupos focales con padres de ni\u00f1as y ni\u00f1os entre 11 a 1...\n[Host response to Brucella infection: review and future perspective.](https://www.ncbi.nlm.nih.gov/pubmed/26230118)\nElfaki, Mohamed G; Alaidan, Alwaleed Abdullah; Al-Hokail, Abdullah Abdulrahman\n2015-07-30\nBrucellosis is a zoonotic and contagious infectious disease caused by infection with Brucella species. The infecting brucellae are capable of causing a devastating multi-organ disease in humans with serious health complications. The pathogenesis of Brucella infection is influenced largely by host factors, Brucella species/strain, and the ability of invading brucellae to survive and replicate within mononuclear phagocytic cells, preferentially macrophages (Mf). Consequently, the course of human infection may appear as an acute fatal or progress into chronic debilitating infection with periodical episodes that leads to bacteremia and death. The existence of brucellae inside Mf represents one of the strategies used by Brucella to evade the host immune response and is responsible for treatment failure in certain human populations treated with anti-Brucella drugs. Moreover, the persistence of brucellae inside Mf complicates the diagnosis and may affect the host cell signaling pathways with consequent alterations in both innate and adaptive immune responses. Therefore, there is an urgent need to pursue the development of novel drugs and/or vaccine targets against human brucellosis using high throughput technologies in genomics, proteomics, and immunology.\nPatarroyo, Manuel Elkin\n2017-01-01\nLa malaria es una enfermedad parasitaria producida por la picadura de un mosquito; una afecci\u00f3n que en el a\u00f1o 2015 registr\u00f3 212 millones de casos y 429.000 muertes. Cada dos minutos, la malaria provoc\u00f3 la muerte de un ni\u00f1o menor de cinco a\u00f1os en todo el mundo. Diferentes cient\u00edficos a lo largo de todo el mundo han hecho m\u00faltiples intentos para combatir esta enfermedad con una vacuna efectiva que pueda erradicarla de ra\u00edz.\n[Desarrollo de una vacuna profil\u00e1ctica de segunda generaci\u00f3n contra el papilomavirus humano Development of a second generation prophylactic vaccine against human papillomavirus](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlonso Leonardo\n2011-06-01\nFull Text Available Los papilomavirus humanos (HPV son el agente etiol\u00f3gico del c\u00e1ncer cervical (CC, la segunda causa de muerte por c\u00e1ncer en mujeres. Se estima que medio mill\u00f3n de nuevos c\u00e1nceres se diagnostica cada a\u00f1o, ocurriendo la mayor\u00eda de ellos en pa\u00edses en v\u00edas de desarrollo debido a la ausencia o ineficiencia de los programas masivos de detecci\u00f3n temprana. Recientemente se han introducido en el mercado dos vacunas profil\u00e1cticas contra las principales cepas oncog\u00e9nicas de HPV, la cepa 16 y 18, responsables por el 80% de todos los CC. Estas vacunas se obtienen en forma recombinante y han demostrado ser extremadamente seguras y eficaces. Sin embargo, su impacto inmediato en la incidencia de la infecci\u00f3n por HPV en pa\u00edses en v\u00edas de desarrollo ser\u00e1 m\u00ednimo, debido principalmente al alto costo de las mismas. Existe la necesidad de contar con vacunas de segunda generaci\u00f3n, de bajo costo y de aplicaci\u00f3n masiva que permitan disminuir sensiblemente el n\u00famero de CC en la poblaci\u00f3n. Con este objetivo hemos desarrollado una plataforma de expresi\u00f3n recombinante que permite obtener part\u00edculas tipo virus (VLPs con las cuales es posible formular vacunas efectivas y accesibles contra la infecci\u00f3n por HPV.Human papillomaviruses (HPV are the etiologic agent for cervical cancer (CC, the second cause of cancer death in women worldwide. It is estimated that half a million new cases are diagnosed each year, mostly in developing countries due to the lack of massive programs for early detection of the virus. Recently, two prophylactic vaccines against the main oncogenic HPV types 16 and 18 (responsible for 80% of CC have been introduced into market. Both of these vaccines, obtained as recombinants, have been shown to be safe and effective; however, their high cost works against its immediate impact in the incidence of HPV infection in developing and low-income countries. There is a need to have in hand second generation, low cost vaccines of massive use\n[Identification of Brucella genus and eight Brucella species by Luminex bead-based suspension array.](https://www.ncbi.nlm.nih.gov/pubmed/29173617)\nLusk Pfefer, Tina S; Timme, Ruth; Kase, Julie A\n2018-04-01\nGlobally, unpasteurized milk products are vehicles for the transmission of brucellosis, a zoonosis responsible for cases of foodborne illness in the United States and elsewhere. Existing PCR assays to detect Brucella species are restricted by the resolution of band sizes on a gel or the number of fluorescent channels in a single real-time system. The Luminex bead-based suspension array is performed in a 96-well plate allowing for high throughput screening of up to 100 targets in one sample with easily discernible results. We have developed an array using the Bio-Plex 200 to differentiate the most common Brucella species: B. abortus, B. melitensis, B. suis, B. suis bv5, B. canis, B. ovis, B. pinnipedia, and B. neotomae, as well as Brucella genus. All probes showed high specificity, with no cross-reaction with non-Brucella strains. We could detect pure DNA from B. abortus, B. melitensis, and genus-level Brucella at concentrations of \u22645 fg/\u03bcL. Pure DNA from all other species tested positive at concentrations well below 500 fg/\u03bcL and we positively identified B. neotomae in six artificially contaminated cheese and milk products. An intra-laboratory verification further demonstrated the assay's accuracy and robustness in the rapid screening (3-4 h including PCR) of DNA. Published by Elsevier Ltd.\n[Antibody Reactivity to Omp31 from Brucella melitensis in Human and Animal Infections by Smooth and Rough Brucellae](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=321362)\nCassataro, Juliana; Pasquevich, Karina; Bruno, Laura; Wallach, Jorge C.; Fossati, Carlos A.; Baldi, Pablo C.\n2004-01-01\nGroup 3 of outer membrane proteins (OMPs) of Brucella includes Omp25 and Omp31, which share 34% identity. Omp25 is highly conserved in Brucella species, and Omp31 is present in all Brucella species, except Brucella abortus. Antibodies to Brucella melitensis Omp31 have been sought only in infected sheep, and Western blotting of sera from infected sheep did not reveal anti-Omp31 reactivity. We obtained recombinant purified Omp31 (B. melitensis) and tested its recognition by sera from humans and animals suffering from brucellosis by an indirect enzyme-linked immunosorbent assay (ELISA). Serum samples from 74 patients, 57 sheep, and 47 dogs were analyzed; brucellosis was confirmed by bacteriological isolation in all ovine and canine cases and 31 human cases of brucellosis. Thirty-five patients (47%) were positive for antibodies to Omp31, including seven cases of Brucella suis infection, two cases of B. abortus infection, and three cases of B. melitensis infection. Of 39 sheep naturally infected with B. melitensis (biovars 1 and 3), 23 (59%) were positive for antibodies to Omp31. Anti-Omp31 antibodies were also detected in 12 of 18 rams (67%) in which Brucella ovis was isolated from semen. Antibodies to Omp31 were also found in 41 (87%) of the 47 dogs, including 13 with recent infection. These results suggest that an indirect ELISA using recombinant purified Omp31 from B. melitensis would be of limited value for the diagnosis of human and animal brucellosis. Nevertheless, the potential usefulness of this antigen in combination with other recombinant proteins from Brucella should not be dismissed. PMID:14715555\n[[Evasion of anti-infectious immunity by Brucella - A review].](https://www.ncbi.nlm.nih.gov/pubmed/29727136)\nQuan, Wurong; Yang, Yongjie\n2016-05-04\nBrucellosis, caused by Brucella species, is a worldwide zoonosis. As facultative intracellular pathogens, Brucella possess non-classical virulence factor, but its virulence is very powerful and can elicit chronic infections of both animals and humans. Evasion of host anti-infectious immunity is a prerequisite for chronic infections, this ability appears increasingly crucial for Brucella virulence. As successful pathogens, Brucella can escape or suppress innate immunity and modulate adaptive immunity to establish long lasting infections in host cells. In this review, we address the molecular mechanisms of Brucella to evade anti-infectious immunity. This will shed new insights on Brucella virulence and will, potentially, open new prophylactic avenues.\n[Brucella epididymo-orchitis: a consideration in endemic area](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382006000300011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJaffar A. Al-Tawfiq\n2006-06-01\nFull Text Available Brucellosis is a zoonotic disease caused by Brucella sp. and may affect many parts of the body. Brucella epididymo-orchitis had been reported in up to 20% of patients with brucellosis. This is a case report of Brucella epididymo-orchitis in a Saudi male patient. He presented with a unilateral swelling of the left testicle. He had fever, arthralgia and night sweats. Ultrasound examination revealed enlarged left epididymis and testicle. Brucella serology was positive and the patient responded to treatment with doxycycline and gentamicin. Thus, brucella infection should be considered in the differential diagnosis of patients presenting with epididymo-orchitis from an endemic area.\n[Hematologic changes in dogs naturally infected Leptospira spp., Brucella abortus and Brucella canis](http://rbmv.org/index.php/BJVM/article/view/434) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJacqueline Ribeiro de Castro\n2014-01-01\nFull Text Available ABSTRACT. Castro J.R., Silva C.B., Souza M.A., Salaberry S.R.S., Guimar\u00e3es E.C., Mundim A.V. & Lima-Ribeiro A.M.C. [Hematologic changes in dogs naturally infected Leptospira spp., Brucella abortus and Brucella canis.] Altera- \u00e7\u00f5es hematol\u00f3gicas em c\u00e3es naturalmente infectados por Leptospira spp., Brucella abortus e Brucella canis. Revista Brasileira de Medicina Veterin\u00e1ria, 36(1:49-54, 2014. Laborat\u00f3rio de Doen\u00e7as Infectocontagiosas, Faculdade de Medicina Veterin\u00e1ria, Universidade Federal de Uberl\u00e2ndia, Av. Cear\u00e1 s/n, Bloco 2D, Sala 33, Campus Umuarama, Uberl\u00e2ndia, MG 38400-902, Brasil. E-mail: jack_ufu@yahoo.com.br The investigations of leptospirosis and brucellosis canine act as sanitary control in public health and zoonoses because they were established by close contact between dog and human. The aim was to determine the main hematological reagents in asymptomatic dogs against Leptospira spp. Brucella abortus and Brucella canis naturally infected, living in urban areas in the city of Uberlandia, Minas Gerais. We examined 140 blood samples from clinically healthy dogs, males and females and different ages. Leptospirosis was diagnosed by microscopic agglutination test (MAT, with a collection of twelve serovars, whereas, brucellosis was identified through the tests of Agar Gel Immunodiffusion (AGID for B. canis and buffered acidified antigen (TAA confirmed 2-Mercaptoethanol (2-ME for B. abortus. The results were analyzed using descriptive statistics with the calculation of simple percentages, mean and standard deviation. He applied and short sample t test for two independent samples to assess whether there were significant differences (p<0.05 between hematological parameters obtained. Dogs evaluated, 15% (21/140 and 2.85% (4/140 were reactive to Leptospira spp. and B. abortus, respectively. There was no sample reagent against B. canis. It was concluded that although no specific thrombocytopenia may be a significant finding in dogs\n[21 CFR 866.3085 - Brucella spp. serological reagents.](https://www.gpo.gov/fdsys/pkg/CFR-2010-title21-vol8/pdf/CFR-2010-title21-vol8-sec866-3085.pdf)\n2010-04-01\n... (CONTINUED) MEDICAL DEVICES IMMUNOLOGY AND MICROBIOLOGY DEVICES Serological Reagents \u00a7 866.3085 Brucella spp... from clinical specimens or to identify antibodies to Brucella spp. in serum. Additionally, some of... to identify Brucella spp. directly from clinical specimens or cultured isolates derived from clinical...\nThe genus Brucella encompasses a group of gram negative bacteria that survive almost exclusively in infected hosts with preference for localization in intracellular compartments of cells. The genus has traditionally been divided into species based on microbe characteristics and host preference, bu...\n[Reactogenicidad e inmunogenicidad de una nueva vacuna de toxoide tet\u00e1nico y dift\u00e9rico con concentraci\u00f3n reducida en adolescentes cubanos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRolando Felipe Ochoa.\n2006-08-01\nFull Text Available Se realiz\u00f3 un estudio aleatorizado, controlado y a doble ciegas en 225 adolescentes cubanos entre 13 y 16 a\u00f1os de edad, con el objetivo de evaluar la reactogenicidad y la inmunogenicidad de una nueva vacuna de toxoide tet\u00e1nico y toxoide dift\u00e9rico con concentraci\u00f3n reducida, producida en el Instituto Finlay, con respecto a su similar comercial IMOVAX dT adult de Aventis Pasteur. Se tomaron muestras de suero antes y 21 d\u00edas despu\u00e9s de la vacunaci\u00f3n. La reactogenicidad de ambas vacunas fue similar. Los s\u00edntomas y signos, tanto locales como generales fueron moderados y aparecieron principalmente durante las primeras 72 h despu\u00e9s de la vacunaci\u00f3n. Todos los voluntarios vacunados alcanzaron niveles protectores (\u00b30,1 UI/mL de antitoxina contra el t\u00e9tanos y la difteria. El 99,25% de los inmunizados con la vacuna experimental y el 98,36% de los voluntarios del grupo control presentaron niveles de antitoxina tet\u00e1nica correspondientes a una protecci\u00f3n de larga duraci\u00f3n (\u00b31,0 UI/mL; para la antitoxina dift\u00e9rica se alcanzaron estos niveles en el 81,20% y 80,33% de los voluntarios en cada grupo. Los t\u00edtulos medios geom\u00e9tricos de antitoxina tet\u00e1nica (21,73 UI/mL y antitoxina dift\u00e9rica (2,55 UI/mL inducidos por la nueva vacuna fueron superiores (p<0,05 a los del grupo control: 15,55 UI/mL y 1,84 UI/Ml respectivamente(p<0.05.\n[Vacunaci\u00f3n de la poblaci\u00f3n de 65 a\u00f1os en Castilla-La Mancha con la vacuna antineumoc\u00f3cica conjugada 13valente (VNC13](http://www.revista-socampar.com/images/articulos/ArticulosSeparadosNum6/Articulo%20especial.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSOCAMPAR\n2018-03-01\nFull Text Available La estrategia de vacunaci\u00f3n antineumoc\u00f3cica en adultos a partir de los 65 a\u00f1os de edad ha ido modific\u00e1ndose, tras la aprobaci\u00f3n de la vacuna 13valente conjugada (VNC13 para adultos y la recomendaci\u00f3n de los Centros de Control y Prevenci\u00f3n de enfermedad de EEUU (CDC en el a\u00f1o 2014 de incluir la vacuna VNC13 a la poblaci\u00f3n a partir de 65 a\u00f1os de edad, a partir de los resultados del estudio CAPiTA. Diversos pa\u00edses, y en Espa\u00f1a varias Comunidades Auto- n\u00f3micas, ya han incluido la vacuna VNC13 en los calendarios vacunales de adultos a partir de los 65 a\u00f1os. En este documento, las sociedades: Sociedad de M\u00e9dicos Generales y de Familia de Castilla-La Mancha, Sociedad Castellano Manchega de Patolog\u00eda Respiratoria, Sociedad Castellano Manchega de M\u00e9dicos Preventivistas, Sociedad Castellano Manchega de Geriatr\u00eda, Sociedad Castellano Manchega de M\u00e9dicos Internistas (Secci\u00f3n Infecciosas, Socie- dad Castellano Manchega de Farmacia Familiar y Comunitaria presentamos a la Direcci\u00f3n General de Salud P\u00fablica de la Junta de Comunidades de Castilla-La Mancha nuestra propuesta y justificaci\u00f3n para la inclusi\u00f3n de la vacuna VNC13 en cohorte de 65 a\u00f1os de edad de Castilla-La Mancha\n[Los precios de la carne vacuna en Buenos Aires colonial. Una interpelaci\u00f3n historiogr\u00e1fica e hist\u00f3rica](https://revistas.utadeo.edu.co/index.php/TyE/article/view/945/984) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAndrea Dupuy\n2014-12-01\nFull Text Available En el \u00e1mbito de los estudios de mercado, los precios constituyen los principales indicadores del comportamiento de la econom\u00eda, aun los de Antiguo R\u00e9gimen. El objetivo del presente trabajo es abordar el an\u00e1lisis de los precios de la carne vacuna de la ciudad de Buenos Aires colonial partiendo de la idea de que este mercado, al igual que los de las distintas ciudades hispanoamericanas, present\u00f3 a lo largo de la etapa colonial una regularidad predominante. Y aun cuando estuvo atravesado por situaciones cr\u00edticas de escasez, estos factores no lograron modificar sustancialmente, desde una mirada de largo plazo, las caracter\u00edsticas del mismo.\n[La articulaci\u00f3n p\u00fablico-privada en la producci\u00f3n de vacunas en M\u00e9xico](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-11042016000400009&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSilvia Tamez\nFull Text Available RESUMEN El art\u00edculo analiza el proceso de privatizaci\u00f3n de la atenci\u00f3n a la salud: la Articulaci\u00f3n P\u00fablico-Privada (APP. Espec\u00edficamente estudia la producci\u00f3n de vacunas em M\u00e9xico, tomando como caso los Laboratorios de Biol\u00f3gicos y Reactivos de M\u00e9xico, S.A. de C.V. (Birmex, empresa paraestatal, responsable de producir, distribuir e investigar biol\u00f3gicos y reactivos en M\u00e9xico. Interesa destacar el comportamiento de Birmex durante el periodo de la pandemia de influenza de 2009, producida por el virus de la influenza A subtipo H1N1. Los resultados muestran que gracias al impulso de las pol\u00edticas de liberalizaci\u00f3n y desregulaci\u00f3n, existe una apertura de los servicios p\u00fablicos a las corporaciones supranacionales.\n[The feasibility of using antigens prepared with rough Brucella strains for diagnosis of canine brucellosis Utilidad de los ant\u00edgenos preparados con cepas rugosas de Brucella en el diagn\u00f3stico de brucelosis canina](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412010000100008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nG. I. Escobar\n2010-02-01\nFull Text Available Clinical diagnosis of canine brucellosis is not sensitive enough and a negative blood culture cannot rule out the disease. Indirect methods of serological testing such as agar gel immunodiffusion (AGID, rapid slide agglutination test (RSAT and indirect enzyme linked immunoassay (IELISA are preferred for routine diagnosis. Since Brucella canis shares antigenic components with the Brucella ovis and Brucella abortus RB51 strain, it would seem that either strain could be used as antigen. We present data on AGID and IELISA tests using the B. ovis antigen, RSAT and IELISA using the B. canis antigen and IELISA using the B. abortus RB51 antigen. The cut-off values were adjusted by the ROC analysis; the IELISA-B. ovis cut-off value was 23 (%P and the IELISA-B. abortus RB51, 24 (%P, with 100% sensitivity and 98.8% specificity. RSAT detected 100% of positive cases, while AGID was less sensitive. The sera from dogs treated with antibiotic showed that %P correlated well with the clinical course. Sera from dogs presumptively infected with B. suis were negative in all tests performed with the rough Brucella strains. RSAT is a very sensitive screening test and IELISA-B. canis, B. ovis and B. abortus RB51 could be used as confirmatory tests, since they show good specificity and sensitivity.Las t\u00e9cnicas m\u00e1s usadas en el diagn\u00f3stico de brucelosis canina son la inmunodifusi\u00f3n en gel de agar (AGID, la microaglutinaci\u00f3n en portaobjetos (RSAT y el ELISA indirecto ya que el diagn\u00f3stico cl\u00ednico es poco sensible y el bacteriol\u00f3gico no excluye la enfermedad. Como Brucella canis comparte componentes antig\u00e9nicos con Brucella ovis y Brucella abortus RB51, estas cepas podr\u00edan ser usadas indistintamente como ant\u00edgenos. En este trabajo presentamos datos sobre las pruebas de AGID e IELISA con ant\u00edgeno B. ovis, RSAT e IELISA con ant\u00edgeno B. canis e IELISA con ant\u00edgeno B. abortus RB51. Los puntos de corte ajustados con la curva ROC fueron (%P 23 para IELISA-B. ovis y\n[Studies on Brucella interferon: Chromatographic behaviour and purification](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=11562070) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nBousquet-Ucla, C.; Wietzerbin, J.; Falcoff, E.\n1980-01-01\nInterferon was induced by infecting mice with Brucella suis. Serum containing interferon activity was analyzed by chromatography on Concanavalin A-Sepharose and Phenyl-Sepharose CL-4B columns. Antiviral activity was completely retained by the lectin column indicating that all the interferon molecules are glycosylated. The chromatographic behaviour of Brucella interferon on Phenyl-Sepharose CL-4B show that, like other interferons, Brucella interferon displays hydrophobic properties. However, the hydrophobicity of the interferon molecule was masked in the crude preparation and was only detectable when purified Brucella interferon was used for chromatography. The antigenic properties of Brucella interferon provided the means for developing an affinity chromatographic method resulting in about 60.000 fold purification. As in the case of viral interferon, treatment of L cells with Brucella interferon induced specific enhanced in vitro phosphorylation of a 67.000 molecular weight protein after incubation of cell extracts with doublestranded RNA and [\u03b3- 32 p]ATP. (auth.)\n[Infec\u00e7\u00e3o em c\u00e3o por Brucella abortus: relato de caso Brucella abortus infection in dog: case report](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352007000600036) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJ. Megid\n2007-12-01\nFull Text Available Brucella abortus infection is reported in a dog from a rural area that presented at clinical evaluation left testicular enlargement and right testicular decrease. Serum resulted negative to rapid agglutination test and agar gel immunodifusion with Brucella ovis antigen but positive to buffered plate agglutination test, tube agglutination test and 2- Mercapthoetanol with B. abortus antigen. Brucella isolation was negative in blood, testicular material, semen and urine. Brucella DNA was detected in PCR from urine and blood.\n[Brucella Infection in HIV Infected Patients](http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/19745.pdf&manuscript_id=19745) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSeyedAhmad SeyedAlinaghi\n2011-12-01\nFull Text Available The purpose of this study was to assess the possible correlation between Brucella and HIV infections. Iran is a country where HIV infection is expanding and Brucellosis is prevalent. In the present study, 184 HIV infected patients were assigned and for all of them HIV infection was confirmed by western blot test. In order to identify the prevalence rate of Brucella infection and systemic brucellosis in these subjects, sera samples were obtained and Brucella specific serological tests were performed to reveal antibody titers. Detailed history was taken and physical examination was carried out for all of patients. 11 (6% subjects had high titers but only 3 of them were symptomatic. Most of these subjects were injection drug user (IDU men and one was a rural woman. Considering both prevalence rates of Brucella infection (3% and symptomatic brucellosis (0.1% in Iran, our HIV positive patients show higher rates of Brucella infection and systemic brucellosis. Preserved cellular immunity of participants and retention of granulocytes activity may explain this poor association; whereas other explanations such as immunological state difference and non-overlapping geographical distribution of the 2 pathogens have been mentioned by various authors.\n[9 CFR 113.32 - Detection of Brucella contamination.](https://www.gpo.gov/fdsys/pkg/CFR-2010-title9-vol1/pdf/CFR-2010-title9-vol1-sec113-32.pdf)\n2010-01-01\n... 9 Animals and Animal Products 1 2010-01-01 2010-01-01 false Detection of Brucella contamination... REQUIREMENTS Standard Procedures \u00a7 113.32 Detection of Brucella contamination. The test for detection of Brucella contamination provided in this section shall be conducted when such a test is prescribed in an...\n[Prevalence of Brucella antibodies in sheep and springbok ...](https://www.ajol.info/index.php/bahpa/article/view/114719) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nIt was concluded that sheep and springbok on the eleven farms had not been exposed to Brucella melitensis and B. abortus infections and that on previously positive farms the infection had been eliminated in sheep and had not spread to springbok. Key words: springbok, sheep, Brucella melitensis, Brucella abortus, ...\n[Primary and booster vaccination with DTPw-HB/Hib pentavalent vaccine in Costa Rican children who had received a birth dose of hepatitis B vaccine Vacunaci\u00f3n primaria y de refuerzo con la vacuna pentavalente DTPw-HB/Hib en ni\u00f1os costarricenses vacunados al nacer contra la hepatitis B](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002001000005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIdis Faingezicht\n2002-10-01\nprotective/seropositive titers for Hib, HB, and tetanus and about 50% for diphtheria and Bordetella pertussis. At 15 months of age, virtually all the toddlers responded with a strong boost response to all the vaccine antigens, whether they received the DTPw-HB/Hib pentavalent vaccine or the DTPw/Hib vaccine as a booster. Both booster regimens were equally well tolerated, indicating that up to five doses of the HB vaccine can be given without impact on safety. Conclusions. Our study confirms that the DTPw-HB/Hib pentavalent vaccine is highly immunogenic as a primary vaccination in children who received an HB vaccine at birth, with the pentavalent combination inducing both persisting immunity and boostable memory. The pentavalent vaccine was safe both for primary and booster vaccinations. Thus, this study in Costa Rican infants supports the routine use of the pentavalent DTPw-HB/Hib vaccine as part of childhood vaccination programs in Latin America and the Caribbean.Objetivos. La vacuna combinada pentavalente DTPw-HB/Hib ha sido creada siguiendo la recomendaci\u00f3n de la Organizaci\u00f3n Mundial de la Salud de a\u00f1adir las vacunas contra la hepatitis b (HB y el Haemophilus influenzae tipo b (Hib a los programas de vacunaci\u00f3n infantil. Los objetivos del presente estudio consistieron en: 1 analizar la inmunogenicidad y reactogenicidad de la vacuna combinada pentavalente DTPw-HB/Hib en comparaci\u00f3n con las inyecciones separadas de las vacunas DTPw-HB e Hib como vacunaci\u00f3n primaria en un grupo de ni\u00f1os que hab\u00edan recibido al nacer una dosis de vacuna contra la HB, y 2 evaluar la persistencia de anticuerpos en el segundo a\u00f1o de vida, as\u00ed como la respuesta a las dosis de recuerdo de DTPw-HB/Hib o DTPw/Hib. M\u00e9todos. En la primera parte del estudio (fase de vacunaci\u00f3n primaria, realizada en 1998-1999, se analiz\u00f3 la inmunogenicidad y reactogenicidad de la vacuna combinada DTPw-HB/Hib en comparaci\u00f3n con inyecciones separadas de las vacunas DTPw-HB e Hib como vacunaci\u00f3n primaria a\n[Infection of cattle in Kenya with Brucella abortus biovar 3 and Brucella melitensis biovar 1 genotypes](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F175b4943-cce5-4a49-8c81-e99e4eda87d2/uquery/Brucella/id/1/Language/EN)\nMuendo, Esther N.; Mbatha, Peter M.; Macharia, Joseph; Abdoel, Theresia H.; Janszen, Paul V.; Pastoor, Rob; Smits, Henk L.\n2012-01-01\nBrucella melitensis biovar 1 was isolated from bovine milk samples from a herd in central Kenya, and Brucella abortus biovar 3 was isolated from aborted fetus materials and vaginal discharge fluids from cattle in central and eastern provinces of Kenya. All infections including those with B.\n[Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN.](https://www.ncbi.nlm.nih.gov/pubmed/20875156)\nHe, Yongqun; Xiang, Zuoshuang\n2010-09-27\nBrucella spp. are Gram-negative, facultative intracellular bacteria that cause brucellosis, one of the commonest zoonotic diseases found worldwide in humans and a variety of animal species. While several animal vaccines are available, there is no effective and safe vaccine for prevention of brucellosis in humans. VIOLIN (http://www.violinet.org) is a web-based vaccine database and analysis system that curates, stores, and analyzes published data of commercialized vaccines, and vaccines in clinical trials or in research. VIOLIN contains information for 454 vaccines or vaccine candidates for 73 pathogens. VIOLIN also contains many bioinformatics tools for vaccine data analysis, data integration, and vaccine target prediction. To demonstrate the applicability of VIOLIN for vaccine research, VIOLIN was used for bioinformatics analysis of existing Brucella vaccines and prediction of new Brucella vaccine targets. VIOLIN contains many literature mining programs (e.g., Vaxmesh) that provide in-depth analysis of Brucella vaccine literature. As a result of manual literature curation, VIOLIN contains information for 38 Brucella vaccines or vaccine candidates, 14 protective Brucella antigens, and 68 host response studies to Brucella vaccines from 97 peer-reviewed articles. These Brucella vaccines are classified in the Vaccine Ontology (VO) system and used for different ontological applications. The web-based VIOLIN vaccine target prediction program Vaxign was used to predict new Brucella vaccine targets. Vaxign identified 14 outer membrane proteins that are conserved in six virulent strains from B. abortus, B. melitensis, and B. suis that are pathogenic in humans. Of the 14 membrane proteins, two proteins (Omp2b and Omp31-1) are not present in B. ovis, a Brucella species that is not pathogenic in humans. Brucella vaccine data stored in VIOLIN were compared and analyzed using the VIOLIN query system. Bioinformatics curation and ontological representation of Brucella vaccines\n[Eficacia de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271997000200003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGonz\u00e1lez Enr\u00edquez Jes\u00fas\n1997-01-01\nFull Text Available FUNDAMENTO: Este trabajo consiste esencialmente en una revisi\u00f3n sistem\u00e1tica de la literatura cient\u00edfica sobre los efectos, intensidad y duraci\u00f3n de la respuesta serol\u00f3gica, as\u00ed como sobre la eficacia, efectividad y seguridad de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C. M\u00c9TODOS: B\u00fasqueda en repertorio MEDLINE en el periodo 1970-1996. B\u00fasqueda espec\u00edfica de ensayos cl\u00ednicos aleatorizados y estudios de intervenci\u00f3n prospectivos en humanos con vacunas de polisac\u00e1ridos capsulares de meningococo en el mismo repertorio y periodo. An\u00e1lisis cr\u00edtico de literatura cient\u00edfica y s\u00edntesis de evidencia. RESULTADOS: La vacuna de polisac\u00e1rido capsular del serogrupo C es considerada segura y ha mostrado una eficacia superior al 85% en adultos y ni\u00f1os mayores, 70% (IC95%: 5-91% en ni\u00f1os menores de 5 a\u00f1os y 55% (IC90%: 14-76% en ni\u00f1os de 2-3 a\u00f1os. La vacuna no se ha mostrado eficaz en ni\u00f1os menores de 2 a\u00f1os. La duraci\u00f3n de niveles de anticuerpos protectores disminuye con la edad. La proporci\u00f3n de ni\u00f1os menores de 6 a\u00f1os efectivamente protegidos al a\u00f1o de la vacunaci\u00f3n es baja. La vacunaci\u00f3n no limita la respuesta serol\u00f3gica de vacunaciones ulteriores. CONCLUSIONES: La vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del serogrupo C est\u00e1 indicada en adultos y ni\u00f1os mayores de 2 a\u00f1os como protecci\u00f3n contra la enfermedad meningoc\u00f3cica causada por este serogrupo en situaciones de alto riesgo de enfermedad. La escasa protecci\u00f3n que ofrece la vacuna en los menores de 2 a\u00f1os, la limitada eficacia en menores de 5 a\u00f1os y la corta duraci\u00f3n de la inmunidad que confiere a estas edades, hace que la vacunaci\u00f3n rutinaria no est\u00e9 recomendada y que la vacuna se use fundamentalmente en el control de brotes epid\u00e9micos causados por serogrupo C.\n[A review of Brucella infection in marine mammals, with special emphasis on Brucella pinnipedialis in the hooded seal (Cystophora cristata)](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3161862)\n2011-01-01\nBrucella spp. were isolated from marine mammals for the first time in 1994. Two novel species were later included in the genus; Brucella ceti and Brucella pinnipedialis, with cetaceans and seals as their preferred hosts, respectively. Brucella spp. have since been isolated from a variety of marine mammals. Pathological changes, including lesions of the reproductive organs and associated abortions, have only been registered in cetaceans. The zoonotic potential differs among the marine mammal Brucella strains. Many techniques, both classical typing and molecular microbiology, have been utilised for characterisation of the marine mammal Brucella spp. and the change from the band-based approaches to the sequence-based approaches has greatly increased our knowledge about these strains. Several clusters have been identified within the B. ceti and B. pinnipedialis species, and multiple studies have shown that the hooded seal isolates differ from other pinniped isolates. We describe how different molecular methods have contributed to species identification and differentiation of B. ceti and B. pinnipedialis, with special emphasis on the hooded seal isolates. We further discuss the potential role of B. pinnipedialis for the declining Northwest Atlantic hooded seal population. PMID:21819589\n[A review of Brucella infection in marine mammals, with special emphasis on Brucella pinnipedialis in the hooded seal (Cystophora cristata](http://www.veterinaryresearch.org/content/42/1/93) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nNymo Ingebj\u00f8rg H\n2011-08-01\nFull Text Available Abstract Brucella spp. were isolated from marine mammals for the first time in 1994. Two novel species were later included in the genus; Brucella ceti and Brucella pinnipedialis, with cetaceans and seals as their preferred hosts, respectively. Brucella spp. have since been isolated from a variety of marine mammals. Pathological changes, including lesions of the reproductive organs and associated abortions, have only been registered in cetaceans. The zoonotic potential differs among the marine mammal Brucella strains. Many techniques, both classical typing and molecular microbiology, have been utilised for characterisation of the marine mammal Brucella spp. and the change from the band-based approaches to the sequence-based approaches has greatly increased our knowledge about these strains. Several clusters have been identified within the B. ceti and B. pinnipedialis species, and multiple studies have shown that the hooded seal isolates differ from other pinniped isolates. We describe how different molecular methods have contributed to species identification and differentiation of B. ceti and B. pinnipedialis, with special emphasis on the hooded seal isolates. We further discuss the potential role of B. pinnipedialis for the declining Northwest Atlantic hooded seal population.\n[Whole-genome analyses of speciation events in pathogenic Brucellae](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=978721) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nChain, Patrick S. G. [Lawrence Livermore National Laboratory (LLNL); Comerci, Diego J. [Universidad Nacional de General San Martin; Tolmasky, Marcelo E. [California State University; Larimer, Frank W [ORNL; Malfatti, Stephanie [Lawrence Livermore National Laboratory (LLNL); Vergez, Lisa [Lawrence Livermore National Laboratory (LLNL); Aguero, Fernan [Universidad Nacional de General San Martin; Land, Miriam L [ORNL; Ugalde, Rodolfo A. [Universidad Nacional de General San Martin; Garcia, Emilio [Lawrence Livermore National Laboratory (LLNL)\n2005-12-01\nDespite their high DNA identity and a proposal to group classical Brucella species as biovars of Brucella melitensis, the commonly recognized Brucella species can be distinguished by distinct biochemical and fatty acid characters, as well as by a marked host range (e.g., Brucella suis for swine, B. melitensis for sheep and goats, and Brucella abortus for cattle). Here we present the genome of B. abortus 2308, the virulent prototype biovar 1 strain, and its comparison to the two other human pathogenic Brucella species and to B. abortus field isolate 9-941. The global distribution of pseudogenes, deletions, and insertions supports previous indications that B. abortus and B. melitensis share a common ancestor that diverged from B. suis. With the exception of a dozen genes, the genetic complements of both B. abortus strains are identical, whereas the three species differ in gene content and pseudogenes. The pattern of species-specific gene inactivations affecting transcriptional regulators and outer membrane proteins suggests that these inactivations may play an important role in the establishment of host specificity and may have been a primary driver of speciation in the genus Brucella. Despite being nonmotile, the brucellae contain flagellum gene clusters and display species-specific flagellar gene inactivations, which lead to the putative generation of different versions of flagellum-derived structures and may contribute to differences in host specificity and virulence. Metabolic changes such as the lack of complete metabolic pathways for the synthesis of numerous compounds (e.g., glycogen, biotin, NAD, and choline) are consistent with adaptation of brucellae to an intracellular life-style.\n[El timerosal y las enfermedades del neurodesarrollo infantil](https://www.openaire.eu/search/publication?articleId=doajarticles::022a82660015c5c135852a1b502182b6)\nLuis Maya; Flora Luna\n2006-01-01\nSe eval\u00faa la relaci\u00f3n causal entre el timerosal (etilmercurio), como preservante en las vacunas pedi\u00e1tricas, y el incremento de casos de enfermedades del neurodesarrollo infantil, como consecuencia de la ampliaci\u00f3n de los esquemas de inmunizaci\u00f3n. Se revis\u00f3 la informaci\u00f3n cient\u00edfica, relacionando el timerosal y las evidencias que permitan evaluar una posible asociaci\u00f3n causal, con estudios epidemiol\u00f3gicos, ecol\u00f3gicos, biomoleculares y toxicol\u00f3gicos, de bioseguridad, toxicol\u00f3gicos fetales y so...\n[Provada amb \u00e8xit en cabres una nova vacuna contra la tuberculosi](https://www.openaire.eu/search/publication?articleId=od______1404::4dfcdb9afa501d98d59e07e37c0dec1f)\nP\u00e9rez del Val, Bernat\n2014-01-01\nInvestigadors del CReSA proven per primer cop i amb \u00e8xit una nova vacuna contra la tuberculosi que millora la protecci\u00f3 de l\u2019\u00fanica vacuna existent en l\u2019actualitat, l\u2019efic\u00e0cia de la qual \u00e9s for\u00e7a limitada. Els estudis s\u2019han realitzat emprant cabres dom\u00e8stiques, que reprodueixen amb elevada similitud les caracter\u00edstiques patol\u00f2giques i la resposta immunol\u00f2gica a la infecci\u00f3 tuberculosa activa en humans i que, pel fet de ser hostes naturals de la tuberculosi, tamb\u00e9 permeten estudiar l\u2019\u00fas potenci...\n[Epizootiology of Brucella infection in Australian fur seals.](https://www.ncbi.nlm.nih.gov/pubmed/21441188)\nLynch, Michael; Duignan, P\u00e1draig J; Taylor, Trevor; Nielsen, Ole; Kirkwood, Roger; Gibbens, John; Arnould, John P Y\n2011-04-01\nNovel members of the bacterial genus Brucella have recently emerged as pathogens of various marine mammal species and as potential zoonotic agents. We investigated the epizootiology of Brucella infection in Australian fur seals (Arctocephalus pusillus doriferus) by establishing demographic and temporal variations in antibody prevalence, attempting isolation of the causative agent, and determining whether this potential pathogen is involved in frequent abortions observed in this pinniped species. Two competitive enzyme-linked immunosorbent assays (cELISAs), an indirect ELISA, and a fluorescence polarization assay (FPA) were used to test sera for Brucella antibodies. The FPA and cELISA proved suitable for use in this species. Significant differences in antibody prevalence were found between age classes of seals sampled between 2007 and 2009 at one colony. Pups sampled at this site (n=134) were negative for Brucella antibodies by all serologic tests but 17 of 45 (38%) of juveniles were antibody-positive. Antibody prevalence in adult females was significantly higher than in juveniles (P=0.044). Antibody prevalence for adult females between 2003 and 2009 varied significantly over time (P=0.011), and for individuals sampled between 2003 and 2005, the likelihood of pregnancy was greater in individuals positive for Brucella antibodies (P=0.034). Inflammatory lesions suggestive of infectious agents were found in 14 of 39 aborted Australian fur seal pups, but pathologic changes were not uniformly consistent for Brucella infection. Culture and PCR investigations on fetal tissues were negative for Brucella. Culture and PCR on selected fresh or frozen tissues from 36 juvenile and adult animals were also negative. We suspect that the prevalence of active infection with Brucella in Australian fur seals is low relative to antibody prevalence.\n[Antimicrobial Susceptibility of Brucella melitensis Isolates in Peru](http://www.dtic.mil/docs/citations/ADA552244)\n2011-03-01\n2011, American Society for Microbiology. All Rights Reserved. Antin1icrobial Susceptibility of Brucella melitensis Isolates in Peru 9 Ryan C. Maves,1...48 human Brucella melitensis biotype 1 strains from Peru between 2000 and 2006. MICs of isolates to doxycycline, azithromycin, gentamicin, rifampin...of testing. Relapses did nut appear to be related tu drug resistance. Infection by Brucella species is a major cause of zoonotic disease\n[Replication of Brucella abortus and Brucella melitensis in fibroblasts does not require Atg5-dependent macroautophagy.](https://www.ncbi.nlm.nih.gov/pubmed/25179110)\nHamer, Isabelle; Goffin, Emeline; De Bolle, Xavier; Letesson, Jean-Jacques; Jadot, Michel\n2014-09-02\nSeveral intracellular bacterial pathogens have evolved subtle strategies to subvert vesicular trafficking pathways of their host cells to avoid killing and to replicate inside the cells. Brucellae are Gram-negative facultative intracellular bacteria that are responsible for brucellosis, a worldwide extended chronic zoonosis. Following invasion, Brucella abortus is found in a vacuole that interacts first with various endosomal compartments and then with endoplasmic reticulum sub-compartments. Brucella establishes its replication niche in ER-derived vesicles. In the past, it has been proposed that B. abortus passed through the macroautophagy pathway before reaching its niche of replication. However, recent experiments provided evidence that the classical macroautophagy pathway was not involved in the intracellular trafficking and the replication of B. abortus in bone marrow-derived macrophages and in HeLa cells. In contrast, another study showed that macroautophagy favoured the survival and the replication of Brucella melitensis in infected RAW264.7 macrophages. This raises the possibility that B. abortus and B. melitensis followed different intracellular pathways before replicating. In the present work, we have addressed this issue by comparing the replication rate of B. abortus and B. melitensis in embryonic fibroblasts derived from wild-type and Atg5-/- mice, Atg5 being a core component of the canonical macroautophagic pathway. Our results indicate that both B. abortus S2308 and B. melitensis 16M strains are able to invade and replicate in Atg5-deficient fibroblasts, suggesting that the canonical Atg5-dependent macroautophagic pathway is dispensable for Brucella replication. The number of viable bacteria was even slightly higher in Atg5-/- fibroblasts than in wild-type fibroblasts. This increase could be due to a more efficient uptake or to a better survival rate of bacteria before the beginning of the replication in Atg5-deficient cells as compared to wild\n[Relevance of Helicobacter pylori virulence factors for vaccine development Relevancia de los factores de virulencia de helicobacter pylori para el desarrollo de vacunas](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900010) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuz del Carmen Hern\u00e1ndez-Hern\u00e1ndez\n2009-01-01\n\u00ed, los individuos infectados por cepas que expresan estos factores de virulencia probablemente desarrollan enfermedades severas como el c\u00e1ncer g\u00e1strico. Sin embargo, la ancestral relaci\u00f3n entre H. pylori y los humanos sugiere que algunas cepas pueden ser beneficiosas para la salud humana. Por lo tanto, la administraci\u00f3n generalizada de tratamientos con antibi\u00f3tico podr\u00eda eventualmente causar problemas. El desarrollo de vacunas con base en factores de virulencia que confieran protecci\u00f3n a largo plazo es la mejor estrategia para el control y/o eliminaci\u00f3n de cepas pat\u00f3genas. Los diferentes esquemas y formulaciones de inmunizaci\u00f3n dise\u00f1ados para evaluar las vacunas con base en factores de virulencia en modelos animales han dado resultados prometedores. Sin embargo, ha sido necesario probar si estos resultados pueden ser reproducidos en humanos. Este trabajo revisa los recientes estudios de vacunaci\u00f3n que han explorado esta posibilidad: vacunas orales usando ureasa o c\u00e9lulas completas-inactivadas con LT como adyuvante y ureasa expresada en vectores de Salmonella spp.; adem\u00e1s de una vacuna intramuscular multicomponente con hidr\u00f3xido de aluminio como adyuvante. Aunque estos estudios han logrado limitado \u00e9xito han establecido las bases para el desarrollo de una vacuna eficaz contra esta infecci\u00f3n.\n[Brucella Dissociation Is Essential for Macrophage Egress and Bacterial Dissemination](http://journal.frontiersin.org/Journal/10.3389/fcimb.2014.00023/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nThomas A Ficht\n2014-03-01\nFull Text Available It has long been observed that smooth Brucella can dissociate into rough mutants that are cytotoxic to macrophages. However, the in vivo biological significance and/or mechanistic de-tails of Brucella dissociation and cytotoxicity remain incomplete. In the current report, a plaque assay was developed using Brucella strains exhibiting varying degrees of cytotoxicity. Infected monolayers were observed daily using phase contrast microscopy for plaque formation while Brucella uptake and replication were monitored using an immunofluorescence assay (IFA. Vis-ible plaques were detected at 4-5 days post infection (p.i. with cytotoxic Brucella 16M\u2206manBA at an MOI of 0.1. IFA staining demonstrated that the plaques consisted of macrophages with replicating Brucella. Visible plaques were not detected in monolayers infected with non-cytotoxic 16M\u2206manBA\u2206virB2 at an MOI of 0.1. However, IFA staining did reveal small groups of macrophages (foci with replicating Brucella in the monolayers infected with 16M\u2206manBA\u2206virB2. The size of the foci observed in macrophage monolayers infected with rough Brucella correlated directly with cytotoxicity measured in liquid culture, suggesting that cytotoxicity was essential for Brucella egress and dissemination. In monolayers infected with 16M, small and large foci were observed. Double antibody staining revealed spontaneous rough mutants within the large, but not the small foci in 16M infected monolayers. Furthermore, plaque formation was observed in the large foci derived from 16M infections. Finally, the addi-tion of gentamicin to the culture medium inhibited plaque formation, suggesting that the cell-to-cell spreading occurred only following release of the organisms from the cells. Taken together, these results demonstrate that Brucella induced cytotoxicity is critical for Brucella egress and dissemination.\n[Brucella dissociation is essential for macrophage egress and bacterial dissemination.](https://www.ncbi.nlm.nih.gov/pubmed/24634889)\nPei, Jianwu; Kahl-McDonagh, Melissa; Ficht, Thomas A\n2014-01-01\nIt has long been observed that smooth Brucella can dissociate into rough mutants that are cytotoxic to macrophages. However, the in vivo biological significance and/or mechanistic details of Brucella dissociation and cytotoxicity remain incomplete. In the current report, a plaque assay was developed using Brucella strains exhibiting varying degrees of cytotoxicity. Infected monolayers were observed daily using phase contrast microscopy for plaque formation while Brucella uptake and replication were monitored using an immunofluorescence assay (IFA). Visible plaques were detected at 4-5 days post infection (p.i.) with cytotoxic Brucella 16M\u0394manBA at an MOI of 0.1. IFA staining demonstrated that the plaques consisted of macrophages with replicating Brucella. Visible plaques were not detected in monolayers infected with non-cytotoxic 16M\u0394manBA\u0394virB2 at an MOI of 0.1. However, IFA staining did reveal small groups of macrophages (foci) with replicating Brucella in the monolayers infected with 16M\u0394manBA\u0394virB2. The size of the foci observed in macrophage monolayers infected with rough Brucella correlated directly with cytotoxicity measured in liquid culture, suggesting that cytotoxicity was essential for Brucella egress and dissemination. In monolayers infected with 16M, small and large foci were observed. Double antibody staining revealed spontaneous rough mutants within the large, but not the small foci in 16M infected monolayers. Furthermore, plaque formation was observed in the large foci derived from 16M infections. Finally, the addition of gentamicin to the culture medium inhibited plaque formation, suggesting that cell-to-cell spread occurred only following release of the organisms from the cells. Taken together, these results demonstrate that Brucella-induced cytotoxicity is critical for Brucella egress and dissemination.\n[Brucella papionis sp. nov., isolated from baboons (Papio spp.).](https://www.ncbi.nlm.nih.gov/pubmed/25242540)\nWhatmore, Adrian M; Davison, Nicholas; Cloeckaert, Axel; Al Dahouk, Sascha; Zygmunt, Michel S; Brew, Simon D; Perrett, Lorraine L; Koylass, Mark S; Vergnaud, Gilles; Quance, Christine; Scholz, Holger C; Dick, Edward J; Hubbard, Gene; Schlabritz-Loutsevitch, Natalia E\n2014-12-01\nTwo Gram-negative, non-motile, non-spore-forming coccoid bacteria (strains F8/08-60(T) and F8/08-61) isolated from clinical specimens obtained from baboons (Papio spp.) that had delivered stillborn offspring were subjected to a polyphasic taxonomic study. On the basis of 16S rRNA gene sequence similarities, both strains, which possessed identical sequences, were assigned to the genus Brucella. This placement was confirmed by extended multilocus sequence analysis (MLSA), where both strains possessed identical sequences, and whole-genome sequencing of a representative isolate. All of the above analyses suggested that the two strains represent a novel lineage within the genus Brucella. The strains also possessed a unique profile when subjected to the phenotyping approach classically used to separate species of the genus Brucella, reacting only with Brucella A monospecific antiserum, being sensitive to the dyes thionin and fuchsin, being lysed by bacteriophage Wb, Bk2 and Fi phage at routine test dilution (RTD) but only partially sensitive to bacteriophage Tb, and with no requirement for CO2 and no production of H2S but strong urease activity. Biochemical profiling revealed a pattern of enzyme activity and metabolic capabilities distinct from existing species of the genus Brucella. Molecular analysis of the omp2 locus genes showed that both strains had a novel combination of two highly similar omp2b gene copies. The two strains shared a unique fingerprint profile of the multiple-copy Brucella-specific element IS711. Like MLSA, a multilocus variable number of tandem repeat analysis (MLVA) showed that the isolates clustered together very closely, but represent a distinct group within the genus Brucella. Isolates F8/08-60(T) and F8/08-61 could be distinguished clearly from all known species of the genus Brucella and their biovars by both phenotypic and molecular properties. Therefore, by applying the species concept for the genus Brucella suggested by the ICSP\n[Prevalencia de anticuerpos contra Brucella sp. En donantes del banco de sangre de un hospital de Lima](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000400013&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAbel Ortega\n2007-10-01\nFull Text Available El Per\u00fa es un pa\u00eds end\u00e9mico de Brucelosis, por lo que existe el riesgo de transmisi\u00f3n a trav\u00e9s de sangre donada por no ser parte del tamizaje regular que realizan los bancos de sangre. Para conocer la prevalencia de anticuerpos contra Brucella en donantes del banco de sangre del Hospital Edgardo Rebagliati Martins, se analiz\u00f3 1003 muestras de suero. La prueba tamiz fue Rosa de Bengala (RB; las muestras positivas fueron evaluadas por las pruebas de aglutinaci\u00f3n en tubo (AT y 2-Mercaptoetanol (2-ME. Dos donantes fueron positivos a RB, confirmados por AT y 2-ME, se encontr\u00f3 una prevalencia de 0,20% (IC99%: 0,01-0,92. Se demostr\u00f3 la presencia de donantes portadores de anticuerpos contra Brucella con posible Brucelosis activa, evidenci\u00e1ndose la posibilidad de transmisi\u00f3n de esta infecci\u00f3n. Se debe realizar mayores estudios con la finalidad de conocer la realidad de otros bancos de sangre.\n[Impacto y efectividad de la vacunaci\u00f3n infantil con la vacuna neumoc\u00f3cica conjugada 13-valente en Navarra](https://www.openaire.eu/search/publication?articleId=od______2347::862e193bff7f2aed1ec83096ecbe1486)\nGuevara Eslava, Marcela\n2015-01-01\nLa vacuna neumoc\u00f3cica conjugada 7 valente (VNC7) comenz\u00f3 a estar disponibles en Espa\u00f1a en 2001, la 10-valente (VNC10) en 2009 y la 13-valente (VNC13) en 2010. En Navarra, sin estar incluidas en el calendario oficial de vacunaciones, se ha extendido su uso en los ni\u00f1os. Los objetivos de este estudio han sido evaluar el impacto de la vacunaci\u00f3n infantil con la VNC13 sobre la epidemiolog\u00eda de la enfermedad neumoc\u00f3cica invasiva (ENI) en la poblaci\u00f3n de Navarra de todas las edade...\n[Soroepidemiologia da brucelose canina causada por Brucella canis e Brucella abortus na cidade de Alfenas, MG Seroepidemiology of canine brucellosis caused by Brucella canis and Brucella abortus in Alfenas, MG, Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352004000200021) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nA.C. Almeida\n2004-04-01\nFull Text Available The prevalence of canine brucellosis was evaluated in the city of Alfenas, MG through the technique of agarose gel imunodifusion for Brucella canis and slow serum agglutination test with 2-mercaptoetanol for Brucella abortus. The prevalence was of 14.2% and 2.8%, respectively, for B. canis and B. abortus. The positives, characterized by animals above one year of age (77.8%, and mongrel dogs (56.2%, showed a prevalence of 50 and 48% for males and females, respectively. The canine brucellosis was prevalent in the city principally in dogs of outskirts.\n[Anticorpos anti-Brucella canis e anti-Brucella abortus em c\u00e3es de Aragua\u00edna, Tocantins](http://www.revistas.usp.br/bjvras/article/view/34369) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nElaine Maria Seles Dorneles\n2011-04-01\nFull Text Available The aims of the present study were to determine the seroprevalence of infection by Brucella canis and Brucella abortus and to evaluate possible risk factors for infection in dogs from Aragua\u00edna, Tocantins, Brazil. Sera from 374 dogs, of the urban zones of the municipality, from both sexes, were submitted to the agar-gel immunodiffusion for Brucella canis-antibodies and to rose Bengal test (AAT and fluorescence polarization assay (FPA for Brucella abortus-antibodies. From the 374 tested dogs, 21 reacted in the AAT, but no one was positive in the FPA. The seroprevalence of B. canis infection found in Aragua\u00edna, Tocantins, Brazil, was 44.53% (95% IC; 39.43 to 49.72. No association was found among seropositivity for B. canis and the risk factors studied. Thus, data from the present study showed that there was no infection by B. abortus among dogs in the sample and that infection by B. canis is widespread and at high prevalence in Aragua\u00edna, Tocantins, Brazil.\n[Brucella microti sp. nov., isolated from the common vole Microtus arvalis.](https://www.ncbi.nlm.nih.gov/pubmed/18218934)\nScholz, Holger C; Hubalek, Zdenek; Sedl\u00e1cek, Ivo; Vergnaud, Gilles; Tomaso, Herbert; Al Dahouk, Sascha; Melzer, Falk; K\u00e4mpfer, Peter; Neubauer, Heinrich; Cloeckaert, Axel; Maquart, Marianne; Zygmunt, Michel S; Whatmore, Adrian M; Falsen, Enevold; Bahn, Peter; G\u00f6llner, Cornelia; Pfeffer, Martin; Huber, Birgit; Busse, Hans-J\u00fcrgen; N\u00f6ckler, Karsten\n2008-02-01\nTwo Gram-negative, non-motile, non-spore-forming, coccoid bacteria (strains CCM 4915(T) and CCM 4916), isolated from clinical specimens of the common vole Microtus arvalis during an epizootic in the Czech Republic in 2001, were subjected to a polyphasic taxonomic study. On the basis of 16S rRNA (rrs) and recA gene sequence similarities, both isolates were allocated to the genus Brucella. Affiliation to Brucella was confirmed by DNA-DNA hybridization studies. Both strains reacted equally with Brucella M-monospecific antiserum and were lysed by the bacteriophages Tb, Wb, F1 and F25. Biochemical profiling revealed a high degree of enzyme activity and metabolic capabilities not observed in other Brucella species. The omp2a and omp2b genes of isolates CCM 4915(T) and CCM 4916 were indistinguishable. Whereas omp2a was identical to omp2a of brucellae from certain pinniped marine mammals, omp2b clustered with omp2b of terrestrial brucellae. Analysis of the bp26 gene downstream region identified strains CCM 4915(T) and CCM 4916 as Brucella of terrestrial origin. Both strains harboured five to six copies of the insertion element IS711, displaying a unique banding pattern as determined by Southern blotting. In comparative multilocus VNTR (variable-number tandem-repeat) analysis (MLVA) with 296 different genotypes, the two isolates grouped together, but formed a separate cluster within the genus Brucella. Multilocus sequence typing (MLST) analysis using nine different loci also placed the two isolates separately from other brucellae. In the IS711-based AMOS PCR, a 1900 bp fragment was generated with the Brucella ovis-specific primers, revealing that the insertion element had integrated between a putative membrane protein and cboL, encoding a methyltransferase, an integration site not observed in other brucellae. Isolates CCM 4915(T) and CCM 4916 could be clearly distinguished from all known Brucella species and their biovars by means of both their phenotypic and molecular\n[Characterisation of North American Brucella isolates from marine mammals.](https://www.ncbi.nlm.nih.gov/pubmed/28934239)\nWhatmore, Adrian M; Dawson, Claire; Muchowski, Jakub; Perrett, Lorraine L; Stubberfield, Emma; Koylass, Mark; Foster, Geoffrey; Davison, Nicholas J; Quance, Christine; Sidor, Inga F; Field, Cara L; St Leger, Judy\n2017-01-01\nExtension of known ecological niches of Brucella has included the description of two novel species from marine mammals. Brucella pinnipedialis is associated predominantly with seals, while two major Brucella ceti clades, most commonly associated with porpoises or dolphins respectively, have been identified. To date there has been limited characterisation of Brucella isolates obtained from marine mammals outside Northern European waters, including North American waters. To address this gap, and extend knowledge of the global population structure and host associations of these Brucella species, 61 isolates from marine mammals inhabiting North American waters were subject to molecular and phenotypic characterisation enabling comparison with existing European isolates. The majority of isolates represent genotypes previously described in Europe although novel genotypes were identified in both B. ceti clades. Harp seals were found to carry B. pinnipedialis genotypes previously confined to hooded seals among a diverse repertoire of sequence types (STs) associated with this species. For the first time Brucella isolates were characterised from beluga whales and found to represent a number of distinct B. pinnipedialis genotypes. In addition the known host range of ST27 was extended with the identification of this ST from California sea lion samples. Finally the performance of the frequently used diagnostic tool Bruce-ladder, in differentiating B. ceti and B. pinnipedialis, was critically assessed based on improved knowledge of the global population structure of Brucella associated with marine mammals.\n[Validation of the Abbreviated Brucella AMOS PCR as a Rapid Screening Method for Differentiation of Brucella abortus Field Strain Isolates and the Vaccine Strains, 19 and RB51](https://www.openaire.eu/search/publication?articleId=od_______908::f382cfe4b1f06bccb36e7dabdad3c112)\nEwalt, Darla R.; Bricker, Betsy J.\n2000-01-01\nThe Brucella AMOS PCR assay was previously developed to identify and differentiate specific Brucella species. In this study, an abbreviated Brucella AMOS PCR test was evaluated to determine its accuracy in differentiating Brucella abortus into three categories: field strains, vaccine strain 19 (S19), and vaccine strain RB51/parent strain 2308 (S2308). Two hundred thirty-one isolates were identified and tested by the conventional biochemical tests and Brucella AMOS PCR. This included 120 isola...\n[Brucella HTRA Protein and Pathogenesis: Brucella Delta HTRA Strains as Vaccines](https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2AwNtIz0EUrEyyT0sySzFOTLVLNUi1SzIySTYwS05KTzUwtU41NU41A-51DQ41dI0z8AkFbY2B7xKC1gC5iKAO8FCoR6fgkQwvQ3JVBXTDo2G1gcx-Y1lkdA13dArgZOPOKkiHqeRAlppsggzDiGlsFYFFeCmIIMTCl5okwxNok2YEDFRgHNvpJdgoeIUGOCgGgIxMy8xSAfXuFAGDDLD8dVA5lFlspoCt3Sc0pSYRoCgbf8VCskFisEJaYDJolLxZlUHdzDXH20IU7LB7qM8iZ1vFQz1QYiTGwAHv_qRKgPdVJxklpyRZJqUYGJqmmoOtZzFPN0kyTko2SjVKSTSUZFAiZJkVYiTQDF-RcVtDYggwDaxow7afKMrCnFefoJhWnAQAi_4sH) [National Research Council Canada - National Science Library](http://science-libraries.canada.ca/eng/national-science-library/)\nRoop\n1997-01-01\n.... The results of studies described in previous reports confirmed that the Brucella HtrA contributes to the resistance of these intracellular pathogens to killing by host neutrophils and macrophages...\n[Thermostable cross-protective subunit vaccine against Brucella species.](https://www.ncbi.nlm.nih.gov/pubmed/25320267)\nCherwonogrodzky, John W; Barab\u00e9, Nicole D; Grigat, Michelle L; Lee, William E; Poirier, Robert T; Jager, Scott J; Berger, Bradley J\n2014-12-01\nA subunit vaccine candidate was produced from Brucella suis 145 (biovar 4; expressing both the A antigen of Brucella abortus and the M antigen of Brucella melitensis). The preparation consisted mostly of polysaccharide (PS; >90% [wt/wt]; both cell-associated PS and exo-PS were combined) and a small amount of protein (1 to 3%) with no apparent nucleic acids. Vaccinated mice were protected (these had a statistically significant reduction in bacterial colonization compared to that of unvaccinated controls) when challenged with representative strains of three Brucella species most pathogenic for humans, i.e., B. abortus, B. melitensis, and B. suis. As little as 1 ng of the vaccine, without added adjuvant, protected mice against B. suis 145 infection (5 \u00d7 10(5) CFU), and a single injection of 1 \u03bcg of this subunit vaccine protected mice from B. suis 145 challenge for at least 14 months. A single immunization induced a serum IgG response to Brucella antigens that remained elevated for up to 9 weeks. The use of heat (i.e., boiling-water bath, autoclaving) in the vaccine preparation showed that it was thermostable. This method also ensured safety and security. The vaccine produced was immunogenic and highly protective against multiple strains of Brucella and represents a promising candidate for further evaluation. Copyright \u00a9 2014, American Society for Microbiology. All Rights Reserved.\n[Vaccines against papillomavirus infections and disease Vacunas contra el virus del papiloma humano y c\u00e1ncer cervical invasor](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003000900019) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuisa Lina Villa\n2003-01-01\nFull Text Available Squamous cell carcinoma of the uterine cervix is the second cause of cancer-related deaths in women, the higher incidence being observed in developing countries. Infection with oncogenic types of human papillomavirus (HPV is considered the major risk factor for the development of malignancies in the uterine cervix. However, HPV is considered to be a necessary but not sufficient cause for cervical cancer and, therefore, other factors contribute to the carcinogenic process, both present in the environment and from the host. Studies performed in animals, and more recently in humans, indicate that vaccination against the capsid proteins of the virus can prevent efficiently from infection. Furthermore, therapeutic vaccines are under investigation aiming the regression of papillomavirus induced tumors. The scientific basis for the development of papillomavirus vaccines and present status of clinical trials will be addressed in this chapter.El c\u00e1ncer de c\u00e9lulas escamosas del c\u00e9rvix uterino es la segunda causa de muerte relacionada con c\u00e1ncer en mujeres en el mundo; la incidencia m\u00e1s alta se ha observado en pa\u00edses en desarrollo. La infecci\u00f3n con tipos oncog\u00e9nicos de virus de papiloma humano es considerado el factor de riesgo principal para el desarrollo de malignidad en el c\u00e9rvix uterino. Sin embargo, el virus es considerado una causa necesaria pero no suficiente para desarrollo de c\u00e1ncer cervical y, por lo tanto, existen otros factores en el ambiente y en el hu\u00e9sped que contribuyen al proceso carcinog\u00e9nico. Estudios desarrollados en animales, y m\u00e1s recientemente en humanos, indican que la vacunaci\u00f3n en contra de la c\u00e1pside de las prote\u00ednas del virus puede prevenir eficientemente la infecci\u00f3n en forma profil\u00e1ctica; adem\u00e1s, las vacunas terap\u00e9uticas est\u00e1n bajo investigaci\u00f3n con el prop\u00f3sito de promover regresi\u00f3n de los tumores inducidos por virus de papiloma humano. Las bases cient\u00edficas de las vacunas desarrolladas contra este\n[MULTILOCUS SEQUENCE TYPING OF BRUCELLA ISOLATES FROM THAILAND.](https://www.ncbi.nlm.nih.gov/pubmed/29634193)\nChawjiraphan, Wireeya; Sonthayanon, Piengchan; Chanket, Phanita; Benjathummarak, Surachet; Kerdsin, Anusak; Kalambhaheti, Thareerat\n2016-11-01\nAlthough brucellosis outbreaks in Thailand are rare, they cause abortions and infertility in animals, resulting in significant economic loss. Because Brucella spp display > 90% DNA homology, multilocus sequence typing (MLST) was employed to categorize local Brucella isolates into sequence types (STs) and to determine their genetic relatedness. Brucella samples were isolated from vaginal secretion of cows and goats, and from blood cultures of infected individuals. Brucella species were determined by multiplex PCR of eight loci, in addition to MLST based on partial DNA sequences of nine house-keeping genes. MLST analysis of 36 isolates revealed 78 distinct novel allele types and 34 novel STs, while two isolates possessed the known ST8. Sequence alignments identified polymorphic sites in each allele, ranging from 2-6%, while overall genetic diversity was 3.6%. MLST analysis of the 36 Brucella isolates classified them into three species, namely, B. melitensis, B. abortus and B. suis, in agreement with multiplex PCR results. Genetic relatedness among ST members of B. melitensis and B. abortus determined by eBURST program revealed ST2 as founder of B. abortus isolates and ST8 the founder of B. melitensis isolates. ST 36, 41 and 50 of Thai Brucella isolates were identified as single locus variants of clonal cluster (CC) 8, while the majority of STs were diverse. The genetic diversity and relatedness identified using MLST revealed hitherto unexpected diversity among Thai Brucella isolates. Genetic classification of isolates could reveal the route of brucellosis transmission among humans and farm animals and also reveal their relationship with other isolates in the region and other parts of the world.\n[Brucella Infection in Asian Sea Otters (Enhydra lutris lutris) on Bering Island, Russia.](https://www.ncbi.nlm.nih.gov/pubmed/28715292)\nBurgess, Tristan L; Johnson, Christine Kreuder; Burdin, Alexander; Gill, Verena A; Doroff, Angela M; Tuomi, Pamela; Smith, Woutrina A; Goldstein, Tracey\n2017-10-01\nInfection with Brucella spp., long known as a cause of abortion, infertility, and reproductive loss in domestic livestock, has increasingly been documented in marine mammals over the past two decades. We report molecular evidence of Brucella infection in Asian sea otters (Enhydra lutris lutris). Brucella DNA was detected in 3 of 78 (4%) rectal swab samples collected between 2004 and 2006 on Bering Island, Russia. These 78 animals had previously been documented to have a Brucella seroprevalence of 28%, markedly higher than the prevalence documented in sea otters (Enhydra lutris) in North America. All of the DNA sequences amplified were identical to one or more previously isolated Brucella spp. including strains from both terrestrial and marine hosts. Phylogenetic analysis of this sequence suggested that one animal was shedding Brucella spp. DNA with a sequence matching a Brucella abortus strain, whereas two animals yielded a sequence matching a group of strains including isolates classified as Brucella pinnipedialis and Brucella melitensis. Our results highlight the diversity of Brucella spp. within a single sea otter population.\n[Brucella contamination in raw milk by polymerase chain reaction](http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5498&slc_lang=en&sid=1) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMohammad Khalili\n2016-10-01\nFull Text Available Background: Human brucellosis is a significant public health problem in many middle east countries including Iran. Brucella organisms, which are small aerobic, facultative intracellular coccobacilli, localize in the reproductive organs of host animals, causing abortions and sterility. They are shed in large numbers in the animal\u2019s urine, milk, placental fluid, and other fluids. Dairy product from raw milk are a potential threat to public health in endemic developing countries. The gold standard for the diagnosis of brucellosis is isolation of Brucella species. However, isolation Brucella species is time consuming and needed to level 3 biocontainment facilities and highly skilled technical personnel to handle samples and live bacteria for eventual identification. Handling Brucella species increase risk of laboratory infection. Polymerase chain reaction (PCR with high sensitivity and specifity overcomed to these disadvantages. The aim of this study was to detect Brucella species in milk from dairy cattle farms in Kerman province, Iran by PCR technique. Methods: Forty and eight bulk tank milk (BTM were collected from October 2015 to March 2016 from 48 dairy cattle farm including 4200 cows. DNA of milk samples extracted by lysis buffer and proteinase K method. All milk samples were examined by PCR to detect Brucella-specific DNA targeting IS 711. Positive samples must be showed 317 bp amplified, corresponding to the expected size of the IS 711 genome region in all Brucella species. Results: Using IS711 primer were detected in 4 samples (8.3% Brucella spp. from 48 BTM samples in this area. Conclusion: The results indicate that brucellosis by Brucella species is endemic in the Kerman province dairy farms. Consumption of raw milk dairy products by individual farmers operating under poor hygienic conditions represents an high risk to public health. The need for implementing control measures and raising public awareness on zoonotic transmission of\n[Duplex PCR for differentiation of the vaccine strain Brucella suis S2 and B. suis biovar 1 from other strains of Brucella spp.](https://www.ncbi.nlm.nih.gov/pubmed/25011712)\nNan, Wenlong; Tan, Pengfei; Wang, Yong; Xu, Zouliang; Mao, Kairong; Peng, Daxin; Chen, Yiping\n2014-09-01\nImmunisation with attenuated Brucella spp. vaccines prevents brucellosis, but may also interfere with diagnosis. In this study, a duplex PCR was developed to distinguish Brucella suis vaccine strain S2 from field strains of B. suis biovar 1 and other Brucella spp. The PCR detected 60 fg genomic DNA of B. suis S2 or biovar 1 field strains and was able to distinguish B. suis S2 and wild-type strains of B. suis biovar 1 among 76 field isolates representing all the common species and biovars, as well as four vaccine strains, of Brucella. Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.\n[Characterisation of North American Brucella isolates from marine mammals.](http://europepmc.org/articles/PMC5608248?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAdrian M Whatmore\nFull Text Available Extension of known ecological niches of Brucella has included the description of two novel species from marine mammals. Brucella pinnipedialis is associated predominantly with seals, while two major Brucella ceti clades, most commonly associated with porpoises or dolphins respectively, have been identified. To date there has been limited characterisation of Brucella isolates obtained from marine mammals outside Northern European waters, including North American waters. To address this gap, and extend knowledge of the global population structure and host associations of these Brucella species, 61 isolates from marine mammals inhabiting North American waters were subject to molecular and phenotypic characterisation enabling comparison with existing European isolates. The majority of isolates represent genotypes previously described in Europe although novel genotypes were identified in both B. ceti clades. Harp seals were found to carry B. pinnipedialis genotypes previously confined to hooded seals among a diverse repertoire of sequence types (STs associated with this species. For the first time Brucella isolates were characterised from beluga whales and found to represent a number of distinct B. pinnipedialis genotypes. In addition the known host range of ST27 was extended with the identification of this ST from California sea lion samples. Finally the performance of the frequently used diagnostic tool Bruce-ladder, in differentiating B. ceti and B. pinnipedialis, was critically assessed based on improved knowledge of the global population structure of Brucella associated with marine mammals.\n[Pathogenesis and immunobiology of brucellosis: review of Brucella-host interactions.](https://www.ncbi.nlm.nih.gov/pubmed/25892682)\nde Figueiredo, Paul; Ficht, Thomas A; Rice-Ficht, Allison; Rossetti, Carlos A; Adams, L Garry\n2015-06-01\nThis review of Brucella-host interactions and immunobiology discusses recent discoveries as the basis for pathogenesis-informed rationales to prevent or treat brucellosis. Brucella spp., as animal pathogens, cause human brucellosis, a zoonosis that results in worldwide economic losses, human morbidity, and poverty. Although Brucella spp. infect humans as an incidental host, 500,000 new human infections occur annually, and no patient-friendly treatments or approved human vaccines are reported. Brucellae display strong tissue tropism for lymphoreticular and reproductive systems with an intracellular lifestyle that limits exposure to innate and adaptive immune responses, sequesters the organism from the effects of antibiotics, and drives clinical disease manifestations and pathology. Stealthy brucellae exploit strategies to establish infection, including i) evasion of intracellular destruction by restricting fusion of type IV secretion system-dependent Brucella-containing vacuoles with lysosomal compartments, ii) inhibition of apoptosis of infected mononuclear cells, and iii) prevention of dendritic cell maturation, antigen presentation, and activation of naive T cells, pathogenesis lessons that may be informative for other intracellular pathogens. Data sets of next-generation sequences of Brucella and host time-series global expression fused with proteomics and metabolomics data from in vitro and in vivo experiments now inform interactive cellular pathways and gene regulatory networks enabling full-scale systems biology analysis. The newly identified effector proteins of Brucella may represent targets for improved, safer brucellosis vaccines and therapeutics. Copyright \u00a9 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.\n[Identification of Secondary Mutations Which Enhance and Stabilize the Attenuation of Brucella HTRA Mutants: Improving Brucella HTRA-Based Strains as Vaccine Candidates](https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LS8NAEF7EIj4uPvEJc_MUDZtHUymFWBJ6Uaxt1VvJbndJQVJwm4Me_Ff-P2eSmIgIve1hGNid3dmZb_ebYczhV7b1xyd0hPZFW8lA-SqY-Vy6PNFS-l5HOZ7ixHeeTJzoxb0fEjXmhyNW3QJWA2UUX6GSX-WTMABxcVd-jqjsNob7uNdb4TCKH7bZZvYmS_mdxjPGu2y_aWML6MpzGuyxNZUdsK-SHqsrvAwWGkaUmGJO_w53efk6buA5ncsUoiwlywCm_IChIX1m_VCAcRuESwx481pFV_QKS6Fhu9eiB4PxY1hoy5bmBmr04F856xZvM9JPHSMMJAaeEklv7tAn3gvBAuaQXcbRuD-w6glPqxUra2VPq0Wy-RFbzxaZOiautnCEloFQ3HaVR21f2srXnpBc8pn0This0na6WuSMbZXcdcIszllL45lSF2xDm1dLGP0NOCqrIA) [National Research Council Canada - National Science Library](http://science-libraries.canada.ca/eng/national-science-library/)\nRoop, R\n2000-01-01\nResults to date from the studies funded under this contract suggest that Brucella genes involved in maintaining efficient stationary phase physiology and allowing the brucellae to make effective use...\n[Prevalence of Brucella spp in humans](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692015000500919&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCatharina de Paula Oliveira Cavalcanti Soares\n2015-10-01\nFull Text Available Objective: to determine the seroprevalence of Brucella spp in humans.Method: this is an observational study, developed with 455 individuals between 18 and 64 years old, who use the Estrat\u00e9gia de Sa\u00fade da Fam\u00edlia (Brazil's family health strategy. The serum samples of volunteers underwent buffered acid antigen tests, such as screening, agar gel immunodiffusion and slow seroagglutination test in tubes and 2-Mercaptoethanol.Results: among the samples, 1.98% has responded to buffered-acid antigen, 2.85% to agar gel immunodiffusion test and 1.54% to the slow seroagglutination tests on tubes/2-Mercaptoethanol. The prevalence of Brucella spp was 4.4%, represented by the last two tests.Conclusion: the results of this research suggest that the studied population is exposed to Brucella spp infection.\n[Molecular investigation of virulence factors of Brucella melitensis and Brucella abortus strains isolated from clinical and non-clinical samples.](https://www.ncbi.nlm.nih.gov/pubmed/28506887)\nMirnejad, Reza; Jazi, Faramarz Masjedian; Mostafaei, Shayan; Sedighi, Mansour\n2017-08-01\nBrucella is zoonotic pathogen that induces abortion and sterility in domestic mammals and chronic infections in humans called Malta fever. It is a facultative intracellular potential pathogen with high infectivity. The virulence of Brucella is dependent upon its potential virulence factors such as enzymes and cell envelope associated virulence genes. The aim of this study was to investigate the Brucella virulence factors among strains isolated from humans and animals in different parts of Iran. Seventy eight strains of Brucella species isolated from suspected human and animal cases from several provinces of Iran during 2015-2016 and identified by phenotypic and molecular methods. The multiplex-PCR (M-PCR) assay was performed in order to detect the ure, wbkA, omp19, mviN, manA and perA genes by using gene specific primers. Out of 78 isolates of Brucella spp., 57 (73%) and 21 (27%) isolates were detected as B. melitensis and B. abortus, respectively, by molecular method. The relative frequency of virulence genes ure, wbkA, omp19, mviN, manA and perA were 74.4%, 89.7%, 93.6%, 94.9%, 100% and 92.3%, respectively. Our results indicate that the most of Brucella strains isolated from this region possess high percent of virulence factor genes (ure, wbkA, omp19, mviN, manA and perA) in their genome. So, each step of infection can be mediated by a number of virulence factors and each strain may have a unique combination of these factors that affected the rate of bacterial pathogenesis. Copyright \u00a9 2017 Elsevier Ltd. All rights reserved.\n[Brucella HTRA Protein and Pathogenesis: Brucella Delta HTA Strains as Vaccines](https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2AwNtIz0EUrEyyT0sySzFOTLVLNUi1SzIySTYwS05KTzUwtU41NU41A-51DQ41dI0z8AkFbY2B7xKC1gC5iKAO8FCoR6fgk0OZfCwPzumDQsdvA5j4wrbM6Brq6BXAzcOYVJUPU8yBKSDdBBmHENbYKwKK8FMQQYmBKzRNhiLFJsgMHKjAObPST7BQ8QoIcFQJARyZk5ikA-_YKAcCGWX46qBzKLLZSQFfukppTkgjU5KgQDL7ioVghsVghLDEZNEleLMqg7uYa4uyhC3dXPNRjkCOt46F-MTcSY2ABdv5TJUBbqpOMk9KSLZJSjQxMUk1Bt7OYp5qlmSYlGyUbpSSbSjIoEDJNirASaQYuyF470NCCDANrGjDpp8oysKcV5-gmFacBAGjOihQ) [National Research Council Canada - National Science Library](http://science-libraries.canada.ca/eng/national-science-library/)\nRoop, Martin\n1998-01-01\n.... The results of studies funded by contract DAMD17-94-C-4054 confirmed that the Brucella HtrA contributes to the resistance of these intracellular pathogens to killing by host neutrophils and macrophages...\n[Analyzing the molecular mechanism of lipoprotein localization in Brucella.](https://www.ncbi.nlm.nih.gov/pubmed/26579096)\nGoolab, Shivani; Roth, Robyn L; van Heerden, Henriette; Crampton, Michael C\n2015-01-01\nBacterial lipoproteins possess diverse structure and functionality, ranging from bacterial physiology to pathogenic processes. As such many lipoproteins, originating from Brucella are exploited as potential vaccines to countermeasure brucellosis infection in the host. These membrane proteins are translocated from the cytoplasm to the cell membrane where they are anchored peripherally by a multifaceted targeting mechanism. Although much research has focused on the identification and classification of Brucella lipoproteins and their potential use as vaccine candidates for the treatment of Brucellosis, the underlying route for the translocation of these lipoproteins to the outer surface of the Brucella (and other pathogens) outer membrane (OM) remains mostly unknown. This is partly due to the complexity of the organism and evasive tactics used to escape the host immune system, the variation in biological structure and activity of lipoproteins, combined with the complex nature of the translocation machinery. The biosynthetic pathway of Brucella lipoproteins involves a distinct secretion system aiding translocation from the cytoplasm, where they are modified by lipidation, sorted by the lipoprotein localization machinery pathway and thereafter equipped for export to the OM. Surface localized lipoproteins in Brucella may employ a lipoprotein flippase or the \u03b2-barrel assembly complex for translocation. This review provides an overview of the characterized Brucella OM proteins that form part of the OM, including a handful of other characterized bacterial lipoproteins and their mechanisms of translocation. Lipoprotein localization pathways in gram negative bacteria will be used as a model to identify gaps in Brucella lipoprotein localization and infer a potential pathway. Of particular interest are the dual topology lipoproteins identified in Escherichia coli and Haemophilus influenza. The localization and topology of these lipoproteins from other gram negative bacteria\n[Analyzing the molecular mechanism of lipoprotein localization in Brucella](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4623201)\nGoolab, Shivani; Roth, Robyn L.; van Heerden, Henriette; Crampton, Michael C.\n2015-01-01\nBacterial lipoproteins possess diverse structure and functionality, ranging from bacterial physiology to pathogenic processes. As such many lipoproteins, originating from Brucella are exploited as potential vaccines to countermeasure brucellosis infection in the host. These membrane proteins are translocated from the cytoplasm to the cell membrane where they are anchored peripherally by a multifaceted targeting mechanism. Although much research has focused on the identification and classification of Brucella lipoproteins and their potential use as vaccine candidates for the treatment of Brucellosis, the underlying route for the translocation of these lipoproteins to the outer surface of the Brucella (and other pathogens) outer membrane (OM) remains mostly unknown. This is partly due to the complexity of the organism and evasive tactics used to escape the host immune system, the variation in biological structure and activity of lipoproteins, combined with the complex nature of the translocation machinery. The biosynthetic pathway of Brucella lipoproteins involves a distinct secretion system aiding translocation from the cytoplasm, where they are modified by lipidation, sorted by the lipoprotein localization machinery pathway and thereafter equipped for export to the OM. Surface localized lipoproteins in Brucella may employ a lipoprotein flippase or the \u03b2-barrel assembly complex for translocation. This review provides an overview of the characterized Brucella OM proteins that form part of the OM, including a handful of other characterized bacterial lipoproteins and their mechanisms of translocation. Lipoprotein localization pathways in gram negative bacteria will be used as a model to identify gaps in Brucella lipoprotein localization and infer a potential pathway. Of particular interest are the dual topology lipoproteins identified in Escherichia coli and Haemophilus influenza. The localization and topology of these lipoproteins from other gram negative bacteria\n[Un An\u00e1lisis de las Variaciones de Precios Diarias en el Mercado de Liniers](https://www.openaire.eu/search/publication?articleId=od______3056::6f997afa8ad420371310199c381d7419)\nRossini, Gustavo\n2007-01-01\nA pesar de la importancia como mercado de referencia para la ganader\u00eda vacuna argentina, pocos estudios han examinado el comportamiento de las variaciones de los precios diarios en las categor\u00edas comercializadas en el Mercado de Liniers. Dado esto, el objetivo de este trabajo es aportar informaci\u00f3n sobre la incidencia de variables seleccionadas sobre los cambios en los precios diarios en este mercado en las categor\u00edas de mayor ingreso diario. Para ello, un Modelo Log\u00edstico Multinomial es usad...\n[Detecci\u00f3n de anticuerpos anti-Brucella spp. en cerdos mediante t\u00e9cnicas de aglutinaci\u00f3n y ELISA indirecto en las provincias de Buenos Aires y La Pampa: Argentina Detection of anti-Brucella spp. antibodies in swine by agglutination techniques and indirect ELISA in the Buenos Aires and La Pampa provinces: Argentina](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412006000200007) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nH.A. Castro\n2006-04-01\nFull Text Available En nuestro pa\u00eds no existe un programa de control sobre brucelosis porcina y su verdadera situaci\u00f3n epidemiol\u00f3gica es desconocida. El objetivo de nuestro trabajo fue detectar la presencia de anticuerpos anti-Brucella spp. en porcinos provenientes de criaderos del sudoeste de la provincia de Buenos Aires y del este de la provincia de La Pampa. La toma de muestras de sangre se realiz\u00f3 en el momento del faenado de los animales. La detecci\u00f3n de anticuerpos se efectu\u00f3 mediante las t\u00e9cnicas de aglutinaci\u00f3n con ant\u00edgeno tamponado en placa (BPA, seroaglutinaci\u00f3n en tubo (SAT, aglutinaci\u00f3n con 2-ME (2-ME y ELISA indirecto, con dos ant\u00edgenos diferentes: el ant\u00edgeno CYT (fracci\u00f3n citoplasm\u00e1tica de B. abortus S19 y el ant\u00edgeno CP (extracto citoplasm\u00e1tico libre de lipopolisac\u00e1rido. Del total de las muestras analizadas (n=325, el 17,8% fue positivo para BPA, el 13,8% fue positivo para SAT y s\u00f3lo el 8,0% fue positivo para 2-ME. Mediante ELISA-CYT, este porcentaje se elev\u00f3 a 21,0%, mientras que a trav\u00e9s del ELISA-CP s\u00f3lo se hall\u00f3 un 10,0% de muestras reactivas. Estos resultados son compatibles con los informados en los escasos reportes previos para todo el pa\u00eds y sugieren la necesidad de extender los estudios a otras zonas, donde sea habitual la cr\u00eda de cerdos.Porcine brucellosis is one of the most important zoonoses in this country. Currently, there is no control program for porcine brucellosis in Argentina and the epidemiological situation is still unknown. The purpose of our study was to detect anti-Brucella spp. antibodies in swine in the southwest of the Buenos Aires province and the east of the La Pampa province. Blood samples were obtained when animals were slaughtered. The presence of anti-brucella antibodies was studied by the buffered plate agglutination test (BPA, the tube agglutination test (SAT, the 2-mercaptoethanol (2-ME agglutination test and indirect ELISA tests, using the cytosolic fraction from Brucella abortus S19\n[In vitro assay for the anti-Brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis.](https://www.ncbi.nlm.nih.gov/pubmed/20593515)\nMotamedi, Hossein; Darabpour, Esmaeil; Gholipour, Mahnaz; Seyyed Nejad, Seyyed Mansour\n2010-07-01\nBrucellosis, a zoonosis caused by four species of brucella, has a high morbidity. Brucella melitensis is the main causative agent of brucellosis in both human and small ruminants. As an alternative to conventional antibiotics, medicinal plants are valuable resources for new agents against antibiotic-resistant strains. The aim of this study was to investigate the usage of native plants for brucellosis treatment. For this purpose, the anti-brucella activities of ethanolic and methanolic extracts of Salvia sclarea, Oliveria decumbens, Ferulago angulata, Vitex pseudo-negundo, Teucrium polium, Plantago ovata, Cordia myxa, and Crocus sativus were assessed. The activity against a resistant Br. melitensis strain was determined by disc diffusion method at various concentrations from 50-400 mg/ml. Antibiotic discs were also used as a control. Among the evaluated herbs, six plant (Salvia sclarea, Oliveria decumbens, Ferulago angulata, Vitex pseudo-negundo, Teucrium polium, and Crocus sativus) showed anti-brucella activity. Oliveria decumbens was chosen as the most effective plant for further studies. A tested isolate exhibited resistance to tetracycline, nafcillin, oxacillin, methicillin, and colistin. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values for Oliveria decumbens against resistant Br. melitensis were the same (5 mg/ml), and for gentamicin they were both 2 mg/ml. Time-kill kinetics for a methanolic extract of Oliveria decumbens was 7 h whereas for an ethanolic extract it was 28 h. Also, Oliveria decumbens extracts showed a synergistic effect in combination with doxycycline and tetracycline. In general, the similar values of MIC and MBC for Oliveria decumbens suggest that these extracts could act as bactericidal agents against Br. melitensis. In addition to Oliveria decumbens, Crocus sativus and Salvia sclarea also had good anti-brucella activity and these should be considered for further study.\n[In vitro assay for the anti-brucella activity of medicinal plants against tetracycline-resistant Brucella melitensis *](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2897020)\nMotamedi, Hossein; Darabpour, Esmaeil; Gholipour, Mahnaz; Seyyed Nejad, Seyyed Mansour\n2010-01-01\nBrucellosis, a zoonosis caused by four species of brucella, has a high morbidity. Brucella melitensis is the main causative agent of brucellosis in both human and small ruminants. As an alternative to conventional antibiotics, medicinal plants are valuable resources for new agents against antibiotic-resistant strains. The aim of this study was to investigate the usage of native plants for brucellosis treatment. For this purpose, the anti-brucella activities of ethanolic and methanolic extracts of Salvia sclarea, Oliveria decumbens, Ferulago angulata, Vitex pseudo-negundo, Teucrium polium, Plantago ovata, Cordia myxa, and Crocus sativus were assessed. The activity against a resistant Br. melitensis strain was determined by disc diffusion method at various concentrations from 50\u2013400 mg/ml. Antibiotic discs were also used as a control. Among the evaluated herbs, six plant (Salvia sclarea, Oliveria decumbens, Ferulago angulata, Vitex pseudo-negundo, Teucrium polium, and Crocus sativus) showed anti-brucella activity. Oliveria decumbens was chosen as the most effective plant for further studies. A tested isolate exhibited resistance to tetracycline, nafcillin, oxacillin, methicillin, and colistin. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values for Oliveria decumbens against resistant Br. melitensis were the same (5 mg/ml), and for gentamicin they were both 2 mg/ml. Time-kill kinetics for a methanolic extract of Oliveria decumbens was 7 h whereas for an ethanolic extract it was 28 h. Also, Oliveria decumbens extracts showed a synergistic effect in combination with doxycycline and tetracycline. In general, the similar values of MIC and MBC for Oliveria decumbens suggest that these extracts could act as bactericidal agents against Br. melitensis. In addition to Oliveria decumbens, Crocus sativus and Salvia sclarea also had good anti-brucella activity and these should be considered for further study. PMID:20593515\n[Vacuna per escur\u00e7ar el tractament contra la tuberculosi](https://www.openaire.eu/search/publication?articleId=od______1404::024354d31010002918ddb339dc0408a6)\nCardona, Pere-Joan\n2006-01-01\nUn grup d'investigadors de la Unitat de Tuberculosi Experimental de la Fundaci\u00f3 Institut Germans Trias i Pujol ha creat una vacuna que permet reduir la durada del tractament de la infecci\u00f3 latent que provoca la tuberculosi de nou mesos a nom\u00e9s un.\n[DETECCION DE Brucella abortus POR PCR EN MUESTRAS DE SANGRE Y LECHE DE VACUNOS](http://apps.unicordoba.edu.co/revistas/revistamvz/mvz-133/v13n3a9.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nXiomara Mosquera C\n2008-12-01\nFull Text Available Objetivo. Evaluar el uso de la Reacci\u00f3n en Cadena de la Polimerasa (PCR para la detecci\u00f3n de Brucella abortus en muestras de sangre y leche de vacunos. Materiales y m\u00e9todos. Este estudio de tipo descriptivo fue realizado durante los a\u00f1os 2004 y 2005. Se analizaron 136 animales de tres fincas localizadas en el municipio de Durania, Norte de Santander, Colombia. Se evalu\u00f3 la presencia de anticuerpos en la leche mediante la prueba del anillo (PAL. Se amplific\u00f3 el fragmento de 223pb del gen BCSP31. Se emplearon los cebadores B4 y B5 de la regi\u00f3n interna de la secuencia del gen BCSP31 (GenBank, n\u00famero M20404. Resultados. En aquellos animales positivos se obtuvo una muestra de sangre y leche para el an\u00e1lisis por PCR, la sangre no fue analizada por serolog\u00eda. Se evaluaron diferentes m\u00e9todos de extracci\u00f3n de ADN. Se encontr\u00f3 que un 13.2% (18/136 de las muestras de leche fueron positivas a la PAL. Se analizaron 33 muestras de leche negativas por PAL de las cuales el 30.3% (10/33 resultaron positivas por PCR. Al analizar las muestras de sangre de los animales positivos por PAL el 94.1% (16/17 fueron positivas por PCR, mientras que el 47% (8/17 de las muestras de leche positivas por PAL, fueron positivas por PCR. Conclusiones. Se demostr\u00f3 la amplificaci\u00f3n de un fragmento de ADN de Brucella abortus en muestras de sangre y leche de vacunos. Los resultados preliminares demostraron que es posible usar PCR como prueba diagn\u00f3stica de brucelosis en Colombia.\n[The changing nature of the Brucella-containing vacuole.](https://www.ncbi.nlm.nih.gov/pubmed/25916795)\nCelli, Jean\n2015-07-01\nBacteria of the genus Brucella are intracellular vacuolar pathogens of mammals that cause the worldwide zoonosis brucellosis, and reside within phagocytes of infected hosts to promote their survival, persistence and proliferation. These traits are essential to the bacterium's ability to cause disease and have been the subject of much investigation to gain an understanding of Brucella pathogenic mechanisms. Although the endoplasmic reticulum-derived nature of the Brucella replicative niche has been long known, major strides have recently been made in deciphering the molecular mechanisms of its biogenesis, including the identification of bacterial determinants and host cellular pathways involved in this process. Here I will review and discuss the most recent advances in our knowledge of Brucella intracellular pathogenesis, with an emphasis on bacterial exploitation of the host endoplasmic reticulum-associated functions, and how autophagy-related processes contribute to the bacterium's intracellular cycle. \u00a9 2015 John Wiley & Sons Ltd.\n[Macrophage activation induced by Brucella DNA suppresses bacterial intracellular replication via enhancing NO production.](https://www.ncbi.nlm.nih.gov/pubmed/26523973)\nLiu, Ning; Wang, Lin; Sun, Changjiang; Yang, Li; Tang, Bin; Sun, Wanchun; Peng, Qisheng\n2015-12-01\nBrucella DNA can be sensed by TLR9 on endosomal membrane and by cytosolic AIM2-inflammasome to induce proinflammatory cytokine production that contributes to partially activate innate immunity. Additionally, Brucella DNA has been identified to be able to act as a major bacterial component to induce type I IFN. However, the role of Brucella DNA in Brucella intracellular growth remains unknown. Here, we showed that stimulation with Brucella DNA promote macrophage activation in TLR9-dependent manner. Activated macrophages can suppresses wild type Brucella intracellular replication at early stage of infection via enhancing NO production. We also reported that activated macrophage promotes bactericidal function of macrophages infected with VirB-deficient Brucella at the early or late stage of infection. This study uncovers a novel function of Brucella DNA, which can help us further elucidate the mechanism of Brucella intracellular survival. Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.\n[An influenza viral vector Brucella abortus vaccine induces good cross-protection against Brucella melitensis infection in pregnant heifers.](https://www.ncbi.nlm.nih.gov/pubmed/26093199)\nTabynov, Kaissar; Ryskeldinova, Sholpan; Sansyzbay, Abylai\n2015-07-17\nBrucella melitensis can be transmitted and cause disease in cattle herds as a result of inadequate management of mixed livestock farms. Ideally, vaccines against Brucella abortus for cattle should also provide cross-protection against B. melitensis. Previously we created a novel influenza viral vector B. abortus (Flu-BA) vaccine expressing the Brucella ribosomal proteins L7/L12 or Omp16. This study demonstrated Flu-BA vaccine with adjuvant Montanide Gel01 provided 100% protection against abortion in vaccinated pregnant heifers and good cross-protection of the heifers and their calves or fetuses (90-100%) after challenge with B. melitensis 16M; the level of protection provided by Flu-BA was comparable to the commercial vaccine B. abortus S19. In terms of the index of infection and colonization of Brucella in tissues, both vaccines demonstrated significant (P=0.02 to P<0.0001) protection against B. melitensis 16M infection compared to the negative control group (PBS+Montanide Gel01). Thus, we conclude the Flu-BA vaccine provides cross-protection against B. melitensis infection in pregnant heifers. Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.\n[Rapid detection of Brucella spp. using loop-mediated isothermal amplification (LAMP).](https://www.ncbi.nlm.nih.gov/pubmed/24026689)\nChen, Shouyi; Li, Xunde; Li, Juntao; Atwill, Edward R\n2013-01-01\nBrucella spp. are facultative intracellular bacteria that cause zoonotic disease of brucellosis worldwide. Livestock that are most vulnerable to brucellosis include cattle, goats, and pigs. Brucella spp. cause serious health problems to humans and animals and economic losses to the livestock industry. Traditional methods for detection of Brucella spp. take 48-72 h (Kumar et al., J Commun Dis 29:131-137, 1997; Barrouin-Melo et al., Res Vet Sci 83:340-346, 2007) that do not meet the food industry's need of rapid detection. Therefore, there is an urgent need of fast, specific, sensitive, and inexpensive method for diagnosing of Brucella spp. Loop-mediated isothermal amplification (LAMP) is a method to amplify nucleic acid at constant temperatures. Amplification can be detected by visual detection, fluorescent stain, turbidity, and electrophoresis. We targeted at the Brucella-specific gene omp25 and designed LAMP primers for detection of Brucella spp. Amplification of DNA with Bst DNA polymerase can be completed at 65 \u00b0C in 60 min. Amplified products can be detected by SYBR Green I stain and 2.0% agarose gel electrophoresis. The LAMP method is feasible for detection of Brucella spp. from blood and milk samples.\n[Knowledge of Brucella as a food-borne pathogen](http://www.ars.usda.gov/research/publications/publication/?seqNo115=317634)\nAlthough Brucella spp. are known for causing reproductive losses in domestic livestock, they are also capable of infecting humans and causing clinical disease. Human infection with Brucella is almost exclusively a result of direct contact with infected animals or consumption of products made from un...\n[Mean platelet volume in brucellosis: correlation between brucella ...](https://www.ajol.info/index.php/ahs/article/view/111374) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nBackground: Brucellosis, a zoonotic infection, was most widely diagnosed by the Brucella standard serum agglutination test (SAT). No previous publication has demonstrated a correlation between the degree of Brucella SAT agglutination positivity and the severity of brucellosis infection. Objective: To contribute to the ...\n[Isolation of Brucella pinnipedialis from Grey Seals (Halichoerus grypus) in the Baltic Sea.](https://www.ncbi.nlm.nih.gov/pubmed/28715291)\nHirvel\u00e4-Koski, Varpu; Nylund, Minna; Skrzypczak, Teresa; Heikkinen, Petra; Kauhala, Kaarina; Jay, Maryne; Isomursu, Marja\n2017-10-01\nBrucella infection in seals was reported for the first time in 1994 around the coast of Scotland. Since then, marine mammal Brucella infections were found to be widely distributed in the northern hemisphere. Two Brucella species affect marine mammals: Brucella pinnipedialis in pinnipeds and Brucella ceti in cetaceans. We examined the livers of Baltic grey seals (Halichoerus grypus) from the Finnish coast (n=122) hunted, found dead, or killed as by-catch in fishing gear in 2013-15 as part of population health monitoring. We detected B. pinnipedialis in the livers of three grey seals. The bacterium was isolated from livers displaying parasitic cholangitis. We also detected Brucella DNA in liver flukes (Pseudamphistomum truncatum) obtained from a Brucella-infected grey seal, suggesting that flukes might be possible vectors of this pathogen in the marine environment.\n[Eficacia de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C](https://www.openaire.eu/search/publication?articleId=doajarticles::665616b0e79abcde2883f393f494e02c)\nGonz\u00e1lez Enr\u00edquez Jes\u00fas; Garc\u00eda Comas Luis; Alcaide Jim\u00e9nez Juan Francisco; S\u00e1enz Calvo Antonio; Conde Olasagasti Jos\u00e9\n1997-01-01\nFUNDAMENTO: Este trabajo consiste esencialmente en una revisi\u00f3n sistem\u00e1tica de la literatura cient\u00edfica sobre los efectos, intensidad y duraci\u00f3n de la respuesta serol\u00f3gica, as\u00ed como sobre la eficacia, efectividad y seguridad de la vacuna meningoc\u00f3cica de polisac\u00e1rido capsular del grupo C. M\u00c9TODOS: B\u00fasqueda en repertorio MEDLINE en el periodo 1970-1996. B\u00fasqueda espec\u00edfica de ensayos cl\u00ednicos aleatorizados y estudios de intervenci\u00f3n prospectivos en humanos con vacunas de polisac\u00e1ridos capsular...\n[Type IV Secretion System of Brucella spp. and its Effectors](http://journal.frontiersin.org/Journal/10.3389/fcimb.2015.00072/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYuehua eKe\n2015-10-01\nFull Text Available Brucella spp. cause brucellosis in domestic and wild animals. They are intracellular bacterial pathogens and used as model organisms to study intracellular bacterial infections. Brucella VirB T4SS is a key virulence factor that plays important roles in mediating intracellular survival and manipulating host immune response to infection. In this review, we will discuss roles of Brucella VirB T4SS and in more detail of all 15 identified effectors, which may be crucial for Brucella pathogenesis. VirB T4SS regulates the inflammation response and manipulates vesicle trafficking inside host cells, suggesting that it plays crucial roles in the inhibition of the host immune response and intracellular survival during infection. So, we listed some key molecular events in the intracellular life cycle of Brucella potentially targeted by the VirB T4SS effectors. Elucidating functions of the effectors secreted will be crucial to clarifying mechanism of T4SS during infection. Studying the effectors secreted by Brucella spp. might provide insights into the mechanisms by which the bacteria hijack the host signaling pathways, which help us to develop better vaccines and therapies against brucellosis.\n[Type IV secretion system of Brucella spp. and its effectors.](https://www.ncbi.nlm.nih.gov/pubmed/26528442)\nKe, Yuehua; Wang, Yufei; Li, Wengfeng; Chen, Zeliang\n2015-01-01\nBrucella spp. are intracellular bacterial pathogens that cause infection in domestic and wild animals. They are often used as model organisms to study intracellular bacterial infections. Brucella VirB T4SS is a key virulence factor that plays important roles in mediating intracellular survival and manipulating host immune response to infection. In this review, we discuss the roles of Brucella VirB T4SS and 15 effectors that are proposed to be crucial for Brucella pathogenesis. VirB T4SS regulates the inflammation response and manipulates vesicle trafficking inside host cells. VirB T4SS also plays crucial roles in the inhibition of the host immune response and intracellular survival during infection. Here, we list the key molecular events in the intracellular life cycle of Brucella that are potentially targeted by the VirB T4SS effectors. Elucidating the functions of these effectors will help clarify the molecular role of T4SS during infection. Furthermore, studying the effectors secreted by Brucella spp. might provide insights into the mechanisms used by the bacteria to hijack the host signaling pathways and aid in the development of better vaccines and therapies against brucellosis.\n[Isolation of a novel 'atypical' Brucella strain from a bluespotted ribbontail ray (Taeniura lymma).](https://www.ncbi.nlm.nih.gov/pubmed/27785661)\nEisenberg, Tobias; Ri\u00dfe, Karin; Schauerte, Nicole; Geiger, Christina; Blom, Jochen; Scholz, Holger C\n2017-02-01\nA pleomorphic Gram-negative, motile coccobacillus was isolated from the gills of a wild-caught bluespotted ribbontail ray after its sudden death during quarantine. Strain 141012304 was observed to grow aerobically, to be clearly positive for cytochrome oxidase, catalase, urease and was initially identified as \"Brucella melitensis\" or \"Ochrobactrum anthropi\" by Matrix-assisted laser desorption/ionization-time of flight mass spectrometry and VITEK2-compact \u00ae , respectively. Affiliation to the genus Brucella was confirmed by bcsp31 and IS711 PCR as well as by Brucella species-specific multiplex PCR, therein displaying a characteristic banding pattern recently described for Brucella strains obtained from amphibian hosts. Likewise, based on recA sequencing, strain 141012304 was found to form a separate lineage, within the so called 'atypical' Brucella, consisting of genetically more distantly related strains. The closest similarity was detected to brucellae, which have recently been isolated from edible bull frogs. Subsequent next generation genome sequencing and phylogenetic analysis confirmed that the ray strain represents a novel Brucella lineage within the atypical group of Brucella and in vicinity to Brucella inopinata and Brucella strain BO2, both isolated from human patients. This is the first report of a natural Brucella infection in a saltwater fish extending the host range of this medically important genus.\n[Successful Management of Prosthetic Valve Brucella Endocarditis with Antibiotherapy Alone](https://www.ejcrim.com/index.php/EJCRIM/article/view/808) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Pedro Fonseca\n2018-01-01\nFull Text Available Objectives: To report a case of mechanical aortic prosthesis Brucella endocarditis successfully treated with antibiotics alone. Materials and methods: We describe a clinical case and present a review of the literature. Results: A 60-year-old female farmer with a mechanical aortic prosthetic valve presented with low back pain and fever. She was diagnosed with prosthetic valve Brucella mellitensis endocarditis and was cured with antibiotic therapy alone. Few cases of successfully treated prosthetic valve Brucella endocarditis without surgery have been reported. Conclusion: Prosthetic valve Brucella endocarditis usually requires surgical valve replacement. However, selected patients may be successfully treated with antibiotic therapy alone.\n[Evaluaci\u00f3n del impacto econ\u00f3mico de la vacuna antirrotav\u00edrica en Venezuela Assessment of the economic impact of the antiretroviral vaccine in Venezuela](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000900001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDagna Constenla\n2006-10-01\nFull Text Available OBJETIVO: El objetivo de este estudio fue evaluar el costo de la atenci\u00f3n m\u00e9dica de la gastroenteritis por rotavirus y la relaci\u00f3n costo-efectividad de la vacuna antirrotav\u00edrica en la poblaci\u00f3n venezolana menor de 5 a\u00f1os de edad. M\u00c9TODOS: Se utiliz\u00f3 un modelo econ\u00f3mico que integra la informaci\u00f3n epidemiol\u00f3gica, la eficacia de la vacuna y los costos de atenci\u00f3n m\u00e9dica de la gastroenteritis por rotavirus, desde la perspectiva de la sociedad. Para determinar la efectividad de la vacuna, se estim\u00f3 el n\u00famero de casos de hospitalizaci\u00f3n, de consultas m\u00e9dicas y de muertes evitados despu\u00e9s de su administraci\u00f3n. La relaci\u00f3n costo-efectividad de la vacuna se evalu\u00f3 partiendo del n\u00famero de a\u00f1os de vida ajustados por discapacidad (AVAD y de casos evitados. RESULTADOS: En Venezuela, los servicios de salud invierten, aproximadamente, 4,2 millones de d\u00f3lares estadounidenses (US$ por a\u00f1o para cubrir los costos de atenci\u00f3n m\u00e9dica causados por el rotavirus. Un programa de vacunaci\u00f3n antirrotav\u00edrica evitar\u00eda aproximadamente el 52% (186 de las muertes, el 54% (7 232 de las hospitalizaciones y el 50% (55 168 de las consultas ambulatorias durante los primeros cinco a\u00f1os de vida, en una cohorte vacunada. Para un precio estimado de US$ 24 por r\u00e9gimen de vacuna, se genera una relaci\u00f3n costo-efectividad de US$ 1 352 por AVAD. CONCLUSIONES: Los resultados de este estudio apuntan a que la vacunaci\u00f3n antirrotav\u00edrica es una estrategia costoefectiva en la prevenci\u00f3n de la gastroenteritis por rotavirus en Venezuela, ya que puede evitar muertes y a\u00f1os de vida ajustados por discapacidad en la poblaci\u00f3n menor de cinco a\u00f1os de edad.OBJECTIVE: To assess the cost of medical care for rotavirus gastroenteritis and the cost-effectiveness of the antiretroviral vaccine in Venezuelan children under five. METHODS: We used an economic model that comprises epidemiologic information, vaccine efficacy, and the cost of medical care in connection with\n[Brucella infection inhibits macrophages apoptosis via Nedd4-dependent degradation of calpain2.](https://www.ncbi.nlm.nih.gov/pubmed/25258171)\nCui, Guimei; Wei, Pan; Zhao, Yuxi; Guan, Zhenhong; Yang, Li; Sun, Wanchun; Wang, Shuangxi; Peng, Qisheng\n2014-11-07\nThe calcium-dependent protease calpain2 is involved in macrophages apoptosis. Brucella infection-induced up-regulation of intracellular calcium level is an essential factor for the intracellular survival of Brucella within macrophages. Here, we hypothesize that calcium-dependent E3 ubiquitin ligase Nedd4 ubiquitinates calpain2 and inhibits Brucella infection-induced macrophage apoptosis via degradation of calpain2.Our results reveal that Brucella infection induces increases in Nedd4 activity in an intracellular calcium dependent manner. Furthermore, Brucella infection-induced degradation of calpain2 is mediated by Nedd4 ubiquitination of calpain2. Brucella infection-induced calpain2 degradation inhibited macrophages apoptosis. Treatment of Brucella infected macrophages with calcium chelator BAPTA or Nedd4 knock-down decreased Nedd4 activity, prevented calpain2 degradation, and resulted in macrophages apoptosis. Copyright \u00a9 2014 Elsevier B.V. All rights reserved.\n[Establishment of Chronic Infection: Brucella's Stealth Strategy](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4791395)\nAhmed, Waqas; Zheng, Ke; Liu, Zheng-Fei\n2016-01-01\nBrucella is a facultative intracellular pathogen that causes zoonotic infection known as brucellosis which results in abortion and infertility in natural host. Humans, especially in low income countries, can acquire infection by direct contact with infected animal or by consumption of animal products and show high morbidity, severe economic losses and public health problems. However for survival, host cells develop complex immune mechanisms to defeat and battle against attacking pathogens and maintain a balance between host resistance and Brucella virulence. On the other hand as a successful intracellular pathogen, Brucella has evolved multiple strategies to evade immune response mechanisms to establish persistent infection and replication within host. In this review, we mainly summarize the \u201cStealth\u201d strategies employed by Brucella to modulate innate and the adaptive immune systems, autophagy, apoptosis and possible role of small noncoding RNA in the establishment of chronic infection. The purpose of this review is to give an overview for recent understanding how this pathogen evades immune response mechanisms of host, which will facilitate to understanding the pathogenesis of brucellosis and the development of novel, more effective therapeutic approaches to treat brucellosis. PMID:27014640\n[Analyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics](http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00002/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nYongqun eHe\n2012-02-01\nFull Text Available Brucella is a Gram-negative, facultative intracellular bacterium that causes zoonotic brucellosis in humans and various animals. Out of ten classified Brucella species, B. melitensis, B. abortus, B. suis, and B. canis are pathogenic to humans. In the past decade, the mechanisms of Brucella pathogenesis and host immunity have been extensively investigated using the cutting edge systems biology and bioinformatics approaches. This article provides a comprehensive review of the applications of Omics (including genomics, transcriptomics, and proteomics and bioinformatics technologies for the analysis of Brucella pathogenesis, host immune responses, and vaccine targets. Based on more than 30 sequenced Brucella genomes, comparative genomics is able to identify gene variations among Brucella strains that help to explain host specificity and virulence differences among Brucella species. Diverse transcriptomics and proteomics gene expression studies have been conducted to analyze gene expression profiles of wild type Brucella strains and mutants under different laboratory conditions. High throughput Omics analyses of host responses to infections with virulent or attenuated Brucella strains have been focused on responses by mouse and cattle macrophages, bovine trophoblastic cells, mouse and boar splenocytes, and ram buffy coat. Differential serum responses in humans and rams to Brucella infections have been analyzed using high throughput serum antibody screening technology. The Vaxign reverse vaccinology has been used to predict many Brucella vaccine targets. More than 180 Brucella virulence factors and their gene interaction networks have been identified using advanced literature mining methods. The recent development of community-based Vaccine Ontology and Brucellosis Ontology provides an efficient way for Brucella data integration, exchange, and computer-assisted automated reasoning.\n[Analyses of Brucella Pathogenesis, Host Immunity, and Vaccine Targets using Systems Biology and Bioinformatics](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3417401)\nHe, Yongqun\n2011-01-01\nBrucella is a Gram-negative, facultative intracellular bacterium that causes zoonotic brucellosis in humans and various animals. Out of 10 classified Brucella species, B. melitensis, B. abortus, B. suis, and B. canis are pathogenic to humans. In the past decade, the mechanisms of Brucella pathogenesis and host immunity have been extensively investigated using the cutting edge systems biology and bioinformatics approaches. This article provides a comprehensive review of the applications of Omics (including genomics, transcriptomics, and proteomics) and bioinformatics technologies for the analysis of Brucella pathogenesis, host immune responses, and vaccine targets. Based on more than 30 sequenced Brucella genomes, comparative genomics is able to identify gene variations among Brucella strains that help to explain host specificity and virulence differences among Brucella species. Diverse transcriptomics and proteomics gene expression studies have been conducted to analyze gene expression profiles of wild type Brucella strains and mutants under different laboratory conditions. High throughput Omics analyses of host responses to infections with virulent or attenuated Brucella strains have been focused on responses by mouse and cattle macrophages, bovine trophoblastic cells, mouse and boar splenocytes, and ram buffy coat. Differential serum responses in humans and rams to Brucella infections have been analyzed using high throughput serum antibody screening technology. The Vaxign reverse vaccinology has been used to predict many Brucella vaccine targets. More than 180 Brucella virulence factors and their gene interaction networks have been identified using advanced literature mining methods. The recent development of community-based Vaccine Ontology and Brucellosis Ontology provides an efficient way for Brucella data integration, exchange, and computer-assisted automated reasoning. PMID:22919594\n[Diversity of virulence genes in Brucella melitensis and Brucella abortus detected from patients with rheumatoid arthritis.](https://www.ncbi.nlm.nih.gov/pubmed/29578063)\nRahdar, Hossein Ali; Golmohammadi, Reza; Mirnejad, Reza; Ataee, Ramezan Ali; Alishiri, Gholam Hossein; Kazemian, Hossein\n2018-03-22\nThe presence of Brucella melitensis and Brucella abortus genomes were investigated in the synovial fluid (SF) samples from 90 patients with rheumatoid arthritis (RA). DNA extraction and PCR assay were performed for simultaneous identification and discrimination of B. melitensis and B. abortus from the SF using three specific primers. After gel electrophoresis, the PCR products were confirmed by DNA sequencing. The cbg, omp31, manA, virB, and znuA virulence genes typing were performed by multiplex-PCR. Of the 90 samples, 14 were positive for B. melitensis (n = 9; 10%) and B. abortus (n = 5; 5.5%). The virulotyping of positive samples revealed the presence of all five virulence genes in B. melitensis. The virB, cbg, and om31 were detected in all five samples of B. abortus. In addition, zhuA and manA were detected in three (60%) and four (80%) samples, respectively, of the B. abortus-positive samples. Moreover, a total of 94.2% and 89.2% of the 14 positive samples were also found positive for manA and znuA, respectively. Our findings revealed that the Brucella spp. genomes can be detected in the SF of RA patients by the PCR-based method. We thus suggest that physicians should consider the Brucella spp. as indicators of potential RA for the timely diagnosis and treatment of RA. Copyright \u00a9 2018. Published by Elsevier Ltd.\n[Evaluation of PCR methods for detection of Brucella strains from culture and tissues.](https://www.ncbi.nlm.nih.gov/pubmed/28255651)\n\u00c7iftci, Alper; \u0130\u00e7a, Tuba; Sava\u015fan, Serap; Sareyy\u00fcpo\u011flu, Bar\u0131\u015f; Akan, Mehmet; Diker, Kadir Serdar\n2017-04-01\nThe genus Brucella causes significant economic losses due to infertility, abortion, stillbirth or weak calves, and neonatal mortality in livestock. Brucellosis is still a zoonosis of public health importance worldwide. The study was aimed to optimize and evaluate PCR assays used for the diagnosis of Brucella infections. For this aim, several primers and PCR protocols were performed and compared with Brucella cultures and biological material inoculated with Brucella. In PCR assays, genus- or species-specific oligonucleotide primers derived from 16S rRNA sequences (F4/R2, Ba148/928, IS711, BruP6-P7) and OMPs (JPF/JPR, 31ter/sd) of Brucella were used. All primers except for BruP6-P7 detected the DNA from reference Brucella strains and field isolates. In spiked blood, milk, and semen samples, F4-R2 primer-oriented PCR assays detected minimal numbers of Brucella. In spiked serum and fetal stomach content, Ba148/928 primer-oriented PCR assays detected minimal numbers of Brucella. Field samples collected from sheep and cattle were examined by bacteriological methods and optimized PCR assays. Overall, sensitivity of PCR assays was found superior to conventional bacteriological isolation. Brucella DNA was detected in 35.1, 1.1, 24.8, 5.0, and 8.0% of aborted fetus, blood, milk, semen, and serum samples by PCR assays, respectively. In conclusion, PCR assay in optimized conditions was found to be valuable in sensitive and specific detection of Brucella infections of animals.\n[Detecci\u00f3n mediante RT-PCR en tiempo real del virus vacunal en cerdos inmunizados con la vacuna cubana contra la peste porcina cl\u00e1sica](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTania Campos-Cuello\n2016-08-01\nFull Text Available La peste porcina cl\u00e1sica (PPC es una enfermedad viral infectocontagiosa, producida por un virus ARN del g\u00e9nero Pestivirus, familia Flaviviridae. En la actualidad es una de las causas de p\u00e9rdidas econ\u00f3micas en la industria porcina a nivel mundial. En su prevenci\u00f3n se han utilizado vacunas vivas atenuadas, empleando la cepa China lapinizada. La Reacci\u00f3n en Cadena de la Polimerasa Reverso Transcriptasa (RT-PCR ha sido uno de los m\u00e9todos m\u00e1s sensibles aplicado en Medicina Veterinaria para la detecci\u00f3n de virus ARN. En el caso del virus de la PPC es muy \u00fatil porque el \u00e1cido nucleico se puede detectar desde muy temprano en la infecci\u00f3n y en periodos m\u00e1s largos en aquellos animales que se recuperan. El objetivo de este estudio fue aplicar la t\u00e9cnica de RT-PCR en tiempo real para la detecci\u00f3n de la cepa China lapinizada de la vacuna cubana contra la PPC. Las tonsilas de los cerdos vacunados fueron el \u00f3rgano m\u00e1s positivo en la detecci\u00f3n del ARN del virus vacunal. Los resultados obtenidos evidenciaron una interferencia del virus vacunal en el diagn\u00f3stico, siendo el d\u00eda 12 posvacunaci\u00f3n en el que se obtiene una emisi\u00f3n umbral de fluorescencia m\u00e1s bajo.\n[Respuesta humoral y consecuencias reproductivas en ovejas desafiadas con Brucella ovis al final de la gestaci\u00f3n Immune response and reproductive consequences in experimentally infected ewes with Brucella ovis during late pregnancy](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000100003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFernando A Paolicchi\n2013-03-01\nFull Text Available La brucelosis ovina por Brucella ovis es una enfermedad de prevalencia alta en Argentina. Para evaluar la patogenicidad de B. ovis y la respuesta serol\u00f3gica durante el \u00faltimo mes de gestaci\u00f3n, 6 ovejas se distribuyeron en dos grupos: G1, ovejas pre\u00f1adas, n = 4 y G2, ovejas no pre\u00f1adas, n = 2. Tres ovejas del G1 (15 d\u00edas preparto y una del G2 fueron inoculadas con B. ovis. Se analizaron muestras de suero mediante diferentes pruebas serol\u00f3gicas. Se realiz\u00f3 aislamiento y PCR a partir de mucus c\u00e9rvico-vaginal (mcv, placenta y leche. En las muestras de placenta se realiz\u00f3 histopatolog\u00eda. Las hembras del G1 parieron corderos vivos; se detectaron anticuerpos en las ovejas desafiadas del G1 a partir de los 5 d\u00edas posinoculaci\u00f3n. El mcv de las ovejas desafiadas result\u00f3 negativo al aislamiento en ambos grupos. Las muestras de leche del G1 fueron positivas por cultivo y PCR a B. ovis. La t\u00e9cnica de PCR result\u00f3 positiva en las placentas de las ovejas desafiadas del G1. La histopatolog\u00eda revel\u00f3 una placentitis necr\u00f3tica supurativa en una de las ovejas desafiadas. El desaf\u00edo con B. ovis preparto result\u00f3 en la invasi\u00f3n de la placenta y de la gl\u00e1ndula mamaria, con la consecuente excreci\u00f3n de la bacteria por leche. La infecci\u00f3n con B. ovis indujo una respuesta humoral temprana en las ovejas. La colonizaci\u00f3n de la placenta por B. ovis y la excreci\u00f3n de la bacteria por la leche sugieren un potencial riesgo de infecci\u00f3n activa para los corderos y la posibilidad de que estos se comporten como portadores latentes de la infecci\u00f3n.Ovine brucellosis by Brucella ovis is a highly prevalent disease in Argentina. This study aimed to evaluate the pathogenicity of B. ovis and the serological response in ewes during late pregnancy and in their offspring. Six adult ewes were distributed in two groupsGI (pregnant females, n = 4 and G2 (nonpregnant females, n = 2. Three pregnant ewes at 15 days prepartum and one nonpregnant eve were inoculated with B\n[Isolation of Brucella inopinata-Like Bacteria from White's and Denny's Tree Frogs.](https://www.ncbi.nlm.nih.gov/pubmed/28437181)\nKimura, Masanobu; Une, Yumi; Suzuki, Michio; Park, Eun-Sil; Imaoka, Koichi; Morikawa, Shigeru\n2017-05-01\nBrucella inopinata strain BO1 and B. sp. strain BO2 isolated from human patients, respectively, are genetically different from classical Brucella species. We isolated bacteria of the genus Brucella from two species of wild-caught tropical frogs kept in the facilities in Japan: White's tree frog, which inhabits Oceania, and Denny's tree frog, which inhabits Southeast Asia. Phylogenetic analyses based on 16S rRNA and recA gene sequences and multilocus sequence analysis showed that two isolates of Brucella spp. showed significant similarity to BO1, BO2, and the isolates from other wild-caught frogs. These results suggest that a variety of frog species are susceptible to a novel clade of Brucella bacteria, including B. inopinata.\n[A rare case of anterior mediastinal mass caused by Brucella infection.](https://www.ncbi.nlm.nih.gov/pubmed/28325071)\nSabzi, Feridoun; Faraji, Reza\n2017-03-01\nA previously healthy man, who had undergone coronary artery bypass 10 years earlier and had been diagnosed with brucellosis due to Brucella septicemia after Brucella arthritis, presented with chest pain and high fever. Anti- Brucella antibiotics were started, but after 4 weeks, his high fever remained. An infected mass was confirmed by computed tomography, and surgical intervention was performed via a median sternotomy. A large amount of thick pus gushed from an abscess in the upper mediastinum. The abscess cavity had a thick granulation wall, and cultured pus was positive for Brucella only. The patient responded well to antibiotic therapy.\n[Importance of Lipopolysaccharide and Cyclic \u03b2-1,2-Glucans in Brucella-Mammalian Infections](http://dx.doi.org/10.1155/2010/124509) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAndreas F. Haag\n2010-01-01\nFull Text Available Brucella species are the causative agents of one of the most prevalent zoonotic diseases: brucellosis. Infections by Brucella species cause major economic losses in agriculture, leading to abortions in infected animals and resulting in a severe, although rarely lethal, debilitating disease in humans. Brucella species persist as intracellular pathogens that manage to effectively evade recognition by the host's immune system. Sugar-modified components in the Brucella cell envelope play an important role in their host interaction. Brucella lipopolysaccharide (LPS, unlike Escherichia coli LPS, does not trigger the host's innate immune system. Brucella produces cyclic \u03b2-1,2-glucans, which are important for targeting them to their replicative niche in the endoplasmic reticulum within the host cell. This paper will focus on the role of LPS and cyclic \u03b2-1,2-glucans in Brucella-mammalian infections and discuss the use of mutants, within the biosynthesis pathway of these cell envelope structures, in vaccine development.\n[Estudios de inmunogenicidad, seguridad y eficacia de la Vacuna Q frente a la leishmaniosis canina](https://www.openaire.eu/search/publication?articleId=od_______296::4dfda7f2f3e4339756541268672e7022)\nFern\u00e1ndez Cotrina, Javier\n2016-01-01\nSe analizaron la seguridad, inmunogenicidad y eficacia protectiva de cuatro dosis de la vacuna Q de Leishmania infantum (VQ). Para ello, cincuenta perros beagle (10 por grupo) fueron vacunados con una dosis \u00fanica de 200, 100, 50 y 25 \u00b5g de VQ. A los perros del grupo control se les inyect\u00f3 el diluyente de la vacuna. Los datos muestran que la vacunaci\u00f3n con VQ indujo una respuesta humoral temprana y espec\u00edfica dependiente de la dosis. Adem\u00e1s, durante el per\u00edodo post-vacunaci\u00f3n no se detect\u00f3 rea...\n[Metal acquisition and virulence in Brucella](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3845367)\nRoop, R. Martin\n2013-01-01\nSimilar to other bacteria, Brucella strains require several biologically essential metals for their survival in vitro and in vivo. Acquiring sufficient levels of some of these metals, particularly iron, manganese and zinc, is especially challenging in the mammalian host, where sequestration of these micronutrients is a well-documented component of both the innate and acquired immune responses. This review describes the Brucella metal transporters that have been shown to play critical roles in the virulence of these bacteria in experimental and natural hosts. PMID:22632611\n[Brucella Intracellular Life Relies on the Transmembrane Protein CD98 Heavy Chain.](https://www.ncbi.nlm.nih.gov/pubmed/25505297)\nKeriel, Anne; Botella, Eric; Estrach, Soline; Bragagnolo, Gabriel; Vergunst, Annette C; Feral, Chloe C; O'Callaghan, David\n2015-06-01\nBrucella are intracellular bacterial pathogens that use a type IV secretion system (T4SS) to escape host defenses and create a niche in which they can multiply. Although the importance of Brucella T4SS is clear, little is known about its interactions with host cell structures. In this study, we identified the eukaryotic protein CD98hc as a partner for Brucella T4SS subunit VirB2. This transmembrane glycoprotein is involved in amino acid transport, modulation of integrin signaling, and cell-to-cell fusion. Knockdown of CD98hc expression in HeLa cells demonstrated that it is essential for Brucella infection. Using knockout dermal fibroblasts, we confirmed its role for Brucella but found that it is not required for Salmonella infection. CD98hc transiently accumulates around the bacteria during the early phases of infection and is required for both optimal bacterial uptake and intracellular multiplication of Brucella. These results provide new insights into the complex interplay between Brucella and its host. \u00a9 The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.\n[Brucella canis: inqu\u00e9ritos sorol\u00f3gico e bacteriol\u00f3gico em popula\u00e7\u00e3o felina Brucella canis: serological and bacteriological surveys in the feline population](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89101984000100005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaria Helena Matiko Akao Larsson\n1984-02-01\nFull Text Available De 134 soros de felinos dom\u00e9sticos examinados pela prova de soroaglutina\u00e7\u00e3o lenta em tubos, 4 (3% foram positivos para Brucella canis, todos com t\u00edtulo igual a 100. N\u00e3o se obteve \u00eaxito na tentativa de isolamento de Brucella canis atrav\u00e9s de hemocultura desses animais.Of the 134 feline sera tested by tube agglutination test, 4 (3% were positive for Brucella canis antibodies, all with titer 100. It was not possible to isolate Brucella canis by blood culture in the case of these animals.\n[Brucella discriminates between mouse dendritic cell subsets upon in vitro infection.](https://www.ncbi.nlm.nih.gov/pubmed/26606688)\nPapadopoulos, Alexia; Gagnaire, Aur\u00e9lie; Degos, Clara; de Chastellier, Chantal; Gorvel, Jean-Pierre\n2016-01-01\nBrucella is a Gram-negative bacterium responsible for brucellosis, a worldwide re-emerging zoonosis. Brucella has been shown to infect and replicate within Granulocyte macrophage colony-stimulating factor (GMCSF) in vitro grown bone marrow-derived dendritic cells (BMDC). In this cell model, Brucella can efficiently control BMDC maturation. However, it has been shown that Brucella infection in vivo induces spleen dendritic cells (DC) migration and maturation. As DCs form a complex network composed by several subpopulations, differences observed may be due to different interactions between Brucella and DC subsets. Here, we compare Brucella interaction with several in vitro BMDC models. The present study shows that Brucella is capable of replicating in all the BMDC models tested with a high infection rate at early time points in GMCSF-IL15 DCs and Flt3l DCs. GMCSF-IL15 DCs and Flt3l DCs are more activated than the other studied DC models and consequently intracellular bacteria are not efficiently targeted to the ER replicative niche. Interestingly, GMCSF-DC and GMCSF-Flt3l DC response to infection is comparable. However, the key difference between these 2 models concerns IL10 secretion by GMCSF DCs observed at 48 h post-infection. IL10 secretion can explain the weak secretion of IL12p70 and TNF\u03b1 in the GMCSF-DC model and the low level of maturation observed when compared to GMCSF-IL15 DCs and Flt3l DCs. These models provide good tools to understand how Brucella induce DC maturation in vivo and may lead to new therapeutic design using DCs as cellular vaccines capable of enhancing immune response against pathogens.\n[Genetic diversity of Brucella abortus and Brucella melitensis in Kazakhstan using MLVA-16.](https://www.ncbi.nlm.nih.gov/pubmed/26160544)\nShevtsov, Alexandr; Ramanculov, Erlan; Shevtsova, Elena; Kairzhanova, Alma; Tarlykov, Pavel; Filipenko, Maxim; Dymova, Maya; Abisheva, Gulzada; Jailbekova, Aygul; Kamalova, Dinara; Chsherbakov, Andrei; Tulegenov, Samat; Akhmetova, Assel; Sytnik, Igor; Karibaev, Talgat; Mukanov, Kasim\n2015-08-01\nBrucellosis is an endemic disease in Central Asia characterized by high infection rates in humans and animals. Currently, little is known about the genetic diversity of Brucella spp. circulating in the region, despite the high prevalence of brucellosis. This study aimed to analyze the genetic diversity of Brucella melitensis and Brucella abortus strains circulating in the Republic of Kazakhstan. We genotyped 128 B. melitensis and 124 B. abortus strains collected in regions with the highest prevalence of brucellosis. Genotyping was performed using multi-locus variable-number tandem-repeat analysis (MLVA). Analysis of a subset of 8 loci (MLVA-8) of 128 B. melitensis strains identified genotypes 42 (n=108), 43 (n=2), and 63 (n=19) related to the 'East Mediterranean' group. An MLVA-16 assay sorted 128 B. melitensis strains into 25 different genotypes. Excluding one variable locus, MLVA-15 of B. melitensis was distinct from strains originating in the Mediterranean region; however, 77% of them were identical to strains isolated in China. A minimum spanning tree for B. melitensis using MLVA-15 analysis clustered the local strains together with strains previously collected in China. MLVA-8 analysis of 124 B. abortus strains identified them as genotype 36, suggesting Eurasian distribution of this lineage. Complete MLVA-16 assay analysis clustered the strains into five genotypes, revealing little diversity of B. abortus when compared on the global scale. A minimum spanning tree for B. abortus obtained using MLVA-15 analysis clustered the 2 most prevalent genotypes (n=117) together with strains previously collected in China. Thus, MLVA analysis was used to characterize 252 strains of Brucella collected in Kazakhstan. The analysis revealed genetic homogeneity among the strains. Interestingly, identical MLVA-15 profiles were found in seemingly unrelated outbreaks in China, Turkey, and Kazakhstan. Further analysis is needed for better understanding of the epidemiology of\n[Case report 469: Spondylitis (lumbar spine) due to Brucella abortus](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=7186793) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nManaster, B.J.\n1988-03-01\nThe current case is interesting in that, although the plain radiographs were diagnostic of infection and the patient's work history suggested brucellosis, both the negative serum antibody titers to brucella and the CT appearance of large calcified psoas abscesses made the diagnosis of tuberculous spondylitis most probable. Open biopsy with tissue culture proved brucella. From this experience it appears that the presence of large calcified psoas abscesses should not eliminate the diagnosis of brucella spondylitis in the proper clinical setting.\n[Case report 469: Spondylitis (lumbar spine) due to Brucella abortus](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=19092716) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nManaster, B.J.\n1988-01-01\nThe current case is interesting in that, although the plain radiographs were diagnostic of infection and the patient's work history suggested brucellosis, both the negative serum antibody titers to brucella and the CT appearance of large calcified psoas abscesses made the diagnosis of tuberculous spondylitis most probable. Open biopsy with tissue culture proved brucella. From this experience it appears that the presence of large calcified psoas abscesses should not eliminate the diagnosis of brucella spondylitis in the proper clinical setting. (orig.)\n[Construction of pTM series plasmids for gene expression in Brucella species.](https://www.ncbi.nlm.nih.gov/pubmed/26851674)\nTian, Mingxing; Qu, Jing; Bao, Yanqing; Gao, Jianpeng; Liu, Jiameng; Wang, Shaohui; Sun, Yingjie; Ding, Chan; Yu, Shengqing\n2016-04-01\nBrucellosis, the most common widespread zoonotic disease, is caused by Brucella spp., which are facultative, intracellular, Gram-negative bacteria. With the development of molecular biology techniques, more and more virulence-associated factors have been identified in Brucella spp. A suitable plasmid system is an important tool to study virulence genes in Brucella. In this study, we constructed three constitutive replication plasmids (pTM1-Cm, pTM2-Amp, and pTM3-Km) using the replication origin (rep) region derived from the pBBR1-MCS vector. Also, a DNA fragment containing multiple cloning sites (MCSs) and a terminator sequence derived from the pCold vector were produced for complementation of the deleted genes. Besides pGH-6\u00d7His, a plasmid containing the groE promoter of Brucella spp. was constructed to express exogenous proteins in Brucella with high efficiency. Furthermore, we constructed the inducible expression plasmid pZT-6\u00d7His, containing the tetracycline-inducible promoter pzt1, which can induce expression by the addition of tetracycline in the Brucella culture medium. The constructed pTM series plasmids will play an important role in the functional investigation of Brucella spp. Copyright \u00a9 2016 Elsevier B.V. All rights reserved.\n[Detection and differentiation of the six Brucella species by polymerase chain reaction.](https://www.ncbi.nlm.nih.gov/pubmed/9407549)\nSifuentes-Rinc\u00f3n, A M; Revol, A; Barrera-Salda\u00f1a, H A\n1997-11-01\nBrucelosis is a severe acute febrile disease caused by bacteria of the genus Brucella. Its current diagnosis is based on clinical observations that may be complemented by serology and microbiological culture tests; however, the former is limited in sensitivity and specificity, the latter is time consuming. To improve brucelosis diagnosis we developed a test which is specific and sensitive and is capable of differentiating the six species of Brucella. Four primers were designed from B. abortus sequences at the well-conserved Omp2 locus that are able to amplify the DNAs of all six species of Brucella. Our test detected all six species of Brucella. Their differentiation resulted directly from differences in the amplification patterns or was achieved indirectly using a RFLP present in one of the PCR products. The sensitivity and specificity of the new test were then determined; it was applied successfully in confirming the diagnosis of a patient whose clinical history and serology indicated infection with Brucella. The results make possible the use of a PCR test for Brucella detection and differentiation without relying on the measurement of the antibodies or microorganism culture. Our first results showed that the PCR test can confirm the presence of Brucella in blood samples of infected patients.\n[A history of the development of Brucella vaccines.](https://www.ncbi.nlm.nih.gov/pubmed/23862154)\nAvila-Calder\u00f3n, Eric Daniel; Lopez-Merino, Ahid\u00e9; Sriranganathan, Nammalwar; Boyle, Stephen M; Contreras-Rodr\u00edguez, Araceli\n2013-01-01\nBrucellosis is a worldwide zoonosis affecting animal and human health. In the last several decades, much research has been performed to develop safer Brucella vaccines to control the disease mainly in animals. Till now, no effective human vaccine is available. The aim of this paper is to review and discuss the importance of methodologies used to develop Brucella vaccines in pursuing this challenge.\n[Evaluation of a New and Rapid Serologic Test for Detecting Brucellosis: Brucella Coombs Gel Test.](https://www.ncbi.nlm.nih.gov/pubmed/29023001)\nHanci, Hayrunisa; Igan, Hakan; Uyanik, Muhammet Hamidullah\n2017-01-01\nMany serological tests have been used for the diagnosis of human brucellosis. A new serological method is identified as Brucella Coombs gel test based on the principle of centrifugation gel system similar to the gel system used in blood group determination. In this system, if Brucella antibodies were present in the serum, antigen and antibody would remain as a pink complex on the gel. Otherwise, the pink Brucella antigens would precipitate at the bottom of the gel card system. In this study, we aimed to compare the Brucella Coombs gel test, a new, rapid screen and titration method for detection of non-agglutinating IgG with the Brucella Coombs test. For this study, a total of 88 serum samples were obtained from 45 healthy persons and 43 individuals who had clinical signs and symptoms of brucellosis. For each specimen, Rose Bengal test, standard agglutination test, Coombs test and Brucella Coombs gel test were carried out. Sensitivity and specificity of Brucella Coombs gel test were found as 100.0 and 82.2%, respectively. Brucella Coombs gel test can be used as a screening test with high sensitivity. By the help of pink Brucella antigen precipitation, the tests' evaluation is simple and objective. In addition, determination of Brucella antibody by rapid titration offers another important advantage.\n[MULTIPLE-LOCUS VARIABLE-NUMBER TANDEM REPEAT ANALYSIS OF BRUCELLA ISOLATES FROM THAILAND.](https://www.ncbi.nlm.nih.gov/pubmed/29644829)\nKumkrong, Khurawan; Chankate, Phanita; Tonyoung, Wittawat; Intarapuk, Apiradee; Kerdsin, Anusak; Kalambaheti, Thareerat\n2017-01-01\nBrucellosis-induced abortion can result in significant economic loss to farm animals. Brucellosis can be transmitted to humans during slaughter of infected animals or via consumption of contaminated food products. Strain identification of Brucella isolates can reveal the route of transmission. Brucella strains were isolated from vaginal swabs of farm animal, cow milk and from human blood cultures. Multiplex PCR was used to identify Brucella species, and owing to high DNA homology among Brucella isolates, multiple-locus variable-number tandem repeat analysis (MLVA) based on the number of tandem repeats at 16 different genomic loci was used for strain identification. Multiplex PCR categorized the isolates into B. abortus (n = 7), B. melitensis (n = 37), B. suis (n = 3), and 5 of unknown Brucella spp. MLVA-16 clustering analysis differentiated the strains into various genotypes, with Brucella isolates from the same geographic region being closely related, and revealed that the Thai isolates were phylogenetically distinct from those in other countries, including within the Southeast Asian region. Thus, MLVA-16 typing has utility in epidemiological studies.\n[Administraci\u00f3n de vacunas y casos de muerte s\u00fabita del lactante en el Per\u00fa, 2001. \u00bfAsociaci\u00f3n o coincidencia temporal?](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::e53e6396d7036924ac4edb136005a9b2)\nVargas H, Javier; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Su\u00e1rez J, Magna; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Llamoga S, Alejandro; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Quispe T, Neyda; Centro Nacional de Salud P\u00fablica, Instituto Nacional de Salud. Lima, Per\u00fa.; Alva R, Fernando; Chu C, Julia; Centro Nacional de Producci\u00f3n de Biol\u00f3gicos, Instituto Nacional de Salud. Lima Per\u00fa.; Pereyra S, H\u00e9ctor; Oficina General de Epidemiolog\u00eda, Ministerio de Salud. Lima, Per\u00fa.; Ticona Z, Mar\u00eda; Oficina General de Epidemiolog\u00eda, Ministerio de Salud. Lima, Per\u00fa.; Medrano G, Jorge; Direcci\u00f3n General de Salud de las Personas, Ministerio de Salud. Lima, Per\u00fa.; Cerna D, Carolina; Direcci\u00f3n General de Salud de las Personas, Ministerio de Salud. Lima, Per\u00fa.\n2006-01-01\nObjetivos: Describir las caracter\u00edsticas cl\u00ednicas, socioecon\u00f3micas, y patol\u00f3gicas de nueve casos de lactantes que fallecieron horas despu\u00e9s de administr\u00e1rseles vacunas antipolio y DPT junto con anti Haemophilus influenzae b o asociada con antihepatitis B o BCG. Materiales y m\u00e9todos: Revisi\u00f3n de la historia cl\u00ednica, entrevista con el equipo de salud a cargo de la vacunaci\u00f3n y con los padres del lactante fallecido. Revisi\u00f3n de los informes del protocolo de autopsia e informes de anatom\u00eda patol\u00f3...\n[Fatores associados \u00e0 cobertura vacinal em adolescentes Factores asociados a la cobertura por vacunas en adolescentes Factors associated to the vaccination covering in adolescents](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21002010000600013) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAyla Maria Calixto de Carvalho\n2010-01-01\nFull Text Available OBJETIVO: Analisar os fatores associados \u00e0 condi\u00e7\u00e3o de estar vacinado entre adolescentes de uma \u00e1rea da Estrat\u00e9gia Sa\u00fade da Fam\u00edlia de Teresina - PI. M\u00c9TODOS: Estudo de natureza quantitativa e do tipo seccional. A amostra foi constitu\u00edda por 261 adolescentes e a an\u00e1lise foi realizada por meio da estat\u00edstica descritiva. RESULTADOS: A cobertura vacinal contra rub\u00e9ola, sarampo e caxumba foi de 5,4%; para a vacina contra difteria e t\u00e9tano, foi de 22,9%; para a vacina contra hepatite-B: foi 27,2% e 35,2% para a vacina contra febre amarela. CONCLUS\u00c3O: A baixa cobertura vacinal encontrada neste estudo est\u00e1 relacionada: \u00e0s oportunidades perdidas de vacina\u00e7\u00e3o (65,5%; \u00e0 defici\u00eancia de conhecimento sobre as vacinas, a faixa et\u00e1ria maior de 15 anos (Raz\u00e3o da Preval\u00eancia (RP = 2,85; \u00cdndice de Confian\u00e7a (IC 95% = 1,63-4,99; o sexo masculino (RP = 2,04; IC95% =1,15-3,62.OBJETIVO: Analizar los factores asociados a la condici\u00f3n de estar vacunado entre adolescentes, en un \u00e1rea de la Estrategia Salud de la Familia, en la ciudad de Teresina, en el estado de Piau\u00ed. M\u00c9TODOS: Estudio de naturaleza cuantitativa y de tipo seccional. La muestra fue constituida por 261 adolescentes y el an\u00e1lisis fue realizado por medio de la estad\u00edstica descriptiva. RESULTADOS: La cobertura por vacuna contra rub\u00e9ola, sarampi\u00f3n e caxumba fue de 5,4%; para la vacuna contra la difteria y t\u00e9tano, fue de 22,9%; para la vacuna contra hepatitis-B, fue 27,2% y de 35,2% para la vacuna contra la fiebre amarilla. CONCLUSI\u00d3N: La baja cobertura por vacunaci\u00f3n encontrada en este estudio est\u00e1 relacionada a: 1 las oportunidades perdidas de vacunaci\u00f3n (65,5%; a la deficiencia de conocimiento sobre las vacunas, al intervalo de edad mayor de 15 a\u00f1os [Raz\u00f3n de la Prevalencia (RP = 2,85; \u00cdndice de Confianza (IC 95% = 1,63-4,99]; al sexo masculino (RP = 2,04; IC95% =1,15-3,62.OBJECTIVE: To analyze the factors associated to the condition of to be vaccinated among\n[[Molecular typing of 12 Brucella strains isolated in Guizhou province in 2010-2013].](https://www.ncbi.nlm.nih.gov/pubmed/26733136)\nWang, Yue; Chen, Hong; Liu, Ying; Zhou, Jingzhu; Li, Shijun; Hang, Yan; Tang, Guangpeng; Wang, Dingming; Chen, Guichun\n2015-09-01\nTo identify and characterize the Brucella strains from Guizhou province in 2010-2013. A total of 12 strains of Brucella suspicious bacteria were isolated in Guizhou province from 2010 to 2013. Four strains (GZLL3, GZLL4, GZLL11 and SH2) were isolated from goat blood samples and eight strains (SH4, GZZY, GZSQ, GZZA, BR13001, BR13004, BR13005 and BR13006) were isolated from blood samples of patient 12 Brucella suspicious strains were identified and characterized using conventional methods. Brucella genus specific gene BCSP31-based PCR (BCSP31-PCR) was used to identify the genus of Brucella and IS711 insert sequence-based PCR (AMOS-PCR) was applied to identify the species of Brucella strains. Goats and patients originated Brucella strains were comparatively analysed using Pulse-field Gel Electrophoresis (PFGE). Both of conventional methods and PCR identified the 12 Brucella suspicious strains as B. melitensis biotype 3. BCSP31-PCR identification results showed that a specific DNA bands (223 bp) were detected in all the 12 strains and positive control samples with no DNA band in negative samples. AMOS-PCR amplified a 731 bp-DNA bands in all the 12 strains, with 731 bp, 498 bp and 275 bp in M5, S2 and A19 strains, respectively, and no DNA band was detected in the negative control samples. PFGE analysis showed that 12 Brucella isolates from patients and goats showed consistent PFGE patterns with the digestion of restriction enzyme Xba I. The epidemic species/type of Brucella in both human and animal in Guizhou province was B. melitensis biotype 3 and goat was the main animal source of infection of brucellosis in Guizhou province.\n[Characterisation of the genetic diversity of Brucella by multilocus sequencing](http://www.biomedcentral.com/1471-2180/7/34) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMacMillan Alastair P\n2007-04-01\nFull Text Available Abstract Background Brucella species include economically important zoonotic pathogens that can infect a wide range of animals. There are currently six classically recognised species of Brucella although, as yet unnamed, isolates from various marine mammal species have been reported. In order to investigate genetic relationships within the group and identify potential diagnostic markers we have sequenced multiple genetic loci from a large sample of Brucella isolates representing the known diversity of the genus. Results Nine discrete genomic loci corresponding to 4,396 bp of sequence were examined from 160 Brucella isolates. By assigning each distinct allele at a locus an arbitrary numerical designation the population was found to represent 27 distinct sequence types (STs. Diversity at each locus ranged from 1.03\u20132.45% while overall genetic diversity equated to 1.5%. Most loci examined represent housekeeping gene loci and, in all but one case, the ratio of non-synonymous to synonymous change was substantially Brucella species, B. abortus, B. melitensis, B. ovis and B. neotomae correspond to well-separated clusters. With the exception of biovar 5, B. suis isolates cluster together, although they form a more diverse group than other classical species with a number of distinct STs corresponding to the remaining four biovars. B. canis isolates are located on the same branch very closely related to, but distinguishable from, B. suis biovar 3 and 4 isolates. Marine mammal isolates represent a distinct, though rather weakly supported, cluster within which individual STs display one of three clear host preferences. Conclusion The sequence database provides a powerful dataset for addressing ongoing controversies in Brucella taxonomy and a tool for unambiguously placing atypical, phenotypically discordant or newly emerging Brucella isolates. Furthermore, by using the phylogenetic backbone described here, robust and rationally selected markers for use in\n[Contamination of bovine, sheep and goat meat with Brucella spp.](http://www.pagepressjournals.org/index.php/ijfs/article/view/5913) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFrancesco Casalinuovo\n2016-06-01\nFull Text Available A study was conducted in order to evaluate the contamination by Brucella spp. of meat from animals slaughtered because they had resulted positive for brucellosis at some time during their life. After slaughter and before delivery to market outlets, swab samples were taken from 307 carcasses of infected animals: 40 cattle, 60 sheep and 207 goats. The swabs were subsequently analysed by means of polymerase chain reaction (PCR tests. In addition, bacteriological tests were carried out on the lymph nodes and internal organs of the same animals. Brucella spp. was detected by means of PCR in 25/307 carcasses (8%: 1 bovine (2.5%, 9 sheep (15% and 15 goats (7.2% and was isolated by means of a cultural method in 136/307 carcasses (44%. Moreover, additional analysis, performed on lymph nodes from the same carcasses that had proved positive by PCR, allowed highlighting type 3 Brucella abortus in the bovine carcass and type 3 Brucella melitensis in the sheep and goat carcasses. The study shows that cattle, sheep and goats meat of animals slaughtered because they had tested positive for brucellosis may be contaminated by Brucella spp. As this could constitute a real risk of transmission to both butchery personnel and consumers, the meat of animals infected by Brucella spp. should be analysed before being marketed. In this respect, PCR technique performed on swabs proved to be more useful, practical and faster than the traditional bacteriological method.\n[Evaluaci\u00f3n de la informaci\u00f3n sanitaria disponible en internet sobre la vacuna antigripal](https://www.openaire.eu/search/publication?articleId=doajarticles::10bf287ae0007ca1c04dfbe102687a3b)\nI. Hern\u00e1ndez-Garc\u00eda; R. Gonz\u00e1lez Celador\n2014-01-01\nFundamento: La calidad de la informaci\u00f3n sanitaria en internet preocupa a gobiernos y usuarios. Nuestro objetivo fue determinar en qu\u00e9 medida la informaci\u00f3n sobre la vacuna antigripal se adhiere al gold est\u00e1ndar representado por lo establecido por el Ministerio de Sanidad espa\u00f1ol. Material y m\u00e9todos: Entre junio-julio 2014 se evalu\u00f3 la adhesi\u00f3n al gold est\u00e1ndar de la informaci\u00f3n sobre indicaciones, efectos adversos y contraindicaciones de la vacuna. Dicha informaci\u00f3n se obtuvo a trav\u00e9s de Goo...\n[HPV vaccine introduction at the local level in a developing country: attitudes and criteria among key actors Introducci\u00f3n de la vacuna contra el VPH en niveles locales de un pa\u00eds en v\u00edas de desarrollo: actitudes y criterios de actores clave](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2010000500012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarion Pi\u00f1eros\n2010-05-01\nFull Text Available In most developing countries, HPV vaccines have been licensed but there are no national policy recommendations, nor is it clear how decisions on the introduction of this new vaccine are made. Decentralization processes in many Latin American countries favor decision-making at the local level. Through a qualitative study we explored knowledge regarding the HPV vaccine and the criteria that influence decision-making among local health actors in four regions of Colombia. We conducted a total of 14 in-depths interviews with different actors; for the analysis we performed content analysis. Results indicate that decision-making on the HPV vaccine at the local level has mainly been driven by pressure from local political actors, in a setting where there is low technical knowledge of the vaccine. This increases the risk of initiatives that may foster inequity. Local decisions and initiatives need to be strengthened technically and supported by national-level decisions, guidelines and follow-up.En gran parte de los pa\u00edses en v\u00edas de desarrollo, las vacunas contra el VPH tienen aprobaci\u00f3n para su comercializaci\u00f3n. Sin embargo, no hay recomendaciones y tampoco hay claridad sobre la forma en la que se toman las decisiones para su introducci\u00f3n. La reforma del sistema de salud en muchos pa\u00edses latinoamericanos permite la toma de decisiones en el nivel local. Mediante un estudio cualitativo con actores claves del sector salud en cuatro regiones de Colombia, exploramos el conocimiento sobre la vacuna del VPH y los criterios que influyen en la toma de decisiones. Se realizaron 14 entrevistas en profundidad y an\u00e1lisis de contenido. Los resultados indican que en el nivel local la toma de decisiones sobre la introducci\u00f3n de la vacuna est\u00e1 determinada en gran parte por la presi\u00f3n ejercida por figuras pol\u00edticas locales. Esto, sumado a un bajo nivel de conocimiento t\u00e9cnico, incrementa la posibilidad de iniciativas con implicaciones \u00e9ticas considerables\n[A History of the Development of Brucella Vaccines](http://dx.doi.org/10.1155/2013/743509) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEric Daniel Avila-Calder\u00f3n\n2013-01-01\nFull Text Available Brucellosis is a worldwide zoonosis affecting animal and human health. In the last several decades, much research has been performed to develop safer Brucella vaccines to control the disease mainly in animals. Till now, no effective human vaccine is available. The aim of this paper is to review and discuss the importance of methodologies used to develop Brucella vaccines in pursuing this challenge.\n[Efectividad de la vacuna contra influenza: metan\u00e1lisis de literatura](http://www.revistabiomedica.org/index.php/biomedica/article/view/44) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJos\u00e9 Moreno\n2009-03-01\nConclusiones. Los an\u00e1lisis sugieren la vacunaci\u00f3n como medida masiva de control para influenza en adultos mayores de 65 a\u00f1os. Existe un importante vac\u00edo de conocimiento en la efectividad de la vacuna en ni\u00f1os menores de dos a\u00f1os y madres gestantes.\n[Introducci\u00f3n de un ELISA como ensayo alternativo en la determinaci\u00f3n de la potencia de vacunas antitet\u00e1nicas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100001&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Carlos Ram\u00edrez\n2005-05-01\nFull Text Available Por m\u00e1s de medio siglo de uso, la vacunaci\u00f3n con el toxoide tet\u00e1nico ha mostrado un elevado porcentaje de eficacia en la prevenci\u00f3n del t\u00e9tanos. Este trabajo pretende introducir un ensayo inmunoenzim\u00e1tico en fase s\u00f3lida (ELISA como m\u00e9todo alternativo a la prueba de seroneutralizaci\u00f3n in vivo utilizada en la evaluaci\u00f3n de la potencia de las vacunas antitet\u00e1nicas.Se desarroll\u00f3 un ELISA de tipo indirecto para la cuantificaci\u00f3n de antitoxina tet\u00e1nica en suero de curiel a partir de un est\u00e1ndar con 29 UI/mL, previamente calibrado. Se determin\u00f3 la precisi\u00f3n, exactitud y linealidad del ensayo. Se analiz\u00f3 la correlaci\u00f3n entre el ELISA y la prueba biol\u00f3gica mediante la evaluaci\u00f3n de un total de 75 muestras de sueros por ambos m\u00e9todos. Por \u00faltimo, se estudi\u00f3 la respuesta individual de un grupo de animales contra 15 lotes de toxoide tet\u00e1nico. El ensayo demostr\u00f3 ser preciso y exacto, con imprecisiones inferiores al 20% y valores de recuperaci\u00f3n entre el 90\u2013110%. Las desviaciones del paralelismo mostraron coeficientes de variaci\u00f3n alrededor del 10%. El an\u00e1lisis por regresi\u00f3n lineal mostr\u00f3 una buena correlaci\u00f3n entre el ELISA y el ensayo biol\u00f3gico (R2= 0,989. El m\u00e9todo alternativo desarrollado prob\u00f3 ser una herramienta \u00fatil para la determinaci\u00f3n de la potencia de vacunas antitet\u00e1nicas a partir de la evaluaci\u00f3n independiente de la respuesta de cada animal contra el toxoide tet\u00e1nico.Los niveles de seroprotecci\u00f3n alcanzados se encontraron entre el 83\u2013100%.\n[Brucella ceti Infection in a Common Minke Whale ( Balaenoptera acutorostrata ) with Associated Pathology.](https://www.ncbi.nlm.nih.gov/pubmed/28418765)\nDavison, Nicholas J; Perrett, Lorraine L; Dawson, Claire; Dagleish, Mark P; Haskins, Gary; Muchowski, Jakub; Whatmore, Adrian M\n2017-07-01\nThere are three major lineages of marine mammal strains of Brucella spp.: Brucella ceti ST23, found predominantly in porpoises; B. ceti ST26, in pelagic delphinids and ziphiids; and Brucella pinnipedialis ST24/25, predominantly in seals. The isolation of Brucella spp. in mysticetes has been described only in common minke whales ( Balaenoptera acutorostrata ) in Norway and Scotland. We report a third case of Brucella infection and isolation in a minke whale associated with a large abscess. In contrast to the two previous reports that involved isolates of B. pinnipedialis ST24 or the porpoise-associated B. ceti complex ST23, this case was associated with the dolphin-associated B. ceti ST26. Thus, minke whales can be infected naturally with members of all the distinct major lineages of Brucella associated with marine mammals. This report is unique in that the B. ceti ST26 did not originate from a pelagic delphinid or a beaked whale.\n[Brucella seropositivity in chicken and risk factors for Brucella infection at the animal-human interface in Anambra State, Nigeria](http://www.onehealthjournal.org/Vol.4/5.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJoseph Ikechukwu Onunkwo\n2018-06-01\nFull Text Available Aim: Brucellosis is an important bacterial zoonosis devastating both animal and human populations in many parts of the world. A seroepidemiological study of avian Brucella infection was conducted to determine the disease prevalence, risk factors, and hence the role of chicken in the epidemiology of brucellosis in Anambra State, Nigeria. Materials and Methods: Rose Bengal plate test was used to test for Brucella antibody in sera samples collected from 410 chickens surveyed. The interview schedule was used to elicit information on the socioeconomic status, awareness of brucellosis and predisposing practices of poultry farmers, live bird sellers, and poultry carcass processors in the study area. Results: An overall seroprevalence of 3% was recorded. Sex (female, free-range management system, breed (indigenous breed, and mix farming were the determinants of avian brucellosis in the state. Risk factors that may enhance human Brucella infection at the animal-human interface are non-use of personal protective clothing; poor awareness on brucellosis and methods of the disease spread or control, cohabitation with animals, and eating while on duty. Conclusion: Chicken may be among the reservoirs of Brucella infection in Anambra State. There is an urgent need for an effective control program against brucellosis in the study area, using a coordinated One Health approach bearing in mind the public health and economic consequences of brucellosis.\n[Comparative Genomics of Early-Diverging Brucella Strains Reveals a Novel Lipopolysaccharide Biosynthesis Pathway](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3445970)\nWattam, Alice R.; Inzana, Thomas J.; Williams, Kelly P.; Mane, Shrinivasrao P.; Shukla, Maulik; Almeida, Nalvo F.; Dickerman, Allan W.; Mason, Steven; Moriy\u00f3n, Ignacio; O\u2019Callaghan, David; Whatmore, Adrian M.; Sobral, Bruno W.; Tiller, Rebekah V.; Hoffmaster, Alex R.; Frace, Michael A.; De Castro, Cristina; Molinaro, Antonio; Boyle, Stephen M.; De, Barun K.; Setubal, Jo\u00e3o C.\n2012-01-01\nABSTRACT Brucella species are Gram-negative bacteria that infect mammals. Recently, two unusual strains (Brucella inopinata BO1T and B. inopinata-like BO2) have been isolated from human patients, and their similarity to some atypical brucellae isolated from Australian native rodent species was noted. Here we present a phylogenomic analysis of the draft genome sequences of BO1T and BO2 and of the Australian rodent strains 83-13 and NF2653 that shows that they form two groups well separated from the other sequenced Brucella spp. Several important differences were noted. Both BO1T and BO2 did not agglutinate significantly when live or inactivated cells were exposed to monospecific A and M antisera against O-side chain sugars composed of N-formyl-perosamine. While BO1T maintained the genes required to synthesize a typical Brucella O-antigen, BO2 lacked many of these genes but still produced a smooth LPS (lipopolysaccharide). Most missing genes were found in the wbk region involved in O-antigen synthesis in classic smooth Brucella spp. In their place, BO2 carries four genes that other bacteria use for making a rhamnose-based O-antigen. Electrophoretic, immunoblot, and chemical analyses showed that BO2 carries an antigenically different O-antigen made of repeating hexose-rich oligosaccharide units that made the LPS water-soluble, which contrasts with the homopolymeric O-antigen of other smooth brucellae that have a phenol-soluble LPS. The results demonstrate the existence of a group of early-diverging brucellae with traits that depart significantly from those of the Brucella species described thus far. PMID:22930339\n[The role of 'atypical' Brucella in amphibians: are we facing novel emerging pathogens?](https://www.ncbi.nlm.nih.gov/pubmed/27740712)\nM\u00fchldorfer, K; Wibbelt, G; Szentiks, C A; Fischer, D; Scholz, H C; Zsch\u00f6ck, M; Eisenberg, T\n2017-01-01\nTo discuss together the novel cases of Brucella infections in frogs with the results of published reports to extend our current knowledge on 'atypical' brucellae isolated from amphibians and to discuss the challenges we face on this extraordinary emerging group of pathogens. Since our first description, an additional 14 isolates from four different frog species were collected. Novel isolates and a subset of Brucella isolates previously cultured from African bullfrogs were characterized by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), Fourier transform-infrared (FT-IR) spectroscopy and broth microdilution susceptibility testing. MALDI-TOF MS worked very efficiently for an accurate bacterial identification to the genus level. Within the cluster analysis, 'atypical' brucellae grouped distant from Brucella melitensis and were even more separated by FT-IR spectroscopy with respect to their geographical origin. Minimum inhibitory concentrations of 14 antimicrobial substances are provided as baseline data on antimicrobial susceptibility. The case history of Brucella infections in amphibians reveals a variety of pathologies ranging from localized manifestations to systemic infections. Some isolates seem to be capable of causing high mortality in zoological exhibitions putting higher demands on the management of endangered frog species. There is considerable risk in overlooking and misidentifying 'atypical' Brucella in routine diagnostics. Brucella have only recently been described in cold-blooded vertebrates. Their presence in frog species native to Africa, America and Australia indicates a more common occurrence in amphibians than previously thought. This study provides an extensive overview of amphibian brucellae by highlighting the main features of their clinical significance, diagnosis and zoonotic potential. \u00a9 2016 The Society for Applied Microbiology.\n[Detection of Brucella melitensis and Brucella abortus strains using a single-stage PCR method](http://www.archrazi.com/browse.php?a_id=544&sid=1&slc_lang=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAlamian, S.\n2015-04-01\nFull Text Available Brucella melitensis and Brucella abortus are of the most important causes of brucellosis, an infectious disease which is transmitted either directly or indirectly including consuming unpasteurized dairy products. Both strains are considered endemic in Iran. Common diagnostic methods such as bacteriologic cultures are difficult and time consuming regarding the bacteria. The aim of this study was to suggest a single-stage PCR method using a pair of primers to detect both B. melitensis and B. abortus. The primers were named UF1 and UR1 and the results showed that the final size of PCR products were 84 bp and 99 bp for B. melitensis and B. abortus, respectively. Therefore the method could be useful for rapid detection of B. melitensis and B. abortus simultaneously.\n[Isolation and identification of bovine Brucella isolates from Pakistan by biochemical tests and PCR.](https://www.ncbi.nlm.nih.gov/pubmed/23868548)\nAli, Shahzad; Ali, Qurban; Melzer, Falk; Khan, Iahtasham; Akhter, Shamim; Neubauer, Heinrich; Jamal, Syed M\n2014-01-01\nBrucellosis is endemic in bovines in Pakistan. The Brucella species and biovars involved, however, are unknown. The objectives of the present study were to isolate and characterize brucellae from seropositive milk samples, aborted fetuses, and vaginal swabs of cattle and buffaloes which had recently aborted. The seropositive milk samples, aborted fetuses, and vaginal swabs of cattle and buffaloes were collected from the Potohar Plateau, Pakistan. Isolation of brucellae was done on modified Farrell's serum dextrose agar. Isolates were characterized by conventional biotyping methods, while molecular typing was done by genus (B4/B5) and species-specific (Brucella abortus, Brucella melitensis, Brucella ovis, and Brucella suis) polymerase chain reaction (PCR). A total of 30 isolates were recovered from milk (n = 5), aborted fetuses (n = 13), and vaginal swabs (n = 12). Most isolates were from cattle (56.7 %). All of them were identified as B. abortus biovar 1 based on conventional biotyping methods and genus and species-specific PCR. This preliminary study provides the first report on the prevalence of B. abortus biovar 1 in cattle and buffaloes in Pakistan.\n[Multiple Locus Variable-Number Tandem-Repeat and Single-Nucleotide Polymorphism-Based Brucella Typing Reveals Multiple Lineages in Brucella melitensis Currently Endemic in China](http://journal.frontiersin.org/article/10.3389/fvets.2017.00215/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMingjun Sun\n2017-12-01\nFull Text Available Brucellosis is a worldwide zoonotic disease caused by Brucella spp. In China, brucellosis is recognized as a reemerging disease mainly caused by Brucella melitensis specie. To better understand the currently endemic B. melitensis strains in China, three Brucella genotyping methods were applied to 110 B. melitensis strains obtained in past several years. By MLVA genotyping, five MLVA-8 genotypes were identified, among which genotypes 42 (1-5-3-13-2-2-3-2 was recognized as the predominant genotype, while genotype 63 (1-5-3-13-2-3-3-2 and a novel genotype of 1-5-3-13-2-4-3-2 were second frequently observed. MLVA-16 discerned a total of 57 MLVA-16 genotypes among these Brucella strains, with 41 genotypes being firstly detected and the other 16 genotypes being previously reported. By BruMLSA21 typing, six sequence types (STs were identified, among them ST8 is the most frequently seen in China while the other five STs were firstly detected and designated as ST137, ST138, ST139, ST140, and ST141 by international multilocus sequence typing database. Whole-genome sequence (WGS-single-nucleotide polymorphism (SNP-based typing and phylogenetic analysis resolved Chinese B. melitensis strains into five clusters, reflecting the existence of multiple lineages among these Chinese B. melitensis strains. In phylogeny, Chinese lineages are more closely related to strains collected from East Mediterranean and Middle East countries, such as Turkey, Kuwait, and Iraq. In the next few years, MLVA typing will certainly remain an important epidemiological tool for Brucella infection analysis, as it displays a high discriminatory ability and achieves result largely in agreement with WGS-SNP-based typing. However, WGS-SNP-based typing is found to be the most powerful and reliable method in discerning Brucella strains and will be popular used in the future.\n[Brucella antibody seroprevalence in Antarctic seals (Arctocephalus gazella, Leptonychotes weddellii and Mirounga leonina).](https://www.ncbi.nlm.nih.gov/pubmed/23999701)\nJensen, Silje-Kristin; Nymo, Ingebj\u00f8rg Helena; Forcada, Jaume; Hall, Ailsa; Godfroid, Jacques\n2013-09-03\nBrucellosis is a worldwide infectious zoonotic disease caused by Gram-negative bacteria of the genus Brucella, and Brucella infections in marine mammals were first reported in 1994. A serosurvey investigating the presence of anti-Brucella antibodies in 3 Antarctic pinniped species was undertaken with a protein A/G indirect enzyme-linked immunosorbent assay (iELISA) and the Rose Bengal test (RBT). Serum samples from 33 Weddell seals Leptonychotes weddelli were analysed, and antibodies were detected in 8 individuals (24.2%) with the iELISA and in 21 (65.6%) with the RBT. We tested 48 southern elephant seal Mirounga leonina sera and detected antibodies in 2 animals (4.7%) with both the iELISA and the RBT. None of the 21 Antarctic fur seals Arctocephalus gazella was found positive. This is the first report of anti-Brucella antibodies in southern elephant seals. The potential impact of Brucella infection in pinnipeds in Antarctica is not known, but Brucella spp. are known to cause abortion in terrestrial species and cetaceans. Our findings suggest that Brucella infection in pinnipeds is present in the Antarctic, but to date B. pinnipedialis has not been isolated from any Antarctic pinniped species, leaving the confirmation of infection pending.\n[Brucella Melitensis Review of the Human Infection Case](http://www.bjbms.org/ojs/index.php/bjbms/article/view/3203) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\n\u0160ukrija Zvizdi\u0107\n2006-02-01\nFull Text Available Brucella spp. prosthetic joint infections are infrequently reported in the literature, particularly in returning travellers, and optimal treatment is unknown.METHOD:We describe a prosthetic joint infection (PJI caused by Brucella melitensis in a traveller returning to the UK from Thailand, which we believe to be the first detailed report of brucellosis in a traveller returning from this area. The 23 patients with Brucella-related PJI reported in the literature are summarised, together with our case.RESULTS:The diagnosis of Brucella-related PJI is difficult to make; only 30% of blood cultures and 75% of joint aspiration cultures were positive in the reported cases. Culture of intraoperative samples provides the best diagnostic yield. In the absence of radiological evidence of joint loosening, combination antimicrobial therapy alone may be appropriate treatment in the first instance; this was successful in 6/7 [86%] of patients, though small numbers of patients and the likelihood of reporting bias warrant caution in drawing any firm conclusions about optimal treatment. Aerosolisation of synovial fluid during joint aspiration procedures and nosocomial infection has been described.CONCLUSIONS:Brucella-related PJI should be considered in the differential of travellers returning from endemic areas with PJI, including Thailand. Personal protective equipment including fit tested filtering face piece-3 (FFP3 mask or equivalent is recommended for personnel carrying out joint aspiration when brucellosis is suspected. Travellers can reduce the risk of brucellosis by avoiding unpasteurised dairy products and animal contact (particularly on farms and abattoirs in endemic areas and should be counselled regarding these risks as part of their pre-travel assessment.\n[Genotyping of Brucella species using clade specific SNPs](http://www.biomedcentral.com/1471-2180/12/110) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFoster Jeffrey T\n2012-06-01\nFull Text Available Abstract Background Brucellosis is a worldwide disease of mammals caused by Alphaproteobacteria in the genus Brucella. The genus is genetically monomorphic, requiring extensive genotyping to differentiate isolates. We utilized two different genotyping strategies to characterize isolates. First, we developed a microarray-based assay based on 1000 single nucleotide polymorphisms (SNPs that were identified from whole genome comparisons of two B. abortus isolates , one B. melitensis, and one B. suis. We then genotyped a diverse collection of 85 Brucella strains at these SNP loci and generated a phylogenetic tree of relationships. Second, we developed a selective primer-extension assay system using capillary electrophoresis that targeted 17 high value SNPs across 8 major branches of the phylogeny and determined their genotypes in a large collection ( n = 340 of diverse isolates. Results Our 1000 SNP microarray readily distinguished B. abortus, B. melitensis, and B. suis, differentiating B. melitensis and B. suis into two clades each. Brucella abortus was divided into four major clades. Our capillary-based SNP genotyping confirmed all major branches from the microarray assay and assigned all samples to defined lineages. Isolates from these lineages and closely related isolates, among the most commonly encountered lineages worldwide, can now be quickly and easily identified and genetically characterized. Conclusions We have identified clade-specific SNPs in Brucella that can be used for rapid assignment into major groups below the species level in the three main Brucella species. Our assays represent SNP genotyping approaches that can reliably determine the evolutionary relationships of bacterial isolates without the need for whole genome sequencing of all isolates.\n[Identification and typing of Brucella spp. in stranded harbour porpoises (Phocoena phocoena) on the Dutch coast.](https://www.ncbi.nlm.nih.gov/pubmed/25115787)\nMaio, Elisa; Begeman, Lineke; Bisselink, Yvette; van Tulden, Peter; Wiersma, Lidewij; Hiemstra, Sjoukje; Ruuls, Robin; Gr\u00f6ne, Andrea; Roest, Hendrik-Ido-Jan; Willemsen, Peter; van der Giessen, Joke\n2014-09-17\nThe presence of Brucella (B.) spp. in harbour porpoises stranded between 2008 and 2011 along the Dutch coast was studied. A selection of 265 tissue samples from 112 animals was analysed using conventional and molecular methods. In total, 4.5% (5/112) of the animals corresponding with 2.3% (6/265) Brucella positive tissue samples were Brucella positive by culture and these were all confirmed by real-time polymerase chain reaction (real-time PCR) based on the insertion element 711 (IS711). In addition, two more Brucella-positive tissue samples from two animals collected in 2011 were identified using real-time PCR resulting in an overall Brucella prevalence of 6.3% (7/112 animals). Brucella spp. were obtained from lungs (n=3), pulmonary lymph node (n=3) and lungworms (n=2). Multi Locus Variable Number of Tandem Repeats (VNTR) Analysis (MLVA) typing based on the MLVA-16 showed that the Brucella isolates were B. ceti. Additional in silico Multi Locus Sequence typing (MLST) after whole genome sequencing of the 6 Brucella isolates confirmed B. ceti ST 23. According to the Brucella 2010 MLVA database, the isolated Brucella strains encountered were of five genotypes, in two distinct subclusters divided in two different time periods of harbour porpoises collection. This study is the first population based analyses for Brucella spp. infections in cetaceans stranded along the Dutch coast. Copyright \u00a9 2014 The Authors. Published by Elsevier B.V. All rights reserved.\n[INMUNOLOG\u00cdA DE LA POLIOMIELITIS: VACUNAS, PROBLEMAS PARA LA PREVENCION/ERRADICACION E INTERVENCIONES DE FUTURO](http://www.redalyc.org/articulo.oa?id=17029171003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEduardo Fern\u00e1ndez-Cruz P\u00e9rez\n2013-01-01\nFull Text Available La poliomielitis es una enfermedad infectocontagiosa que afecta preferentemente a los ni\u00f1os menores de 5 a\u00f1os y est\u00e1 causada por el poliovirus, un enterovirus perteneciente a la familia Picornaviridae. El virus entra a trav\u00e9s de la mucosa oral y se multiplica en las c\u00e9lulas del epitelio tanto de la orofaringe como del tracto gastrointestinal, liberando virus a nivel de las secreciones orofar\u00edngeas y a trav\u00e9s de la materia fecal. La v\u00eda de transmisi\u00f3n es fecal-oral y/o oral-oral. La mayor\u00eda de los casos de infecci\u00f3n son asintom\u00e1ticos y autolimitados al tracto gastrointestinal. Eventualmente puede diseminarse al sistema nervioso central y afectar a las motoneuronas del asta anterior de la m\u00e9dula espinal ocasionando par\u00e1lisis e incluso la muerte El curso natural de la infecci\u00f3n depende de m\u00faltiples factores, como el tipo de in\u00f3culo viral (serotipos VP1, 2 y 3 y factores del hu\u00e9sped/sistema inmunol\u00f3gico, que incluye el estado nutricional, las infecciones concurrentes y la capacidad de inducir respuestas inmunol\u00f3gicas protectoras sist\u00e9micas de tipo humoral, con anticuerpos antiv\u00edricos circulantes neutralizantes, y respuestas de la inmunidad de mucosas y adaptativa. Discutiremos los aspectos actuales de la inmunopatog\u00e9nesis de la infecci\u00f3n por el poliovirus, la interacci\u00f3n hu\u00e9sped-virus y la eficacia y los problemas en el desarrollo de las estrategias con las diferentes vacunas antipoliovirus, para que la inmunizaci\u00f3n sea m\u00e1s efectiva en relaci\u00f3n a la inducci\u00f3n de los mecanismos protectores que evitan el des- arrollo de la enfermedad, la transmisi\u00f3n del virus, los rebrotes de infecci\u00f3n y eventualmente facilitan la consecuci\u00f3n de su erradicaci\u00f3n.\n[Evoluci\u00f3n de las coberturas vacunales antigripales entre 1993-2001 en Espa\u00f1a: An\u00e1lisis por Comunidades Aut\u00f3nomas](http://www.redalyc.org/articulo.oa?id=17078406) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nElga Mayo Montero\n2004-01-01\nFull Text Available Fundamento: La gripe es una enfermedad con una elevada morbilidad y que ocasiona un alto coste sanitario, para la que adem\u00e1s se dispone de una vacuna eficaz. El objetivo de este trabajo es evaluar la evoluci\u00f3n de las coberturas vacunales antigripales en Espa\u00f1a por Comunidades Aut\u00f3nomas entre 1993 y 2001. M\u00e9todos: Se han analizado un total de 42.123 registros de la Encuesta Nacional de Salud (ENS de los a\u00f1os 1993 (n=21.051 y 2001(n=21.072. Todos ellos corresponden a adultos espa\u00f1oles mayores de 15 a\u00f1os no institucionalizados. Ambas encuestas son representativas a nivel de Comunidad Aut\u00f3noma. Resultados: Para el total de la muestra se estima una cobertura vacunal en 1993 de 17,94% (IC 95% 17,42-18,46 y de 19,30% (18,77-19,83 en 2001. En el modelo de regresi\u00f3n log\u00edstica, ajustado por edad, g\u00e9nero y enfermedad cr\u00f3nica asociada, se observan mejoras significativas en las coberturas del grupo de mayores de 64 a\u00f1os (OR= 1,28 IC 95% 1,10-1,50 para el total de Espa\u00f1a y para cinco de las 17 Comunidades Aut\u00f3nomas entre 1993 y 2001. Sin embargo, no encontramos cambios significativos en las coberturas para el grupo de menores de 65 a\u00f1os con enfermedad cr\u00f3nica asociada que supone una indicaci\u00f3n para la vacunaci\u00f3n. Conclusiones: Tanto en Espa\u00f1a como en la mayor\u00eda de las Comunidades Aut\u00f3nomas entre 1993 y 2001 se observa una ligera pero insuficiente mejor\u00eda en las coberturas de vacunaci\u00f3n en los grupos de riesgo estudiados. Las Comunidades Aut\u00f3nomas muestran coberturas dispares entre s\u00ed. Los sujetos menores de 65 a\u00f1os con enfermedades cr\u00f3nicas asociadas que incrementan el riesgo de sufrir las complicaciones de la gripe no han mejorado las coberturas de esta vacuna durante el periodo de estudio. La dificultad para mejorar las coberturas en este tipo de pacientes podr\u00eda hacernos considerar la opci\u00f3n y el beneficio potencial de rebajar la edad limite de las actuales recomendaciones de indicaci\u00f3n de vacuna antigripal en Espa\u00f1a.\n[Marine Mammal Brucella Reference Strains Are Attenuated in a BALB/c Mouse Model.](https://www.ncbi.nlm.nih.gov/pubmed/26959235)\nNymo, Ingebj\u00f8rg H; Arias, Maykel A; Pardo, Juli\u00e1n; \u00c1lvarez, Mar\u00eda Pilar; Alcaraz, Ana; Godfroid, Jacques; Jim\u00e9nez de Bag\u00fc\u00e9s, Mar\u00eda Pilar\n2016-01-01\nBrucellosis is a zoonosis of worldwide distribution with numerous animal host species. Since the novel isolation of Brucella spp. from marine mammals in 1994 the bacteria have been isolated from various marine mammal hosts. The marine mammal reference strains Brucella pinnipedialis 12890 (harbour seal, Phoca vitulina) and Brucella ceti 12891 (harbour porpoise, Phocoena phocoena) were included in genus Brucella in 2007, however, their pathogenicity in the mouse model is pending. Herein this is evaluated in BALB/c mice with Brucella suis 1330 as a control. Both marine mammal strains were attenuated, however, B. ceti was present at higher levels than B. pinnipedialis in blood, spleen and liver throughout the infection, in addition B. suis and B. ceti were isolated from brains and faeces at times with high levels of bacteraemia. In B. suis-infected mice serum cytokines peaked at day 7. In B. pinnipedialis-infected mice, levels were similar, but peaked predominantly at day 3 and an earlier peak in spleen weight likewise implied an earlier response. The inflammatory response induced pathology in the spleen and liver. In B. ceti-infected mice, most serum cytokine levels were comparable to those in uninfected mice, consistent with a limited inflammatory response, which also was indicated by restricted spleen and liver pathology. Specific immune responses against all three strains were detected in vitro after stimulation of splenocytes from infected mice with the homologous heat-killed brucellae. Antibody responses in vivo were also induced by the three brucellae. The immunological pattern of B. ceti in combination with persistence in organs and limited pathology has heretofore not been described for other brucellae. These two marine mammal wildtype strains show an attenuated pattern in BALB/c mice only previously described for Brucella neotomea.\n[Marine Mammal Brucella Reference Strains Are Attenuated in a BALB/c Mouse Model.](http://europepmc.org/articles/PMC4784796?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIngebj\u00f8rg H Nymo\nFull Text Available Brucellosis is a zoonosis of worldwide distribution with numerous animal host species. Since the novel isolation of Brucella spp. from marine mammals in 1994 the bacteria have been isolated from various marine mammal hosts. The marine mammal reference strains Brucella pinnipedialis 12890 (harbour seal, Phoca vitulina and Brucella ceti 12891 (harbour porpoise, Phocoena phocoena were included in genus Brucella in 2007, however, their pathogenicity in the mouse model is pending. Herein this is evaluated in BALB/c mice with Brucella suis 1330 as a control. Both marine mammal strains were attenuated, however, B. ceti was present at higher levels than B. pinnipedialis in blood, spleen and liver throughout the infection, in addition B. suis and B. ceti were isolated from brains and faeces at times with high levels of bacteraemia. In B. suis-infected mice serum cytokines peaked at day 7. In B. pinnipedialis-infected mice, levels were similar, but peaked predominantly at day 3 and an earlier peak in spleen weight likewise implied an earlier response. The inflammatory response induced pathology in the spleen and liver. In B. ceti-infected mice, most serum cytokine levels were comparable to those in uninfected mice, consistent with a limited inflammatory response, which also was indicated by restricted spleen and liver pathology. Specific immune responses against all three strains were detected in vitro after stimulation of splenocytes from infected mice with the homologous heat-killed brucellae. Antibody responses in vivo were also induced by the three brucellae. The immunological pattern of B. ceti in combination with persistence in organs and limited pathology has heretofore not been described for other brucellae. These two marine mammal wildtype strains show an attenuated pattern in BALB/c mice only previously described for Brucella neotomea.\n[BrucellaCapt versus classical tests in the serological diagnosis and management of human brucellosis.](https://www.ncbi.nlm.nih.gov/pubmed/19369480)\nCasanova, Aurora; Ariza, Javier; Rubio, Manuel; Masuet, Cristina; D\u00edaz, Ram\u00f3n\n2009-06-01\nThe BrucellaCapt test is an immunocapture agglutination test suggested as a possible substitute for the Coombs test in the diagnosis of human brucellosis. Here it is compared with classical tests using 321 samples from 48 patients with brucellosis (6.9 +/- 1.7 samples per patient), including 20 patients with focal disease and 8 patients with a total of 9 relapse episodes (mean follow-up, 18 months). The BrucellaCapt test was used according to the manufacturer's instructions, and we also used a variant of the BrucellaCapt test in which the microtiter plates were not coated with antibodies against total human immunoglobulin (BCAPV). The correlation between the BrucellaCapt and BCAPV tests was 0.982 (P < 0.001), with 260 coincident pairs of titers (81%). The areas under the receiver operating characteristic curve for the BrucellaCapt and BCAPV tests with respect to the Coombs test were 0.969 and 0.960, respectively. Upon admission, the BrucellaCapt, BCAPV, and Coombs tests and the microagglutination test (MAT) were positive for all cases: titers were 1/2,560 by the BrucellaCapt test, 1/2,560 by the BCAPV test, 1/1,280 by the Coombs test, and 1/320 by the MAT. The decreases in the BrucellaCapt and BCAPV titers over time were pronounced in comparison with the Coombs titers. Cumulative probabilities of persistence 12 months after therapy were as follows: 80% by the BrucellaCapt test, 80% by the BCAPV test, 87% by the Coombs test, and 35% by the MAT. Serological changes during relapse were detected in seven cases (88%) by the Coombs test, in five cases by the BrucellaCapt and BCAPV tests, and in three cases by the MAT. The BrucellaCapt test is a sensitive, specific, and simple test for routine use in human brucellosis. Similar results were obtained with the BCAPV test. However, in some cases of relapse and chronic forms of the disease, the slight changes observed in low-affinity antibodies alone are better detected by the Coombs test.\n[Comparison of two recombinant hepatitis B vaccines and their interchangeability in Argentine infants Comparaci\u00f3n de dos vacunas recombinantes contra la hepatitis B y su intercambiabilidad en lactantes argentinos](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMiguel Tregnaghi\n2004-01-01\n-B.OBJETIVO: Comparar dos vacunas pedi\u00e1tricas recombinantes contra la hepatitis B -Euvax-B y la vacuna de referencia Engerix-B- en cuanto a su inmunogenicidad y reactogenicidad, e investigar su intercambiabilidad, es decir, si el esquema de vacunaci\u00f3n contra la hepatitis B de tres dosis comenzado con una primera dosis de Engerix-B puede completarse con dos dosis de Euvax-B. M\u00c9TODOS: Este estudio se llev\u00f3 a cabo en la ciudad de C\u00f3rdoba, Argentina, entre marzo de 1999 y febrero de 2000. Se vacun\u00f3 contra la hepatitis B a tres grupos de 100 lactantes argentinos a los 0, 1 y 6 meses de edad. El grupo A recibi\u00f3 tres dosis de Euvax-B; el grupo B, tres dosis de Engerix-B; y el grupo C, una dosis de Engerix-B seguida de dos dosis de Euvax-B. Para evaluar la reactogenicidad se utiliz\u00f3 la informaci\u00f3n brindada por los padres acerca de determinados fen\u00f3menos locales o sist\u00e9micos solicitados por los investigadores que hubieran ocurrido durante los siete d\u00edas posteriores a la vacunaci\u00f3n. Para establecer si eran id\u00e9nticas cl\u00ednicamente las vacunas Euvax-B y Engerix-B se utilizaron las tasas de seroprotecci\u00f3n -es decir, t\u00edtulos de anticuerpos contra el ant\u00edgeno de superficie de hepatitis B (anti-HBsAg > 10 miliunidades internacionales por mililitro (mUI/mL- alcanzados dos meses despu\u00e9s de la tercera dosis. RESULTADOS: La reactogenicidad fue baja en los tres grupos de estudio. A los 5 meses de la segunda dosis (es decir, inmediatamente antes de la tercera dosis, las tasas de seroprotecci\u00f3n fueron 95,9%, 94,7% y 90,2% en los grupos A, B y C, respectivamente. Dos meses despu\u00e9s de la tercera dosis, todos los lactantes se encontraban protegidos, con concentraciones medias geom\u00e9tricas de anti-HBsAg de 2 468,1 mUI/mL en el grupo A, de 1 714,8 mUI/mL en el grupo B y de 2 075,3 mUI/mL en el grupo C. CONCLUSIONES: Las dos vacunas recombinantes contra la hepatitis B estudiadas fueron bien toleradas y altamente inmunog\u00e9nicas. La vacuna Euvax-B fue cl\u00ednicamente id\u00e9ntica (no inferior a la\n[Brucella abortus S19 vaccine protects dairy cattle against natural infection with Brucella melitensis.](https://www.ncbi.nlm.nih.gov/pubmed/27771184)\nvan Straten, Michael; Bardenstein, Svetlana; Keningswald, Gaby; Banai, Menachem\n2016-11-21\nBrucellosis is a zoonotic disease that can cause severe illness in humans and considerable economic loss in the livestock industry. Although small ruminants are the preferential host for Brucella melitensis, this pathogen has emerged as a cause for Brucella outbreaks in cattle. S19 vaccination is implemented in many countries where B. abortus is endemic but its effectiveness against B. melitensis has not been validated. Here we show that vaccine effectiveness in preventing disease transmission between vaccinated and unvaccinated cohorts, as determined by seroconversion, was 87.2% (95% CI 69.5-94.6%). Furthermore, vaccination was associated with a reduced risk for abortion. Together, our data emphasize the role S19 vaccination could play in preventing B. melitensis outbreaks in areas where this pathogen is prevalent in small ruminant populations. Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.\n[Desarrollo de una vacuna probi\u00f3tica para el tratamiento del c\u00e1ncer c\u00e9rvico-uterino](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1ea3de1bdf059dfdef615fb2bb624b84)\nCort\u00e9s P\u00e9rez, Naima Gisela; Berm\u00fadez Humar\u00e1n, Luis Gilberto; Alcocer Gonz\u00e1lez, Juan Manuel; Gruss, Alexandra; Le Loir, Yves; Langella, Phillipe; Luna Leal, Roberto Montes de Oca\n2003-01-01\nDado que el virus del papiloma humano tipo 16 (HPV- 16) es la principal causa del c\u00e1ncer c\u00e9rvicouterino, hay una gran necesidad de desarrollar una vacuna profil\u00e1ctica y/o terap\u00e9utica. La oncoprote\u00edna E7 es constitutivamente producida por neoplasias cervicales y, por tanto, considerada como un blanco potencial para dirigir el desarrollo de una vacuna terap\u00e9utica contra el c\u00e1ncer c\u00e9rvico-uterino. En este trabajo desarrollamos un sistema inducible para expresar la prote\u00edn...\n[Desarrollo y pruebas de campo de la vacuna sint\u00e9tica contra la malaria SPf66](https://revistas.unal.edu.co/index.php/revfacmed/article/view/27236) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMauricio Rojas\n1993-04-01\nFull Text Available De acuerdo a estad\u00edsticas recientes de la Organizaci\u00f3n Mundial de la Salud, se estima que 2100 millones de personas habitan en cerca de 100 pa\u00edses donde la malaria es una enfermedad end\u00e9mica, afectando cerca de 270 millones de individuos anualmente y siendo la causa directa de por 10 menos dos millones de muertos al a\u00f1o, especialmente de ni\u00f1os menores de cinco a\u00f1os de edad. Las medidas de control del vector y del par\u00e1sito con insecticidas y quimioterapia parec\u00edan ser suficientes para la erradicaci\u00f3n, pero a lo largo del tiempo se ha demostrado la poca eficacia de estas medidas, hacienda que el desarrollo de una vacuna sea esencial como un componente efectivo para el control y erradicaci\u00f3n de la malaria especialmente en los pa\u00edses del tercer mundo.\n[Vacuna contra la fiebre hemorr\u00e1gica argentina Candid#1 producida en la Argentina: Inmunogenicidad y seguridad Candid#1 vaccine against Argentine Hemorrhagic Fever produced in Argentina: Immunogenicity and safety](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDelia A. Enria\n2010-06-01\nFull Text Available Se realiz\u00f3 un estudio cl\u00ednico en 946 voluntarios humanos sanos, donde se compar\u00f3 la vacuna Candid#1 producida en Argentina con la elaborada en EE.UU., que hab\u00eda sido utilizada en estudios previos. Como objetivo primario se evalu\u00f3 la equivalencia en la eficacia utilizando como marcador subrogante a la inmunogenicidad medida por detecci\u00f3n de anticuerpos neutralizantes. Como objetivo secundario se evalu\u00f3 la equivalencia en inocuidad comparando las tasas de reacciones adversas. Ambas vacunas mostraron una tasa equivalente de inmunogenicidad ligeramente superior al 95.5%, que es la eficacia estimada para Candid #1 en estudios previos. No se observaron eventos adversos graves relacionados con la vacuna. Los eventos adversos generales considerados relacionados fueron de escasa significaci\u00f3n cl\u00ednica y de resoluci\u00f3n espont\u00e1nea o con tratamiento sintom\u00e1tico; se presentaron en los receptores de ambas vacunas en tasas equivalentes (29.9% para la vacuna fabricada en la Argentina y 35.0% para la fabricada en EE.UU., e incluyeron: cefalea, decaimiento, mialgias, plaquetopenia leve (A clinical study in 946 human volunteers was done to compare Candid #1 vaccine manufactured in Argentina with the vaccine produced in USA that had been previously used. The efficacy was evaluated using immunogenicity measured by the detection of neutralizing antibodies as a subrogate marker. Safety was evaluated comparing the rate of adverse events. Both vaccines showed a comparable rate of seroconversion, slighty higher than the efficacy estimated from previous studies (95.5%. There were no severe adverse events related to the vaccines. The general events considered related to the vaccines were not clinically relevant and disappeared either spontaneously or with symptomatic treatment. Similar rates of adverse events (29.9% for the Argentine vaccine and 35.0% for the USA vaccine were found for both vaccines. These included: headache, weakness, myalgias, mild low blood\n[Regional meeting for the Americas assesses progress against rotavirus Reuni\u00f3n regional para las Am\u00e9ricas eval\u00faa el progreso contra los rotavirus](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100014) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\n2004-01-01\nFull Text Available La diarrea provocada por la infecci\u00f3n por rotavirus es una de las principales causas de morbilidad y mortalidad en el mundo. Los rotavirus ocasionan un total de alrededor de 111 millones de casos de diarrea y 440 000 muertes, 82% de ellas en pa\u00edses en desarrollo. Solo en la Regi\u00f3n de las Am\u00e9ricas, los rotavirus causan aproximadamente 75 000 ingresos hospitalarios y 15 000 muertes cada a\u00f1o. Con el objetivo de evaluar la marcha de la lucha contra los rotavirus en la Regi\u00f3n, a principios de septiembre de 2003 se celebr\u00f3 en Lima, Per\u00fa, una reuni\u00f3n cuyos participantes examinaron la informaci\u00f3n epidemiol\u00f3gica, debatieron acerca de los adelantos alcanzados en el desarrollo de nuevas vacunas contra rotavirus y describieron sus experiencias con la vigilancia de la infecci\u00f3n rotav\u00edrica. En los pr\u00f3ximos a\u00f1os pueden aparecer en el mercado varias vacunas, entre ellas Rotarix (GlaxoSmithKline y RotaTeq (Merck. Ambas vacunas ya han pasado exitosamente por los estudios de fases I y II y en estos momentos se llevan a cabo extensos estudios de fase III. No obstante, a\u00fan no se conoce lo suficiente acerca del impacto econ\u00f3mico de la enfermedad, la efectividad en funci\u00f3n del costo que pueda llegar a alcanzar la vacunaci\u00f3n y la vigilancia de los rotavirus en el laboratorio. La reuni\u00f3n realizada en Lima gener\u00f3 varias recomendaciones, entre ellas algunas de car\u00e1cter general acerca de los estudios epidemiol\u00f3gicos sobre rotavirus, la metodolog\u00eda de los estudios de corte econ\u00f3mico y una base de datos para su vigilancia. En relaci\u00f3n con los laboratorios y las t\u00e9cnicas anal\u00edticas, las recomendaciones se centraron en las redes de laboratorios, el mejor momento para recolectar las muestras de heces y la manera de almacenar y procesar esas muestras.\n[A History of the Development of Brucella Vaccines](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::6ef7b58983f5b0ca0d0bcc5a7870b293)\nAvila-Calder?n, Eric Daniel; Lopez-Merino, Ahid?; Sriranganathan, Nammalwar; Boyle, Stephen M.; Contreras-Rodr?guez, Araceli\n2013-01-01\nBrucellosis is a worldwide zoonosis affecting animal and human health. In the last several decades, much research has been performed to develop safer Brucella vaccines to control the disease mainly in animals. Till now, no effective human vaccine is available. The aim of this paper is to review and discuss the importance of methodologies used to develop Brucella vaccines in pursuing this challenge. CONACYT CB-2011-01, 169259 SIP-IPN 20110891, 20134610 ICYTDF-IPN (Project of Investiga...\n[Identification of Brucella spp. isolated from human brucellosis in Malaysia using high-resolution melt (HRM) analysis.](https://www.ncbi.nlm.nih.gov/pubmed/25641125)\nMohamed Zahidi, Jama'ayah; Bee Yong, Tay; Hashim, Rohaidah; Mohd Noor, Azura; Hamzah, Siti Hawa; Ahmad, Norazah\n2015-04-01\nMolecular approaches have been investigated to overcome difficulties in identification and differentiation of Brucella spp. using conventional phenotypic methods. In this study, high-resolution melt (HRM) analysis was used for rapid identification and differentiation of members of Brucella genus. A total of 41 Brucella spp. isolates from human brucellosis were subjected to HRM analysis using 4 sets of primers, which identified 40 isolates as Brucella melitensis and 1 as Brucella canis. The technique utilized low DNA concentration and was highly reproducible. The assay is shown to be a useful diagnostic tool, which can rapidly differentiate Brucella up to species level. Copyright \u00a9 2015 The Authors. Published by Elsevier Inc. All rights reserved.\n[Respuesta inmune intratecal y caracter\u00edsticas cl\u00ednicas de la meningoencefalitis por Neisseria meningitidis en pacientes inmunizados con la vacuna cubana VA-MENGOC-BC\u00ae](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2008000200004&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nElena Noris-Garc\u00eda\n2008-08-01\nFull Text Available La morbimortalidad por la enfermedad meningoc\u00f3cica en Cuba disminuy\u00f3 notablemente despu\u00e9s de la introducci\u00f3n de la vacuna VA-MENGOC-BC\u00ae. Sin embargo, a\u00f1os despu\u00e9s de ser vacunados se han reportado algunos ni\u00f1os que enfermaron. En este trabajo nos propusimos describir el comportamiento neuroinmunol\u00f3gico y cl\u00ednico de esta enfermedad en 12 pacientes vacunados que fueron ingresados en el Hospital Pedi\u00e1trico de San Miguel del Padr\u00f3n con el diagn\u00f3stico de meningoencefalitis producida por Neisseria meningitidis. Se tomaron muestras de forma simult\u00e1nea de sangre y l\u00edquido cefalorraqu\u00eddeo para la cuantificaci\u00f3n de alb\u00famina e inmunoglobulinas mayores por inmunodifusi\u00f3n radial; para el an\u00e1lisis de los resultados se tom\u00f3 como referencia el registro hist\u00f3rico de los resultados de ocho pacientes no inmunizados que enfermaron antes de incluir esta vacuna en el Esquema Nacional de Vacunaci\u00f3n. La respuesta neuroinmunol\u00f3gica y las caracter\u00edsticas cl\u00ednicas de los pacientes vacunados resultaron diferentes a lo observado previamente en pacientes no vacunados. El grupo vacunado mostr\u00f3 un cuadro menos grave de la enfermedad. El patr\u00f3n de s\u00edntesis intratecal de inmunoglobulinas fue diferente entre los dos grupos. La media de la s\u00edntesis intratecal de IgG, IgM e IgA fue significativamente superior en el grupo de los pacientes no vacunados. Este estudio nos permiti\u00f3 concluir que en la muestra estudiada la vacuna modific\u00f3 la respuesta neuroinmunol\u00f3gica y el cuadro cl\u00ednico de la enfermedad.\n[[Detection of Brucella with an automatic hemoculture system: Bact/Alert].](https://www.ncbi.nlm.nih.gov/pubmed/7865557)\nCasas, J; Partal, Y; Llos\u00e1, J; Leiva, J; Navarro, J M; de la Rosa, M\n1994-12-01\nThe ability of in vitro and in vivo detection of Brucella spp. with the Bact/Alert system was studied. Three strains of Brucella melitensis and two of Brucella abortus were used. Different dilutions of the five strains were performed in trypticase soy broth (TSB), achieving concentrations of 1 cfu/ml, 5 cfu/ml, 10 cfu/ml and 100 cfu/ml. Ten ml of each dilution and strain were inoculated into 5 aerobic bottles Bact/Alert and 5 biphasic Hem\u00f3line bottles. Furthermore, over a 9 month period, 8,216 bottles of Bact/Alert bottles from hospitalized patients and from the emergency department were processed in the authors' laboratory. The mean detection time for Brucella growth was from 2 to 3 days with the Bact/Alert system, and 14 days in the biphasic bottles. Former bottles processed in the authors' laboratory, 11 aerobic bottles belonged to 5 patients in whom brucelosis was confirmed by bloodculture. The Bact/Alert system detected Brucella melitensis in only on bottle at 2.9 days of incubation. In 7 bottles Bact/Alert detected B. melitensis by a blind pass of these bottles at 10 to 20 days of incubation. These results suggest that the Bact/Alert system does not totally solve the diagnosis of brucellosis. Blind passes of the bloodcultures are required.\n[Caracterizaci\u00f3n de eventos adversos asociados a vacunas que inmunizan contra enfermedades infecciosas.A\u00f1os 2006-2007 Characterization of adverse events associated with vaccines immunizing against infectious diseases. 2006-2007](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152010000300006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIvette D\u00edaz Mato\n2010-09-01\nFull Text Available Se realiz\u00f3 un estudio descriptivo, transversal y retrospectivo para caracterizar los eventos adversos temporalmente asociados con las vacunas que se emplean en la prevenci\u00f3n y el control de las enfermedades infecciosas, y que fueron notificados a la Unidad Coordinadora Nacional de Farmacovigilancia entre los a\u00f1os 2006-2007. Se determin\u00f3 su comportamiento de acuerdo con la edad, sexo, procedencia de la notificaci\u00f3n, personal que reporta, localizaci\u00f3n y severidad. Se identificaron adem\u00e1s los principales eventos reportados y las vacunas implicadas en su aparici\u00f3n. La fiebre constituy\u00f3 el 60 % del total de eventos notificados. Estos \u00faltimos se distribuyeron de igual forma entre uno y otro sexos, en tanto los lactantes resultaron ser los m\u00e1s afectados (46,8 %. Se destac\u00f3 en el reporte la Atenci\u00f3n Primaria de Salud con 812 notificaciones. Los m\u00e9dicos fueron los profesionales que m\u00e1s reportaron (36 %. El comportamiento en cuanto a severidad no se diferenci\u00f3 de lo reportado en la literatura, pues afortunadamente predominaron los eventos leves (66,4 %. Sin embargo, contrario a lo que se esperaba, los eventos sist\u00e9micos fueron los de mayor cuant\u00eda (80,2 %. La vacuna pentavalente estuvo implicada en el 29,6 % de los eventos adversos temporalmente asociados a vacunaci\u00f3n.A descriptive, transversal and retrospective study was conducted to characterize the adverse events temporarily associated with vaccines used in prevention and control of infectious diseases and that were notified to National Coordinator Unit of Pharmacosurveillance between the 2006-2007 years. Its behavior was determined according to the age, sex, notification origin, reporting staff, location and severity. Also, it was possible to identify the leading events reported and the vaccines involved in its appearance. Fever accounted for the 60 % of total of reported events. These latter were distributed equally between both sexes where the infants were the most affected (46\n[Evaluaci\u00f3n de vacunas aut\u00f3genas como herramienta para el control de la Mastitis durante la lactancia en vacas Holstein](http://www.redalyc.org/articulo.oa?id=203315187001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJuan Sep\u00falveda Aceves\n2010-01-01\nFull Text Available Se evalu\u00f3 la eficacia de las autovacunas como herramienta en el control de mastitis en 52 vacas en producci\u00f3n. Se cultiv\u00f3 leche de los animales seleccionados y de los microorganismos ambientales aislados se prepar\u00f3 una autovacuna polivalente de c\u00e9lulas muertas con pseudoc\u00e1psula, se aplicaron 2 dosis de 5 ml cada una con intervalo de 15 d\u00edas a 26 animales, el resto de ellos fue un grupo control, los animales ten\u00edan caracter\u00edsticas similares. Se contaron las c\u00e9lulas som\u00e1ticas por mililitro de leche (CCS / ml cada tercer d\u00eda desde la primera aplicaci\u00f3n de vacuna hasta completar 30 d\u00edas, el grupo vacunado mantuvo una media geom\u00e9trica con menor n\u00famero de c\u00e9lulas som\u00e1ticas por mililitro (272,952 que el grupo control (326,098; se obtuvo una reducci\u00f3n del 16.2% (p= 0.01. Luego se midieron c\u00e9lulas som\u00e1ticas cada mes durante 6 meses y el grupo tratamiento present\u00f3 una reducci\u00f3n de 23% (p = 0.02 con respecto al grupo control (252,000 y 328,500 ccs/ml respectivamente. Tambi\u00e9n se observ\u00f3 en animales vacunados una reducci\u00f3n de la incidencia de mastitis subcl\u00ednica de 16.9% y cl\u00ednica de 35.3% (p= 0.01 y p= 0.1. A su vez se registr\u00f3 la producci\u00f3n promedio de leche de 0 a 30 d\u00edas pos tratamiento, la cual fue superior en los animales vacunados por 0.6 L (2.7%, p = 0.04, de 15 d\u00edas a 4 meses pos tratamiento 1.9 L (7.3%, p < 0.05 y de 15 d\u00edas a 6 meses pos tratamiento de 1.1 L (4.3%, p < 0.05. Las vacunas aut\u00f3genas demostraron ser efectivas para control de mastitis subcl\u00ednica y cl\u00ednica adem\u00e1s de ayudar a mejorar la producci\u00f3n l\u00e1ctea.\n[MLVA and MLST typing of Brucella from Qinghai, China.](https://www.ncbi.nlm.nih.gov/pubmed/27072820)\nMa, Jun-Ying; Wang, Hu; Zhang, Xue-Fei; Xu, Li-Qing; Hu, Gui-Ying; Jiang, Hai; Zhao, Fang; Zhao, Hong-Yan; Piao, Dong-Ri; Qin, Yu-Min; Cui, Bu-Yun; Lin, Gong-Hua\n2016-04-13\nThe Qinghai-Tibet Plateau (QTP) of China is an extensive pastoral and semi-pastoral area, and because of poverty and bad hygiene conditions, Brucella is highly prevalent in this region. In order to adequately prevent this disease in the QTP region it is important to determine the identity of Brucella species that caused the infection. A total of 65 Brucella isolates were obtained from human, livestock and wild animals in Qinghai, a Chinese province in east of the QTP. Two molecular typing methods, MLVA (multi-locus variable-number tandem-repeat analysis) and MLST (multi locus sequence typing) were used to identify the species and genotypes of these isolates. Both MLVA and MLST typing methods classified the 65 isolates into three species, B. melitensis, B. abortus and B. suis, which included 60, 4 and 1 isolates respectively. The MLVA method uniquely detected 34 (Bm01 ~ Bm34), 3 (Ba01 ~ Ba03), and 1 (Bs01) MLVA-16 genotypes for B. melitensis, B. abortus and B. suis, respectively. However, none of these genotypes exactly matched any of the genotypes in the Brucella2012 MLVA database. The MLST method identified five known ST types: ST7 and ST8 (B. melitensis), ST2 and ST5 (B. abortus), and ST14 (B. suis). We also detected a strain with a mutant type (3-2-3-2-?-5-3-8-2) of ST8 (3-2-3-2-1-5-3-8-2). Extensive genotype-sharing events could be observed among isolates from different host species. There were at least three Brucella (B. melitensis, B. abortus and B. suis) species in Qinghai, of which B. melitensis was the predominant species in the area examined. The Brucella population in Qinghai was very different from other regions of the world, possibly owing to the unique geographical characteristics such as extremely high altitude in QTP. There were extensive genotype-sharing events between isolates obtained from humans and other animals. Yaks, sheep and blue sheep were important zoonotic reservoirs of brucellosis causing species found in humans.\n[Infection of cattle in Kenya with Brucella abortus biovar 3 and Brucella melitensis biovar 1 genotypes.](https://www.ncbi.nlm.nih.gov/pubmed/21660647)\nMuendo, Esther N; Mbatha, Peter M; Macharia, Joseph; Abdoel, Theresia H; Janszen, Paul V; Pastoor, Rob; Smits, Henk L\n2012-01-01\nBrucella melitensis biovar 1 was isolated from bovine milk samples from a herd in central Kenya, and Brucella abortus biovar 3 was isolated from aborted fetus materials and vaginal discharge fluids from cattle in central and eastern provinces of Kenya. All infections including those with B. melitensis were in cattle with reproductive problems kept in mixed herds indicating that cross infection occurs from small ruminants. Multiple-locus variable-number tandem repeat analysis genotyping revealed a close molecular homology of the B. melitensis isolates with an isolate from Israel and a close homology of the B. abortus isolates with an isolate from Uganda indicating that these genotypes have a wide geographic distribution. Infection of cattle with B. melitensis may complicate the control of brucellosis in this country.\n[Ontology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3180695)\n2011-01-01\nBackground Vaccine literature indexing is poorly performed in PubMed due to limited hierarchy of Medical Subject Headings (MeSH) annotation in the vaccine field. Vaccine Ontology (VO) is a community-based biomedical ontology that represents various vaccines and their relations. SciMiner is an in-house literature mining system that supports literature indexing and gene name tagging. We hypothesize that application of VO in SciMiner will aid vaccine literature indexing and mining of vaccine-gene interaction networks. As a test case, we have examined vaccines for Brucella, the causative agent of brucellosis in humans and animals. Results The VO-based SciMiner (VO-SciMiner) was developed to incorporate a total of 67 Brucella vaccine terms. A set of rules for term expansion of VO terms were learned from training data, consisting of 90 biomedical articles related to Brucella vaccine terms. VO-SciMiner demonstrated high recall (91%) and precision (99%) from testing a separate set of 100 manually selected biomedical articles. VO-SciMiner indexing exhibited superior performance in retrieving Brucella vaccine-related papers over that obtained with MeSH-based PubMed literature search. For example, a VO-SciMiner search of \"live attenuated Brucella vaccine\" returned 922 hits as of April 20, 2011, while a PubMed search of the same query resulted in only 74 hits. Using the abstracts of 14,947 Brucella-related papers, VO-SciMiner identified 140 Brucella genes associated with Brucella vaccines. These genes included known protective antigens, virulence factors, and genes closely related to Brucella vaccines. These VO-interacting Brucella genes were significantly over-represented in biological functional categories, including metabolite transport and metabolism, replication and repair, cell wall biogenesis, intracellular trafficking and secretion, posttranslational modification, and chaperones. Furthermore, a comprehensive interaction network of Brucella vaccines and genes were\n[LA VACUNACI\u00d3N ANTI-NEUMOC\u00d3CICA CON LA VACUNA CONJUGADA 13-VALENTE EN POBLACI\u00d3N INMUNOCOMPETENTE DE 65 A\u00d1OS: ANALISIS DEL IMPACTO PRESUPUESTARIO EN ESPA\u00d1A APLICANDO UN MODELO DE TRANSMISI\u00d3N DIN\u00c1MICA](http://www.redalyc.org/articulo.oa?id=17043728001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nReyes Lorente Anto\u00f1anzas\n2016-01-01\nFull Text Available Fundamentos: Las infecciones causadas por el Streptococcus pneumoniae en el adulto tienen repercusiones importantes en la salud. El objetivo fue analizar el impacto econ\u00f3mico y sanitario en 5 a\u00f1os de la vacunaci\u00f3n de la cohorte espa\u00f1ola de 65 a\u00f1os inmunocompetente con la vacuna antineumoc\u00f3cica conjugada 13-valente.M\u00e9todos: Mediante un modelo de transmisi\u00f3n din\u00e1mica basado en ecuaciones diferenciales se analiz\u00f3 la carga de la enfermedad neumoc\u00f3cica (EN en sujetos de 65 a\u00f1os en 5 a\u00f1os, siendo vacunada anualmente el 36,5% de la cohorte. Se aplic\u00f3 la eficacia de la vacuna del 52,5% observada en el estudio CAPITA en pacientes de 65 a\u00f1os inmunocompetentes, cobertura de serotipos vacunales del 63,4% (estudio CAPA, incidencia de infecci\u00f3n neumoc\u00f3cica de 162,2/100.000 casos a\u00f1o (CMBD 2010-2013 y proporci\u00f3n de vacunados previamente al arranque del modelo del 0,99%. La perspectiva fue la del Sistema Nacional de Salud (SNS. Costes de casos de EN seg\u00fan CMBD y precio de venta de laboratorio de la vacuna conjugada.Resultados: En 5 a\u00f1os la vacunaci\u00f3n con vacuna conjugada 13-valente espera evitar 10.360 casos de EN (7.411 hospitalizaciones por neumon\u00edas y 699 muertes (14.736 a\u00f1os de vida ganados -AVG-, en una cohorte de 65 a 69 a\u00f1os de edad. El coste de vacunaci\u00f3n esperado de 36,5 millones de euros se compensar\u00eda completamente por la reducci\u00f3n de 41,5 millones de costes m\u00e9dicos evitados, con un ahorro neto acumulado de 3,8 millones de euros a precios constantes (4,9 a precios corrientes.Conclusi\u00f3n: La vacunaci\u00f3n con vacuna conjugada 13-valente en adultos de 65 a\u00f1os inmunocompetentes resulta eficiente para el Sistema Nacional de Salud, reduciendo la carga de enfermedad y evitando un n\u00famero importante de muertes.\n[Glutamate decarboxylase-dependent acid resistance in Brucella spp.: distribution and contribution to fitness under extremely acidic conditions.](https://www.ncbi.nlm.nih.gov/pubmed/25381237)\nDamiano, Maria Alessandra; Bastianelli, Daniela; Al Dahouk, Sascha; K\u00f6hler, Stephan; Cloeckaert, Axel; De Biase, Daniela; Occhialini, Alessandra\n2015-01-01\nBrucella is an expanding genus of major zoonotic pathogens, including at least 10 genetically very close species occupying a wide range of niches from soil to wildlife, livestock, and humans. Recently, we have shown that in the new species Brucella microti, the glutamate decarboxylase (Gad)-dependent system (GAD system) contributes to survival at a pH of 2.5 and also to infection in mice by the oral route. In order to study the functionality of the GAD system in the genus Brucella, 47 isolates, representative of all known species and strains of this genus, and 16 strains of the closest neighbor genus, Ochrobactrum, were studied using microbiological, biochemical, and genetic approaches. In agreement with the genome sequences, the GAD system of classical species was not functional, unlike that of most strains of Brucella ceti, Brucella pinnipedialis, and newly described species (B. microti, Brucella inopinata BO1, B. inopinata-like BO2, and Brucella sp. isolated from bullfrogs). In the presence of glutamate, these species were more acid resistant in vitro than classical terrestrial brucellae. Expression in trans of the gad locus from representative Brucella species in the Escherichia coli MG1655 mutant strain lacking the GAD system restored the acid-resistant phenotype. The highly conserved GAD system of the newly described or atypical Brucella species may play an important role in their adaptation to acidic external and host environments. Furthermore, the GAD phenotype was shown to be a useful diagnostic tool to distinguish these latter Brucella strains from Ochrobactrum and from classical terrestrial pathogenic Brucella species, which are GAD negative. Copyright \u00a9 2015, American Society for Microbiology. All Rights Reserved.\n[Whole-genome analyses of the speciation events in the pathogenic Brucellae](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=878626) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nChain, P; Comerci, D; Tolmasky, M; Larimer, F; Malfatti, S; Vergez, L; Aguero, F; Land, M; Ugalde, R; Garcia, E\n2005-07-14\nDespite their high DNA identity and a proposal to group classical Brucella species as biovars of B. melitensis, the commonly recognized Brucella species can be distinguished by distinct biochemical and fatty acid characters as well as by a marked host range (e.g. B. suis for swine, B. melitensis for sheep and goats, B. abortus for cattle). Here we present the genome of B. abortus 2308, the virulent prototype biovar 1 strain, and its comparison to the two other human pathogenic Brucellae species and to the B. abortus field isolate 9-941. The global distribution of pseudogenes, deletions and insertions support previous indications that B. abortus and B. melitensis share a common ancestor that diverged from B. suis. With the exception of a dozen genes, the genetic complement of both B. abortus strains is identical, whereas the three species differ in gene content and pseudogenes. The pattern of species-specific gene inactivations affecting transcriptional regulators and outer membrane proteins suggest that these inactivations may play an important role in the establishment of host-specificity and may have been a primary driver of speciation in the Brucellae. Despite being non-motile, the Brucellae contain flagellum gene clusters and display species-specific flagellar gene inactivations, which lead to the putative generation of different versions of flagellum-derived structures, and may contribute to differences in host-specificity and virulence. Metabolic changes such as the lack of complete metabolic pathways for the synthesis of numerous compounds (e.g. glycogen, biotin, NAD, and choline) are consistent with adaptation of Brucellae to an intracellular lifestyle.\n[Trypanosoma Infection Favors Brucella Elimination via IL-12/IFN\u03b3-Dependent Pathways](http://journal.frontiersin.org/article/10.3389/fimmu.2017.00903/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nArnaud Machelart\n2017-07-01\nFull Text Available This study develops an original co-infection model in mice using Brucella melitensis, the most frequent cause of human brucellosis, and Trypanosoma brucei, the agent of African trypanosomiasis. Although the immunosuppressive effects of T. brucei in natural hosts and mice models are well established, we observed that the injection of T. brucei in mice chronically infected with B. melitensis induces a drastic reduction in the number of B. melitensis in the spleen, the main reservoir of the infection. Similar results are obtained with Brucella abortus- and Brucella suis-infected mice and B. melitensis-infected mice co-infected with Trypanosoma cruzi, demonstrating that this phenomenon is not due to antigenic cross-reactivity. Comparison of co-infected wild-type and genetically deficient mice showed that Brucella elimination required functional IL-12p35/IFN\u03b3 signaling pathways and the presence of CD4+ T cells. However, the impact of wild type and an attenuated mutant of T. brucei on B. melitensis were similar, suggesting that a chronic intense inflammatory reaction is not required to eliminate B. melitensis. Finally, we also tested the impact of T. brucei infection on the course of Mycobacterium tuberculosis infection. Although T. brucei strongly increases the frequency of IFN\u03b3+CD4+ T cells, it does not ameliorate the control of M. tuberculosis infection, suggesting that it is not controlled by the same effector mechanisms as Brucella. Thus, whereas T. brucei infections are commonly viewed as immunosuppressive and pathogenic, our data suggest that these parasites can specifically affect the immune control of Brucella infection, with benefits for the host.\n[Perspectivas para el desarrollo de vacunas e inmunoterapia contra c\u00e1ncer cervicouterino](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341998000100006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGUZM\u00c1N-ROJAS LILIANA\n1998-01-01\nFull Text Available El c\u00e1ncer cervicouterino representa un grave problema de salud p\u00fablica, debido a la asociaci\u00f3n de la neoplasia con el virus del papiloma humano; actualmente se realizan estudios usando estrategias dirigidas a combatir este pat\u00f3geno, mediante vacunas, que podr\u00edan ser de gran utilidad para el control de la progresi\u00f3n de la enfermedad. El estudio tanto de la inmunolog\u00eda humoral como celular ha servido para el desarrollo de vacunas. As\u00ed, la utilizaci\u00f3n de part\u00edculas virales sint\u00e9ticas para el estudio de anticuerpos neutralizantes y el uso de prote\u00ednas tempranas virales, entre otras, para la inducci\u00f3n de inmunidad mediada por c\u00e9lulas, han sido la pauta para realizar estudios que dirijan la respuesta inmune para prevenir la infecci\u00f3n celular tanto hacia c\u00e9lulas infectadas no transformadas como hacia c\u00e9lulas transformadas viralmente con resultados favorables.\n[J-GLOBAL MeSH Dictionary: Brucella melitensis [MeCab user dictionary for science technology term[Archive](https://togodb.biosciencedbc.jp/mecab_jstmesh/show/247#en) [Lifescience Database Archive (English)](http://biosciencedbc.jp/dbsearch/index.php?lang=en)\nFull Text Available MeCab user dictionary for science technology term Brucella melitensis \u540d\u8a5e \u4e00\u822c * * * * Brucella melitens...is ... MeSH D017347 200906028294406644 C LS07 UNKNOWN_2 Brucella melitensis\n[Evaluation of Brucella contamination in raw milk in Kerman dairy farms by PCR](http://tumj.tums.ac.ir/browse.php?a_code=A-10-1245-2&slc_lang=en&sid=1) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMohammad Khalili\n2016-10-01\nFull Text Available Background: Human brucellosis is a significant public health problem in many middle east countries including Iran. In endemic developing countries, dairy products produced from untreated milk are a potential threat to public health. The aim of this study was to detect brucellae in milk from dairy cattle farms in Kerman (Iran. Methods: Forthy and eight Bulk Tank Milk (BTM were collected from 48 dairy cattle farm including 4200 cow. All milk samples were examined by PCR to detect Brucella-specific DNA. Results: Using IS711 primer were detected in 4 samples (8.3% Brucella spp from 48 BTM samples in this area.. Conclusions: The detection of Brucella DNA in milk for human consumption, especially the highly pathogenic species B. melitensis, is of obvious concern. The shedding of Brucella spp. in milk poses an increasing threat to consumers in Iran. Consumption of dairy products produced from non-pasteurized milk by individual farmers operating under poor hygienic conditions represents an unacceptable risk to public health.\n[Differential phenotyping of Brucella species using a newly developed semi-automated metabolic system](http://www.biomedcentral.com/1471-2180/10/269) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAppel Bernd\n2010-10-01\nFull Text Available Abstract Background A commercial biotyping system (Taxa Profile\u2122, Merlin Diagnostika testing the metabolization of various substrates by bacteria was used to determine if a set of phenotypic features will allow the identification of members of the genus Brucella and their differentiation into species and biovars. Results A total of 191 different amines, amides, amino acids, other organic acids and heterocyclic and aromatic substrates (Taxa Profile\u2122 A, 191 different mono-, di-, tri- and polysaccharides and sugar derivates (Taxa Profile\u2122 C and 95 amino peptidase- and protease-reactions, 76 glycosidase-, phosphatase- and other esterase-reactions, and 17 classic reactions (Taxa Profile\u2122 E were tested with the 23 reference strains representing the currently known species and biovars of Brucella and a collection of 60 field isolates. Based on specific and stable reactions a 96-well \"Brucella identification and typing\" plate (Micronaut\u2122 was designed and re-tested in 113 Brucella isolates and a couple of closely related bacteria. Brucella species and biovars revealed characteristic metabolic profiles and each strain showed an individual pattern. Due to their typical metabolic profiles a differentiation of Brucella isolates to the species level could be achieved. The separation of B. canis from B. suis bv 3, however, failed. At the biovar level, B. abortus bv 4, 5, 7 and B. suis bv 1-5 could be discriminated with a specificity of 100%. B. melitensis isolates clustered in a very homogenous group and could not be resolved according to their assigned biovars. Conclusions The comprehensive testing of metabolic activity allows cluster analysis within the genus Brucella. The biotyping system developed for the identification of Brucella and differentiation of its species and biovars may replace or at least complement time-consuming tube testing especially in case of atypical strains. An easy to handle identification software facilitates the\n[In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics](http://www.ann-clinmicrob.com/content/5/1/24) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLoukaides Feidias\n2006-10-01\nFull Text Available Abstract Background Brucellosis is an endemic disease present in many countries worldwide, but it is rare in Europe and North America. Nevertheless brucella is included in the bacteria potentially used for bioterrorism. The aim of this study was the investigation of the antibiotic susceptibility profile of brucella isolates from areas of the eastern Mediterranean where it has been endemic. Methods The susceptibilities of 74 Brucella melitensis isolates derived from clinical samples (57 and animal products (17 were tested in vitro. The strains originate from Crete (59, Cyprus (10, and Syria (5. MICs of tetracycline, rifampicin, streptomycin, gentamicin, norfloxacin, ciprofloxacin, levofloxacin, trimethoprim/sulfamethoxazole, ampicillin, amoxicillin/clavulanic acid, and erythromycin were detected by E-test method. The NCCLS criteria for slow growing bacteria were considered to interpret the results. Results All the isolates were susceptible to tetracycline, streptomycin, gentamicin, ciprofloxacin, norfloxacin, and levofloxacin. Two isolates presented reduced susceptibility to rifampicin (MIC value: 1.5 mg/l and eight to SXT (MIC values: 0.75\u20131.5 mg/l. Erythromycin had the highest (4 mg/l MIC90value and both norfloxacin and erythromycin the highest (1.5 mg/l MIC50 value. Conclusion Brucella isolates remain susceptible in vitro to most antibiotics used for treatment of brucellosis. The establishment of a standardized antibiotic susceptibility method for Brucella spp would be useful for resistance determination in these bacteria and possible evaluation of bioterorism risks.\n[Brucella abortus is Prevalent in Both Humans and Animals in Bangladesh.](https://www.ncbi.nlm.nih.gov/pubmed/28068003)\nRahman, A K M A; Saegerman, C; Berkvens, D; Melzer, F; Neubauer, H; Fretin, D; Abatih, E; Dhand, N; Ward, M P\n2017-08-01\nTo determine the role of different Brucella (B.) spp. in Bangladesh, 62 animal samples and 500 human sera were tested. Animal samples from cattle, goats and sheep (including milk, bull semen, vaginal swabs and placentas) were cultured for Brucella spp. Three test-positive human sera and all animal samples were screened by Brucella genus-specific real-time PCR (RT-PCR), and positive samples were then tested by IS711 RT-PCR to detect B. abortus and B. melitensis DNA. Only B. abortus DNA was amplified from 13 human and six animal samples. This is the first report describing B. abortus as the aetiological agent of brucellosis in occupationally exposed humans in Bangladesh. Of note is failure to detect B. melitensis DNA, the species most often associated with human brucellosis worldwide. Further studies are required to explore the occurrence of Brucella melitensis in Bangladesh. \u00a9 2017 Blackwell Verlag GmbH.\n[Blastogenic response of bovine lymphocytes to Brucella abortus lipopolysaccharide.](https://www.openaire.eu/search/publication?articleId=od_______908::cacb64baa2ac1317d6c406c65df338fa)\nBaldwin, C L; Winter, A J\n1985-01-01\nBrucella abortus lipopolysaccharide was tested in a blastogenesis assay with unfractionated and nylon wool-separated peripheral blood lymphocytes of Brucella-naive cattle and cattle immunized with B. abortus. Our results indicated that in cattle the lipopolysaccharide of B. abortus is not a B-cell mitogen. In immunized animals it stimulated predominantly nylon wool-adherent cells. The lipopolysaccharide of Escherichia coli O128:B12, in contrast, induced a substantially greater proliferative r...\n[Brucella ovis: invasion, traffic, virulence factors and immune responseBrucella ovis: invas\u00e3o, tr\u00e1fego, fatores de virul\u00eancia e resposta imune](http://www.uel.br/revistas/uel/index.php/semagrarias/article/view/12582) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJo\u00e3o Marcelo Azevedo de Paula Antunes\n2013-06-01\nFull Text Available Brucellosis remains an economic problem in animals and public health. Worldwide ovine brucellosis caused by Brucella ovis is considered a major cause of infertility in sheep. The factors responsible for persistence of the agent in these locations are not known, as well as the mechanisms involved in immune defense and possibly the persistence of the agent. Brucella spp. induces moderate inflammatory response. The nature of the intracellular agent stimulates immune response of the type 1 helper T lymphocytes. Studies of the pathogenesis of ovine brucellosis are scarce. Recent developments have shown that the inflammatory response induced by moderate brucelas represent probably the result of an attempt to escape the immune response and suppression of host immune response. Were reviewed by the mechanisms described by brucelas and Brucella ovis for penetration into the host, escape of the immune response and the immune response generated by the infection. A brucelose permanece como problema econ\u00f4mico em animais e de sa\u00fade p\u00fablica. Em todo o mundo a brucelose ovina ocasionada pela Brucella ovis \u00e9 considerada uma das principais causas de infertilidade em ovinos. Os fatores respons\u00e1veis pela persist\u00eancia do agente nestes locais n\u00e3o s\u00e3o conhecidos, bem como os mecanismos imunes envolvidos na defesa e eventualmente na persist\u00eancia do agente. Brucella spp. induz resposta inflamat\u00f3ria moderada. A natureza intracelular do agente estimula resposta imune celular do tipo linf\u00f3cito T helper 1. Os estudos de patogenia da brucelose ovina s\u00e3o escassos. Recentes avan\u00e7os demonstraram que a resposta inflamat\u00f3ria moderada induzida pelas brucelas representam provavelmente o resultado de tentativa de escape da resposta imune e supress\u00e3o da resposta imune hospedeira. Foram revisados os mecanismos descritos pelas brucelas e pela Brucella ovis para penetra\u00e7\u00e3o no hospedeiro, escape da resposta imune, bem como a resposta imunol\u00f3gica gerada pela infec\u00e7\u00e3o.\n[Analysis of pan-genome to identify the core genes and essential genes of Brucella spp.](https://www.ncbi.nlm.nih.gov/pubmed/26724943)\nYang, Xiaowen; Li, Yajie; Zang, Juan; Li, Yexia; Bie, Pengfei; Lu, Yanli; Wu, Qingmin\n2016-04-01\nBrucella spp. are facultative intracellular pathogens, that cause a contagious zoonotic disease, that can result in such outcomes as abortion or sterility in susceptible animal hosts and grave, debilitating illness in humans. For deciphering the survival mechanism of Brucella spp. in vivo, 42 Brucella complete genomes from NCBI were analyzed for the pan-genome and core genome by identification of their composition and function of Brucella genomes. The results showed that the total 132,143 protein-coding genes in these genomes were divided into 5369 clusters. Among these, 1710 clusters were associated with the core genome, 1182 clusters with strain-specific genes and 2477 clusters with dispensable genomes. COG analysis indicated that 44 % of the core genes were devoted to metabolism, which were mainly responsible for energy production and conversion (COG category C), and amino acid transport and metabolism (COG category E). Meanwhile, approximately 35 % of the core genes were in positive selection. In addition, 1252 potential essential genes were predicted in the core genome by comparison with a prokaryote database of essential genes. The results suggested that the core genes in Brucella genomes are relatively conservation, and the energy and amino acid metabolism play a more important role in the process of growth and reproduction in Brucella spp. This study might help us to better understand the mechanisms of Brucella persistent infection and provide some clues for further exploring the gene modules of the intracellular survival in Brucella spp.\n[Molecular prevalence of putative virulence-associated genes in Brucella melitensis and Brucella abortus isolates from human and livestock specimens in Iran.](https://www.ncbi.nlm.nih.gov/pubmed/28284850)\nHashemifar, Iman; Yadegar, Abbas; Jazi, Faramarz Masjedian; Amirmozafari, Nour\n2017-04-01\nMolecular prevalence of nine putative virulence factors in two more prevalent Brucella species in Iranian patients and livestock was investigated. During five years (2010-2015), 120 human and animal specimens were collected from three geographical areas of Iran. All samples were cultured in blood culture media and subcultured into Brucella agar medium. Nine primer pairs were designed for detection of VirB2, VirB5, VceC, BtpA, BtpB, PrpA, BetB, BPE275 and BSPB virulence factors using PCR and sequence analysis. Totally, 68 Brucella isolates including 60 B. melitensis and 8 B. abortus were isolated from the human and animal specimens examined. Approximately, all B. melitensis and B. abortus strains were positive (100%) regarding btpA, btpB, virB5, vceC, bpe275, bspB, and virB2 genes except for prpA and betB that were detected in 86% and 97% of the strains, respectively. Significant relationships were found between the presence of prpA and human B. melitensis isolates (P = 0.04), and also between the presence of betB and human isolates of B. abortus (P = 0.03). In conclusion, our results revealed that Iranian Brucella strains, regardless of human or animal sources, are extremely virulent due to high prevalence of virulence attributes in almost all strains studied. Copyright \u00a9 2017 Elsevier Ltd. All rights reserved.\n[The Change of a Medically Important Genus: Worldwide Occurrence of Genetically Diverse Novel Brucella Species in Exotic Frogs.](https://www.ncbi.nlm.nih.gov/pubmed/28036367)\nScholz, Holger C; M\u00fchldorfer, Kristin; Shilton, Cathy; Benedict, Suresh; Whatmore, Adrian M; Blom, Jochen; Eisenberg, Tobias\n2016-01-01\nThe genus Brucella comprises various species of both veterinary and human medical importance. All species are genetically highly related to each other, sharing intra-species average nucleotide identities (ANI) of > 99%. Infections occur among various warm-blooded animal species, marine mammals, and humans. Until recently, amphibians had not been recognized as a host for Brucella. In this study, however, we show that novel Brucella species are distributed among exotic frogs worldwide. Comparative recA gene analysis of 36 frog isolates from various continents and different frog species revealed an unexpected high genetic diversity, not observed among classical Brucella species. In phylogenetic reconstructions the isolates consequently formed various clusters and grouped together with atypical more distantly related brucellae, like B. inopinata, strain BO2, and Australian isolates from rodents, some of which were isolated as human pathogens. Of one frog isolate (10RB9215) the genome sequence was determined. Comparative genome analysis of this isolate and the classical Brucella species revealed additional genetic material, absent from classical Brucella species but present in Ochrobactrum, the closest genetic neighbor of Brucella, and in other soil associated genera of the Alphaproteobacteria. The presence of gene clusters encoding for additional metabolic functions, flanked by tRNAs and mobile genetic elements, as well as by bacteriophages is suggestive for a different ecology compared to classical Brucella species. Furthermore it suggests that amphibian isolates may represent a link between free living soil saprophytes and the pathogenic Brucella with a preferred intracellular habitat. We therefore assume that brucellae from frogs have a reservoir in soil and, in contrast to classical brucellae, undergo extensive horizontal gene transfer.\n[Intracellularly Induced Cyclophilins Play an Important Role in Stress Adaptation and Virulence of Brucella abortus](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3553818)\nGarc\u00eda Fern\u00e1ndez, Luc\u00eda; DelVecchio, Vito G.; Briones, Gabriel\n2013-01-01\nBrucella is an intracellular bacterial pathogen that causes the worldwide zoonotic disease brucellosis. Brucella virulence relies on its ability to transition to an intracellular lifestyle within host cells. Thus, this pathogen must sense its intracellular localization and then reprogram gene expression for survival within the host cell. A comparative proteomic investigation was performed to identify differentially expressed proteins potentially relevant for Brucella intracellular adaptation. Two proteins identified as cyclophilins (CypA and CypB) were overexpressed in the intracellular environment of the host cell in comparison to laboratory-grown Brucella. To define the potential role of cyclophilins in Brucella virulence, a double-deletion mutant was constructed and its resulting phenotype was characterized. The Brucella abortus \u0394cypAB mutant displayed increased sensitivity to environmental stressors, such as oxidative stress, pH, and detergents. In addition, the B. abortus \u0394cypAB mutant strain had a reduced growth rate at lower temperature, a phenotype associated with defective expression of cyclophilins in other microorganisms. The B. abortus \u0394cypAB mutant also displays reduced virulence in BALB/c mice and defective intracellular survival in HeLa cells. These findings suggest that cyclophilins are important for Brucella virulence and survival in the host cells. PMID:23230297\n[IMPLICACIONES \u00c9TICAS Y SOCIALES DE LA INTRODUCCI\u00d3N DE LA VACUNA CONTRA EL VIRUS DEL PAPILOMA HUMANO EN M\u00c9XICO: REFLEXIONES SOBRE UNA PROPUESTA DE INTERVENCI\u00d3N IMPLICA\u00c7\u00d5ES \u00c9TICAS E SOCIAIS DA INTRODU\u00c7\u00c3O DA VACINA CONTRA O VIRUS DO PAPILOMA HUMANO NO M\u00c9XICO: REFLEX\u00d5ES SOBRE UMA PROPOSTA DE INTERVEN\u00c7\u00c3O ETHICAL AND SOCIAL IMPLICATIONS OF THE INTRODUCTION OF THE VACCINE AGAINST THE HUMAN PAPILLOMA VIRUS IN MEXICO: REFLECTIONS ON A PROPOSED INTERVENTION](https://www.openaire.eu/search/publication?articleId=doajarticles::f3f4ecc159ebb48d37bb75cddc626a36)\nAlejandra Prieto de la Rosa; Cristina Guti\u00e9rrez Delgado; Dafna Feinholz Klip; Gisela Morales Gonz\u00e1lez; Renee Witlen\n2008-01-01\nEl objetivo de este trabajo es identificar aspectos \u00e9ticos y sociales relacionados con la introducci\u00f3n de la vacuna contra el virus del papiloma humano (VPH) en M\u00e9xico para una decisi\u00f3n informada y justa que considere no s\u00f3lo los aspectos financieros. De acuerdo con la informaci\u00f3n sobre eficiencia y costo de la vacuna, su introducci\u00f3n al sistema p\u00fablico mexicano puede acarrear consecuencias no previstas para las participantes y para toda la sociedad, por lo que debe examinarse en el contexto ...\n[Brucella Antibodies in Alaskan True Seals and Eared Seals\u2014Two Different Stories](http://journal.frontiersin.org/article/10.3389/fvets.2018.00008/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIngebj\u00f8rg H. Nymo\n2018-01-01\nFull Text Available Brucella pinnipedialis was first isolated from true seals in 1994 and from eared seals in 2008. Although few pathological findings have been associated with infection in true seals, reproductive pathology including abortions, and the isolation of the zoonotic strain type 27 have been documented in eared seals. In this study, a Brucella enzyme-linked immunosorbent assay (ELISA and the Rose Bengal test (RBT were initially compared for 206 serum samples and a discrepancy between the tests was found. Following removal of lipids from the serum samples, ELISA results were unaltered while the agreement between the tests was improved, indicating that serum lipids affected the initial RBT outcome. For the remaining screening, we used ELISA to investigate the presence of Brucella antibodies in sera of 231 eared and 1,412 true seals from Alaskan waters sampled between 1975 and 2011. In eared seals, Brucella antibodies were found in two Steller sea lions (Eumetopias jubatus (2% and none of the 107 Northern fur seals (Callorhinus ursinus. The low seroprevalence in eared seals indicate a low level of exposure or lack of susceptibility to infection. Alternatively, mortality due to the Brucella infection may remove seropositive animals from the population. Brucella antibodies were detected in all true seal species investigated; harbor seals (Phoca vitulina (25%, spotted seals (Phoca largha (19%, ribbon seals (Histriophoca fasciata (16%, and ringed seals (Pusa hispida hispida (14%. There was a low seroprevalence among pups, a higher seroprevalence among juveniles, and a subsequent decreasing probability of seropositivity with age in harbor seals. Similar patterns were present for the other true seal species; however, solid conclusions could not be made due to sample size. This pattern is in accordance with previous reports on B. pinnipedialis infections in true seals and may suggest environmental exposure to B. pinnipedialis at the juvenile stage, with a\n[Molecular Survey on Brucellosis in Rodents and Shrews - Natural Reservoirs of Novel Brucella Species in Germany?](https://www.ncbi.nlm.nih.gov/pubmed/26398680)\nHammerl, J A; Ulrich, R G; Imholt, C; Scholz, H C; Jacob, J; Kratzmann, N; N\u00f6ckler, K; Al Dahouk, S\n2017-04-01\nBrucellosis is a widespread zoonotic disease introduced from animal reservoirs to humans. In Germany, bovine and ovine/caprine brucellosis were eradicated more than a decade ago and mandatory measures in livestock have been implemented to keep the officially brucellosis-free status. In contrast, surveillance of wildlife is still challenging, and reliable data on the prevalence of brucellae in small mammal populations do not exist. To assess the epidemiology of Brucella spp. in rodents and shrews, a molecular survey was carried out. A total of 537 rodents and shrews were trapped in four federal states located throughout Germany and investigated for the presence of Brucella. Using a two-step molecular assay based on the detection of the Brucella-specific bcsp31 and IS711 sequences in tissue samples, 14.2% (n = 76) of the tested animals were positive. These originated mainly from western and south-western Germany, where preliminary analyses indicate population density-dependent Brucella prevalence in voles (Myodes glareolus) and mice (Apodemus spp.). recA typing revealed a close relationship to a potentially novel Brucella species recently isolated from red foxes (Vulpes vulpes) in Austria. The molecular detection of brucellae in various rodent taxa and for the first time in shrew species shows that these animals may be naturally infected or at least have a history of exposure to Brucella spp. \u00a9 2015 Blackwell Verlag GmbH.\n[Brucella Modulates Secretory Trafficking via Multiple Type IV Secretion Effector Proteins](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3738490)\nMyeni, Sebenzile; Child, Robert; Ng, Tony W.; Kupko, John J.; Wehrly, Tara D.; Porcella, Stephen F.; Knodler, Leigh A.; Celli, Jean\n2013-01-01\nThe intracellular pathogenic bacterium Brucella generates a replicative vacuole (rBCV) derived from the endoplasmic reticulum via subversion of the host cell secretory pathway. rBCV biogenesis requires the expression of the Type IV secretion system (T4SS) VirB, which is thought to translocate effector proteins that modulate membrane trafficking along the endocytic and secretory pathways. To date, only a few T4SS substrates have been identified, whose molecular functions remain unknown. Here, we used an in silico screen to identify putative T4SS effector candidate proteins using criteria such as limited homology in other bacterial genera, the presence of features similar to known VirB T4SS effectors, GC content and presence of eukaryotic-like motifs. Using \u03b2-lactamase and CyaA adenylate cyclase reporter assays, we identified eleven proteins translocated into host cells by Brucella, five in a VirB T4SS-dependent manner, namely BAB1_0678 (BspA), BAB1_0712 (BspB), BAB1_0847 (BspC), BAB1_1671 (BspE) and BAB1_1948 (BspF). A subset of the translocated proteins targeted secretory pathway compartments when ectopically expressed in HeLa cells, and the VirB effectors BspA, BspB and BspF inhibited protein secretion. Brucella infection also impaired host protein secretion in a process requiring BspA, BspB and BspF. Single or combined deletions of bspA, bspB and bspF affected Brucella ability to replicate in macrophages and persist in the liver of infected mice. Taken together, these findings demonstrate that Brucella modulates secretory trafficking via multiple T4SS effector proteins that likely act coordinately to promote Brucella pathogenesis. PMID:23950720\n[Progress in Brucella vaccine development](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3666581)\nYANG, Xinghong; SKYBERG, Jerod A.; CAO, Ling; CLAPP, Beata; THORNBURG, Theresa; PASCUAL, David W.\n2012-01-01\nBrucella spp. are zoonotic, facultative intracellular pathogens, which cause animal and human disease. Animal disease results in abortion of fetuses; in humans, it manifests flu-like symptoms with an undulant fever, with osteoarthritis as a common complication of infection. Antibiotic regimens for human brucellosis patients may last several months and are not always completely effective. While there are no vaccines for humans, several licensed live Brucella vaccines are available for use in livestock. The performance of these animal vaccines is dependent upon the host species, dose, and route of immunization. Newly engineered live vaccines, lacking well-defined virulence factors, retain low residual virulence, are highly protective, and may someday replace currently used animal vaccines. These also have possible human applications. Moreover, due to their enhanced safety and efficacy in animal models, subunit vaccines for brucellosis show great promise for their application in livestock and humans. This review summarizes the progress of brucellosis vaccine development and presents an overview of candidate vaccines. PMID:23730309\n[Brucella vulpis sp. nov., isolated from mandibular lymph nodes of red foxes (Vulpes vulpes).](https://www.ncbi.nlm.nih.gov/pubmed/26928956)\nScholz, Holger C; Revilla-Fern\u00e1ndez, Sandra; Al Dahouk, Sascha; Hammerl, Jens A; Zygmunt, Michel S; Cloeckaert, Axel; Koylass, Mark; Whatmore, Adrian M; Blom, Jochen; Vergnaud, Gilles; Witte, Angela; Aistleitner, Karin; Hofer, Erwin\n2016-05-01\nTwo slow-growing, Gram-negative, non-motile, non-spore-forming, coccoid bacteria (strains F60T and F965), isolated in Austria from mandibular lymph nodes of two red foxes (Vulpes vulpes), were subjected to a polyphasic taxonomic analysis. In a recent study, both isolates were assigned to the genus Brucella but could not be attributed to any of the existing species. Hence, we have analysed both strains in further detail to determine their exact taxonomic position and genetic relatedness to other members of the genus Brucella. The genome sizes of F60T and F965 were 3 236 779 and 3 237 765 bp, respectively. Each genome consisted of two chromosomes, with a DNA G+C content of 57.2 %. A genome-to-genome distance of >80 %, an average nucleotide identity (ANI) of 97 % and an average amino acid identity (AAI) of 98 % compared with the type species Brucella melitensis confirmed affiliation to the genus. Remarkably, 5 % of the entire genetic information of both strains was of non-Brucella origin, including as-yet uncharacterized bacteriophages and insertion sequences as well as ABC transporters and other genes of metabolic function from various soil-living bacteria. Core-genome-based phylogenetic reconstructions placed the novel species well separated from all hitherto-described species of the genus Brucella, forming a long-branched sister clade to the classical species of Brucella. In summary, based on phenotypic and molecular data, we conclude that strains F60T and F965 are members of a novel species of the genus Brucella, for which the name Brucella vulpis sp. nov. is proposed, with the type strain F60T ( = BCCN 09-2T = DSM 101715T).\n[Brucella spp. in equines slaughtered in the south region of Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352016000400853&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nR.F. Santos\n2016-08-01\nFull Text Available ABSTRACT Bacteria of the genus Brucella are widespread in many countries. These microorganisms can infect humans and many wild and domestic animal species. These bacteria have zoonotic potential, and can cause economic and public health problems since they can be transmitted by direct contact with sick animals, through consumption of contaminated milk, raw meat and its derivatives (Soares et al., 2015. Brucellosis is considered a chronic evolving disease, unusual in horses, predominantly caused by Brucella abortus. However, it is not characterized by reproductive disorders in horses, but primarily by abscess in the cervical region, bursa, tendons, and joints. Transmission is likely to occur via ingestion of contaminated water and pastures, especially in areas endemic for bovine brucellosis (Ribeiro et al., 2008. The slaughterhouse is a strategic point for obtaining information about the animal and animal products, edible or not. This study investigated the presence of anti-Brucella spp. immunoglobulins in the serum samples from horses slaughtered in a slaughterhouse in southern Brazil, to estimate the frequency of Brucella spp. antibodies and determine the spatial distribution of the cases.\n[Triad of infective endocarditis, splenic abscess, and septicemia caused by Brucella melitensis](http://www.jlponline.org/article.asp?issn=0974-2727;year=2017;volume=9;issue=4;spage=340;epage=342;aulast=Purwar) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nShashank Purwar\n2017-01-01\nFull Text Available A 40-year-old farmer from the district of North Karnataka who had received treatment for high fever of 8 days duration was admitted with fever, dyspnea, and poor general condition. Ultrasonography and echocardiogram revealed multiple splenic abscesses, vegetation on atrioventricular valve, aortic regurgitation (Grade I\u2013II, and mitral valve regurgitation (Grade II\u2013III, respectively. Brucella melitensis was detected in blood culture, and high titers of IgM and IgG anti-Brucella antibodies were observed in Brucella specific serological tests. The patient developed fulminant septicemia and succumbed due to multi-organ failure.\n[Inmunogenicidad y capacidad protectora en hamsters de vacunas antileptospir\u00f3sicas monovalentes de c\u00e9lulas enteras del serogrupo Ballum Immunogenicity and protective capacity of leptospiral whole-cell monovalent serogroup Ballum vaccines in hamsters](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412005000400002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nA. Gonz\u00e1lez\n2005-12-01\nFull Text Available El serogrupo Ballum de Leptospira constituye en la actualidad la primera causa de leptospirosis humana en Cuba. Vacunas de c\u00e9lulas enteras qu\u00edmicamente inactivadas fueron formuladas a partir de dos cepas cl\u00ednicas de Leptospira interrogans serogrupo Ballum empleando como adyuvante hidr\u00f3xido de aluminio. Los niveles de aglutininas inducidos en hamsters por una u otra preparaci\u00f3n vacunal fueron estimados mediante aglutinaci\u00f3n microsc\u00f3pica y la actividad IgG espec\u00edfica fue cuantificada mediante ELISA. La capacidad de protecci\u00f3n hom\u00f3loga y heter\u00f3loga contra la infecci\u00f3n letal y subletal se determin\u00f3 mediante el desaf\u00edo con 100 y 10 000 DL50 de cinco cepas virulentas pertenecientes a los serogrupos Ballum, Canicola, Icterohaemorrhagiae y Pomona. Las evaluaciones realizadas demostraron que ambas vacunas fueron inmunog\u00e9nicas e indujeron una completa protecci\u00f3n hom\u00f3loga en el modelo animal empleado. La protecci\u00f3n cruzada frente a serogrupos heter\u00f3logos solo fue significativa en una de las preparaciones monovalentes frente al desaf\u00edo con 100 DL50 de Canicola. Como resultado de este estudio se pudo comprobar la alta inmunogenicidad y capacidad protectora en hamsters de vacunas monovalentes de c\u00e9lulas enteras formuladas a partir de dos cepas candidatas vacunales del serogrupo de Leptospira de mayor circulaci\u00f3n en humanos en Cuba no incluido en la vacuna actualmente disponible.Leptospira serogroup Ballum is at present the first cause of human leptospirosis in Cuba. Killed whole-cell vaccines were formulated with two clinical isolates of Leptospira interrogans serogroup Ballum using aluminum hydroxide as adjuvant. Agglutinins levels induced by each vaccine in hamsters were estimated by microscopic agglutination test and specific IgG activities were quantified by a whole cell-based enzyme-linked immunosorbent assay. Homologous and cross protective capacity against lethal and sublethal infection were determined in vaccinated animals by\n[Isolation of Brucella microti from soil](http://hdl.handle.net/11104/0162961) [Czech Academy of Sciences Publication Activity Database](https://www.library.sk/arl-cav/en/expanded-search/)\nScholz, H. C.; Hub\u00e1lek, Zden\u011bk; Nesvadbov\u00e1, Ji\u0159ina; Tomaso, H.; Vergnaud, G.; Le Fleche, P.; Whatmore, A. M.; Al Dahouk, S.; Kr\u00fcger, M.; Lodri, C.; Pfeffer, M.\n2008-01-01\nRo\u010d. 14, \u010d. 8 (2008), s. 1316-1317 ISSN 1080-6040 Institutional research plan: CEZ:AV0Z60930519 Keywords : Brucella microti * Microtus arvalis Subject RIV: EE - Microbiology, Virology Impact factor: 6.449, year: 2008\n[Highly Sensitive Bacteriophage-Based Detection of Brucella abortus in Mixed Culture and Spiked Blood.](https://www.ncbi.nlm.nih.gov/pubmed/28604602)\nSergueev, Kirill V; Filippov, Andrey A; Nikolich, Mikeljon P\n2017-06-10\nFor decades, bacteriophages (phages) have been used for Brucella species identification in the diagnosis and epidemiology of brucellosis. Traditional Brucella phage typing is a multi-day procedure including the isolation of a pure culture, a step that can take up to three weeks. In this study, we focused on the use of brucellaphages for sensitive detection of the pathogen in clinical and other complex samples, and developed an indirect method of Brucella detection using real-time quantitative PCR monitoring of brucellaphage DNA amplification via replication on live Brucella cells. This assay allowed the detection of single bacteria (down to 1 colony-forming unit per milliliter) within 72 h without DNA extraction and purification steps. The technique was equally efficient with Brucella abortus pure culture and with mixed cultures of B . abortus and \u03b1-proteobacterial near neighbors that can be misidentified as Brucella spp., Ochrobactrum anthropi and Afipia felis . The addition of a simple short sample preparation step enabled the indirect phage-based detection of B . abortus in spiked blood, with the same high sensitivity. This indirect phage-based detection assay enables the rapid and sensitive detection of live B . abortus in mixed cultures and in blood samples, and can potentially be applied for detection in other clinical samples and other complex sample types.\n[Highly Sensitive Bacteriophage-Based Detection of Brucella abortus in Mixed Culture and Spiked Blood](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5490821)\nSergueev, Kirill V.; Filippov, Andrey A.; Nikolich, Mikeljon P.\n2017-01-01\nFor decades, bacteriophages (phages) have been used for Brucella species identification in the diagnosis and epidemiology of brucellosis. Traditional Brucella phage typing is a multi-day procedure including the isolation of a pure culture, a step that can take up to three weeks. In this study, we focused on the use of brucellaphages for sensitive detection of the pathogen in clinical and other complex samples, and developed an indirect method of Brucella detection using real-time quantitative PCR monitoring of brucellaphage DNA amplification via replication on live Brucella cells. This assay allowed the detection of single bacteria (down to 1 colony-forming unit per milliliter) within 72 h without DNA extraction and purification steps. The technique was equally efficient with Brucella abortus pure culture and with mixed cultures of B. abortus and \u03b1-proteobacterial near neighbors that can be misidentified as Brucella spp., Ochrobactrum anthropi and Afipia felis. The addition of a simple short sample preparation step enabled the indirect phage-based detection of B. abortus in spiked blood, with the same high sensitivity. This indirect phage-based detection assay enables the rapid and sensitive detection of live B. abortus in mixed cultures and in blood samples, and can potentially be applied for detection in other clinical samples and other complex sample types. PMID:28604602\n[Analyses of Brucella Pathogenesis, Host Immunity, and Vaccine Targets using Systems Biology and Bioinformatics](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::c580d41545043deca12d565f9de29d89)\nHe, Yongqun\n2012-01-01\nBrucella is a Gram-negative, facultative intracellular bacterium that causes zoonotic brucellosis in humans and various animals. Out of 10 classified Brucella species, B. melitensis, B. abortus, B. suis, and B. canis are pathogenic to humans. In the past decade, the mechanisms of Brucella pathogenesis and host immunity have been extensively investigated using the cutting edge systems biology and bioinformatics approaches. This article provides a comprehensive review of the applications of Omi...\n[Estudio de tolerancia local de la vacuna vax-TyVi\u00ae en ratas Sprague Dawley](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100003&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEligio Sosa Roble\n2005-05-01\nFull Text Available La vacuna antitifo\u00eddica vax-TyVi\u00ae consiste en una preparaci\u00f3n de polisac\u00e1rido capsular Vi de Salmonella typhi, el cual es diluido en una soluci\u00f3n buffer isot\u00f3nica soluci\u00f3n amortiguador, a la que se le a\u00f1ade fenol como preservo. Cada dosis de 0,5 mL contiene 25 \u03bcg de polisac\u00e1rido como sustancia activa. En nuestro pa\u00eds el esquema de vacunaci\u00f3n contra la fiebre tifoidea con vax- TyVi\u00ae se aplica a los alumnos de 9-10 a\u00f1os (5to grado, una 2da dosis a la edad de 12-13 a\u00f1os (8vo grado y una 3ra dosis a la edad de 16-17 a\u00f1os (11no grado. Adem\u00e1s, es vacunado el personal de riesgo de Salud P\u00fablica y el personal que manipula alimentos. En el presente trabajo se describe el ensayo de tolerancia local llevado a cabo con la vacuna vax-TyVi\u00ae durante su fase de estudios precl\u00ednicos, actualmente utilizada en la vacunaci\u00f3n contra la fiebre tifoidea en Cuba. Se emple\u00f3 un total de 170 ratas que fueron tratadas con la vacuna, su placebo (todos los componentes, excepto la materia prima activa, o que no recibieron tratamiento alguno (controles. Se realizaron observaciones cl\u00ednicas diarias durante todo el ensayo, se determin\u00f3 el consumo de agua y alimentos y se realizaron investigaciones anatomopatol\u00f3gicas a animales sacrificados 3, 7, 14, 21, 28, 35 y 42 d\u00edas despu\u00e9s de la inoculaci\u00f3n. No se observaron muertes ni s\u00edntomas de toxicidad; no se encontraron diferencias estad\u00edsticamente significativas entre los pesos vivos, el consumo de agua ni el de alimentos entre los grupos del ensayo. Tampoco se observaron lesiones anatomopatol\u00f3gicas que indicaran toxicidad por parte del producto inoculado. Los resultados permitieron concluir que la potencialidad de la vacuna vax-TyVi\u00ae para producir efectos adversos locales es baja.\n[Differences in two-component signal transduction proteins among the genus Brucella: implications for host preference and pathogenesis](http://www.forskningsdatabasen.dk/en/catalog/78986016) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBinnewies, Tim Terence; Ussery, David; Lav\u00edn, JL\n2010-01-01\n. anthropi lacks orthologs of the Brucella TCSs NodVW, TceSR and TcfSR, suggesting that these TCS proteins could be necessary for the adaptation of Brucella as an intracellular pathogen. This genomic analysis revealed the presence of a differential distribution of TCS pseudogenes among Brucella species....... Moreover, there were also differences in TCS pseudogenes between strains belonging to the same Brucella species, and in particular between B. suis biovars 1 and 2....\n[El Documento de las Am\u00e9ricas: Buenas Pr\u00e1cticas Cl\u00ednicas para Autoridades Reguladoras](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::e0bd92d25a74133eb0953454de67c655)\nRicardo Palacios\n2009-01-01\nEn 1996, cuando se adoptaron las Normas de Buenas Pr\u00e1cticas Cl\u00ednicas de la Conferencia Internacional de Armonizaci\u00f3n (ICH, por su sigla en ingl\u00e9s), se proyect\u00f3 facilitar la acci\u00f3n de autoridades reguladoras sobre los diferentes actores de la investigaci\u00f3n cl\u00ednica. Estas normas fueron creadas e incorporadas a la legislaci\u00f3n de las tres regiones del mundo (Estados Unidos, Uni\u00f3n Europea y Jap\u00f3n) que producen la mayor parte de medicamentos, vacunas, biol\u00f3gicos, pruebas diagn\u00f3sticas y equipos m\u00e9d...\n[[Characterization of the genetic variability of field strains of Brucella canis isolated in Antioquia].](https://www.ncbi.nlm.nih.gov/pubmed/29277251)\nVidal Arboleda, Juana L; Ortiz Roman, Luisa F; Olivera Angel, Martha\n2017-12-22\nBrucella canis is a facultative intracellular pathogen responsible for canine brucellosis, a zoonotic disease that affects canines, causing abortions and reproductive failure; and the production of non-specific symptoms in humans. In 2005 the presence of B. canis in Antioquia was demonstrated and the strains were identified as type 2. The sequencing of the genome of a field strain denoted Brucella canis str. Oliveri, showed species-specific indel events, which led us to investigate the genomic characteristics of the B. canis strain isolated and to establish the phylogenetic relationships and the divergence time of B. canis str. Oliveri. Conventional PCR sequencing was performed in 30 field strains identifying 5 indel events recognized in B. canis str. Oliveri. ADN from Brucella suis, Brucella melitensis and vaccine strains from Brucella abortus were used as control, and it was determined that all of the studied field strains shared 4 out of the 5 indels of the sequenced Oliveri strain, indicating the presence of more than one strain circulating in the region. Phylogenetic analysis was performed with 24 strains of Brucella using concatenated sequences of genetic markers for species differentiation. The molecular clock hypothesis and Tajima's relative rate test were tested, showing that the Oliveri strain, similarly to other canis species, diverged from B. suis. The molecular clock hypothesis between Brucella species was rejected and an evolution rate and a similar genetic distance between the B. canis were demonstrated. Copyright \u00a9 2017 Asociaci\u00f3n Argentina de Microbiolog\u00eda. Publicado por Elsevier Espa\u00f1a, S.L.U. All rights reserved.\n[Comparison of a New and Rapid Method: Brucella Coombs Gel Test With Other Diagnostic Tests.](https://www.ncbi.nlm.nih.gov/pubmed/26990900)\nKalem, Fatma; Erg\u00fcn, Ay\u015fe G\u00fcl; Durmaz, S\u00fcleyman; Do\u011fan, Metin; Ertu\u011frul, \u00d6m\u00fcr; G\u00fcndem, Seval\n2016-09-01\nThe aim of this study was to detect reliability of Brucella Coombs gel test (BCGT) by comparing with with ELISA (IgG + IgM), Standard agglutination test, and Brucella immunocapture agglutination methods in serological diagnosis of brucellosis. Brucella Coombs gel test (BCGT), Brucella ELISA (IgG + IgM), Standard agglutination test, and Brucella immunocapture agglutination tests of 78 patients with presumptive diagnosis of brucellosis which were sent to Microbiology Laboratory of Konya Numune Hospital from various regions of Konya were studied. Of 78 patients with ELISA IgG and IgM, STA, BICA and BCGT; 26, 21, 10, 12 and 12 were positive. When compared with BICA, the sensitivity and specifity of BCGT were 100% and 100%, respectively. According to results BCGT can be used as a diagnostic test in routine laboratories after more comprehensive studies in control groups and patients. \u00a9 2016 Wiley Periodicals, Inc.\n[ISOLATION AND CHARACTERIZATION OF A NOVEL MARINE BRUCELLA FROM A SOUTHERN SEA OTTER (ENHYDRA LUTRIS NEREIS), CALIFORNIA, USA.](https://www.ncbi.nlm.nih.gov/pubmed/28151078)\nMiller, Melissa A; Burgess, Tristan L; Dodd, Erin M; Rhyan, Jack C; Jang, Spencer S; Byrne, Barbara A; Gulland, Frances M D; Murray, Michael J; Toy-Choutka, Sharon; Conrad, Patricia A; Field, Cara L; Sidor, Inga F; Smith, Woutrina A\n2017-04-01\nWe characterize Brucella infection in a wild southern sea otter ( Enhydra lutris nereis) with osteolytic lesions similar to those reported in other marine mammals and humans. This otter stranded twice along the central California coast, US over a 1-yr period and was handled extensively at two wildlife rehabilitation facilities, undergoing multiple surgeries and months of postsurgical care. Ultimately the otter was euthanized due to severe, progressive neurologic disease. Necropsy and postmortem radiographs revealed chronic, severe osteoarthritis spanning the proximal interphalangeal joint of the left hind fifth digit. Numerous coccobacilli within the joint were strongly positive on Brucella immunohistochemical labelling, and Brucella sp. was isolated in pure culture from this lesion. Sparse Brucella-immunopositive bacteria were also observed in the cytoplasm of a pulmonary vascular monocyte, and multifocal granulomas were observed in the spinal cord and liver on histopathology. Findings from biochemical characterization, 16S ribosomal DNA, and bp26 gene sequencing of the bacterial isolate were identical to those from marine-origin brucellae isolated from cetaceans and phocids. Although omp2a gene sequencing revealed 100% homology with marine Brucella spp. infecting pinnipeds, whales, and humans, omp2b gene sequences were identical only to pinniped-origin isolates. Multilocus sequence typing classified the sea otter isolate as ST26, a sequence type previously associated only with cetaceans. Our data suggest that the sea otter Brucella strain represents a novel marine lineage that is distinct from both Brucella pinnipedialis and Brucella ceti. Prior reports document the zoonotic potential of the marine brucellae. Isolation of Brucella sp. from a stranded sea otter highlights the importance of wearing personal protective equipment when handling sea otters and other marine mammals as part of wildlife conservation and rehabilitation efforts.\n[Brucella and Coxiella; if you don't look, you don't find.](https://www.ncbi.nlm.nih.gov/pubmed/25650208)\nLambourne, Jonathan R; Brooks, Tim\n2015-02-01\nBrucella and Coxiella are similar; both are obligate intracellular, zoonotic pathogens with a broad geographic distribution. Infection in animals is usually asymptomatic, but causes fetal loss and therefore has significant economic impact. Human infection may be asymptomatic or give rise to either organ-specific or multi-system disease. Organism culture is challenging for Coxiella and can lack sensitivity for Brucella. Therefore, infection is most commonly diagnosed by serology, but this may be negative in early infection and serology results may be challenging to interpret. Both Brucella and Coxiella are typically susceptible to a wide range of antimicrobials, but long courses may be needed. \u00a9 2015 Royal College of Physicians.\n[Genomic comparisons of Brucella spp. and closely related bacteria using base compositional and proteome based methods](http://orbit.dtu.dk/ws/files/9907332/289EDd01.pdf) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nBohlin, Jon; Snipen, Lars; Cloeckaert, Axel\n2010-01-01\nBACKGROUND: Classification of bacteria within the genus Brucella has been difficult due in part to considerable genomic homogeneity between the different species and biovars, in spite of clear differences in phenotypes. Therefore, many different methods have been used to assess Brucella taxonomy....... In the current work, we examine 32 sequenced genomes from genus Brucella representing the six classical species, as well as more recently described species, using bioinformatical methods. Comparisons were made at the level of genomic DNA using oligonucleotide based methods (Markov chain based genomic signatures...... between the oligonucleotide based methods used. Whilst the Markov chain based genomic signatures grouped the different species in genus Brucella according to host preference, the codon and amino acid frequencies based methods reflected small differences between the Brucella species. Only minor differences...\n[Seroprevalencia de Brucella spp en estudiantes de Medicina Veterinaria, Bogot\u00e1, Colombia](http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-08072013000200006&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIv\u00e1n Alberto M\u00e9ndez R\n2013-08-01\nFull Text Available Introducci\u00f3n: La brucelosis es un enfermedad zoonotica relacionada al contacto con perros y con ganado vacuno, porcino y caprino, el agente etiol\u00f3gico pertenece al g\u00e9nero Brucella con diez especies de importancia para el ser humano; su capacidad para evadir el sistema inmune y sobrevivir en el fago-lisosoma genera un cuadro cl\u00ednico cr\u00f3nico en el ser humano caracterizado por fiebre ondulante y afectaci\u00f3n osteoarticular. Su amplia variedad de expresi\u00f3n cl\u00ednica genera un reto al momento del diagn\u00f3stico y tratamiento; por tal raz\u00f3n es relevante el reconocimiento de las pruebas diagn\u00f3sticas que permitan establecer el posible contacto con el microorganismo. Objetivo: Establecer la seroprevalencia a Brucella spp en una poblaci\u00f3n de estudiantes de Medicina Veterinaria con posible exposici\u00f3n ocupacional. Materiales y M\u00e9todos: Estudio descriptivo observacional donde se estudiaron 272 sueros obtenidos de estudiantes de medicina veterinaria mediante la t\u00e9cnica de rosa de bengala. Resultados: El 18,4% (50/272 de los sujetos presento positividad por rosa de bengala; 28 hombres (56% y 22 mujeres (44%. Conclusiones: La serolog\u00eda mediante rosa de bengala en esta poblaci\u00f3n de riesgo evidenci\u00f3 un 18,5% de sujetos seropositivos. Se sugiere el empleo de barreras efectivas de protecci\u00f3n durante el contacto con animales portadores del microorganismo durante el entrenamiento como estudiantes de Medicina veterinaria.\n[Endocarditis por Brucella canis: primer caso documentado en un paciente adulto en Argentina Brucella canis endocarditis: first documented case in Argentina](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000100009) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nValeria Manias\n2013-03-01\nFull Text Available Se describe el primer caso documentado de endocarditis por Brucella canis en Argentina. El paciente fue un var\u00f3n adulto que consult\u00f3 por edemas en miembros inferiores, registros febriles aislados de 2 meses de evoluci\u00f3n y dolor precordial opresivo que irradiaba a brazo izquierdo. Negaba contacto con animales de cr\u00eda o consumo de productos sin pasteurizaci\u00f3n. Estudios cardiol\u00f3gicos constataron endocarditis infecciosa. Se resuelve cirug\u00eda de recambio valvular ante fracaso terap\u00e9utico emp\u00edrico con cefalotina, ampicilina y gentamicina. Los hemocultivos fueron positivos (4 de 4 muestras con bacilos gram negativos. Se realiz\u00f3 la identificaci\u00f3n con t\u00e9cnica API 20 NE (bioM\u00e9rieux, el m\u00e9todo automatizado Phoenix (BD y las pruebas bioqu\u00edmicas convencionales, sin concluir g\u00e9nero ni especie. Se deriv\u00f3 la cepa al departamento de Bacteriolog\u00eda Especial INEI-ANLIS \"Dr. Carlos G. Malbr\u00e1n\" donde se identific\u00f3 al aislamiento como Brucella canis. Se rot\u00f3 el esquema terap\u00e9utico a doxiciclina, rifampicina y trimetoprima-sulfametoxazol con buena evoluci\u00f3n. La importancia del caso radica en la posible falla del tratamiento antimicrobiano emp\u00edrico administrado para endocarditis, ya que B. canis no responde a los antimicrobianos convencionales para esta patolog\u00eda.We herein present the case of an adult male patient who consulted for lower extremity edema, a 2- month history of fever and oppressive chest pain radiating to the left arm. He referred neither contact with breeding animals nor consumption of unpasteurized dairy products. A diagnosis of endocarditis was confirmed by cardiac studies. Since the empirical treatment with cephalotin, ampicillin and gentamicin failed, the patient underwent aortic valve replacement. A total of four blood cultures were positive with a gram-negative rod. Bacterial identification was performed using the API 20 NE technique (bioMerieux, the Phoenix automated method (BD and conventional biochemical tests which were\n[Case Report: Acute brucella meningomyeloencephalo ...](https://www.ajol.info/index.php/ahs/article/view/6901) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nAfrican Health Sciences ... There are 4 species of brucella pathogenic to humans and each of them has a specific types of animal reservoir: B.arbotus (cattle, buffallo),B.melitensis (goats, sheep, camels), B.suis (pigs), B.canis (Dogs). Humans are infected when they are exposed to body fluids from an infected animal.\n[Highly Sensitive Bacteriophage-Based Detection of Brucella abortus in Mixed Culture and Spiked Blood](http://www.mdpi.com/1999-4915/9/6/144) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nKirill V. Sergueev\n2017-06-01\nFull Text Available For decades, bacteriophages (phages have been used for Brucella species identification in the diagnosis and epidemiology of brucellosis. Traditional Brucella phage typing is a multi-day procedure including the isolation of a pure culture, a step that can take up to three weeks. In this study, we focused on the use of brucellaphages for sensitive detection of the pathogen in clinical and other complex samples, and developed an indirect method of Brucella detection using real-time quantitative PCR monitoring of brucellaphage DNA amplification via replication on live Brucella cells. This assay allowed the detection of single bacteria (down to 1 colony-forming unit per milliliter within 72 h without DNA extraction and purification steps. The technique was equally efficient with Brucella abortus pure culture and with mixed cultures of B. abortus and \u03b1-proteobacterial near neighbors that can be misidentified as Brucella spp., Ochrobactrum anthropi and Afipia felis. The addition of a simple short sample preparation step enabled the indirect phage-based detection of B. abortus in spiked blood, with the same high sensitivity. This indirect phage-based detection assay enables the rapid and sensitive detection of live B. abortus in mixed cultures and in blood samples, and can potentially be applied for detection in other clinical samples and other complex sample types.\n[Desarrollo de un m\u00e9todo de CLAR-IR para la determinaci\u00f3n de etanol residual en vacuna Development of a HPLC-IR method for determination of residual ethanol in vaccine](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000200004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMatilde Cuevas Valdespino\n2009-08-01\nFull Text Available Los ingredientes farmac\u00e9uticos activos de la vacuna antimeningoc\u00f3cica cubana VA-MENGOC-BC TM (ves\u00edculas de membrana externa purificadas de Neisseria meningitidis, serogrupo B y polisac\u00e1rido capsular purificado de Neisseria meningitidis, serogrupo C son conservados en etanol, de ah\u00ed que dicha vacuna posea un contenido de etanol residual, cuya concentraci\u00f3n real no se conoc\u00eda hasta el momento. Las regulaciones internacionales plantean que los productos biofarmac\u00e9uticos y sus ingredientes farmac\u00e9uticos activos deben tener bien caracterizadas todas sus impurezas, por lo que el objetivo de este trabajo fue el desarrollo de un m\u00e9todo de determinaci\u00f3n de etanol mediante cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n-\u00edndice de refracci\u00f3n para estos fines y su comparaci\u00f3n con un m\u00e9todo utilizado frecuentemente para cuantificar este solvente, como es la cromatograf\u00eda gaseosa. El m\u00e9todo evaluado result\u00f3 ser \u00fatil y con una buena robustez para la determinaci\u00f3n de este solvente org\u00e1nico en esta vacuna antimenigoc\u00f3cica. No se detectaron diferencias estad\u00edsticamente significativas entre los resultados obtenidos al evaluar las mismas muestras de vacuna mediante ambos m\u00e9todos cromatogr\u00e1ficos (cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n y cromatograf\u00eda gaseosa, lo que indica la posibilidad del uso de la cromatograf\u00eda l\u00edquida de alta resoluci\u00f3n en sustituci\u00f3n de la cromatograf\u00eda gaseosa para esta determinaci\u00f3n.Active pharmaceutical ingredients of Cuban anti-meningococcal vaccine VA-MENGOC-BC TM (vesicles of purified external membranes of Neisseria meningitidis, B serum-group, and purified capsular polysaccharide of Neisseria meningitidis, serum-group C are stored in ethanol, thus that such vaccine has residual ethanol content, of which real concentration is not known just now. International regulations propose that the biopharmaceutical products and its active pharmaceutical ingredients must to have well defined all impurities, thus\n[Reliable identification at the species level of Brucella isolates with MALDI-TOF-MS](http://www.biomedcentral.com/1471-2180/11/267) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLista Florigio\n2011-12-01\nFull Text Available Abstract Background The genus Brucella contains highly infectious species that are classified as biological threat agents. The timely detection and identification of the microorganism involved is essential for an effective response not only to biological warfare attacks but also to natural outbreaks. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS is a rapid method for the analysis of biological samples. The advantages of this method, compared to conventional techniques, are rapidity, cost-effectiveness, accuracy and suitability for the high-throughput identification of bacteria. Discrepancies between taxonomy and genetic relatedness on the species and biovar level complicate the development of detection and identification assays. Results In this study, the accurate identification of Brucella species using MALDI-TOF-MS was achieved by constructing a Brucella reference library based on multilocus variable-number tandem repeat analysis (MLVA data. By comparing MS-spectra from Brucella species against a custom-made MALDI-TOF-MS reference library, MALDI-TOF-MS could be used as a rapid identification method for Brucella species. In this way, 99.3% of the 152 isolates tested were identified at the species level, and B. suis biovar 1 and 2 were identified at the level of their biovar. This result demonstrates that for Brucella, even minimal genomic differences between these serovars translate to specific proteomic differences. Conclusions MALDI-TOF-MS can be developed into a fast and reliable identification method for genetically highly related species when potential taxonomic and genetic inconsistencies are taken into consideration during the generation of the reference library.\n[Exposure of harbour seals Phoca vitulina to Brucella in declining populations across Scotland.](https://www.ncbi.nlm.nih.gov/pubmed/28930081)\nKershaw, Joanna L; Stubberfield, Emma J; Foster, Geoffrey; Brownlow, Andrew; Hall, Ailsa J; Perrett, Lorraine L\n2017-09-20\nSince 2000 there has been a major decline in the abundance of Scottish harbour seals Phoca vitulina. The causes of the decline remain uncertain. The aim of this study was to establish the extent to which the seals in the regions of greatest decline have been exposed to Brucella, a bacterial pathogen that causes reproductive failure in terrestrial mammalian hosts. Tissues from dead seals collected between 1992 and 2013 were cultured for Brucella (n = 150). Serum samples collected from live capture-released seals (n = 343) between 1997 and 2012 were tested for Brucella antibodies using the Rose Bengal plate agglutination test (RBT) and a competitive enzyme-linked immunosorbent assay (cELISA). In total, 16% of seals cultured had Brucella isolated from one or more tissues, but there were no pathological signs of infection. The cELISA results were more sensitive than the RBT results, showing that overall 25.4% of seals were seropositive, with the highest seroprevalence in juveniles. As there was no evidence of either a higher seroprevalence or higher circulating antibody levels in seropositive animals in the areas with the greatest declines, it was concluded that Brucella infection is likely not a major contributing factor to recent declines. However, the consistently high proportion of seals exposed to Brucella indicates possible endemicity in these populations, likely due to B. pinnipedialis, which has demonstrated a preference for pinniped hosts. Importantly, given the close proximity between seals, humans and livestock in many areas, there is the potential for cross-species infections.\n[Anafilaxia associada \u00e0 vacina contra sarampo, caxumba e rub\u00e9ola Anafilaxia asociada a la vacuna contra sarampi\u00f3n, varicela y rub\u00e9ola Anaphylaxis associated with the vaccine against measles, mumps and rubella](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102010000200020) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIolanda Maria Novadzki\n2010-04-01\nFull Text Available Estudo do tipo caso-controle cujo objetivo foi descrever os casos e as causas de anafilaxia associada \u00e0 vacina contra sarampo, caxumba e rub\u00e9ola. Foram estudados 22 casos notificados em crian\u00e7as de Curitiba, PR, durante Campanha Nacional de Vacina\u00e7\u00e3o de 2004, que apresentaram manifesta\u00e7\u00f5es mucocut\u00e2neas. Para o controle, foram selecionadas 66 crian\u00e7as vizinhas dos casos, que n\u00e3o apresentaram sintomatologia ap\u00f3s a aplica\u00e7\u00e3o vacinal. Foram realizadas dosagens s\u00e9ricas de anticorpos para os ant\u00edgenos vacinais, IgE total e espec\u00edficas para diversos al\u00e9rgenos, e testes cut\u00e2neos. A resposta vacinal foi adequada, a dosagem de IgE espec\u00edfica e os testes cut\u00e2neos mostraram que os al\u00e9rgenos potenciais constituintes da vacina e a atopia n\u00e3o foram relacionados \u00e0s rea\u00e7\u00f5es anafil\u00e1ticas. Os testes cut\u00e2neos com a vacina e o dextrano foram positivos somente nos casos, sugerindo sensibiliza\u00e7\u00e3o por algum componente residual da vacina e poss\u00edvel rea\u00e7\u00e3o cruzada com o dextrano.Estudio del tipo caso-control cuyo objetivo fue describir los casos y las causas de anafilaxia asociada a la vacuna contra sarampi\u00f3n, varicela y rub\u00e9ola. Fueron estudiados 22 casos notificados en ni\u00f1os de Curitiba, Sureste de Brasil, durante Campa\u00f1a Nacional de Vacunaci\u00f3n de 2004, que presentaron manifestaciones mococut\u00e1neas. Para el control, fueron seleccionados 66 ni\u00f1os vecinos de los casos, que no presentaron sintomatolog\u00eda posterior a la aplicaci\u00f3n vacunal. Fueron realizadas dosificaciones s\u00e9ricas de anticuerpos para los ant\u00edgenos vacunales, IgE total y espec\u00edficas para diversos al\u00e9rgenos, y pruebas cut\u00e1neas. La respuesta vacunal fue adecuada, la dosificaci\u00f3n de IgE espec\u00edfica y las pruebas cut\u00e1neas mostraron que los al\u00e9rgenos potenciales constituyentes de la vacuna y la atopia no fueron relacionados a las reacciones anafil\u00e1cticas. Las pruebas cut\u00e1neas con la vacuna y el dextrano fueron positivas solamente en los casos, sugiriendo\n[Epidemiology of Brucella infection in the human, livestock and wildlife interface in the Katavi-Rukwa ecosystem, Tanzania.](https://www.ncbi.nlm.nih.gov/pubmed/26253151)\nAssenga, Justine A; Matemba, Lucas E; Muller, Shabani K; Malakalinga, Joseph J; Kazwala, Rudovick R\n2015-08-08\nBrucellosis is a zoonosis of public health importance worldwide. In Tanzania, the disease is underreported due to insufficient awareness, inadequate diagnostic protocols, including lack of appropriate reagents for diagnosis. Livestock and wildlife are considered potential sources of infection to humans; however, the role played by these carriers in the epidemiology of the disease in the ecosystems in Tanzania is not fully understood. The objective of this study was to establish the prevalence of anti-Brucella antibodies in humans, wildlife and livestock; and molecular prevalence of Brucella spp in cattle and goats in the Katavi- Rukwa ecosystem. Anti-Brucella antibodies were detected in humans at 0.6 % (95 % CI: 0.1, 2.1 %); cattle at 6.8 % (95 % CI: 5.4, 8.5 %), goats at 1.6 % (95 % CI: 0.4, 4.1 %) and buffaloes at 7.9 % (95 % CI: 1.7, 21.4 %). One of the two sampled lions tested positive. Cattle had a significantly higher prevalence of anti-Brucella antibodies as compared to goats (P Brucella infection. Eight (3.5 %) out of 231 milk samples tested were positive for Brucella spp on Polymerase Chain Reaction (PCR), and Brucella abortus biovar 1 was detected in cattle milk. However, no Brucella spp were detected in goat milk. This study has shown the presence of anti- Brucella antibodies in humans, livestock, and wildlife in the Katavi- Rukwa ecosystem. Transmission of the infection between wildlife, livestock and humans is likely to continue due to increasing human activities in the human wildlife interface. This information is an important contribution to public health policy development in the human wildlife interface of the Katavi- Rukwa ecosystem.\n[Infection of California sea lions (Zalophus californianus) with terrestrial Brucella spp.](https://www.ncbi.nlm.nih.gov/pubmed/25066000)\nAvalos-T\u00e9llez, Rosal\u00eda; Ram\u00edrez-Pfeiffer, Carlos; Hern\u00e1ndez-Castro, Rigoberto; D\u00edaz-Aparicio, Efr\u00e9n; S\u00e1nchez-Dom\u00ednguez, Carlos; Zavala-Norzagaray, Alan; Arellano-Reynoso, Beatriz; Su\u00e1rez-G\u00fcemes, Francisco; Aguirre, A Alonso; Aurioles-Gamboa, David\n2014-10-01\nInfections with Brucella ceti and pinnipedialis are prevalent in marine mammals worldwide. A total of 22 California sea lions (Zalophus californianus) were examined to determine their exposure to Brucella spp. at San Esteban Island in the Gulf of California, Mexico, in June and July 2011. Although samples of blood, vaginal mucus and milk cultured negative for these bacteria, the application of rose Bengal, agar gel immunodiffusion, PCR and modified fluorescence polarization assays found that five animals (22.7%) had evidence of exposure to Brucella strains. The data also suggested that in two of these five sea lions the strains involved were of terrestrial origin, a novel finding in marine mammals. Further work will be required to validate and determine the epidemiological significance of this finding. Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.\n[Diverse Genetic Regulon of the Virulence-Associated Transcriptional Regulator MucR in Brucella abortus 2308](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3639602)\nCaswell, Clayton C.; Elhassanny, Ahmed E. M.; Planchin, Emilie E.; Roux, Christelle M.; Weeks-Gorospe, Jenni N.; Ficht, Thomas A.; Dunman, Paul M.\n2013-01-01\nThe Ros-type regulator MucR is one of the few transcriptional regulators that have been linked to virulence in Brucella. Here, we show that a Brucella abortus in-frame mucR deletion strain exhibits a pronounced growth defect during in vitro cultivation and, more importantly, that the mucR mutant is attenuated in cultured macrophages and in mice. The genetic basis for the attenuation of Brucella mucR mutants has not been defined previously, but in the present study the genes regulated by MucR in B. abortus have been elucidated using microarray analysis and real-time reverse transcription-PCR (RT-PCR). In B. abortus 2308, MucR regulates a wide variety of genes whose products may function in establishing and maintaining cell envelope integrity, polysaccharide biosynthesis, iron homeostasis, genome plasticity, and transcriptional regulation. Particularly notable among the MucR-regulated genes identified is arsR6 (nolR), which encodes a transcriptional regulator previously linked to virulence in Brucella melitensis 16 M. Importantly, electrophoretic mobility shift assays (EMSAs) determined that a recombinant MucR protein binds directly to the promoter regions of several genes repressed by MucR (including arsR6 [nolR]), and in Brucella, as in other alphaproteobacteria, MucR binds to its own promoter to repress expression of the gene that encodes it. Overall, these studies have uncovered the diverse genetic regulon of MucR in Brucella, and in doing so this work has begun to define the MucR-controlled genetic circuitry whose misregulation contributes to the virulence defect of Brucella mucR mutants. PMID:23319565\n[Brucella placentitis and seroprevalence in northern fur seals ( Callorhinus ursinus) of the Pribilof Islands, Alaska.](https://www.ncbi.nlm.nih.gov/pubmed/24803576)\nDuncan, Colleen G; Tiller, Rebekah; Mathis, Demetrius; Stoddard, Robyn; Kersh, Gilbert J; Dickerson, Bobette; Gelatt, Tom\n2014-07-01\nBrucella species infect a wide range of hosts with a broad spectrum of clinical manifestations. In mammals, one of the most significant consequences of Brucella infection is reproductive failure. There is evidence of Brucella exposure in many species of marine mammals, but the outcome of infection is often challenging to determine. The eastern Pacific stock of northern fur seals (NFSs, Callorhinus ursinus) has declined significantly, spawning research into potential causes for this trend, including investigation into reproductive health. The objective of the current study was to determine if NFSs on St. Paul Island, Alaska have evidence of Brucella exposure or infection. Archived DNA extracted from placentas ( n = 119) and serum ( n = 40) samples were available for testing by insertion sequence (IS) 711 polymerase chain reaction (PCR) and the Brucella microagglutination test (BMAT), respectively. As well, placental tissue was available for histologic examination. Six (5%) placentas were positive by PCR, and a single animal had severe placentitis. Multilocus variable number tandem repeat analysis profiles were highly clustered and closely related to other Brucella pinnipedialis isolates. A single animal was positive on BMAT, and 12 animals had titers within the borderline range; 1 borderline animal was positive by PCR on serum. The findings suggest that NFSs on the Pribilof Islands are exposed to Brucella and that the organism has the ability to cause severe placental disease. Given the population trend of the NFS, and the zoonotic nature of this pathogen, further investigation into the epidemiology of this disease is recommended.\n[A rapid minor groove binder PCR method for distinguishing the vaccine strain Brucella abortus 104M.](https://www.ncbi.nlm.nih.gov/pubmed/29361960)\nNan, Wenlong; Qin, Lide; Wang, Yong; Zhang, Yueyong; Tan, Pengfei; Chen, Yuqi; Mao, Kairong; Chen, Yiping\n2018-01-24\nBrucellosis is a widespread zoonotic disease caused by Gram-negative Brucella bacteria. Immunisation with attenuated vaccine is an effective method of prevention, but it can interfere with diagnosis. Live, attenuated Brucella abortus strain 104M has been used for the prevention of human brucellosis in China since 1965. However, at present, no fast and reliable method exists that can distinguish this strain from field strains. Single nucleotide polymorphism (SNP)-based assays offer a new approach for such discrimination. SNP-based minor groove binder (MGB) and Cycleave assays have been used for rapid identification of four Brucella vaccine strains (B. abortus strains S19, A19 and RB51, and B. melitensis Rev1). The main objective of this study was to develop a PCR assay for rapid and specific detection of strain 104M. We developed a SNP-based MGB PCR assay that could successfully distinguish strain 104M from 18 representative strains of Brucella (B. abortus biovars 1, 2, 3, 4, 5, 6, 7 and 9, B. melitensis biovars 1, 2 and 3, B. suis biovars 1, 2, 3 and 4, B. canis, B. neotomae, and B. ovis), four Brucella vaccine strains (A19, S19, S2, M5), and 55 Brucella clinical field strains. The assay gave a negative reaction with four non-Brucella species (Escherichia coli, Pasteurella multocida, Streptococcus suis and Pseudomonas aeruginosa). The minimum sensitivity of the assay, evaluated using 10-fold dilutions of chromosomal DNA, was 220 fg for the 104M strain and 76 fg for the single non-104M Brucella strain tested (B. abortus A19). The assay was also reproducible (intra- and inter-assay coefficients of variation = 0.006-0.022 and 0.012-0.044, respectively). A SNP-based MGB PCR assay was developed that could straightforwardly and unambiguously distinguish B. abortus vaccine strain 104M from non-104M Brucella strains. Compared to the classical isolation and identification approaches of bacteriology, this real-time PCR assay has substantial advantages in terms of\n[Estudios sobre la funci\u00f3n de las c\u00e9lulas dendr\u00edticas y su aplicaci\u00f3n en inmunoterapia del c\u00e1ncer](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::5a3d15d15f7f64f4480c15e8217237c8)\nSuarez, N. (Natalia); Gonzalez, A. (\u00c1lvaro); Melero, I. (Ignacio)\n2013-01-01\nSe ha realizado un ensayo cl\u00ednico en fase II con vacunas de c\u00e9lulas dendr\u00edticas (CD)comprobando que el tratamiento combinado basado en la vacunaci\u00f3n con CD (obtenidas a partir de la diferenciaci\u00f3n de monocitos de sangre perif\u00e9rica y pulsadas con lisado tumoral aut\u00f3logo) y la administraci\u00f3n de ciclofosfamida, reduce la poblaci\u00f3n de linfocitos T reguladores, las c\u00e9lulas endoteliales y las c\u00e9lulas tumorales en sangre perif\u00e9rica en algunos pacientes con c\u00e1ncer avanzado. Las CD-tipo 1 obtenidas pr...\n[Evaluaci\u00f3n de la reacci\u00f3n en cadena de la polimerasa para el diagn\u00f3stico de la brucelosis en un reba\u00f1o lechero infectado con Brucellaspp Assessment of polymerase chain reaction (PCR to diagnose brucellosis in a Brucella infected herd](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412004000300002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nO. Lavaroni\n2004-09-01\nFull Text Available Para el diagn\u00f3stico de la brucelosis bovina en muestras de sangre y/o leche, se compar\u00f3 la reacci\u00f3n en cadena de la polimerasa (PCR con el aislamiento in vitro de Brucella abortus, las pruebas serol\u00f3gicas defijaci\u00f3n del complemento (FC e inmunoenzim\u00e1ticas de competici\u00f3n (ELISA-C en suero e indirecto (ELISA-I en leche. Se analizaron muestras de vacas lecheras de un reba\u00f1o infectado \u201cA\u201d, vacunadas con B. abortus cepa 19 antes de los 8 meses de edad y revacunadas con B. abortus cepa RB51 como adultas (n= 99 y de otro \u201cB\u201d, libre de brucelosis (n=100, como control. En A, la PCR identific\u00f3 14 vacas infectadas con B. abortus: nueve con cepa silvestre y cinco con cepa silvestre y RB51. No se identific\u00f3 B. abortus cepa 19. El biotipo 1 se aisl\u00f3 en un caso. Las 14 vacas infectadas con la cepa silvestre resultaron positivas en las tres pruebas serol\u00f3gicas. En B, por PCR no se identific\u00f3 Brucella. Las pruebas serol\u00f3gicas mostraron una sensibilidad del 100% respecto de PCR. La especificidad para FC, ELISA-C y ELISA-I fue del 100%, 99% y 95%, respectivamente. Se concluye que la PCR ser\u00eda \u00fatil como complemento de las pruebas serol\u00f3gicas o cuando no hay un resultado concluyente.The diagnosis of bovine brucellosis using PCR in blood and milk samples from two dairy herds were compared to in vitro isolation, complement fixation test (CF, competitive ELISA (C-ELISA in serum, and indirect ELISA (I-ELISA in milk. Samples were obtained from 99 cows vaccinated with Brucella abortus strain 19, from a naturally infected herd (A, whose cows were also vaccinated with B. abortus strain RB51 as adults, and 100 from brucellosis free herd (B. In herd A, PCR identified 14 B. abortus infected cows: nine infected with wild type, and five with wild type and RB51, B. abortus S 19 was not identified. B. abortus biotype 1 was isolated from one cow. All cows infected with a wild strain of B. abortus were positive in serologic tests. Brucella was not found in\n[Brucella DNA is not detected in in-vitro produced embryos derived from ovaries of naturally infected Brucella DNA is not detected in in-vitro produced embryos derived from ovaries of naturally infected buffaloes](http://www.aspajournal.it/index.php/ijas/article/view/1142) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nL. Manna\n2010-02-01\nFull Text Available The aim of this study was to screen for Brucella spp. buffalo embryos produced in- vitro, by using cumulus oocytes complexes (COCs recovered from ovaries of slaughtered buffaloes naturally infected with Brucella spp. Ovaries were collected from 5 female pluriparous buffaloes slaughtered in a local abattoir. EDTA-blood samples and nasal swabs collected from each animal were used for Brucella spp. DNA detection by real-time PCR. Buffalo ovaries (n = 10 were transported to the laboratory and maintained strictly separated throughout laboratory processing. Recovered COCs were matured, fertilized and cultured in vitro until day 7. Some immature COCs, all uncleaved COCs, all blocked cleaved embryos (2 to 16 cells and all transferable embryos (tight morulae and blastocysts were separately analysed by real-time PCR assay. Brucella spp. DNA was detected in both blood and nasal mucus of all subjects, whereas no trace of DNA of Brucella spp. was found on either COCs or embryos. Currently, the infected or seropositive buffaloes have to be slaughtered for sanitary reasons. Interestingly, the results of this preliminary trial suggest a possible utilization of the COCs from the infected subjects of high genetic value to obtain safe embryos.\n[The role of TREM-2 in internalization and intracellular survival of Brucella abortus in murine macrophages.](https://www.ncbi.nlm.nih.gov/pubmed/25563793)\nWei, Pan; Lu, Qiang; Cui, Guimei; Guan, Zhenhong; Yang, Li; Sun, Changjiang; Sun, Wanchun; Peng, Qisheng\n2015-02-15\nTriggering receptor expressed on myeloid cells-2 (TREM-2) is a cell surface receptor primarily expressed on macrophages and dendritic cells. TREM-2 functions as a phagocytic receptor for bacteria as well as an inhibitor of Toll like receptors (TLR) induced inflammatory cytokines. However, the role of TREM-2 in Brucella intracellular growth remains unknown. To investigate whether TREM-2 is involved in Brucella intracellular survival, we chose bone marrow derived macrophages (BMDMs), in which TREM-2 is stably expressed, as cell model. Colony formation Units (CFUs) assay suggests that TREM-2 is involved in the internalization of Brucella abortus (B. abortus) by macrophages, while silencing of TREM-2 decreases intracellular survival of B. abortus. To further study the underlying mechanisms of TREM-2-mediated bacterial intracellular survival, we examined the activation of B. abortus-infected macrophages through determining the kinetics of activation of the three MAPKs, including ERK, JNK and p38, and measuring TNF\u03b1 production in response to lipopolysaccharide (LPS) of Brucella (BrLPS) or B. abortus stimulation. Our data show that TREM-2 deficiency promotes activation of Brucella-infected macrophages. Moreover, our data also demonstrate that macrophage activation promotes killing of Brucella by enhancing nitric oxygen (NO), but not reactive oxygen species (ROS) production, macrophage apoptosis or cellular death. Taken together, these findings provide a novel interpretation of Brucella intracellular growth through inhibition of NO production produced by TREM-2-mediated activated macrophages. Copyright \u00a9 2014 Elsevier B.V. All rights reserved.\n[Prevenci\u00f3n de las infecciones respiratorias agudas: Presente y futuro](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312003000400006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRoberto Raz\u00f3n Behar\n2003-12-01\nFull Text Available Las infecciones respiratorias agudas (IRA, son las causas m\u00e1s frecuentes de morbilidad en el mundo y de elevada mortalidad particularmente en los pa\u00edses en desarrollo. Los virus son los agentes etiol\u00f3gicos m\u00e1s frecuentes. Los virus influenza a y b, y el virus sincitial respiratorio (VSR son los m\u00e1s importantes por la severidad de la enfermedad y por la alta transmisibilidad. Las bacterias, principalmente el Streptococcus pneumoniae (neumococo, y el Haemophilus influenzae tipo B (Hib, son las causas m\u00e1s frecuentes de neumon\u00edas adquiridas en la comunidad. Las estrategias generales en la prevenci\u00f3n y en el tratamiento se basan en: evaluar sistem\u00e1ticamente los conocimientos existentes acerca de las IRA, divulgarlos y aplicarlos, desarrollar una gu\u00eda nacional para las indicaciones de los antibi\u00f3ticos, aplicar las vacunas existentes: DPT, triple viral (SRP, anti-Hi, incrementar la inmunizaci\u00f3n contra el neumococo y los virus influenza, particularmente en grupos de riesgo y desarrollar y evaluar nuevas vacunas contra el VSR, Haemophilus influenzae no serotipificables, Bordetella pertussis y otros agentes infecciosos que afectan el aparato respiratorio. Se realiza una revisi\u00f3n de nuevos agentes y drogas antivirales, as\u00ed como del desarrollo presente y futuro de las inmunizaciones contra los principales virus y bacterias, que causan infecciones respiratorias agudas.Acute respiratory infections (ARI are the most frequent cause of morbidity and of the high mortality in the world, particularly in the developing countries. The viruses are the most common etiological agents.The influenza a and b viruses and the syncytial respiratory virus (SRV are the most important due to the severity of the disease and to their high transmissibility. The bacteria, mainly Streptococcus pneumoniae (Pneumococcus, and Haemophilus influenzae type B (Hib, are the most frequent cause of pneumonias acquired in the community. The general strategies in the prevention and\n[Differentiation of Brucella melitensis field strains from the vaccine strain Rev-1](https://www.openaire.eu/search/publication?articleId=od______1457::861141a5b3a1c81718b3bd8af3bb9c00)\nNoutsios, G.T; Papi, R.M.; Ekateriniadou, L.V.; Minas, A.; Kyriakidis, D.A.\n2008-01-01\nAbstract Poster Preseantation Journal URL: http://www3.interscience.wiley.com/journal/119877016/tocgroup Past efforts to differentiate the Brucella spp. have been hampered owing to the high genetic homogeneity among Brucella species. The availability of discriminatory molecular tools to inform and assist conventional epidemiological approaches is invaluable in controlling these infections. The hypervariable octameric oligonucleotide finger-printing method was implemented using microsate...\n[Real-time PCR assays for detection of Brucella spp. and the identification of genotype ST27 in bottlenose dolphins (Tursiops truncatus).](https://www.ncbi.nlm.nih.gov/pubmed/24632518)\nWu, Qingzhong; McFee, Wayne E; Goldstein, Tracey; Tiller, Rebekah V; Schwacke, Lori\n2014-05-01\nRapid detection of Brucella spp. in marine mammals is challenging. Microbiologic culture is used for definitive diagnosis of brucellosis, but is time consuming, has low sensitivity and can be hazardous to laboratory personnel. Serological methods can aid in diagnosis, but may not differentiate prior exposure versus current active infection and may cross-react with unrelated Gram-negative bacteria. This study reports a real-time PCR assay for the detection of Brucella spp. and application to screen clinical samples from bottlenose dolphins stranded along the coast of South Carolina, USA. The assay was found to be 100% sensitive for the Brucella strains tested, and the limit of detection was 0.27fg of genomic DNA from Brucella ceti B1/94 per PCR volume. No amplification was detected for the non-Brucella pathogens tested. Brucella DNA was detected in 31% (55/178) of clinical samples tested. These studies indicate that the real-time PCR assay is highly sensitive and specific for the detection of Brucella spp. in bottlenose dolphins. We also developed a second real-time PCR assay for rapid identification of Brucella ST27, a genotype that is associated with human zoonotic infection. Positive results were obtained for Brucella strains which had been identified as ST27 by multilocus sequence typing. No amplification was found for other Brucella strains included in this study. ST27 was identified in 33% (18/54) of Brucella spp. DNA-positive clinical samples. To our knowledge, this is the first report on the use of a real-time PCR assay for identification of Brucella genotype ST27 in marine mammals. Copyright \u00a9 2014 Elsevier B.V. All rights reserved.\n[Vector Development for the Expression of Foreign Proteins in the Vaccine Strain Brucella abortus S19](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=108437)\nComerci, Diego J.; Pollevick, Guido D.; Vigliocco, Ana M.; Frasch, Alberto C. C.; Ugalde, Rodolfo A.\n1998-01-01\nA vector for the expression of foreign antigens in the vaccine strain Brucella abortus S19 was developed by using a DNA fragment containing the regulatory sequences and the signal peptide of the Brucella bcsp31 gene. This fragment was cloned in broad-host-range plasmid pBBR4MCS, resulting in plasmid pBEV. As a reporter protein, a repetitive antigen of Trypanosoma cruzi was used. The recombinant fusion protein is stably expressed and secreted into the Brucella periplasmic space, inducing a good antibody response against the T. cruzi antigen. The expression of the repetitive antigen in Brucella neither altered its growth pattern nor generated a toxic or lethal effect during experimental infection. The application of this strategy for the generation of live recombinant vaccines and the tagging of B. abortus S19 vaccine is discussed. This is the first time that a recombinant protein has been expressed in the periplasm of brucellae. PMID:9673273\n[Effectively managing public concerns about immunization safety](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002001000021) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\n2002-01-01\nFull Text Available Los beneficios de la vacunaci\u00f3n frente a las enfermedades prevenibles de este modo son muy superiores a sus m\u00ednimos riesgos. Con el fin de mantener o fortalecer los programas nacionales de vacunaci\u00f3n, los trabajadores de todos los niveles de la salud p\u00fablica deber\u00edan recibir formaci\u00f3n sobre los temas relacionados con la vacunaci\u00f3n y estar preparados para responder a las dudas planteadas por el p\u00fablico. Una respuesta r\u00e1pida y franca a los temores del p\u00fablico acerca de las vacunas podr\u00eda garantizar la integridad de los programas de vacunaci\u00f3n en todo el continente americano, seg\u00fan el documento \"Directrices para enfrentarse a los temores sobre la seguridad de las vacunaciones\" (Guidelines for Managing Immunization Safety Concerns, elaborado por la Divisi\u00f3n de Vacunas e Inmunizaci\u00f3n de la Organizaci\u00f3n Panamericana de la Salud (OPS y resumido aqu\u00ed. Todo acontecimiento m\u00e9dico que se considere posiblemente relacionado con una vacuna debe ser investigado en el \u00e1mbito local. Si su distribuci\u00f3n temporal y los s\u00edntomas respaldan la sospecha de que pueda estar relacionado con una vacuna, se debe iniciar una investigaci\u00f3n m\u00e1s formal y, una vez finalizada, el acontecimiento debe ser clasificado en una de las cuatro categor\u00edas siguientes: 1 relacionado con el programa, 2 relacionado con la vacuna, 3 no relacionado, o 4 desconocido (investigaci\u00f3n no concluyente. Dependiendo de la categor\u00eda a la que haya sido asignado el acontecimiento, las acciones posteriores pueden consistir en tranquilizar a los padres, a los cuidadores y a otros adultos; comunicarse con el p\u00fablico y con otros trabajadores de la salud; instaurar tratamiento; corregir los errores del programa, como pueden ser la manipulaci\u00f3n de la vacuna, su almacenamiento, su administration o los problemas relacionados con la jeringuilla; comentar con los fabricantes problemas relacionados con la calidad y eficacia de la vacuna; retirar la vacuna del mercado, o iniciar nuevas\n[Obtenci\u00f3n y evaluaci\u00f3n preliminar de un virus canarypox recombinante como candidato a vacuna antirr\u00e1bica Development and preliminary assessment of a recombinant canarypox virus as an antirabic vaccine candidate](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000200004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nFlavia Zanetti\n2012-06-01\nFull Text Available En la Argentina, la rabia est\u00e1 circunscripta a algunas provincias del norte. La disponibilidad de nuevas vacunas que eliminen la manipulaci\u00f3n del virus r\u00e1bico y que permitan el control de la enfermedad es de importancia estrat\u00e9gica nacional y regional. Las vacunas basadas en poxvirus recombinantes se han utilizado con \u00e9xito como vacunas antirr\u00e1bicas a nivel mundial. SI bien estos sistemas no est\u00e1n disponibles comercialmente, la plataforma de obtenci\u00f3n de virus canarypox (CNPV recombinantes ya ha sido implementada en nuestro laboratorio. El objetivo de este trabajo fue obtener y evaluar un candidato a vacuna antirr\u00e1bica basado en CNPV recombinantes que expresan la glicoprote\u00edna G (RG del virus r\u00e1bico (RV. Se construy\u00f3 un virus recombinante que expresa la secuencia codificante de RG (CNPV-RG. La inoculaci\u00f3n de ratones con este virus indujo altos t\u00edtulos de anticuerpos seroneutralizantes de RV (3,58 y 9,76 Ul/ml despu\u00e9s de una o dos inmunizaciones, respectivamente y protegi\u00f3 al 78 % de los animales desafiados intracerebralmente con RV. Adem\u00e1s, se determin\u00f3 que el CNPV-RG posee una potencia relativa de 3,5 Ul/ml. Los resultados obtenidos constituyen la primera etapa en la evaluaci\u00f3n del CNPV-RG como candidato a vacuna antirr\u00e1bica. Se requerir\u00e1n nuevos ensayos para confirmar su utilidad en especies de inter\u00e9s veterinario.In Argentina, rabies is limited to some northern provinces. Availability of new vaccines abolishing the handling of the rabies virus and allowing disease control has regional and national strategic importance. Vaccines based on recombinant poxviruses have been successfully used as antirabic vaccines worldwide. Although these systems are not commercially available, the platform to obtain recombinant canarypox viruses (CNPV has been previously set up in our laboratory. The aim of this work was the development and evaluation of an antirabic vaccine candidate based on recombinant CNPV expressing the rabies virus (RV\n[Host-Brucella interactions and the Brucella genome as tools for subunit antigen discovery and immunization against brucellosis](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3655278)\nGomez, Gabriel; Adams, Leslie G.; Rice-Ficht, Allison; Ficht, Thomas A.\n2013-01-01\nVaccination is the most important approach to counteract infectious diseases. Thus, the development of new and improved vaccines for existing, emerging, and re-emerging diseases is an area of great interest to the scientific community and general public. Traditional approaches to subunit antigen discovery and vaccine development lack consideration for the critical aspects of public safety and activation of relevant protective host immunity. The availability of genomic sequences for pathogenic Brucella spp. and their hosts have led to development of systems-wide analytical tools that have provided a better understanding of host and pathogen physiology while also beginning to unravel the intricacies at the host-pathogen interface. Advances in pathogen biology, host immunology, and host-agent interactions have the potential to serve as a platform for the design and implementation of better-targeted antigen discovery approaches. With emphasis on Brucella spp., we probe the biological aspects of host and pathogen that merit consideration in the targeted design of subunit antigen discovery and vaccine development. PMID:23720712\n[Assay dependence of Brucella antibody prevalence in a declining Alaskan harbor seal (Phoca vitulina population](http://www.actavetscand.com/content/55/1/2) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHueffer Karsten\n2013-01-01\nFull Text Available Abstract Background Brucella is a group of bacteria that causes brucellosis, which can affect population health and reproductive success in many marine mammals. We investigated the serological prevalence of antibodies against Brucella bacteria in a declining harbor seal population in Glacier Bay National Park, Alaska. Results Prevalence ranged from 16 to 74 percent for those tests detecting antibodies, indicating that harbor seals in Glacier Bay have been exposed to Brucella bacteria. However, the actual level of serological prevalence could not be determined because results were strongly assay-dependent. Conclusions This study reinforces the need to carefully consider assay choice when comparing different studies on the prevalence of anti\u2013Brucella antibodies in pinnipeds and further highlights the need for species- or taxon-specific assay validation for both pathogen and host species.\n[Risk Factors Associated with Brucella Seropositivity in Sheep and Goats in Duhok Province, Iraq](http://www.mdpi.com/2306-7381/4/4/65) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAli. G. Alhamada\n2017-12-01\nFull Text Available Sera from 432 small ruminants (335 sheep and 97 goats from 72 farms in Duhok Province, northern Iraq, were collected to investigate risk factors associated with brucellosis seropositivity. Serum samples were tested using the Rose Bengal test (RBT and an indirect enzyme-linked immunosorbent assay (iELISA. Using parallel interpretation, RBT and iELISA results showed that 31.7% (95% confidence interval (CI: 26.1, 36.3 of sheep and 34.0% (95% CI: 24.7, 44.3 of goats had antibodies against Brucella in the study area. A random-effects multivariable logistic regression model indicated that a higher chance of being seropositive (odds ratio (OR = 1.7; 95% 1.4; 2.2 was associated with an increase in the age of animals. The odds of Brucella seropositivity in flocks where sheep and goats grazed together was 2.0 times higher (95% CI: 1.08; 3.9 compared to flocks where sheep and goats grazed separately. The odds of Brucella seropositivity in small ruminants was 2.2 higher (95% CI: 1.2; 4.3 for animals originating from farms with a history of goat abortion in the preceding 12 months. In contrast, for every 1000 Iraqi Dinars (~0.85 US Dollar spent by the farmers on control of Brucella in their flocks, the odds of Brucella seropositivity decreased significantly (OR = 0.9, p-value = 0.021. The final model also indicated significant differences in Brucella seropositivity between the different districts of Duhok Province. This study provides a contribution to the epidemiology of brucellosis in small ruminants in northern Iraq.\n[Serologic evidence of Brucella infection in pinnipeds along the coast of Hokkaido, the northernmost main island of Japan.](https://www.ncbi.nlm.nih.gov/pubmed/28262966)\nAbe, Erika; Ohishi, Kazue; Ishinazaka, Tsuyoshi; Fujii, Kei; Maruyama, Tadashi\n2017-04-01\nBrucella infection in Hokkaido was serologically surveyed in four species of pinnipeds inhabiting Cape Erimo during 2008-2013 and the Shiretoko Peninsula in 1999 by ELISA using Brucella abortus and B. canis as antigens. Anti-Brucella positive sera showed higher absorbance to B. abortus than B. canis in almost all samples. Anti-B. abortus antibodies were detected in serum samples from 24% (n = 55) of Western Pacific harbor seals (Phoca vitulina stejnegeri) in Cape Erimo and from 66% (n = 41) of spotted seals (P. largha), 15% (n = 20) of ribbon seals (Histriophoca fasciata) and 18% (n = 17) of Western Steller's sea lions (Eumetopias jubatus jubatus) in the Shiretoko Peninsula. Anti-Brucella antibodies were detected at higher absorbance in 1- to 4-year-old harbor seals than in the pups and mature animals, suggesting either that Brucella infection mainly occurs after weaning or that it is maternally transmitted to pups with premature or suppressed immunity. Anti-Brucella antibodies were detected in both immature and mature spotted seals and ribbon seals, with higher absorbance in the former. The antibodies were detected only in mature Western Steller's sea lions. Western blot analysis of the serum samples showed some differences in band appearances, namely discrete versus smeary, and in the number of bands, indicating that multiple different Brucella may be prevalent in pinnipeds in Hokkaido. Alternatively, the Brucella of pinnipeds may have some intra-species diversity. \u00a9 2017 The Societies and John Wiley & Sons Australia, Ltd.\n[Serological response of cattle to Brucella allergen after repeated intradermal applications of this allergen](http://www.narcis.nl/publication/RecordID/oai%3Alibrary.wur.nl%3Awurpubs%2F303465/uquery/brucella%20AND%20abortus/id/14/Language/EN)\nMuskens, J.A.M.; Bercovich, Z.; Damen, C.P.R.M.\n1996-01-01\nA study was conducted to determine whether an allergen that has been prepared from a mucoid strain of Brucella abortus triggers a serum antibody response that interferes with the interpretation of serologic tests results. Fifteen cattle seronegative for Brucella antigen were tested with the SDTH\n[Enfermedad neumoc\u00f3cica en el adulto: niveles de riesgo y recomendaciones de vacunaci\u00f3n](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::fb3ccd9dfed07a473c165abd115b9a9a)\nVila-C\u00f3rcoles, Angel; Ochoa-Gondar, Olga\n2017-01-01\nActualmente 2 vacunas antineumoc\u00f3cicas est\u00e1n disponibles para uso en adultos: la \u00abcl\u00e1sica\u00bb vacuna neumoc\u00f3cica polisac\u00e1rida tricosavalente (VNP23) y la \u00abnueva\u00bb vacuna neumoc\u00f3cica conjugada tridecavalente (VNC13). La principal ventaja de la VNC13 ser\u00eda su potencial mejor inmunogenicidad, siendo sus principales inconvenientes el elevado coste y la baja cobertura de serotipos en comparaci\u00f3n con la VNP23. Las evidencias actualmente disponibles apoyan las siguientes recomendaciones b\u00e1sicas: a) en l...\n[Detection and characterization of Brucella spp. in bovine milk in small-scale urban and peri-urban farming in Tajikistan](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5367834)\nLindahl-Rajala, Elisabeth; Hoffman, Tove; Fretin, David; Godfroid, Jacques; Sattorov, Nosirjon; Boqvist, Sofia; Lundkvist, \u00c5ke; Magnusson, Ulf\n2017-01-01\nBrucellosis is one of the most common zoonoses globally, and Central Asia remains a Brucella hotspot. The World Health Organization classifies brucellosis as a neglected zoonotic disease that is rarely in the spotlight for research and mainly affects poor, marginalized people. Urban and peri-urban farming is a common practice in many low-income countries, and it increases the incomes of families that are often restrained by limited economic resources. However, there is a concern that the growing number of people and livestock living close together in these areas will increase the transmission of zoonotic pathogens such as Brucella. This study investigates the presence of Brucella DNA in bovine milk in the urban and peri-urban area of Dushanbe, Tajikistan. Brucella DNA was detected in 10.3% of 564 cow milk samples by IS711-based real-time PCR. This finding is concerning because consumption of unpasteurized dairy products is common in the region. Furthermore, Brucella DNA was detected in the milk of all seropositive cows, but 8.3% of the seronegative cows also showed the presence of Brucella DNA. In addition, sequence analysis of the rpoB gene suggests that one cow was infected with B. abortus and another cow was most likely infected with B. melitensis. The discrepancies between the serology and real-time PCR results highlight the need to further investigate whether there is a need for implementing complementary diagnostic strategies to detect false serological negative individuals in Brucella surveillance, control, and eradication programmes. Furthermore, vaccination of cattle with S19 in addition to vaccination of small ruminants with Rev 1 might be needed in order to control Brucella infections in the livestock population but further research focusing on the isolation of Brucella is required to obtain a comprehensive understanding of the Brucella spp. circulating among the livestock in this region. PMID:28296882\n[Detection and characterization of Brucella spp. in bovine milk in small-scale urban and peri-urban farming in Tajikistan.](https://www.ncbi.nlm.nih.gov/pubmed/28296882)\nLindahl-Rajala, Elisabeth; Hoffman, Tove; Fretin, David; Godfroid, Jacques; Sattorov, Nosirjon; Boqvist, Sofia; Lundkvist, \u00c5ke; Magnusson, Ulf\n2017-03-01\nBrucellosis is one of the most common zoonoses globally, and Central Asia remains a Brucella hotspot. The World Health Organization classifies brucellosis as a neglected zoonotic disease that is rarely in the spotlight for research and mainly affects poor, marginalized people. Urban and peri-urban farming is a common practice in many low-income countries, and it increases the incomes of families that are often restrained by limited economic resources. However, there is a concern that the growing number of people and livestock living close together in these areas will increase the transmission of zoonotic pathogens such as Brucella. This study investigates the presence of Brucella DNA in bovine milk in the urban and peri-urban area of Dushanbe, Tajikistan. Brucella DNA was detected in 10.3% of 564 cow milk samples by IS711-based real-time PCR. This finding is concerning because consumption of unpasteurized dairy products is common in the region. Furthermore, Brucella DNA was detected in the milk of all seropositive cows, but 8.3% of the seronegative cows also showed the presence of Brucella DNA. In addition, sequence analysis of the rpoB gene suggests that one cow was infected with B. abortus and another cow was most likely infected with B. melitensis. The discrepancies between the serology and real-time PCR results highlight the need to further investigate whether there is a need for implementing complementary diagnostic strategies to detect false serological negative individuals in Brucella surveillance, control, and eradication programmes. Furthermore, vaccination of cattle with S19 in addition to vaccination of small ruminants with Rev 1 might be needed in order to control Brucella infections in the livestock population but further research focusing on the isolation of Brucella is required to obtain a comprehensive understanding of the Brucella spp. circulating among the livestock in this region.\n[Detection and characterization of Brucella spp. in bovine milk in small-scale urban and peri-urban farming in Tajikistan.](http://europepmc.org/articles/PMC5367834?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nElisabeth Lindahl-Rajala\n2017-03-01\nFull Text Available Brucellosis is one of the most common zoonoses globally, and Central Asia remains a Brucella hotspot. The World Health Organization classifies brucellosis as a neglected zoonotic disease that is rarely in the spotlight for research and mainly affects poor, marginalized people. Urban and peri-urban farming is a common practice in many low-income countries, and it increases the incomes of families that are often restrained by limited economic resources. However, there is a concern that the growing number of people and livestock living close together in these areas will increase the transmission of zoonotic pathogens such as Brucella. This study investigates the presence of Brucella DNA in bovine milk in the urban and peri-urban area of Dushanbe, Tajikistan. Brucella DNA was detected in 10.3% of 564 cow milk samples by IS711-based real-time PCR. This finding is concerning because consumption of unpasteurized dairy products is common in the region. Furthermore, Brucella DNA was detected in the milk of all seropositive cows, but 8.3% of the seronegative cows also showed the presence of Brucella DNA. In addition, sequence analysis of the rpoB gene suggests that one cow was infected with B. abortus and another cow was most likely infected with B. melitensis. The discrepancies between the serology and real-time PCR results highlight the need to further investigate whether there is a need for implementing complementary diagnostic strategies to detect false serological negative individuals in Brucella surveillance, control, and eradication programmes. Furthermore, vaccination of cattle with S19 in addition to vaccination of small ruminants with Rev 1 might be needed in order to control Brucella infections in the livestock population but further research focusing on the isolation of Brucella is required to obtain a comprehensive understanding of the Brucella spp. circulating among the livestock in this region.\n[Reconocimiento y prevenci\u00c3\u00b3n de la tosferina(Recognizing and Preventing Whooping Cough)](https://tools.cdc.gov/medialibrary/index.aspx#/media/id/302981) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\nEste podcast proporciona informaci\u00c3\u00b3n acerca de los s\u00c3ntomas de la tosferina y la manera en que las vacunas pueden ayudar a prevenir esta grave enfermedad en personas de todas las edades. Es especialmente importante que las personas que tendr\u00c3\u00a1n contacto cercano con un beb\u00c3\u00a9 est\u00c3\u00a9n al d\u00c3a con la vacuna contra la tosferina.\n[Brucella abortus Cell Cycle and Infection Are Coordinated.](https://www.ncbi.nlm.nih.gov/pubmed/26497941)\nDe Bolle, Xavier; Crosson, Sean; Matroule, Jean-Yves; Letesson, Jean-Jacques\n2015-12-01\nBrucellae are facultative intracellular pathogens. The recent development of methods and genetically engineered strains allowed the description of cell-cycle progression of Brucella abortus, including unipolar growth and the ordered initiation of chromosomal replication. B. abortus cell-cycle progression is coordinated with intracellular trafficking in the endosomal compartments. Bacteria are first blocked at the G1 stage, growth and chromosome replication being resumed shortly before reaching the intracellular proliferation compartment. The control mechanisms of cell cycle are similar to those reported for the bacterium Caulobacter crescentus, and they are crucial for survival in the host cell. The development of single-cell analyses could also be applied to other bacterial pathogens to investigate their cell-cycle progression during infection. Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.\n[Overexpression of Cu-Zn SOD in Brucella abortus suppresses bacterial intracellular replication via down-regulation of Sar1 activity](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5839387)\nLiu, Xiaofeng; Zhou, Mi; Yang, Yanling; Wu, Jing; Peng, Qisheng\n2018-01-01\nBrucella Cu-Zn superoxide dismutase (Cu-Zn SOD) is a periplasmic protein, and immunization of mice with recombinant Cu-Zn SOD protein confers protection against Brucella abortus infection. However, the role of Cu-Zn SOD during the process of Brucella infection remains unknown. Here, we report that Cu-Zn SOD is secreted into culture medium and is translocated into host cells independent of type IV secretion systems (T4SS). Furthermore, co-immunoprecipitation and immunofluorescence studies reveal that Brucella abortus Cu-Zn SOD interacts with the small GTPase Sar1. Overexpression of Cu-Zn SOD in Brucella abortus inhibits bacterial intracellular growth by abolishing Sar1 activity in a manner independent of reactive oxygen species (ROS) production. PMID:29515756\n[Isolation and Molecular Characterization of Brucella Isolates in Cattle Milk in Uganda](http://dx.doi.org/10.1155/2015/720413) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDenis Rwabiita Mugizi\n2015-01-01\nFull Text Available Brucellosis is endemic in livestock and humans in Uganda and its transmission involves a multitude of risk factors like consumption of milk from infected cattle. To shed new light on the epidemiology of brucellosis in Uganda the present study used phenotypic and molecular approaches to delineate the Brucella species, biovars, and genotypes shed in cattle milk. Brucella abortus without a biovar designation was isolated from eleven out of 207 milk samples from cattle in Uganda. These isolates had a genomic monomorphism at 16 variable number tandem repeat (VNTR loci and showed in turn high levels of genetic variation when compared with other African strains or other B. abortus biovars from other parts of the world. This study further highlights the usefulness of MLVA as an epidemiological tool for investigation of Brucella infections.\n[Identification of Secondary Mutations Which Enhance and Stabilize the Attenuation of Brucella HTRA Mutants: Improving Brucella HTRA-Based Strains as Vaccine](https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LSwMxEB7EIj4uPvEJc_O02mYf3UoprLKlF8XaVr2VTZqwgqRgugc9-IP8lWZ2110RobcchoFkksnMJN83AC67aDp_fEKHq4C3pQhlIMNZwITHEiVE4Hek60tGeOfJxI2fvbshQWN-MGLlLeDUpYz8K1Tyiz6pFRLfTOtzRLTbNty3e70RDeP-_Sas6zdRyG_VnrK_Dbt1G1u0rjyjwQ6sSL0HXwU8VpX1MpwrHFFianP6d7zNitdxg0_pi0gx1ilZBm3KjzY0pM-sHxJt3IbRwga8WaWiy3u5paxhu5e8h4PxQ5Rr0wtzhVX14F8559reZqSfOkYYTAw-JoLe3PfhvB-PbwZONctpuUwFQfa0XJmQHcCqnmt5SABt7nIlQi5Z05M-9Xppy0D5XDDBZsI_Alym7Xi5yAlsFOQGVKg4hYayB0mewZoyrw436htfKac9) [National Research Council Canada - National Science Library](http://science-libraries.canada.ca/eng/national-science-library/)\nRoop, R\n1999-01-01\n.... Studies completed to date under this contract indicate that although the Brucella HtrA contributes to resistance to oxidative killing in vitro and resistance to killing by cultured murine neutrophils...\n[Meta-analysis of variables affecting mouse protection efficacy of whole organism Brucella vaccines and vaccine candidates](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3633026)\n2013-01-01\nBackground Vaccine protection investigation includes three processes: vaccination, pathogen challenge, and vaccine protection efficacy assessment. Many variables can affect the results of vaccine protection. Brucella, a genus of facultative intracellular bacteria, is the etiologic agent of brucellosis in humans and multiple animal species. Extensive research has been conducted in developing effective live attenuated Brucella vaccines. We hypothesized that some variables play a more important role than others in determining vaccine protective efficacy. Using Brucella vaccines and vaccine candidates as study models, this hypothesis was tested by meta-analysis of Brucella vaccine studies reported in the literature. Results Nineteen variables related to vaccine-induced protection of mice against infection with virulent brucellae were selected based on modeling investigation of the vaccine protection processes. The variable \"vaccine protection efficacy\" was set as a dependent variable while the other eighteen were set as independent variables. Discrete or continuous values were collected from papers for each variable of each data set. In total, 401 experimental groups were manually annotated from 74 peer-reviewed publications containing mouse protection data for live attenuated Brucella vaccines or vaccine candidates. Our ANOVA analysis indicated that nine variables contributed significantly (P-value Brucella vaccine protection efficacy: vaccine strain, vaccination host (mouse) strain, vaccination dose, vaccination route, challenge pathogen strain, challenge route, challenge-killing interval, colony forming units (CFUs) in mouse spleen, and CFU reduction compared to control group. The other 10 variables (e.g., mouse age, vaccination-challenge interval, and challenge dose) were not found to be statistically significant (P-value > 0.05). The protection level of RB51 was sacrificed when the values of several variables (e.g., vaccination route, vaccine viability, and\n[The Bacterial Second Messenger Cyclic di-GMP Regulates Brucella Pathogenesis and Leads to Altered Host Immune Response.](https://www.ncbi.nlm.nih.gov/pubmed/27672085)\nKhan, Mike; Harms, Jerome S; Marim, Fernanda M; Armon, Leah; Hall, Cherisse L; Liu, Yi-Ping; Banai, Menachem; Oliveira, Sergio C; Splitter, Gary A; Smith, Judith A\n2016-12-01\nBrucella species are facultative intracellular bacteria that cause brucellosis, a chronic debilitating disease significantly impacting global health and prosperity. Much remains to be learned about how Brucella spp. succeed in sabotaging immune host cells and how Brucella spp. respond to environmental challenges. Multiple types of bacteria employ the prokaryotic second messenger cyclic di-GMP (c-di-GMP) to coordinate responses to shifting environments. To determine the role of c-di-GMP in Brucella physiology and in shaping host-Brucella interactions, we utilized c-di-GMP regulatory enzyme deletion mutants. Our results show that a \u0394bpdA phosphodiesterase mutant producing excess c-di-GMP displays marked attenuation in vitro and in vivo during later infections. Although c-di-GMP is known to stimulate the innate sensor STING, surprisingly, the \u0394bpdA mutant induced a weaker host immune response than did wild-type Brucella or the low-c-di-GMP guanylate cyclase \u0394cgsB mutant. Proteomics analysis revealed that c-di-GMP regulates several processes critical for virulence, including cell wall and biofilm formation, nutrient acquisition, and the type IV secretion system. Finally, \u0394bpdA mutants exhibited altered morphology and were hypersensitive to nutrient-limiting conditions. In summary, our results indicate a vital role for c-di-GMP in allowing Brucella to successfully navigate stressful and shifting environments to establish intracellular infection. Copyright \u00a9 2016, American Society for Microbiology. All Rights Reserved.\n[Characterization of some Brucella species from Zimbabwe by biochemical profiling and AMOS-PCR](http://www.biomedcentral.com/1756-0500/2/261) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSkjerve Eystein\n2009-12-01\nFull Text Available Abstract Background Bovine brucellosis caused by Brucella abortus is endemic in most large commercial and smallholder cattle farms of Zimbabwe, while brucellosis in other domestic animals is rare. The diagnosis of brucellosis is mainly accomplished using serological tests. However, some Brucella spp. have been isolated from clinical cases in the field and kept in culture collection but their biochemical profiles were not documented. We report biochemical profiling and AMOS-PCR characterization of some of these field isolates of Brucella originating from both commercial and smallholder cattle farming sectors of Zimbabwe. Findings Fourteen isolates of Brucella from culture collection were typed using biochemical profiles, agglutination by monospecific antisera, susceptibility to Brucella-specific bacteriophages and by AMOS-PCR that amplifies species- specific IS711. The results of the biochemical profiles for B. abortus biovar 1 (11 isolates and biovar 2 (2 isolates were consistent with those of reference strains. A single isolate from a goat originating from a smallholder mixed animal farm was identified as B. melitensis biovar 1. The AMOS-PCR produced DNA products of sizes 498 bp and 731 bp for B. abortus (biovar 1 and 2 and B. melitensis biovar 1, respectively. Conclusion We concluded that the biochemical profiles and AMOS-PCR characterization were consistent with their respective species and biovars. B. abortus biovar 1 is likely to be the predominant cause of brucellosis in both commercial and smallholder cattle farms in Zimbabwe.\n[Validation of the multiplex PCR for identification of Brucella spp.](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782016000500847&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nL\u00edvia de Lima Orzil\n2016-05-01\nFull Text Available ABSTRACT: A multiplex PCR technique for detection of Brucella spp. in samples of bacterial suspension was validated as a complementary tool in the diagnosis of the disease. This technique allows the characterization of the agent without performing biochemical tests, which greatly reduces the time for a final diagnosis, and provides more security for the analyst by reducing the time of exposure to microorganisms. The validation was performed in accordance with the Manual of Diagnostic Tests from OIE (2008 and following the requirements present in the ABNT NBR ISO/IEC 17025:2005. The mPCR validated in this study identified the different species of Brucella ( Brucella abortus , B. suis , B. ovis e B. melitensis of bacterial suspension obtained from the slaughterhouse samples, as well as distinguished the biovars (1, 2 e 4; 3b, 5, 6 e 9 of B. abortus in grouped form and differentiated the field strains from vaccine strains, as a quick, useful and less expensive technique in diagnosis of brucellosis in Brazil.\n[Identification of Brucella spp. in feral swine (Sus scrofa) at abattoirs in Texas, USA](http://www.ars.usda.gov/research/publications/publication/?seqNo115=335414)\nVarious tissues, nasal swabs, urine, and blood samples were collected from 376 feral swine at two federally-inspected abattoirs in Texas during six separate sampling periods in 2015. Samples were tested for Brucella spp. by culture and serology. Brucella spp. were cultured from 13.0% of feral swin...\n[The Antibacterial Activity of Selected Labiatae (Lamiaceae) Essential Oils against Brucella melitensis.](https://www.ncbi.nlm.nih.gov/pubmed/23645957)\nAl-Mariri, Ayman; Safi, Mazen\n2013-03-01\nBrucellosis, a zoonosis caused by four species of brucella, has a high morbidity. The major cause of brucellosis worldwide is brucella melitensis. Medicinal plants are considered as new antibacterial sources that could replace conventional antibiotics in the treatment of antibiotic-resistant bacteria. The aim of this study was to evaluate the efficacy of some native plants, alone and in combination with some antibiotics, in the treatment of brucellosis. The present experimental in vitro study was carried out to evaluate the anti-brucella activities of essential oils of Rosmarinus officinalis L., Origanum syriacum, Thymus syriacus, Salvia palaestina Benth, Mentha piperia, and Lavandula stoechas L., alone and in combination with some antibiotics. The activity against 16 tetracycline-resistant B. melitensis isolates was determined by disc diffusion method incorporating a concentration of 5%. Antibiotic discs were also used as a control. Microdilution brucella broth susceptibility assay was used in order to determine the MICs of essential oils and five antibiotics. Among all the herbs evaluated, only the essential oils of O. syriacum and T. syriacus plants demonstrated most effective anti-brucella activity, and were then chosen for MIC study. The minimal inhibitory concentrations (MIC50) of essential oils of O. syriacum and T. syriacus against tetracycline-resistant B. melitensis were 3.125 \u00b5l/ml and 6.25 \u00b5l/ml, respectively. Among the essential oils studied, those of O. syriacum and T. syriacus were most effective. Since a combination of levofloxacin and Thymus syriacus essential oil increased the efficacy of this antibiotic, O. syriacum and T. syriacus are recommended to be used as bactericidal agents against B. melitensis.\n[The Antibacterial Activity of Selected Labiatae (Lamiaceae Essential Oils against Brucella melitensis](http://ijms.sums.ac.ir/index.php/ijms/article/view/835) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAyman Al-Mariri\n2013-03-01\nFull Text Available Background: Brucellosis, a zoonosis caused by four species of brucella, has a high morbidity. The major cause of brucellosis worldwide is brucella melitensis. Medicinal plants are considered as new antibacterial sources that could replace conventional antibiotics in the treatment of antibiotic-resistant bacteria. The aim of this study was to evaluate the efficacy of some native plants, alone and in combination with some antibiotics, in the treatment of brucellosis.Methods: The present experimental in vitro study was carried out to evaluate the anti-brucella activities of essential oils of Rosmarinus officinalis L., Origanum syriacum, Thymus syriacus, Salvia palaestina Benth, Mentha piperia, and Lavandula stoechas L., alone and in combination with some antibiotics. The activity against 16 tetracycline-resistant B. melitensis isolates was determined by disc diffusion method incorporating a concentration of 5%. Antibiotic discs were also used as a control. Microdilution brucella broth susceptibility assay was used in order to determine the MICs of essential oils and five antibiotics.Results: Among all the herbs evaluated, only the essential oils of O. syriacum and T. syriacus plants demonstrated most effective anti-brucella activity, and were then chosen for MIC study. The minimal inhibitory concentrations (MIC50 of essential oils of O. syriacum and T. syriacus against tetracycline-resistant B. melitensis were 3.125 \u00b5l/ml and 6.25 \u00b5l/ml, respectively. Conclusion: Among the essential oils studied, those of O. syriacum and T. syriacus were most effective. Since a combination of levofloxacin and Thymus syriacus essential oil increased the efficacy of this antibiotic, O. syriacum and T. syriacus are recommended to be used as bactericidal agents against B. melitensis.\n[Efectos neurot\u00f3xicos del timerosal, a dosis de vacuna, sobre el enc\u00e9falo y el desarrollo en h\u00e1msteres de 7 d\u00edas de nacidos](http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832007000300003&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJonny Laurente\n2007-09-01\nFull Text Available Objetivos: Determinar si la administraci\u00f3n de timerosal, en cantidades equivalentes al contenido en las vacunas, produce efectos neurot\u00f3xicos a nivel encef\u00e1lico en h\u00e1msteres de 7 d\u00edas de nacidos y evaluar las influencias sobre el desarrollo de los animales de experimentaci\u00f3n. Dise\u00f1o: Estudio experimental, prospectivo y biet\u00e1pico. Lugar: Bioterio de la Facultad de Medicina de San Fernando, Universidad Nacional Mayor de San Marcos. Material biol\u00f3gico: H\u00e1msteres de 7 d\u00edas de nacidos. M\u00e9todos: Se estudi\u00f3 45 h\u00e1msteres divididos en tres grupos: grupo A (n = 15, grupo B (n = 15 y grupo C (n = 15. Se administr\u00f3 a los grupos B y C, por v\u00eda intramuscular, 3 dosis equivalentes de sucrosa y timerosal, respectivamente, los d\u00edas 7 (0,227 \u00b5g, 9 (0,216 \u00b5g y 11 (0,220 \u00b5g de nacimiento, en un volumen de 20 \u00b5L de suero fisiol\u00f3gico. El grupo A solo recibi\u00f3 igual cantidad de suero fisiol\u00f3gico en los mismos d\u00edas. Principales medidas de resultados: Peso corporal, peso encef\u00e1lico, talla de los h\u00e1msteres y alteraciones histopat\u00f3l\u00f3gicas encef\u00e1licas. Resultados: Las pruebas Anova y t de student fueron significativas en favor al menor peso corporal, menor peso encef\u00e1lico y menor talla del grupo C con respecto a los grupos A y B (p<0,000. Mediante \u03c72, se obtuvo significancia en relaci\u00f3n a la presencia de alteraciones histopatol\u00f3gicas en el grupo C (p<0,000. El RR de presentar alteraciones fue muy elevado en este grupo. Conclusiones: La exposici\u00f3n a timerosal, en cantidades equivalentes al contenido en las vacunas, disminuy\u00f3 de manera significativa el peso corporal, el peso encef\u00e1lico y la talla de h\u00e1msteres posnatales. Asimismo, produjo efectos neurot\u00f3xicos a nivel encef\u00e1lico, encontr\u00e1ndose a nivel del hipocampo (regiones CA1, CA3, DG, corteza cerebral y cerebelo (c\u00e9lulas de Purkinje y c\u00e9lulas granulosas disminuci\u00f3n de la densidad neuronal, necrosis neuronal, desmielinizaci\u00f3n axonal y gliosis; adem\u00e1s, el riesgo de presentar\n[Identification and characterization of Brucella effector proteins](https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2Ff7a9e3d1-4991-46ca-90fd-a78de1e3d079/uquery/Brucella/id/8/Language/EN)\nde Jong, Maarten Frederik\n2012-01-01\nBrucella-bacteri\u00ebn gebruiken de eiwitten VceB en VceC om het immuunsysteem van humane gastheercellen te omzeilen, blijkt uit het promotieonderzoek van Maarten de Jong. Dit biedt nieuwe aanknopingspunten voor de bestrijding van deze gevaarlijke bacterie. Brucellose is een wereldwijd voorkomende\n[Meeting the challenge: prevention of pneumococcal disease with conjugate vaccines Al encuentro del reto: prevenci\u00f3n de la enfermedad neumoc\u00f3cica con vacunas conjugadas](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342001000400012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nIrma Gabriela Ech\u00e1niz-Avil\u00e9s\n2001-08-01\nFull Text Available Streptococcus pneumoniae is one of the leading causes of both invasive and noninvasive diseases in the pediatric population and continues to represent a significant public health burden worldwide. The increasing incidence of antibioticresistant strains of the pathogen has complicated treatment and management of the various pneumococcal disease manifestations. Thus, the best management strategy may be the prevention of pneumococcal diseases through vaccination. Although several pneumococcal conjugate vaccines have been clinically studied in infants and children, only a 7-valent conjugate vaccine (PNCRM7; Prevnar\u00ae/Prevenar\u00ae is currently approved for the prevention of invasive disease. Vaccination with PNCRM7 is safe and effective in infants and young children. Routine vaccination with the conjugate vaccine could improve outcomes by safeguarding against the development of antibiotic-resistant strains of S. pneumoniae, thus simplifying the management of pneumococcal disease. Additionally, the overall costs associated with the treatment of pneumococcal diseases could be substantially reduced, particularly in developing countries. The time has come for fully applying this new advancement against S. pneumoniae, to benefit the children of the world. The Spanish version of this paper is available at: http://www.insp.mx/salud/index.htmlStreptococcus pneumoniae es uno de los principales agentes causantes de enfermedades invasoras y no invasoras en la poblaci\u00f3n pedi\u00e1trica y sigue representando uno de los principales problemas de salud p\u00fablica a nivel mundial. La incidencia creciente de cepas resistentes a diversos antimicrobianos ha complicado el tratamiento y manejo de varias de las manifestaciones de la enfermedad neumoc\u00f3cica. Con \u00e9stas consideraciones, la mejor estrategia de manejo es la prevenci\u00f3n de \u00e9stas enfermedades a trav\u00e9s de la vacunaci\u00f3n. A pesar de que se han estudiado diversas vacunas neumoc\u00f3cicas conjugadas en ni\u00f1os, solo una\n[Neospora caninum versus Brucella spp. exposure among dairy cattle in Ethiopia: a case control study.](https://www.ncbi.nlm.nih.gov/pubmed/24781154)\nAsmare, Kassahun\n2014-08-01\nThis case-control study aimed at assessing the relative association of Neospora caninum and Brucella species exposure with reproductive disorders. The study was carried out between October 2011 and June 2012 on 731 dairy cows sampled from 150 dairy farms in selected 17 conurbations of Ethiopia. Two hundred sixty-six of the cows were categorized as cases based on their history of abortion or stillbirth while the remaining 465 were controls. The presence of antibody to N. caninum was screened using indirect ELISA, while Brucella spp. exposure was assayed serially using Rose Bengal Plate Test and Complement Fixation Test. Exposure to N. caninum was more frequently observed among cases (23.8%) than controls (12.7%), while no significant difference (p > 0.05) was noted for Brucella exposure between the two groups. Moreover, the proportion of cows with disorders like retention of fetal membrane, endometritis and increased inter-calving period were significantly higher (p Brucella spp. exposure. However, neither N. caninum nor Brucella spp. could explain the majority (73.2%) of the reported abortions and stillbirths in cattle. Hence, this observation underscores the need for more intensive investigation on the identification of causes of the aforementioned disorders in dairy cattle of Ethiopia.\n[La t\u00e9cnica de Western Blot como criterio de identidad para la vacuna antimeningoc\u00f3cica Men B Western Blot technique as an identity criterion for Men B antimeningococcal vaccine](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000300004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nR. Rosario Di\u00e9guez Castro\n2009-12-01\nFull Text Available Se desarroll\u00f3 y valid\u00f3 la t\u00e9cnica de Western Blot aplicada a la vacuna antimeningoc\u00f3cica Men B producida en el Instituto Finlay con el objetivo de demostrar un criterio de identidad. En el estudio de las prote\u00ednas antig\u00e9nicas de la vacuna, P1.15 y P1.4 en ves\u00edcula de membrana externa,monograneles y producto final se emplearon en la identificaci\u00f3n anticuerpos monoclonales espec\u00edficos para estas prote\u00ednas. Los par\u00e1metros desarrollados en la validaci\u00f3n de la t\u00e9cnica fueron: especificidad, l\u00edmite de detecci\u00f3n, repetibilidad, precisi\u00f3n intermedia, reproducibilidad y robustez. El m\u00e9todo cumpli\u00f3 con los par\u00e1metros se\u00f1alados, por lo que se consider\u00f3 validado.Western Blot technique was developed and validated, applied to Men B meningococcal vaccine produced in \"Carlos J, Finlay\" Institute to demonstrate an identity criterion. In study of antigenic proteins of the vaccine, we used P1.15 y P1.4 in vesicle of external membrane, monogranels, and end product to identify the monoclonal antibodies specific of these proteins. Parameters developed in technique validation included: specificity, detection limit, repetition, average accuracy, reproduction, and strength. Method fulfilled with specified parameters, thus considering its validation.\n[Genotyping of Indian antigenic, vaccine, and field Brucella spp. using multilocus sequence typing.](https://www.ncbi.nlm.nih.gov/pubmed/27031455)\nShome, Rajeswari; Krithiga, Natesan; Shankaranarayana, Padmashree B; Jegadesan, Sankarasubramanian; Udayakumar S, Vishnu; Shome, Bibek Ranjan; Saikia, Girin Kumar; Sharma, Narendra Kumar; Chauhan, Harshad; Chandel, Bharat Singh; Jeyaprakash, Rajendhran; Rahman, Habibur\n2016-03-31\nBrucellosis is one of the most important zoonotic diseases that affects multiple livestock species and causes great economic losses. The highly conserved genomes of Brucella, with > 90% homology among species, makes it important to study the genetic diversity circulating in the country. A total of 26 Brucella spp. (4 reference strains and 22 field isolates) and 1 B. melitensis draft genome sequence from India (B. melitensis Bm IND1) were included for sequence typing. The field isolates were identified by biochemical tests and confirmed by both conventional and quantitative polymerase chain reaction (qPCR) targeting bcsp 31Brucella genus-specific marker. Brucella speciation and biotyping was done by Bruce ladder, probe qPCR, and AMOS PCRs, respectively, and genotyping was done by multilocus sequence typing (MLST). The MLST typing of 27 Brucella spp. revealed five distinct sequence types (STs); the B. abortus S99 reference strain and 21 B. abortus field isolates belonged to ST1. On the other hand, the vaccine strain B. abortus S19 was genotyped as ST5. Similarly, B. melitensis 16M reference strain and one B. melitensis field isolate were grouped into ST7. Another B. melitensis field isolate belonged to ST8 (draft genome sequence from India), and only B. suis 1330 reference strain was found to be ST14. The sequences revealed genetic similarity of the Indian strains to the global reference and field strains. The study highlights the usefulness of MLST for typing of field isolates and validation of reference strains used for diagnosis and vaccination against brucellosis.\n[A rapid cycleave PCR method for distinguishing the vaccine strain Brucella abortus A19 in China.](https://www.ncbi.nlm.nih.gov/pubmed/27075847)\nNan, Wenlong; Zhang, Yueyong; Tan, Pengfei; Xu, Zouliang; Chen, Yuqi; Mao, Kairong; Chen, Yiping\n2016-05-01\nBrucellosis is a widespread zoonotic disease caused by Brucella spp. Immunization with attenuated vaccines has proved to be an effective method of prevention; however, it may also interfere with diagnosis. Brucella abortus strain A19, which is homologous to B. abortus strain S19, is widely used for the prevention of bovine brucellosis in China. For effective monitoring of the control of brucellosis, it is essential to distinguish A19 from field strains. Single-nucleotide polymorphism-based assays offer a new approach to such discrimination studies. In the current study, we developed a cycleave PCR assay that successfully distinguished attenuated vaccine strains A19 and S19 from 22 strains of B. abortus and 57 strains of 5 other Brucella species. The assay gave a negative reaction with 4 non-Brucella species. The minimum sensitivity of the assay, evaluated using 10-fold dilutions of chromosomal DNA, was 7.6 fg for the A19 strain and 220 fg for the single non-A19/non-S19 Brucella strain tested (B. abortus 104M). The assay was also reproducible (intra- and interassay coefficients of variation: 0.003-0.01 and 0.004-0.025, respectively). The cycleave assay gave an A19/S19-specific reaction in 3 out of 125 field serum samples, with the same 3 samples being positive in an alternative A19/S19-specific molecular assay. The cycleave assay gave a total of 102 Brucella-specific reactions (3 being the A19/S19-specific reactions), whereas an alternative Brucella-specific assay gave 92 positive reactions (all also positive in the cycleave assay). Therefore, this assay represents a simple, rapid, sensitive, and specific tool for use in brucellosis control. \u00a9 2016 The Author(s).\n[Coordinated zinc homeostasis is essential for the wild-type virulence of Brucella abortus.](https://www.ncbi.nlm.nih.gov/pubmed/25691532)\nSheehan, Lauren M; Budnick, James A; Roop, R Martin; Caswell, Clayton C\n2015-05-01\nMetal homeostasis in bacterial cells is a highly regulated process requiring intricately coordinated import and export, as well as precise sensing of intracellular metal concentrations. The uptake of zinc (Zn) has been linked to the virulence of Brucella abortus; however, the capacity of Brucella strains to sense Zn levels and subsequently coordinate Zn homeostasis has not been described. Here, we show that expression of the genes encoding the zinc uptake system ZnuABC is negatively regulated by the Zn-sensing Fur family transcriptional regulator, Zur, by direct interactions between Zur and the promoter region of znuABC. Moreover, the MerR-type regulator, ZntR, controls the expression of the gene encoding the Zn exporter ZntA by binding directly to its promoter. Deletion of zur or zntR alone did not result in increased zinc toxicity in the corresponding mutants; however, deletion of zntA led to increased sensitivity to Zn but not to other metals, such as Cu and Ni, suggesting that ZntA is a Zn-specific exporter. Strikingly, deletion of zntR resulted in significant attenuation of B. abortus in a mouse model of chronic infection, and subsequent experiments revealed that overexpression of zntA in the zntR mutant is the molecular basis for its decreased virulence. The importance of zinc uptake for Brucella pathogenesis has been demonstrated previously, but to date, there has been no description of how overall zinc homeostasis is maintained and genetically controlled in the brucellae. The present work defines the predominant zinc export system, as well as the key genetic regulators of both zinc uptake and export in Brucella abortus. Moreover, the data show the importance of precise coordination of the zinc homeostasis systems as disregulation of some elements of these systems leads to the attenuation of Brucella virulence in a mouse model. Overall, this study advances our understanding of the essential role of zinc in the pathogenesis of intracellular bacteria\n[Producci\u00f3n a nivel de laboratorio de Clostridium septicum IRP15 para la formulaci\u00f3n de una vacuna veterinaria](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152014000200009&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda Lorena Gonz\u00e1lez Ram\u00edrez\nFull Text Available Objetivo: establecer las condiciones de producci\u00f3n a nivel de laboratorio de la alfa toxina de Clostridium septicum IRP15 para la formulaci\u00f3n de una vacuna veterinaria y la optimizaci\u00f3n del proceso de producci\u00f3n. M\u00e9todos: se caracteriz\u00f3 y estandariz\u00f3 la edad apropiada del in\u00f3culo para los cultivos en un fermentador New Brunswick Scientific 7 L. Las condiciones de cultivo fueron: cepa C. septicum IRP15, medio de cultivo VBH, 5 L/vaso de 7 L, in\u00f3culo de 250 mL (5 %, 37 \u00baC, 24 h, bajo agitaciones prueba de 0, 25 y 50 r.p.m. Se estableci\u00f3 el perfil cin\u00e9tico morfol\u00f3gico, de biomasa, consumo de sustrato y producci\u00f3n de toxina. Resultados: para las fermentaciones de 0 y 25 r.p.m. no se present\u00f3 fase de adaptaci\u00f3n; el microorganismo creci\u00f3 de manera exponencial hasta las 4 y 6 h de fermentaci\u00f3n, consumiendo simult\u00e1neamente la mayor cantidad de glucosa presente en el medio. A partir de estas horas y hasta las 24, se realiz\u00f3 la prueba de DL50 en ratones y se destaca que a 25 r.p.m. se obtuvo el mayor t\u00edtulo de toxina (1/23. En las fermentaciones a 50 r.p.m. se observ\u00f3 que el microorganismo experimenta una fase de adaptaci\u00f3n de 4 h aproximadamente; con un retardo en producci\u00f3n de biomasa, consumo de glucosa y producci\u00f3n de toxina, condici\u00f3n que no resulta \u00f3ptima para la producci\u00f3n del ant\u00edgeno. Conclusiones: la producci\u00f3n de toxina se presenta en la fase logar\u00edtmica y durante la fase estacionaria, asoci\u00e1ndose as\u00ed al crecimiento y al fen\u00f3meno de esporulaci\u00f3n.\n[Gene Discovery through Genomic Sequencing of Brucella abortus](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=97963)\nS\u00e1nchez, Daniel O.; Zandomeni, Ruben O.; Cravero, Silvio; Verd\u00fan, Ramiro E.; Pierrou, Ester; Faccio, Paula; Diaz, Gabriela; Lanzavecchia, Silvia; Ag\u00fcero, Fern\u00e1n; Frasch, Alberto C. C.; Andersson, Siv G. E.; Rossetti, Osvaldo L.; Grau, Oscar; Ugalde, Rodolfo A.\n2001-01-01\nBrucella abortus is the etiological agent of brucellosis, a disease that affects bovines and human. We generated DNA random sequences from the genome of B. abortus strain 2308 in order to characterize molecular targets that might be useful for developing immunological or chemotherapeutic strategies against this pathogen. The partial sequencing of 1,899 clones allowed the identification of 1,199 genomic sequence surveys (GSSs) with high homology (BLAST expect value < 10\u22125) to sequences deposited in the GenBank databases. Among them, 925 represent putative novel genes for the Brucella genus. Out of 925 nonredundant GSSs, 470 were classified in 15 categories based on cellular function. Seven hundred GSSs showed no significant database matches and remain available for further studies in order to identify their function. A high number of GSSs with homology to Agrobacterium tumefaciens and Rhizobium meliloti proteins were observed, thus confirming their close phylogenetic relationship. Among them, several GSSs showed high similarity with genes related to nodule nitrogen fixation, synthesis of nod factors, nodulation protein symbiotic plasmid, and nodule bacteroid differentiation. We have also identified several B. abortus homologs of virulence and pathogenesis genes from other pathogens, including a homolog to both the Shda gene from Salmonella enterica serovar Typhimurium and the AidA-1 gene from Escherichia coli. Other GSSs displayed significant homologies to genes encoding components of the type III and type IV secretion machineries, suggesting that Brucella might also have an active type III secretion machinery. PMID:11159979\n[Brucella Rough Mutant Induce Macrophage Death via Activating IRE1\u03b1 Pathway of Endoplasmic Reticulum Stress by Enhanced T4SS Secretion.](https://www.ncbi.nlm.nih.gov/pubmed/29021973)\nLi, Peng; Tian, Mingxing; Bao, Yanqing; Hu, Hai; Liu, Jiameng; Yin, Yi; Ding, Chan; Wang, Shaohui; Yu, Shengqing\n2017-01-01\nBrucella is a Gram-negative facultative intracellular pathogen that causes the worldwide zoonosis, known as brucellosis. Brucella virulence relies mostly on its ability to invade and replicate within phagocytic cells. The type IV secretion system (T4SS) and lipopolysaccharide are two major Brucella virulence factors. Brucella rough mutants reportedly induce the death of infected macrophages, which is T4SS dependent. However, the underlying molecular mechanism remains unclear. In this study, the T4SS secretion capacities of Brucella rough mutant and its smooth wild-type strain were comparatively investigated, by constructing the firefly luciferase fused T4SS effector, BPE123 and VceC. In addition, quantitative real-time PCR and western blotting were used to analyze the T4SS expression. The results showed that T4SS expression and secretion were enhanced significantly in the Brucella rough mutant. We also found that the activity of the T4SS virB operon promoter was notably increased in the Brucella rough mutant, which depends on quorum sensing-related regulators of VjbR upregulation. Cell infection and cell death assays revealed that deletion of vjbR in the Brucella rough mutant absolutely abolished cytotoxicity within macrophages by downregulating T4SS expression. This suggests that up-regulation of T4SS promoted by VjbR in rough mutant \u0394 rfbE contribute to macrophage death. In addition, we found that the Brucella rough mutant induce macrophage death via activating IRE1\u03b1 pathway of endoplasmic reticulum stress. Taken together, our study provide evidence that in comparison to the Brucella smooth wild-type strain, VjbR upregulation in the Brucella rough mutant increases transcription of the virB operon, resulting in overexpression of the T4SS gene, accompanied by the over-secretion of effecter proteins, thereby causing the death of infected macrophages via activating IRE1\u03b1 pathway of endoplasmic reticulum stress, suggesting novel insights into the molecular\n[Brucella Rough Mutant Induce Macrophage Death via Activating IRE1\u03b1 Pathway of Endoplasmic Reticulum Stress by Enhanced T4SS Secretion](http://journal.frontiersin.org/article/10.3389/fcimb.2017.00422/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nPeng Li\n2017-09-01\nFull Text Available Brucella is a Gram-negative facultative intracellular pathogen that causes the worldwide zoonosis, known as brucellosis. Brucella virulence relies mostly on its ability to invade and replicate within phagocytic cells. The type IV secretion system (T4SS and lipopolysaccharide are two major Brucella virulence factors. Brucella rough mutants reportedly induce the death of infected macrophages, which is T4SS dependent. However, the underlying molecular mechanism remains unclear. In this study, the T4SS secretion capacities of Brucella rough mutant and its smooth wild-type strain were comparatively investigated, by constructing the firefly luciferase fused T4SS effector, BPE123 and VceC. In addition, quantitative real-time PCR and western blotting were used to analyze the T4SS expression. The results showed that T4SS expression and secretion were enhanced significantly in the Brucella rough mutant. We also found that the activity of the T4SS virB operon promoter was notably increased in the Brucella rough mutant, which depends on quorum sensing-related regulators of VjbR upregulation. Cell infection and cell death assays revealed that deletion of vjbR in the Brucella rough mutant absolutely abolished cytotoxicity within macrophages by downregulating T4SS expression. This suggests that up-regulation of T4SS promoted by VjbR in rough mutant \u0394rfbE contribute to macrophage death. In addition, we found that the Brucella rough mutant induce macrophage death via activating IRE1\u03b1 pathway of endoplasmic reticulum stress. Taken together, our study provide evidence that in comparison to the Brucella smooth wild-type strain, VjbR upregulation in the Brucella rough mutant increases transcription of the virB operon, resulting in overexpression of the T4SS gene, accompanied by the over-secretion of effecter proteins, thereby causing the death of infected macrophages via activating IRE1\u03b1 pathway of endoplasmic reticulum stress, suggesting novel insights into the\n[Brucella cyclic \u03b2-1,2-glucan plays a critical role in the induction of splenomegaly in mice.](http://europepmc.org/articles/PMC4077732?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMara S Roset\nFull Text Available Brucella, the etiological agent of animal and human brucellosis, is a bacterium with the capacity to modulate the inflammatory response. Cyclic \u03b2-1,2-glucan (C\u03b2G is a virulence factor key for the pathogenesis of Brucella as it is involved in the intracellular life cycle of the bacteria. Using comparative studies with different C\u03b2G mutants of Brucella, cgs (C\u03b2G synthase, cgt (C\u03b2G transporter and cgm (C\u03b2G modifier, we have identified different roles for this polysaccharide in Brucella. While anionic C\u03b2G is required for bacterial growth in low osmolarity conditions, the sole requirement for a successful Brucella interaction with mammalian host is its transport to periplasmic space. Our results uncover a new role for C\u03b2G in promoting splenomegaly in mice. We showed that C\u03b2G-dependent spleen inflammation is the consequence of massive cell recruitment (monocytes, dendritics cells and neutrophils due to the induction of pro-inflammatory cytokines such as IL-12 and TNF-\u03b1 and also that the reduced splenomegaly response observed with the cgs mutant is not the consequence of changes in expression levels of the characterized Brucella PAMPs LPS, flagellin or OMP16/19. Complementation of cgs mutant with purified C\u03b2G increased significantly spleen inflammation response suggesting a direct role for this polysaccharide.\n[Brucella neotomae Infection in Humans, Costa Rica.](https://www.ncbi.nlm.nih.gov/pubmed/28518028)\nSu\u00e1rez-Esquivel, Marcela; Ruiz-Villalobos, Nazareth; Jim\u00e9nez-Rojas, C\u00e9sar; Barquero-Calvo, El\u00edas; Chac\u00f3n-D\u00edaz, Carlos; V\u00edquez-Ruiz, Eunice; Rojas-Campos, Norman; Baker, Kate S; Oviedo-S\u00e1nchez, Gerardo; Amuy, Ernesto; Chaves-Olarte, Esteban; Thomson, Nicholas R; Moreno, Edgardo; Guzm\u00e1n-Verri, Caterina\n2017-06-01\nSeveral species of Brucella are known to be zoonotic, but B. neotomae infection has been thought to be limited to wood rats. In 2008 and 2011, however, B. neotomae was isolated from cerebrospinal fluid of 2 men with neurobrucellosis. The nonzoonotic status of B. neotomae should be reassessed.\n[Serologic response in bottlenose dolphins Tursiops truncatus infected with Brucella sp. using a dolphin-specific indirect ELISA.](https://www.ncbi.nlm.nih.gov/pubmed/23209080)\nMeegan, Jenny; Dunn, J Lawrence; Venn-Watson, Stephanie K; Smith, Cynthia R; Sidor, Inga; Jensen, Eric D; Van Bonn, William G; Pugh, Roberta; Ficht, Thomas; Adams, L Garry; Nielsen, Klaus; Romano, Tracy A\n2012-12-03\nMarine-origin Brucella infections and serologic evidence of exposure have been documented in multiple cetacean species. A dolphin-specific indirect enzyme-linked immunosorbent assay (ELISA) was developed to screen bottlenose dolphin sera for anti-Brucella antibodies. A total of 131 serum samples collected over a 2 to 18 yr period from 6 bottlenose dolphins Tursiops truncatus with confirmed Brucella infections were analyzed for the presence and magnitude of antibody titers against marine-origin Brucella to compare individual antibody responses to various disease manifestations. Additionally, an epidemiologic serologic survey of a managed population of 64 bottlenose dolphins was performed to evaluate for the presence of antibodies and to determine whether there were any clinical pathology predictors for exposure or infection. The serologic results revealed that the dolphins with Brucella-associated abortions were seronegative for 7 to 18 yr until after the abortion and maintained positive titers for several years, with 2 of 3 animals returning to seronegative status. In contrast, the dolphins with Brucella-associated pulmonary or bone lesions maintained persistent positive titers for 2 to 18 yr. The population serosurvey revealed no significant differences in antibody levels among males and females, and dolphins between the ages of 17 and 25 yr were 6.8 times more likely to be Brucella antibody positive compared to those that were younger or older. Seropositive dolphins did not have significant inflammation compared to seronegative dolphins but were more likely to have higher levels of aspartate aminotransferase and gamma-glutamyl transpeptidase. Among 16 dolphins that tested seropositive, 13 (81.3%) had previously been seropositive for at least 3 to 5 yr.\n[Efectos adversos asociados a la vacunaci\u00f3n anti-gripal en pediatr\u00eda](https://www.openaire.eu/search/publication?articleId=doajarticles::367390cf9b2dbf37007ca178aa36ab20)\nMart\u00edn Moreno Vicente; Molina Cabrerizo Mar\u00eda del Rosario; Sotillo Rinc\u00f3n Mar\u00eda Jes\u00fas; G\u00f3mez G\u00f3mez Carlos; Alvarez G\u00f3mez Julia\n1998-01-01\nFUNDAMENTO: las dificultades para valorar adecuadamente la morbimortalidad por gripe en la infancia y las limitaciones de la propia vacuna, hacen que su uso en esta etapa siga siendo limitado. El objetivo del presente estudio es valorar los efectos adversos asociados a la vacunaci\u00f3n antigripal en ni\u00f1os. M\u00c9TODOS: estudio prospectivo realizado en las campa\u00f1as 92/93, 93/94 y 97/98 en 105 ni\u00f1os de Navalcarnero, con vacuna antigripal de virus fraccionados e inactivados con las cepas vacunales reco...\n[Cell-mediated immune responses differentiate infections with Brucella suis from Yersinia enterocolitica serotype O : 9 in pigs](http://www.forskningsdatabasen.dk/en/catalog/1372964) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nRiber, Ulla; Jungersen, Gregers\n2007-01-01\nDue to almost identical lipopolysaccharide (LPS) O-antigens, infections with Yersinia enterocolitica serotype 0:9 (YeO:9) cause false positive serological reactions (FPSR) in tests for Brucella and thus cause problems in National Brucella surveillance programs. As LPS are strong inducers...... of antibody responses it was hypothesized that cell-mediated immune responses to non-LPS antigens of the two bacteria can be used to separate immune responses to these two biologically very different infections. Following subclinical experimental infections with Brucella suis biovar 2, high interferon......-gamma (IFN-gamma) assay responses with a commercial Brucella melitensis antigen preparation (Brucellergene OCB) preceded the development of antibodies. High IFN-gamma responses in the seven B. suis inoculated pigs with serological evidence of infection were consistent throughout a 20-week postinoculation...\n[Desarrollo de vacunas contra el virus de la inmunodeficiencia humana tipo 1: Relevancia de la inmunidad celular contra subtipos Development of vaccines for HIV-1: Relevance of subtype-specific cellular immunity](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAna Mar\u00eda Rodr\u00edguez\n2010-12-01\nFull Text Available Han pasado casi 30 a\u00f1os de la detecci\u00f3n de los primeros casos de infecci\u00f3n con HIV-1 y a\u00fan no se ha conseguido desarrollar una vacuna efectiva y segura. A pesar del impacto positivo sobre la pandemia que se ha conseguido gracias a los avances en la terapia antirretroviral (TARV, el HIV/sida sigue constituyendo un grave problema para la salud p\u00fablica, especialmente en los pa\u00edses en desarrollo, donde es dif\u00edcil el acceso al tratamiento. En el mundo, 33 millones de personas viven con el virus del sida, mientras que en la Argentina se calcula que habr\u00eda unos 120 000 infectados. Uno de los desaf\u00edos para lograr una vacuna contra el HIV es la variabilidad viral. El grupo M, responsable de la pandemia, se encuentra dividido en 10 subtipos y varios sub-subtipos, adem\u00e1s de las 48 formas recombinantes circulantes y m\u00e1s de cien formas recombinantes \u00fanicas. La epidemia de HIV en nuestro pa\u00eds es tan compleja como en el resto del mundo, con la co-circulaci\u00f3n principalmente de virus pertenecientes al subtipo B y recombinantes BF (CRF12_BF y derivadas. A pesar de la cantidad de trabajos dedicados a la caracterizaci\u00f3n de la respuesta inmune y al desarrollo de vacunas, no queda claro cu\u00e1l es el impacto de la variabilidad en la elecci\u00f3n del ant\u00edgeno. Trabajos realizados en nuestro laboratorio demuestran el papel que juega la inmunidad celular con respecto a las variantes recombinantes BF, tanto en humanos como en modelos animales. Estos resultados son de importancia en el desarrollo de futuras vacunas para nuestra regi\u00f3n.It has been almost 30 years since the detection of the first HIV-1 cases and yet an effective and safe vaccine has not been developed. Although, advances in antiretroviral therapy (HAART have produced a major impact on the pandemic, and even though HIV/aids remains a major concern for developing countries, where access to therapy is limited. The last report from UNAIDS notified 33 million people living with HIV/aids, worldwide\n[Detecci\u00f3n de un complejo clonal con el genotipo de Brucella abortus biovariedad 2 como fundador en aislamientos de B. abortus de Argentina](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000400003&lng=en&tlng=en) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDaiana Hollender\nFull Text Available Brucella abortus es el agente causal de la brucelosis bovina, enfermedad zoon\u00f3tica que se encuentra ampliamente distribuida en el mundo. Actualmente existen ocho biovariedades de B. abortus. En Argentina se encuentra con mayor frecuencia la biovariedad 1, pero tambi\u00e9n se suele aislar la biovariedad 2, que es m\u00e1s patog\u00e9nica que la anterior. Resulta necesario contar con m\u00e9todos de tipificaci\u00f3n que tengan la resoluci\u00f3n suficiente para permitir el seguimiento epidemiol\u00f3gico de los brotes de brucelosis y de los programas de control de la enfermedad. Debido a la gran homogeneidad gen\u00e9tica que existe entre las distintas especies del g\u00e9nero Brucella, ha sido dificultoso el desarrollo de herramientas moleculares para realizar el an\u00e1lisis epidemiol\u00f3gico de los aislamientos. La publicaci\u00f3n del genoma de varias especies de Brucella facilit\u00f3 el dise\u00f1o de estas herramientas. El objetivo del presente trabajo fue emplear un esquema de an\u00e1lisis multilocus de VNTR en aislamientos de Argentina obtenidos en nuestro laboratorio. De los 56 aislamientos analizados se obtuvieron 47 perfiles genot\u00edpicos diferentes. El empleo de este esquema permiti\u00f3 asignarles a dichos aislamientos la biovariedad correspondiente. A trav\u00e9s del an\u00e1lisis goeBURST se pudo relacionar a todos los genotipos entre s\u00ed, y adem\u00e1s, proponer al genotipo de la biovariedad 2 como fundador.\n[Seguimiento de la reactogenicidad de la vacuna DTP cubana, utilizando dos m\u00e9todos paralelos](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda de los \u00c1ngeles Pe\u00f1a Machado\n2005-05-01\nFull Text Available Con el objetivo de caracterizar la reactogenicidad de la vacuna Antidift\u00e9rica-Antitet\u00e1nica- Antipertusis (DTP cubana, desarrollada por el Instituto Finlay, se realiz\u00f3 un estudio utilizando dos m\u00e9todos o fuentes de informaci\u00f3n diferentes y paralelos. La primera se obtuvo de un ensayo cl\u00ednico (EC Fase IV, abierto, no controlado, en el que se incluyeron 57 lactantes. La segunda fuente de informaci\u00f3n se obtuvo de los reportes de los eventos temporalmente asociados a la vacunaci\u00f3n (ETAV, recepcionados por la Unidad Coordinadora Nacional de Farmacovigilancia (UCNFv que incluyen a 86 lactantes que fueron atendidos por sospechas de ETAV. En el EC se aplicaron 167 dosis, los eventos adversos esperados e inesperados se observaron en un escaso n\u00famero de lactantes, fueron mayoritariamente ligeros y autolimitados en el tiempo y su frecuencia de aparici\u00f3n se redujo en la 2da y 3ra dosis. El dolor fue el evento local m\u00e1s frecuente y la fiebre fue el evento general que m\u00e1s se present\u00f3. No se reportaron v\u00f3mitos y la anorexia, la somnolencia, y el llanto persistente aparecieron en un n\u00famero limitado de sujetos vacunados.Se presentaron 12 eventos no esperados, solo en 2 de ellos se consider\u00f3 que exist\u00eda relaci\u00f3n causal con la vacunaci\u00f3n. Se report\u00f3 un evento adverso grave (ni\u00f1a hospitalizada por s\u00edndrome febril prolongado postvacunaci\u00f3n, que se estudi\u00f3 y demostr\u00f3 que fue causado por una sepsis urinaria persistente provocada por una malformaci\u00f3n vesico-ureteral. Los 86 reportes recepcionados por la UCNFv inclu\u00edan un total de 141 ETAV, dentro de los s\u00edntomas locales, el eritema alcanz\u00f3 un 9,30% y la induraci\u00f3n un 5,81%, la fiebre fue un s\u00edntoma frecuente aunque no se especifica la temperatura corporal alcanzada. Aunque existen varias diferencias con relaci\u00f3n a las condiciones en que se realiza la vigilancia de eventos adversos en un EC o en la pr\u00e1ctica cl\u00ednica habitual, los resultados aqu\u00ed analizados nos confirman que la\n[Genome degradation in Brucella ovis corresponds with narrowing of its host range and tissue tropism.](http://europepmc.org/articles/PMC2677664?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRenee M Tsolis\nFull Text Available Brucella ovis is a veterinary pathogen associated with epididymitis in sheep. Despite its genetic similarity to the zoonotic pathogens B. abortus, B. melitensis and B. suis, B. ovis does not cause zoonotic disease. Genomic analysis of the type strain ATCC25840 revealed a high percentage of pseudogenes and increased numbers of transposable elements compared to the zoonotic Brucella species, suggesting that genome degradation has occurred concomitant with narrowing of the host range of B. ovis. The absence of genomic island 2, encoding functions required for lipopolysaccharide biosynthesis, as well as inactivation of genes encoding urease, nutrient uptake and utilization, and outer membrane proteins may be factors contributing to the avirulence of B. ovis for humans. A 26.5 kb region of B. ovis ATCC25840 Chromosome II was absent from all the sequenced human pathogenic Brucella genomes, but was present in all of 17 B. ovis isolates tested and in three B. ceti isolates, suggesting that this DNA region may be of use for differentiating B. ovis from other Brucella spp. This is the first genomic analysis of a non-zoonotic Brucella species. The results suggest that inactivation of genes involved in nutrient acquisition and utilization, cell envelope structure and urease may have played a role in narrowing of the tissue tropism and host range of B. ovis.\n[Molecular strain typing of Brucella abortus isolates from Italy by two VNTR allele sizing technologies.](https://www.ncbi.nlm.nih.gov/pubmed/23585050)\nDe Santis, Riccardo; Ancora, Massimo; De Massis, Fabrizio; Ciammaruconi, Andrea; Zilli, Katiuscia; Di Giannatale, Elisabetta; Pittiglio, Valentina; Fillo, Silvia; Lista, Florigio\n2013-10-01\nBrucellosis, one of the most important re-emerging zoonoses in many countries, is caused by bacteria belonging to the genus Brucella. Furthermore these bacteria represent potential biological warfare agents and the identification of species and biovars of field strains may be crucial for tracing back source of infection, allowing to discriminate naturally occurring outbreaks instead of bioterrorist events. In the last years, multiple-locus variable-number tandem repeat analysis (MLVA) has been proposed as complement of the classical biotyping methods and it has been applied for genotyping large collections of Brucella spp. At present, the MLVA band profiles may be resolved by automated or manual procedures. The Lab on a chip technology represents a valid alternative to standard genotyping techniques (as agarose gel electrophoresis) and it has been previously used for Brucella genotyping. Recently, a new high-throughput genotyping analysis system based on capillary gel electrophoresis, the QIAxcel, has been described. The aim of the study was to evaluate the ability of two DNA sizing equipments, the QIAxcel System and the Lab chip GX, to correctly call alleles at the sixteen loci including one frequently used MLVA assay for Brucella genotyping. The results confirmed that these technologies represent a meaningful advancement in high-throughput Brucella genotyping. Considering the accuracy required to confidently resolve loci discrimination, QIAxcel shows a better ability to measure VNTR allele sizes compared to LabChip GX.\n[Dextran sulfate sodium upregulates MAPK signaling for the uptake and subsequent intracellular survival of Brucella abortus in murine macrophages.](https://www.ncbi.nlm.nih.gov/pubmed/26626959)\nReyes, Alisha Wehdnesday Bernardo; Arayan, Lauren Togonon; Simborio, Hannah Leah Tadeja; Hop, Huynh Tan; Min, WonGi; Lee, Hu Jang; Kim, Dong Hee; Chang, Hong Hee; Kim, Suk\n2016-02-01\nBrucellosis is one of the major zoonoses worldwide that inflicts important health problems in animal and human. Here, we demonstrated that dextran sulfate sodium (DSS) significantly increased adhesion of Brucella (B.) abortus in murine macrophages compared to untreated cells. Even without infection, Brucella uptake into macrophages increased and F-actin reorganization was induced compared with untreated cells. Furthermore, DSS increased the phosphorylation of MAPKs (ERK1/2 and p38\u03b1) in Brucella-infected, DSS-treated cells compared with the control cells. Lastly, DSS markedly increased the intracellular survival of Brucella abortus in macrophages by up to 48 h. These results suggest that DSS enhanced the adhesion and phagocytosis of B. abortus into murine macrophages by stimulating the MAPK signaling proteins phospho-ERK1/2 and p38\u03b1 and that DSS increased the intracellular survival of B. abortus by inhibiting colocalization of Brucella-containing vacuoles (BCVs) with the late endosome marker LAMP-1. This study emphasizes the enhancement of the phagocytic and intracellular modulatory effects of DSS, which may suppress the innate immune system and contribute to prolonged Brucella survival and chronic infection. Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.\n[Promotion and Rescue of Intracellular Brucella neotomae Replication during Coinfection with Legionella pneumophila.](https://www.ncbi.nlm.nih.gov/pubmed/28264909)\nKang, Yoon-Suk; Kirby, James E\n2017-05-01\nWe established a new Brucella neotomae in vitro model system for study of type IV secretion system-dependent (T4SS) pathogenesis in the Brucella genus. Importantly, B. neotomae is a rodent pathogen, and unlike B. abortus , B. melitensis , and B. suis , B. neotomae has not been observed to infect humans. It therefore can be handled more facilely using biosafety level 2 practices. More particularly, using a series of novel fluorescent protein and lux operon reporter systems to differentially label pathogens and track intracellular replication, we confirmed T4SS-dependent intracellular growth of B. neotomae in macrophage cell lines. Furthermore, B. neotomae exhibited early endosomal (LAMP-1) and late endoplasmic reticulum (calreticulin)-associated phagosome maturation. These findings recapitulate prior observations for human-pathogenic Brucella spp. In addition, during coinfection experiments with Legionella pneumophila , we found that defective intracellular replication of a B. neotomae T4SS virB4 mutant was rescued and baseline levels of intracellular replication of wild-type B. neotomae were significantly stimulated by coinfection with wild-type but not T4SS mutant L. pneumophila Using confocal microscopy, it was determined that intracellular colocalization of B. neotomae and L. pneumophila was required for rescue and that colocalization came at a cost to L. pneumophila fitness. These findings were not completely expected based on known temporal and qualitative differences in the intracellular life cycles of these two pathogens. Taken together, we have developed a new system for studying in vitro Brucella pathogenesis and found a remarkable T4SS-dependent interplay between Brucella and Legionella during macrophage coinfection. Copyright \u00a9 2017 American Society for Microbiology.\n[Activation of Host IRE1\u03b1-Dependent Signaling Axis Contributes the Intracellular Parasitism of Brucella melitensis](http://journal.frontiersin.org/article/10.3389/fcimb.2018.00103/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAseem Pandey\n2018-04-01\nFull Text Available Brucella spp. are intracellular vacuolar pathogens that causes brucellosis, a worldwide zoonosis of profound importance. We previously demonstrated that the activity of host unfolded protein response (UPR sensor IRE1\u03b1 (inositol-requiring enzyme 1 and ER-associated autophagy confer susceptibility to Brucella melitensis and Brucella abortus intracellular replication. However, the mechanism by which host IRE1\u03b1 regulates the pathogen intracellular lifestyle remains elusive. In this study, by employing a diverse array of molecular approaches, including biochemical analyses, fluorescence microscopy imaging, and infection assays using primary cells derived from Ern1 (encoding IRE1 conditional knockout mice, we address this gap in our understanding by demonstrating that a novel IRE1\u03b1 to ULK1, an important component for autophagy initiation, signaling axis confers susceptibility to Brucella intracellular parasitism. Importantly, deletion or inactivation of key signaling components along this axis, including IRE1\u03b1, BAK/BAX, ASK1, and JNK as well as components of the host autophagy system ULK1, Atg9a, and Beclin 1, resulted in striking disruption of Brucella intracellular trafficking and replication. Host kinases in the IRE1\u03b1-ULK1 axis, including IRE1\u03b1, ASK1, JNK1, and/or AMPK\u03b1 as well as ULK1, were also coordinately phosphorylated in an IRE1\u03b1-dependent fashion upon the pathogen infection. Taken together, our findings demonstrate that the IRE1\u03b1-ULK1 signaling axis is subverted by the bacterium to promote intracellular parasitism, and provide new insight into our understanding of the molecular mechanisms of intracellular lifestyle of Brucella.\n[Un An\u00e1lisis de las Variaciones de Precios Diarias en el Mercado de Liniers](https://bibliotecavirtual.unl.edu.ar/publicaciones/index.php/CE/article/view/1109) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nGustavo Rossini\n2007-12-01\nFull Text Available A pesar de la importancia como mercado de referencia para la ganader\u00eda vacuna argentina, pocos estudios han examinado el comportamiento de las variaciones de los precios diarios en las categor\u00edas comercializadas en el Mercado de Liniers. Dado esto, el objetivo de este trabajo es aportar informaci\u00f3n sobre la incidencia de variables seleccionadas sobre los cambios en los precios diarios en este mercado en las categor\u00edas de mayor ingreso diario. Para ello, un Modelo Log\u00edstico Multinomial es usado para predecir la incidencia de dichas variables sobre los cambios en las probabilidades de suba, baja o igualdad de los precios promedios con respecto al d\u00eda h\u00e1bil anterior. Los resultados evidencias qeu los d\u00edas de la semana, los niveles de concentraci\u00f3n de los compradores, la variaci\u00f3n del n\u00famero de cabezas y el comportamiento de la plaza el d\u00eda h\u00e1bil anterior son importantes en la predicci\u00f3n de las variaciones de precios diarias. Implicancias de los resultados, como as\u00ed tambi\u00e9n algunas de las limitaciones del modelo son analizadas.\n[The role of NLRP3 and AIM2 in inflammasome activation during Brucella abortus infection.](https://www.ncbi.nlm.nih.gov/pubmed/27405866)\nMarim, Fernanda M; Franco, Miriam M Costa; Gomes, Marco Tulio R; Miraglia, Maria Cruz; Giambartolomei, Guillermo H; Oliveira, Sergio C\n2017-02-01\nThe innate immune system is essential for the detection and elimination of bacterial pathogens. Upon inflammasome activation, caspase-1 cleaves pro-IL-1\u03b2 and pro-IL-18 to their mature forms IL-1\u03b2 and IL-18, respectively, and the cell undergoes inflammatory death termed pyroptosis. Here, we reviewed recent findings demonstrating that Brucella abortus ligands activate NLRP3 and AIM2 inflammasomes which lead to control of infection. This protective effect is due to the inflammatory response caused by IL-1\u03b2 and IL-18 rather than cell death. Brucella DNA is sensed by AIM2 and bacteria-induced mitochondrial reactive oxygen species is detected by NLRP3. However, deregulation of pro-inflammatory cytokine production can lead to immunopathology. Nervous system invasion by bacteria of the genus Brucella results in an inflammatory disorder termed neurobrucellosis. Herein, we discuss the mechanism of caspase-1 activation and IL-1\u03b2 secretion in glial cells infected with B. abortus. Our results demonstrate that the ASC inflammasome is indispensable for inducing the activation of caspase-1 and secretion of IL-1\u03b2 upon infection of astrocytes and microglia with Brucella. Moreover, our results demonstrate that secretion of IL-1\u03b2 by Brucella-infected glial cells depends on NLRP3 and AIM2 and leads to neurobrucellosis. Further, the inhibition of the host cell inflammasome as an immune evasion strategy has been described for bacterial pathogens. We discuss here that the bacterial type IV secretion system VirB is required for inflammasome activation in host cells during infection. Taken together, our results indicate that Brucella is sensed by ASC inflammasomes mainly NLRP3 and AIM2 that collectively orchestrate a robust caspase-1 activation and pro-inflammatory response.\n[Exploring the Diversity of Field Strains of Brucella abortus Biovar 3 Isolated in West Africa](http://journal.frontiersin.org/article/10.3389/fmicb.2017.01232/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMoussa Sanogo\n2017-06-01\nFull Text Available Brucellosis is one of the most widespread bacterial zoonotic diseases in the world, affecting both humans and domestic and wild animals. Identification and biotyping of field strains of Brucella are of key importance for a better knowledge of the epidemiology of brucellosis, for identifying appropriate antigens, for managing disease outbreaks and for setting up efficient preventive and control programmes. Such data are required both at national and regional level to assess potential threats for public health. Highly discriminative genotyping methods such as the multiple locus variable number of tandem repeats analysis (MLVA allow the comparison and assessment of genetic relatedness between field strains of Brucella within the same geographical area. In this study, MLVA biotyping data retrieved from the literature using a systematic review were compared using a clustering analysis and the Hunter-Gaston diversity index (HGDI. Thus, the analysis of the 42 MLVA genotyping results found in the literature on West Africa [i.e., from Ivory Coast (1, Niger (1, Nigeria (34, The Gambia (3, and Togo (3] did not allow a complete assessment of the actual diversity among field strains of Brucella. However, it provided some preliminary indications on the co-existence of 25 distinct genotypes of Brucella abortus biovar 3 in this region with 19 genotypes from Nigeria, three from Togo and one from Ivory Coast, The Gambia, and Niger. The strong and urgent need for more sustainable molecular data on prevailing strains of Brucella in this sub-region of Africa and also on all susceptible species including humans is therefore highlighted. This remains a necessary stage to allow a comprehensive understanding of the relatedness between field strains of Brucella and the epidemiology of brucellosis within West Africa countries.\n[Whole-genome sequence of the first sequence type 27 Brucella ceti strain isolated from European waters](http://orbit.dtu.dk/ws/files/137906590/Genome_Announc._2017_Duvnjak_.pdf) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nDuvnjak, Sanja; Spicic, Silvio; Kusar, Darja\n2017-01-01\nBrucella spp. that cause marine brucellosis are becoming more important, as the disease appears to be more widespread than originally thought. Here, we report a whole and annotated genome sequence of Brucella ceti CRO350, a sequence type 27 strain isolated from a bottlenose dolphin carcass found...\n[N-Formyl-Perosamine Surface Homopolysaccharides Hinder the Recognition of Brucella abortus by Mouse Neutrophils.](https://www.ncbi.nlm.nih.gov/pubmed/27001541)\nMora-Cart\u00edn, Ricardo; Chac\u00f3n-D\u00edaz, Carlos; Guti\u00e9rrez-Jim\u00e9nez, Cristina; Gurdi\u00e1n-Murillo, Stephany; Lomonte, Bruno; Chaves-Olarte, Esteban; Barquero-Calvo, El\u00edas; Moreno, Edgardo\n2016-06-01\nBrucella abortus is an intracellular pathogen of monocytes, macrophages, dendritic cells, and placental trophoblasts. This bacterium causes a chronic disease in bovines and in humans. In these hosts, the bacterium also invades neutrophils; however, it fails to replicate and just resists the killing action of these leukocytes without inducing significant activation or neutrophilia. Moreover, B. abortus causes the premature cell death of human neutrophils. In the murine model, the bacterium is found within macrophages and dendritic cells at early times of infection but seldom in neutrophils. Based on this observation, we explored the interaction of mouse neutrophils with B. abortus In contrast to human, dog, and bovine neutrophils, naive mouse neutrophils fail to recognize smooth B. abortus bacteria at early stages of infection. Murine normal serum components do not opsonize smooth Brucella strains, and neutrophil phagocytosis is achieved only after the appearance of antibodies. Alternatively, mouse normal serum is capable of opsonizing rough Brucella mutants. Despite this, neutrophils still fail to kill Brucella, and the bacterium induces cell death of murine leukocytes. In addition, mouse serum does not opsonize Yersinia enterocolitica O:9, a bacterium displaying the same surface polysaccharide antigen as smooth B. abortus Therefore, the lack of murine serum opsonization and absence of murine neutrophil recognition are specific, and the molecules responsible for the Brucella camouflage are N-formyl-perosamine surface homopolysaccharides. Although the mouse is a valuable model for understanding the immunobiology of brucellosis, direct extrapolation from one animal system to another has to be undertaken with caution. Copyright \u00a9 2016, American Society for Microbiology. All Rights Reserved.\n[Anti-Brucella Antibodies in Moose (Alces alces gigas), Muskoxen (Ovibos moschatus), and Plains Bison (Bison bison bison) in Alaska, USA.](https://www.ncbi.nlm.nih.gov/pubmed/26540335)\nNymo, Ingebj\u00f8rg Helena; Beckmen, Kimberlee; Godfroid, Jacques\n2016-01-01\nWe used an indirect enzyme-linked immunosorbent assay (iELISA) and the rose bengal test (RBT) to test for anti-Brucella antibodies in moose (Alces alces gigas), muskoxen (Ovibos moschatus), and plains bison (Bison bison bison) from various game management units (GMUs) in Alaska, US, sampled from 1982 to 2010. A portion of the sera had previously been tested with the standard plate test (SPT), the buffered Brucella antigen (BBA) card test, and the card test (CARD). No antibody-positive plains bison were identified. Anti-Brucella antibodies were detected in moose (iELISA, n=4/87; RBT, n=4/87; SPT, n=4/5; BBA, n=4/4) from GMU 23 captured in 1992, 1993, and 1995 and in muskoxen (iELISA, n=4/52; RBT, n=4/52; CARD, n=4/35) from GMUs 26A and 26B captured in 2004, 2006, and 2007. A negative effect of infection on the health of individuals of these species is probable. The presence of antibody-positive animals from 1992 to 2007 suggests presence of brucellae over time. The antibody-positive animals were found in northern Alaska, an area with a historically higher prevalence of Brucella-positive caribou, and a spillover of Brucella suis biovar 4 from caribou may have occurred. Brucella suis biovar 4 causes human brucellosis, and transmission from consumption of moose and muskoxen is possible.\n[The Glutaminase-Dependent System Confers Extreme Acid Resistance to New Species and Atypical Strains of Brucella](http://journal.frontiersin.org/article/10.3389/fmicb.2017.02236/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nLuca Freddi\n2017-11-01\nFull Text Available Neutralophilic bacteria have developed specific mechanisms to cope with the acid stress encountered in environments such as soil, fermented foods, and host compartments. In Escherichia coli, the glutamate decarboxylase (Gad-dependent system is extremely efficient: it requires the concerted action of glutamate decarboxylase (GadA/GadB and of the glutamate (Glu/\u03b3-aminobutyrate antiporter, GadC. Notably, this system is operative also in new strains/species of Brucella, among which Brucella microti, but not in the \u201cclassical\u201d species, with the exception of marine mammals strains. Recently, the glutaminase-dependent system (named AR2_Q, relying on the deamination of glutamine (Gln into Glu and on GadC activity, was described in E. coli. In Brucella genomes, a putative glutaminase (glsA-coding gene is located downstream of the gadBC genes. We found that in B. microti these genes are expressed as a polycistronic transcript. Moreover, using a panel of Brucella genus-representative strains, we show that the AR2_Q system protects from extreme acid stress (pH \u22642.5, in the sole presence of Gln, only the Brucella species/strains predicted to have functional glsA and gadC. Indeed, mutagenesis approaches confirmed the involvement of glsA and gadC of B. microti in AR2_Q and that the acid-sensitive phenotype of B. abortus can be ascribed to a Ser248Leu substitution in GlsA, leading to loss of glutaminase activity. Furthermore, we found that the gene BMI_II339, of unknown function and downstream of the gadBC\u2013glsA operon, positively affects Gad- and GlsA-dependent AR. Thus, we identified novel determinants that allow newly discovered and marine mammals Brucella strains to be better adapted to face hostile acidic environments. As for significance, this work may contribute to the understanding of the host preferences of Brucella species and opens the way to alternative diagnostic targets in epidemiological surveillance of brucellosis.\n[BRUCELLA ENDOCARDITIS IN IRANIAN PATIENTS: COMBINED MEDICAL AND SURGICAL TREATMENT](http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5067.pdf&manuscript_id=5067) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEbrahim Nematipour\n1995-06-01\nFull Text Available Brucella endocarditis is a Tare but serious complication ofbrucellosis and is the main cause of death reuuedto thisdisease: Itis not rare in the endemic areas and aaualiy accounts for up to 8~lO% ofendocarditis infections: We report seven adult cases of brucella endocarditis in lmam-Khorneini Hospual: Contrary to previous independent reports, female patients were not rare in this study and accountedfor three out ofseven. Four patients were cared for by combined medical and surgical treatment and were recovered Three of the patients that did not receive the combined theraPl could not he saved This report confirms the necessity of prompt combined medical and surgical treatment ofbrucella endocarditis.\n[Liderazgo en las vacunas sobre \"dar informaci\u00f3n a los padres\"](https://www.openaire.eu/search/publication?articleId=od_______935::97010ba19bdb0882f040b83dc73c2b43)\nBod\u00ed Belda, Mar\u00eda Jos\u00e9\n2016-01-01\nLa vacunaci\u00f3n en los \u00faltimos a\u00f1os se est\u00e1 incrementando en los casos de ni\u00f1os que padecen enfermedades graves y que bien por la propia enfermedad o por el tratamiento de \u00e9sta, se encuentran en un estado de inmunodepresi\u00f3n. Constituye uno de los tratamientos preventivos que m\u00e1s vidas ha salvado en las \u00faltimas d\u00e9cadas y tiene especial relevancia en este grupo de pacientes pedi\u00e1tricos, para los cuales contraer una enfermedad infecciosa podr\u00eda poner en riesgo su vida. En este trabajo, se plantean...\n[Brucella BioR Regulator Defines a Complex Regulatory Mechanism for Bacterial Biotin Metabolism](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3719536)\nXu, Jie; Zhang, Huimin; Srinivas, Swaminath\n2013-01-01\nThe enzyme cofactor biotin (vitamin H or B7) is an energetically expensive molecule whose de novo biosynthesis requires 20 ATP equivalents. It seems quite likely that diverse mechanisms have evolved to tightly regulate its biosynthesis. Unlike the model regulator BirA, a bifunctional biotin protein ligase with the capability of repressing the biotin biosynthetic pathway, BioR has been recently reported by us as an alternative machinery and a new type of GntR family transcriptional factor that can repress the expression of the bioBFDAZ operon in the plant pathogen Agrobacterium tumefaciens. However, quite unusually, a closely related human pathogen, Brucella melitensis, has four putative BioR-binding sites (both bioR and bioY possess one site in the promoter region, whereas the bioBFDAZ [bio] operon contains two tandem BioR boxes). This raised the question of whether BioR mediates the complex regulatory network of biotin metabolism. Here, we report that this is the case. The B. melitensis BioR ortholog was overexpressed and purified to homogeneity, and its solution structure was found to be dimeric. Functional complementation in a bioR isogenic mutant of A. tumefaciens elucidated that Brucella BioR is a functional repressor. Electrophoretic mobility shift assays demonstrated that the four predicted BioR sites of Brucella plus the BioR site of A. tumefaciens can all interact with the Brucella BioR protein. In a reporter strain that we developed on the basis of a double mutant of A. tumefaciens (the \u0394bioR \u0394bioBFDA mutant), the \u03b2-galactosidase (\u03b2-Gal) activity of three plasmid-borne transcriptional fusions (bioBbme-lacZ, bioYbme-lacZ, and bioRbme-lacZ) was dramatically decreased upon overexpression of Brucella bioR. Real-time quantitative PCR analyses showed that the expression of bioBFDA and bioY is significantly elevated upon removal of bioR from B. melitensis. Together, we conclude that Brucella BioR is not only a negative autoregulator but also a repressor of\n[Modeling the survivability of brucella to exposure of Ultraviolet radiation and temperature](http://adsabs.harvard.edu/abs/2002cosp...34E...5H)\nHowe, R.\nAccumulated summation of daily Ultra Violet-B (UV-B = 290? to 320 ? ) data? from The USDA Ultraviolet Radiation Monitoring Program show good correlation (R^2 = 77%) with daily temperature data during the five month period from February through June, 1998. Exposure of disease organisms, such as brucella to the effects of accumulated UV-B radiation, can be modeled for a 5 month period from February through June, 1998. Estimates of a lethal dosage for brucell of UV-B in the environment is dependent on minimum/maximum temperature and Solar Zenith Angle for the time period. The accumulated increase in temperature over this period also effects the decomposition of an aborted fetus containing brucella. Decomposition begins at some minimum daily temperature at 27 to 30 degrees C and peaks at 39 to 40C. It is useful to view the summation of temperature as a threshold for other bacteria growth, so that accumulated temperature greater than some value causes decomposition through competition with other bacteria and brucella die from the accumulated effects of UV-B, temperature and organism competition. Results of a study (Cook 1998) to determine survivability of brucellosis in the environment through exposure of aborted bovine fetuses show no one cause can be attributed to death of the disease agent. The combination of daily increase in temperature and accumulated UV-B radiation reveal an inverse correlation to survivability data and can be modeled as an indicator of brucella survivability in the environment in arid regions.\n[Brucella 'HOOF-Prints': strain typing by multi-locus analysis of variable number tandem repeats (VNTRs](http://www.biomedcentral.com/1471-2180/3/15) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHalling Shirley M\n2003-07-01\nFull Text Available Abstract Background Currently, there are very few tools available for subtyping Brucella isolates for epidemiological trace-back. Subtyping is difficult because of the genetic homogeneity within the genus. Sequencing of the genomes from three Brucella species has facilitated the search for DNA sequence variability. Recently, hypervariability among short tandem repeat sequences has been exploited for strain-typing of several bacterial pathogens. Results An eight-base pair tandem repeat sequence was discovered in nine genomic loci of the B. abortus genome. Eight loci were hypervariable among the three Brucella species. A PCR-based method was developed to identify the number of repeat units (alleles at each locus, generating strain-specific fingerprints. None of the loci exhibited species- or biovar-specific alleles. Sometimes, a species or biovar contained a specific allele at one or more loci, but the allele also occurred in other species or biovars. The technique successfully differentiated the type strains for all Brucella species and biovars, among unrelated B. abortus biovar 1 field isolates in cattle, and among B. abortus strains isolated from bison and elk. Isolates from the same herd or from short-term in vitro passage exhibited little or no variability in fingerprint pattern. Sometimes, isolates from an animal would have multiple alleles at a locus, possibly from mixed infections in enzootic areas, residual disease from incomplete depopulation of an infected herd or molecular evolution within the strain. Therefore, a mixed population or a pool of colonies from each animal and/or tissue was tested. Conclusion This paper describes a new method for fingerprinting Brucella isolates based on multi-locus characterization of a variable number, eight-base pair, tandem repeat. We have named this technique \"HOOF-Prints\" for Hypervariable Octameric Oligonucleotide Finger-Prints. The technique is highly discriminatory among Brucella species, among\n[Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F55d90f9f-e2d0-488d-9a14-7c12c6b501cd/uquery/Brucella/id/16/Language/EN)\nSmits, Henk L.; Abdoel, Theresia H.; Solera, Javier; Clavijo, Encarnacion; Diaz, Ramon\n2003-01-01\nTo fulfill the need for a simple and rapid diagnostic test for human brucellosis, we used the immunochromatographic lateral flow assay format to develop two assays, one for the detection of Brucella-specific immunoglobulin M (IgM) antibodies and one for the detection of Brucella-specific IgG\n[Seroprevalence of Brucella antibodies in camels in Katsina State, Nigeria.](https://www.ncbi.nlm.nih.gov/pubmed/28456876)\nSalisu, U S; Kudi, C A; Bale, J O O; Babashani, M; Kaltungo, B Y; Saidu, S N A; Asambe, A; Baba, A Y\n2017-06-01\nA cross-sectional study was carried out to determine the status of Brucella infection in one-humped (Dromedary) camels in the North and Central senatorial districts of Katsina State, Nigeria. Nine hundred and eighty serum samples from live and slaughtered camels were tested. Modified Rose Bengal plate test (RBPT) and serum agglutination test (SAT) with ethylenediaminetetraacetic acid, (EDTA) were used as screening and standard tests, respectively. The prevalence of Brucella antibodies were 110 (11.2%) and 103 (10.5%) for RBPT and SAT, respectively. Of the 472 and 508 serum samples tested from the herds and abattoirs, respectively, 63 (13.3%) and 47 (9.3%) were positive by RBPT while 62 (13.1%) and 41 (8.1%) were positive by SAT, respectively. Based on the results, it was concluded that Brucella antibodies were present in camels in the study area. Poor management practices and mixing of camels with other species of livestock as well as unrestricted movement of camels were proposed to be the reasons for the prevalence of the disease in the study area. In view of the public health importance of the disease, it is recommended that there is the need to develop a strategic plan to decrease spread of brucellosis in the study area.\n[MLVA genotyping of human Brucella isolates from Peru](https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F0fe0791f-8b6e-402f-8bbb-bb7a2f7487db/uquery/Brucella/id/9/Language/EN)\nSmits, Henk L.; Espinosa, Benjamin; Castillo, Rosa; Hall, Eric; Guillen, Alfredo; Zevaleta, Milagros; Gilman, Robert H.; Melendez, Paolo; Guerra, Carlos; Draeger, Angelika; Broglia, Alessandro; N\u00f6ckler, Karsten\n2009-01-01\nRecent human Brucella melitensis isolates from Peru were genotyped by multiple locus variable number repeat analysis. All 24 isolates originated from hospitalized patients living in the central part of Peru and consisted of six genomic groups comprising two to four isolates and nine unique\n[Evaluation and selection of tandem repeat loci for a Brucella MLVA typing assay](http://www.biomedcentral.com/1471-2180/6/9) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDenoeud France\n2006-02-01\nFull Text Available Abstract Background The classification of Brucella into species and biovars relies on phenotypic characteristics and sometimes raises difficulties in the interpretation of the results due to an absence of standardization of the typing reagents. In addition, the resolution of this biotyping is moderate and requires the manipulation of the living agent. More efficient DNA-based methods are needed, and this work explores the suitability of multiple locus variable number tandem repeats analysis (MLVA for both typing and species identification. Results Eighty tandem repeat loci predicted to be polymorphic by genome sequence analysis of three available Brucella genome sequences were tested for polymorphism by genotyping 21 Brucella strains (18 reference strains representing the six 'classical' species and all biovars as well as 3 marine mammal strains currently recognized as members of two new species. The MLVA data efficiently cluster the strains as expected according to their species and biovar. For practical use, a subset of 15 loci preserving this clustering was selected and applied to the typing of 236 isolates. Using this MLVA-15 assay, the clusters generated correspond to the classical biotyping scheme of Brucella spp. The 15 markers have been divided into two groups, one comprising 8 user-friendly minisatellite markers with a good species identification capability (panel 1 and another complementary group of 7 microsatellite markers with higher discriminatory power (panel 2. Conclusion The MLVA-15 assay can be applied to large collections of Brucella strains with automated or manual procedures, and can be proposed as a complement, or even a substitute, of classical biotyping methods. This is facilitated by the fact that MLVA is based on non-infectious material (DNA whereas the biotyping procedure itself requires the manipulation of the living agent. The data produced can be queried on a dedicated MLVA web service site.\n[Immunogenicity and tolerability of inactivated flu vaccine In high risk and healthy children Inmunogenicidad y tolerancia de la vacuna inactivada anti-influenza en ni\u00f1os en alto riesgo y en controles sanos](http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802007000400005) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaria Luisa Avila Aguero\n2007-08-01\nconducido en dos temporadas de gripe, durante las cuales la vacuna utilizada contenia las mismas cepas A pero diferentes cepas B. Los resultados para las cepas A/H3N2 y A/H1N1 de las dos temporadas de gripe fueron combinados ( pool de datos, pero no los de las cepas B. Los t\u00edtulos de anticuerpos anti-hemaglutinina (HA fueron determinados inmediatamente antes y un mes despues de cada vacunaci\u00f3n, y la seguridad o tolerancia fue evaluada seg\u00fan la informaci\u00f3n de efectos adversos notificados, en cartillas para llenado diario, que inclu\u00edan todos los eventos, figuraran o no en la lista de los \"eventos solicitados\". En cada grupo, las tasas de seroconversion y de seroprotecci\u00f3n, y la raz\u00f3n de la media geom\u00e9trica de t\u00edtulos post-/ pre-vacunaci\u00f3n (GMTR para las cepas A/H3N2 y A/H1N1 cumplieron con todos los requisitos del Comit\u00e9 de Especialidades Farmac\u00e9uticas (CPMP de la Uni\u00f3n Europea. Las respuestas inmunes fueron similares en los ni\u00f1os con alto riesgo y en los sanos, y consistentes con los resultados observados en los estudios anteriores en los ni\u00f1os sanos. La vacuna fue bien tolerada y la reactogenicidad fue baja y similar en los dos grupos de ni\u00f1os estudiados. Las reacciones locales listadas en la solicitud, fueron observadas en el 9.5 a 15.4% y en el 12% de ni\u00f1os con alto riego y sanos respectivamente; mientras que los s\u00edntomas sist\u00e9micos solicitados fueron observados en el 23.0 a 28.8% y el 25.3% de ni\u00f1os respectivamente. Los resultados de este estudio proveen informati\u00f3n adicional a favor de la vacunaci\u00f3n de ni\u00f1os con alto riesgo de complicaciones relacionadas con influenza.\n[Enzyme-Linked Immunosorbent Assay To Differentiate the Antibody Responses of Animals Infected with Brucella Species from Those of Animals Infected with Yersinia enterocolitica O9](https://www.openaire.eu/search/publication?articleId=od_______908::143d466e23900c306cb807c160920c8a)\nErdenebaatar, Janchivdorj; Bayarsaikhan, Balgan; Watarai, Masahisa; Makino, Sou-ichi; Shirahata, Toshikazu\n2003-01-01\nEnzyme-linked immunosorbent assays using antigens extracted from Brucella abortus with n-lauroylsarcosine differentiated natural Brucella-infected animals from Brucella-vaccinated or Yersinia enterocolitica O9-infected animals. A field trial in Mongolia showed cattle, sheep, goat, reindeer, camel, and human sera without infection could be distinguished from Brucella-infected animals by conventional serological tests.\n[An evaluation of ELISA using recombinant Brucella abortus bacterioferritin (Bfr) for bovine brucellosis.](https://www.ncbi.nlm.nih.gov/pubmed/27012915)\nHop, Huynh Tan; Arayan, Lauren Togonon; Simborio, Hannah Leah; Reyes, Alisha Wehdnesday Bernardo; Min, WonGi; Lee, Hu Jang; Lee, Jin Ju; Chang, Hong Hee; Kim, Suk\n2016-04-01\nTo date, detection of antibodies against the lipopolysaccharide portion is the backbone of most serodiagnostic methods for brucellosis screening. However this pose a risk for false positive reactions related to other pathogens especially that of Yersinia enterocolitica O:9 which has the most prominent cross reactivity with Brucella spp. In this study, cloning and expression of Brucella abortus bacterioferritin (Bfr) was accomplished by PCR amplification into an expression vector system, and purification of a recombinant B. abortus Bfr (rBfr). The immunogenicity of rBfr was confirmed by Western blot with Brucella-positive bovine serum. To determine whether rBfr has a potential benefit for use in the serodiagnosis of bovine brucellosis, rBfr-based ELISA was performed. Interestingly, rBfr was able to detect anti-Brucella antibodies in positive sera in a dependent manner of TAT values but did not show an immunoreaction with negative samples. Particularly, average OD492 values at the lowest, medium and highest TAT titer levels were 1.4, 2.2 and 2.6-fold increase compared with the cutoff value, respectively. The accuracy, specificity and sensitivity of rBfr showed 89.09%, 93.6% and 85.33%, respectively. These findings suggest that rBfr might be a good candidate for serological diagnosis development of bovine brucellosis. Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.\n[Identification of Brucella ovis exclusive genes in field isolates from Argentina.](https://www.ncbi.nlm.nih.gov/pubmed/26831160)\nAlvarez, Luc\u00eda Paula; Garc\u00eda-Effr\u00f3n, Guillermo; Robles, Carlos Alejandro\n2016-03-01\nBrucellosis caused by Brucella ovis is one of the most important infectious diseases of sheep. The aim of this study was to determine the presence of genes both inside and outside the specific B. ovis pathogenicity island 1 (BOPI-1) in a large collection of field isolates of B. ovis and other Brucella spp. from Argentina. The BOV_A0500 gene from B. ovis BOPI-1 was identified in all 104 B. ovis isolates studied. The BOPI-1 complete sequence was found to be conserved in 10 B. ovis strains from the collection, for which whole genome sequencing was performed. The BOV_0198 gene, which is outside BOPI-1 and considered exclusive to B. ovis, showed 90-100% identity with genomic regions of B. ovis, B. melitensis, B. abortus, B. canis, B. suis, B. microti, B. ceti and B. pinnipedialis. The results demonstrate that BOPI-1 is the only exclusive genetic region of B. ovis and marine Brucella spp. and that it is highly conserved in B. ovis field isolates from Argentina. Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.\n[Structural Insights into the HWE Histidine Kinase Family: The Brucella Blue Light-Activated Histidine Kinase Domain.](https://www.ncbi.nlm.nih.gov/pubmed/26851072)\nRinaldi, Jimena; Arrar, Mehrnoosh; Sycz, Gabriela; Cerutti, Mar\u00eda Laura; Berguer, Paula M; Paris, Gast\u00f3n; Estr\u00edn, Dar\u00edo Ariel; Mart\u00ed, Marcelo Adri\u00e1n; Klinke, Sebasti\u00e1n; Goldbaum, Fernando Alberto\n2016-03-27\nIn response to light, as part of a two-component system, the Brucella blue light-activated histidine kinase (LOV-HK) increases its autophosphorylation, modulating the virulence of this microorganism. The Brucella histidine kinase (HK) domain belongs to the HWE family, for which there is no structural information. The HWE family is exclusively present in proteobacteria and usually coupled to a wide diversity of light sensor domains. This work reports the crystal structure of the Brucella HK domain, which presents two different dimeric assemblies in the asymmetric unit: one similar to the already described canonical parallel homodimers (C) and the other, an antiparallel non-canonical (NC) dimer, each with distinct relative subdomain orientations and dimerization interfaces. Contrary to these crystallographic structures and unlike other HKs, in solution, the Brucella HK domain is monomeric and still active, showing an astonishing instability of the dimeric interface. Despite this instability, using cross-linking experiments, we show that the C dimer is the functionally relevant species. Mutational analysis demonstrates that the autophosphorylation activity occurs in cis. The different relative subdomain orientations observed for the NC and C states highlight the large conformational flexibility of the HK domain. Through the analysis of these alternative conformations by means of molecular dynamics simulations, we also propose a catalytic mechanism for Brucella LOV-HK. Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.\n[Public health consequences of a false-positive laboratory test result for Brucella--Florida, Georgia, and Michigan, 2005.](https://www.ncbi.nlm.nih.gov/pubmed/18528317)\n2008-06-06\nHuman brucellosis, a nationally notifiable disease, is uncommon in the United States. Most human cases have occurred in returned travelers or immigrants from regions where brucellosis is endemic, or were acquired domestically from eating illegally imported, unpasteurized fresh cheeses. In January 2005, a woman aged 35 years who lived in Nassau County, Florida, received a diagnosis of brucellosis, based on results of a Brucella immunoglobulin M (IgM) enzyme immunoassay (EIA) performed in a commercial laboratory using analyte specific reagents (ASRs); this diagnosis prompted an investigation of dairy products in two other states. Subsequent confirmatory antibody testing by Brucella microagglutination test (BMAT) performed at CDC on the patient's serum was negative. The case did not meet the CDC/Council of State and Territorial Epidemiologists' (CSTE) definition for a probable or confirmed brucellosis case, and the initial EIA result was determined to be a false positive. This report summarizes the case history, laboratory findings, and public health investigations. CDC recommends that Brucella serology testing only be performed using tests cleared or approved by the Food and Drug Administration (FDA) or validated under the Clinical Laboratory Improvement Amendments (CLIA) and shown to reliably detect the presence of Brucella infection. Results from these tests should be considered supportive evidence for recent infection only and interpreted in the context of a clinically compatible illness and exposure history. EIA is not considered a confirmatory Brucella antibody test; positive screening test results should be confirmed by Brucella-specific agglutination (i.e., BMAT or standard tube agglutination test) methods.\n[La construcci\u00f3 de fets cient\u00edfics : La vacuna SPf66](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::69504224a67a1db5cf7f4eafc85160f1)\nNaspleda Pardo, Joan\n2015-01-01\nEn aquest treball, a partir de la teoria de l'actor-xarxa i la Sociologia del Coneixement Cient\u00edfic (SCC), analitzem la creaci\u00f3 i evoluci\u00f3 de la vacuna contra la mal\u00e0ria de l'equip del Dr. Manuel Elkin Patarroyo, durant els anys 80 i 90 del passat segle, per mostrar com les interaccions socials participen de manera decisiva en l'acceptaci\u00f3 o rebuig d'una proposta cient\u00edfica. En este trabajo, a partir de la teor\u00eda del actor-red y la Sociolog\u00eda del Conocimiento Cient\u00edfico (SCC), analizamos l...\n[Evaluaci\u00f3n de un ant\u00edgeno de Brucella abortus para aglutinaci\u00f3n en placa como prueba tamiz en el diagn\u00f3stico de la brucelosis bovina](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000300002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDavid Rajme-Manzur\n2017-12-01\nFull Text Available Este trabajo tuvo como objetivo obtener y validar un ant\u00edgeno buferado de Brucella abortus para la prueba de aglutinaci\u00f3n en placa como prueba diagn\u00f3stica de base de la brucelosis bovina. Se formularon tres lotes de ant\u00edgeno a partir de la multiplicaci\u00f3n de la cepa 99 de Brucella abortus. Se realizaron los controles de calidad correspondientes (determinaci\u00f3n de pH, volumen celular, esterilidad, capacidad buferante y las pruebas serol\u00f3gicas para la evaluaci\u00f3n del desempe\u00f1o. Se emplearon 1070 muestras de suero bovino (350 positivas y 720 negativas previamente controladas con las pruebas de diagn\u00f3stico establecidas. Se determin\u00f3 la sensibilidad y especificidad diagn\u00f3stica y relativa, los valores predictivos positivos y negativos, la eficacia y la concordancia. En los tres lotes todas las caracter\u00edsticas evaluadas resultaron estar dentro de los par\u00e1metros establecidos para este tipo de producto. La especificidad y sensibilidad diagn\u00f3sticas fueron de 99,5% y 100% respectivamente. El valor predictivo positivo fue de 99,1%, el valor predictivo negativo fue de 100% y la eficacia de un 99,7%. El ant\u00edgeno mostr\u00f3 una sensibilidad y especificidad relativas de un 100% y la concordancia result\u00f3 ser clasificada como muy buena. La evaluaci\u00f3n del desempe\u00f1o arroj\u00f3 resultados satisfactorios, demostrando que el m\u00e9todo de producci\u00f3n empleado es factible para la obtenci\u00f3n de un producto con adecuada eficacia.\n[Examination of taxonomic uncertainties surrounding Brucella abortus bv. 7 by phenotypic and molecular approaches.](https://www.ncbi.nlm.nih.gov/pubmed/24362435)\nGarin-Bastuji, Bruno; Mick, Virginie; Le Carrou, Gilles; Allix, Sebastien; Perrett, Lorraine L; Dawson, Claire E; Groussaud, Pauline; Stubberfield, Emma J; Koylass, Mark; Whatmore, Adrian M\n2014-03-01\nBrucella taxonomy is perpetually being reshuffled, at both the species and intraspecies levels. Biovar 7 of Brucella abortus was suspended from the Approved Lists of Bacterial Names Brucella classification in 1988, because of unpublished evidence that the reference strain 63/75 was a mixture of B. abortus biovars 3 and 5. To formally clarify the situation, all isolates previously identified as B. abortus bv. 7 in the AHVLA and ANSES strain collections were characterized by classical microbiological and multiple molecular approaches. Among the 14 investigated strains, including strain 63/75, only four strains, isolated in Kenya, Turkey, and Mongolia, were pure and showed a phenotypic profile in agreement with the former biovar 7, particularly agglutination with both anti-A/anti-M monospecific sera. These results were strengthened by molecular strategies. Indeed, genus- and species-specific methods allowed confirmation that the four pure strains belonged to the B. abortus species. The combination of most approaches excluded their affiliation with the recognized biovars (biovars 1 to 6 and 9), while some suggested that they were close to biovar 3.These assays were complemented by phylogenetic and/or epidemiological methods, such as multilocus sequence analysis (MLSA) and variable-number tandem repeat (VNTR) analysis. The results of this polyphasic investigation allow us to propose the reintroduction of biovar 7 into the Brucella classification, with at least three representative strains. Interestingly, the Kenyan strain, sharing the same biovar 7 phenotype, was genetically divergent from other three isolates. These discrepancies illustrate the complexity of Brucella taxonomy. This study suggests that worldwide collections could include strains misidentified as B. abortus bv. 7, and it highlights the need to verify their real taxonomic position.\n[Validaci\u00f3n de un ELISA tipo inhibici\u00f3n para cuantificar polisac\u00e1rido Vi en la vacuna antitifo\u00eddica cubana vax-TyVi](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEsther Mar\u00eda Fajardo\n2006-08-01\nFull Text Available Se describe la validaci\u00f3n de un ELISA tipo inhibici\u00f3n, reportado por primera vez en la literatura cient\u00edfica para cuantificar un ant\u00edgeno vacunal: el polisac\u00e1rido Vi de Salmonella Typhi, para ser empleado en el control de la calidad de la vacuna antitifo\u00eddica cubana vax- TyVi\u00e2. El ensayo consta de seis pasos: 1 Recubrimiento de placa de reacci\u00f3n con poli-L-lisina y posteriormente polisac\u00e1rido Vi; 2 Bloqueo con leche descremada; 3 Inhibici\u00f3n o neutralizaci\u00f3n en tubos de suero anti-Vi de conejo, respectivamente, con polisac\u00e1rido Vi de Curva de Calibraci\u00f3n (concentraciones desde 1\u201332 \u03bcg/mL, control positivo y muestras de vacuna (3 diluciones; 4 Neutralizaci\u00f3n de anticuerpos anti-Vi libres, presentes en las mezclas anteriores, por el Polisac\u00e1rido de Recubrimiento; 5 Reconocimiento de anticuerpos anti-Vi unidos a la placa (conjugado anti-IgG de conejo-fosfatasa alcalina y 6 Revelado por reacci\u00f3n enzima-sustrato. Los par\u00e1metros de validaci\u00f3n estudiados y sus resultados fueron: 1 Precisi\u00f3n, expresada como coeficiente de variaci\u00f3n a tres niveles de concentraci\u00f3n de polisac\u00e1rido, comprendidos en el rango de su especificaci\u00f3n (35, 50 y 70 \u03bcg/mL y evaluada en t\u00e9rminos de repetibilidad; precisi\u00f3n intraensayos (cuatro analistas y reproducibilidad (seis analistas: \u00a3 20%; 2 Linealidad (100*R2: 99,68 %; 3 L\u00edmite de detecci\u00f3n: 0,5 \u03bcg/mL; 4 Exactitud (recuperaci\u00f3n para las tres diluciones de la muestra: entre 100 y 118%, y 5 Robustez: no influye 1,5 h de bloqueo (p = 0,52 ni \u00b1 5 min para leer placa (p = 0,56; influye grandemente la calidad del agua (p = 0,026, a favor del agua para inyecci\u00f3n. El ensayo es adecuado para los fines propuestos y es una medida de la inmunogenicidad in vitro del polisac\u00e1rido Vi.\n[Estrat\u00e9gias de campo em ensaios cl\u00ednicos com novas vacinas produzidas no Brasil Estrategias de campo en ensayos cl\u00ednicos con nuevas vacunas producidas en Brasil Clinical trials field strategies with novel vaccines produced in Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822012000200008) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nEm\u00edlia de Faria Carniel\n2012-06-01\nFull Text Available OBJETIVO: Relatar as estrat\u00e9gias de campo utilizadas em dois ensaios cl\u00ednicos com vacinas desenvolvidas pelo Instituto Butantan, em 2004 e 2006. M\u00c9TODOS: Estudo do tipo relato de experi\u00eancia, em que se descreve o planejamento e a operacionaliza\u00e7\u00e3o dos ensaios cl\u00ednicos, que avaliaram a imunogenicidade e a seguran\u00e7a da vacina BCG combinada com a vacina da hepatite B (VrHB-IB e da tetravalente bacteriana modificada pela extra\u00e7\u00e3o do lipopolissacar\u00eddeo (LPS do componente pertussis (DTPm/Hib. RESULTADOS: As principais estrat\u00e9gias de campo utilizadas foram: a Parceria entre os pesquisadores e os gestores da Secretaria Municipal de Sa\u00fade e b Realiza\u00e7\u00e3o dos procedimentos da pesquisa nos domic\u00edlios ou nos Centros de Sa\u00fade frequentados pelos participantes. No primeiro estudo, foram vacinados 552 rec\u00e9m-nascidos na maternidade com a BCG/VrHB-IB (combinadas ou separadas e nos domic\u00edlios, com as duas doses subsequentes de VrHB-IB. O segundo estudo incluiu 241 lactentes em Centros de Sa\u00fade da rede municipal, vacinados com tetravalente bacteriana (com componente pertussis total ou modificado. Em ambos os estudos, amostras de sangue foram colhidas nas resid\u00eancias. N\u00e3o houve relatos de eventos adversos. A ades\u00e3o foi de 90,2% para o primeiro estudo e 93,8%, para o segundo. As vacinas foram administradas nas datas preconizadas pelo Programa Nacional de Imuniza\u00e7\u00f5es e as coletas de sangue, de acordo com o cronograma dos estudos. CONCLUS\u00d5ES: As estrat\u00e9gias utilizadas facilitaram o recrutamento das crian\u00e7as e garantiram cumprir o protocolo da pesquisa com alta ades\u00e3o, sem interferir no v\u00ednculo da fam\u00edlia com o Servi\u00e7o de Sa\u00fade, no calend\u00e1rio vacinal ou no seguimento pedi\u00e1trico dos participantes.OBJETIVO: Relatar las estrategias de campo utilizadas en dos ensayos cl\u00ednicos con vacunas desarrolladas por el Instituto Butantan, en 2004 y 2006. M\u00c9TODOS: Estudio de tipo relato de experiencia, en que se describe la planificaci\u00f3n y la\n[ISOLATION AND IDENTIFICATION OF BRUCELLA SUIS IN PIGS AS ZOONOTIC DISEASE IN ENDEMIC AREAS OF EAST JAVA, INDONESIA.](https://www.ncbi.nlm.nih.gov/pubmed/29619446)\nS, Emy Koestanti; Misaco, Wiwik; Chusniati, Sri; Maslachah, Lilik\n2018-01-01\nBrucellosis in pigs at East Java Indonesia has not only cause great economic losses due to a decrease in productivity of livestock but also are zoonotic. Infection on free brucelosis pigs were initially begun with the infected pigs both male and female, or the use of superior male pigs together. The elimination of the disease either on a group or population is considered as the most effective way to prevent the spread of the disease in pigs. Prevention efforts mainly addressed to vaccination, sanitary maintenace and government policy. The purpose of this study was to isolated and identified Brucella suis as the causative agent. The survey area were the pig farm owned by breeder farmers in the area of East Java Indonesia, at Kediri, Malang, Blitar and Probolinggo district. Blood samples obtained were tested with RBT. Pigs are suspected of being infected with Brucella if the RBT was positive that characterized with agglutination in the test results. If RBT was positive, bacteriological examination will be performed, with samples of visceral foetus organ, ie liver, spleen, placenta and amniotic fluid. Isolation and identification of Brucella suis were used Brucella Broth and Brucella Agar, and if the bacteri growthwill be continued with biochemical test ie H2S, urease, citrate, catalase and oxidase test. The positive results of Brucella suis showed positive urease, catalase andoxidase, but negative for citrate and H2S. RBT and bacteriolgical examination showed that 1 sample was positive Brucella suis , and 19 negative. The positive results showed positive urease, catalase and oxidase, but negative for citrate and H2S. Based on RBT test and bacteriological examination, there was 1 positive sample of brucellla suis, that is sample coming from Kediri district.\n[Culture of uterine flushings, cervical mucus, and udder secretions collected post-abortion from heifers artificially exposed to Brucella abortus.](https://www.ncbi.nlm.nih.gov/pubmed/16725834)\nStringfellow, D A; Scanlan, C M; Hannon, S S; Panangala, V S; Gray, B W; Galik, P A\n1983-07-01\nUterine flushings, cervical mucus swabs and udder secretions collected at weekly intervals from five mixed breed beef cows (four Brucella abortus strain 19 vaccinates, and 1 non-vaccinate) were cultured for Brucella abortus . Prior to sampling, four of the five had aborted 7-to 8-month-old fetuses and one gave brith to a weak calf. The fetuses and/or udder secretions from the cows were culture positive for B. abortus at the time of parturition. Three of the cows developed persistent udder infections. Two of these cows were also shown to have brucellae in their cervical mucus for 10 and 20 days and in their uterine flushings for 17 and 41 days after parturition, respectively. One other cow had brucellae in the cervical mucus for 16 days and in the uterine flushings for up to 36 days post-abortion. All attempts to isolate the organism from this cow's udder secretions in culture were negative. In two cows with culture-positive uterine flushings, isolations of brucellae were made subsequent to normal postpabortion return to estrus.\n[Opciones vacunales contra los virus pat\u00f3genos de porcinos PRRS y PCV2, un binomio frecuente](http://www.redalyc.org/articulo.oa?id=457650040009) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMarcos Cajero-Ju\u00e1rez\n2017-01-01\nFull Text Available En la \u00faltima d\u00e9cada, el s\u00edndrome reproductivo y respiratorio porcino (PRRS, por sus siglas en ingl\u00e9s y las enfermedades asociadas al circovirus porcino tipo 2 (PCV2, por sus siglas en ingl\u00e9s, representan una gran preocupaci\u00f3n para la industria porc\u00edcola, debido a la afectaci\u00f3n de los \u00edndices productivos. En consecuencia, su presencia va acompa\u00f1ada de cuantiosas p\u00e9rdidas econ\u00f3micas. Actualmente, en la mayor\u00eda de los centros de producci\u00f3n, se utilizan vacunas cl\u00e1sicas, es decir, elaboradas a partir del virus completo viable \u00f3 atenuado. En relaci\u00f3n al PCV2, se dispone de pocas vacunas de nueva generaci\u00f3n, referidas como aquellas obtenidas a trav\u00e9s de la tecnolog\u00eda del ADN recombinante, mientras que, \u00fanicamente vacunas cl\u00e1sicas est\u00e1n disponibles contra el virus PRRSV. En este manuscrito, revisamos la naturaleza de los virus PRRSV y PCV2, as\u00ed tambi\u00e9n, resaltamos la importancia econ\u00f3mica, de acuerdo a los datos de prevalencia nacional e internacional. Adem\u00e1s, se incluyen datos de nuevas opciones vacunales, en relaci\u00f3n con las vacunas comerciales que, en algunos casos, se ha documentado una baja protecci\u00f3n contra cepas heter\u00f3logas y cepas de reciente aparici\u00f3n. Por un lado, la investigaci\u00f3n en vacunas de nueva generaci\u00f3n, ha tenido buena aceptaci\u00f3n, debido a la posibilidad de seleccionar la informaci\u00f3n gen\u00e9tica del virus para estimular la respuesta inmune protectora del hospedero y, por otro, porque se acelera el desarrollo de vacunas, e incluso, es posible evitar las infecciones de las cuales es responsable el virus vacunal.\n[A Rapid Detection Method of Brucella with Quantum Dots and Magnetic Beads Conjugated with Different Polyclonal Antibodies](http://adsabs.harvard.edu/abs/2017NRL....12..179S)\nSong, Dandan; Qu, Xiaofeng; Liu, Yushen; Li, Li; Yin, Dehui; Li, Juan; Xu, Kun; Xie, Renguo; Zhai, Yue; Zhang, Huiwen; Bao, Hao; Zhao, Chao; Wang, Juan; Song, Xiuling; Song, Wenzhi\n2017-03-01\nBrucella spp. are facultative intracellular bacteria that cause zoonotic disease of brucellosis worldwide. Traditional methods for detection of Brucella spp. take 48-72 h that does not meet the need of rapid detection. Herein, a new rapid detection method of Brucella was developed based on polyclonal antibody-conjugating quantum dots and antibody-modified magnetic beads. First, polyclonal antibodies IgG and IgY were prepared and then the antibody conjugated with quantum dots (QDs) and immunomagnetic beads (IMB), respectively, which were activated by N-(3-dimethylaminopropyl)- N'-ethylcar-bodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS) to form probes. We used the IMB probe to separate the Brucella and labeled by the QD probe, and then detected the fluorescence intensity with a fluorescence spectrometer. The detection method takes 105 min with a limit of detection of 103 CFU/mL and ranges from 10 to 105 CFU/mL ( R 2 = 0.9983), and it can be well used in real samples.\nInstituto Nacional de Salud\n2007-01-01\nLa vacunaci\u00f3n es uno de los hallazgos cient\u00edficos m\u00e1s importantes de todos los tiempos. Es innegable su importancia en la prevenci\u00f3n y el control de las enfermedades infecciosas, logrando la erradicaci\u00f3n de alguna de ellas. Las vacunas, sin embargo, al igual que cualquier otro medicamento, no est\u00e1n libres de presentar efectos secundarios, la mayor parte de \u00e9stos corresponden a casos leves y muy rara vez a casos particularmente graves. Est\u00e1 reconocido que las vacunas podr\u00edan producir anafil...\n[Development of a bead-based Luminex assay using lipopolysaccharide specific monoclonal antibodies to detect biological threats from Brucella species.](https://www.ncbi.nlm.nih.gov/pubmed/26438077)\nSilbereisen, Angelika; Tamborrini, Marco; Wittwer, Matthias; Sch\u00fcrch, Nadia; Pluschke, Gerd\n2015-10-05\nBrucella, a Gram-negative bacterium, is classified as a potential bioterrorism agent mainly due to the low dose needed to cause infection and the ability to transmit the bacteria via aerosols. Goats/sheep, cattle, pigs, dogs, sheep and rodents are infected by B. melitensis, B. abortus, B. suis, B. canis, B. ovis and B. neotomae, respectively, the six classical Brucella species. Most human cases are caused by B. melitensis and B. abortus. Our aim was to specifically detect Brucellae with 'smooth' lipopolysaccharide (LPS) using a highly sensitive monoclonal antibody (mAb) based immunological assay. To complement molecular detection systems for potential bioterror agents, as required by international biodefense regulations, sets of mAbs were generated by B cell hybridoma technology and used to develop immunological assays. The combination of mAbs most suitable for an antigen capture assay format was identified and an immunoassay using the Luminex xMAP technology was developed. MAbs specific for the LPS O-antigen of Brucella spp. were generated by immunising mice with inactivated B. melitensis or B. abortus cells. Most mAbs recognised both B. melitensis and B. abortus and antigen binding was not impeded by inactivation of the bacterial cells by \u03b3 irradiation, formalin or heat treatment, a step required to analyse the samples immunologically under biosafety level two conditions. The Luminex assay recognised all tested Brucella species with 'smooth' LPS with detection limits of 2\u00d710(2) to 8\u00d710(4) cells per mL, depending on the species tested. Milk samples spiked with Brucella spp. cells were identified successfully using the Luminex assay. In addition, the bead-based immunoassay was integrated into a multiplex format, allowing for simultaneous, rapid and specific detection of Brucella spp., Bacillus anthracis, Francisella tularensis and Yersinia pestis within a single sample. Overall, the robust Luminex assay should allow detection of Brucella spp. in both natural\n[Serological survey of Brucella canis in dogs in urban Harare and selected rural communities in Zimbabwe](https://jsava.co.za/index.php/jsava/article/view/1087) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSimbarashe Chinyoka\n2014-04-01\nFull Text Available A cross-sectional study was conducted in order to detect antibodies for Brucella canis (B. canis in dogs from urban Harare and five selected rural communities in Zimbabwe. Sera from randomly selected dogs were tested for antibodies to B. canis using an enzyme-linked immunosorbent assay. Overall, 17.6% of sera samples tested (57/324, 95% CI: 13.5\u201321.7 were positive for B. canis antibodies. For rural dogs, seroprevalence varied from 11.7% \u2013 37.9%. Rural dogs recorded a higher seroprevalence (20.7%, 95% CI: 15.0\u201326.4 compared with Harare urban dogs (12.7%, 95% CI: 6.9\u201318.5 but the difference was not significant (p = 0.07. Female dogs from both sectors had a higher seroprevalence compared with males, but the differences were not significant (p > 0.05. Five and two of the positive rural dogs had titres of 1:800 and 1:1600, respectively, whilst none of the positive urban dogs had a titre above 1:400. This study showed that brucellosis was present and could be considered a risk to dogs from the studied areas. Further studies are recommended in order to give insight into the epidemiology of brucellosis in dogs and its possible zoonotic consequences in Zimbabwe. Screening for other Brucella spp. (Brucella abortus, Brucella melitensis and Brucella suis other than B. canis is also recommended.\n[First isolation and characterization of Brucella microti from wild boar.](https://www.ncbi.nlm.nih.gov/pubmed/26163135)\nR\u00f3nai, Zsuzsanna; Kreizinger, Zsuzsa; D\u00e1n, \u00c1d\u00e1m; Drees, Kevin; Foster, Jeffrey T; B\u00e1nyai, Kriszti\u00e1n; Marton, Szilvia; Szeredi, Levente; J\u00e1nosi, Szil\u00e1rd; Gyuranecz, Mikl\u00f3s\n2015-07-11\nBrucella microti was first isolated from common vole (Microtus arvalis) in the Czech Republic in Central Europe in 2007. As B. microti is the only Brucella species known to live in soil, its distribution, ecology, zoonotic potential, and genomic organization is of particular interest. The present paper is the first to report the isolation of B. microti from a wild boar (Sus scrofa), which is also the first isolation of this bacterial species in Hungary. The B. microti isolate was cultured, after enrichment in Brucella-selective broth, from the submandibular lymph node of a female wild boar that was taken by hunters in Hungary near the Austrian border in September 2014. Histological and immunohistological examinations of the lymph node sections with B. abortus-, B. suis- and B. canis-specific sera gave negative results. The isolate did not require CO2 for growth, was oxidase, catalase, and urease positive, H2S negative, grew well in the presence of 20 \u03bcg/ml basic fuchsin and thionin, and had brownish pigmentation after three days of incubation. It gave strong positive agglutination with anti-A and anti-M but had a negative reaction with anti-R monospecific sera. The API 20 NE test identified it as Ochrobactrum anthropi with 99.9% identity, and it showed B. microti-specific banding pattern in the Bruce- and Suis-ladder multiplex PCR systems. Whole genome re-sequencing identified 30 SNPs in orthologous loci when compared to the B. microti reference genome available in GenBank, and the MLVA analysis yielded a unique profile. Given that the female wild boar did not develop any clinical disease, we hypothesize that this host species only harboured the bacterium, serving as a possible reservoir capable of maintaining and spreading this pathogen. The infectious source could have been either a rodent, a carcass that had been eaten or infection occurred via the boar rooting in soil. The low number of discovered SNPs suggests an unexpectedly high level of genetic homogeneity\n[Mutant Brucella abortus membrane fusogenic protein induces protection against challenge infection in mice.](https://www.ncbi.nlm.nih.gov/pubmed/25644010)\nde Souza Filho, Job Alves; de Paulo Martins, Vicente; Campos, Priscila Carneiro; Alves-Silva, Juliana; Santos, Nathalia V; de Oliveira, Fernanda Souza; Menezes, Gustavo B; Azevedo, Vasco; Cravero, Silvio Lorenzo; Oliveira, Sergio Costa\n2015-04-01\nBrucella species can cause brucellosis, a zoonotic disease that causes serious livestock economic losses and represents a public health threat. The mechanism of virulence of Brucella spp. is not yet fully understood. Therefore, it is crucial to identify new molecules that serve as virulence factors to better understand this host-pathogen interplay. Here, we evaluated the role of the Brucella membrane fusogenic protein (Mfp) and outer membrane protein 19 (Omp19) in bacterial pathogenesis. In this study, we showed that B. abortus \u0394mfp::kan and \u0394omp19::kan deletion mutant strains have reduced persistence in vivo in C57BL/6 and interferon regulatory factor 1 (IRF-1) knockout (KO) mice. Additionally, 24 h after macrophage infection with a \u0394mfp::kan or \u0394omp19::kan strain expressing green fluorescent protein (GFP) approximately 80% or 65% of Brucella-containing vacuoles (BCVs) retained the late endosomal/lysosomal marker LAMP-1, respectively, whereas around 60% of BCVs containing wild-type S2308 were found in LAMP-1-negative compartments. B. abortus \u0394omp19::kan was attenuated in vivo but had a residual virulence in C57BL/6 and IRF-1 KO mice, whereas the \u0394mfp::kan strain had a lower virulence in these same mouse models. Furthermore, \u0394mfp::kan and \u0394omp19::kan strains were used as live vaccines. Challenge experiments revealed that in C57BL/6 and IRF-1 KO mice, the \u0394mfp::kan strain induced greater protection than the vaccine RB51 and protection similar that of vaccine S19. However, a \u0394omp19::kan strain induced protection similar to that of RB51. Thus, these results demonstrate that Brucella Mfp and Omp19 are critical for full bacterial virulence and that the \u0394mfp::kan mutant may serve as a potential vaccine candidate in future studies. Copyright \u00a9 2015, American Society for Microbiology. All Rights Reserved.\n[[Determination of in vitro susceptibilities of Brucella spp. strains against 11 different antibacterial gents isolated from blood cultures].](https://www.ncbi.nlm.nih.gov/pubmed/28929962)\nKe\u015fli, Recep; Bilgin, H\u00fcseyin; Y\u0131lmaz, Halim\n2017-07-01\nBrucellosis is a worldwide zoonotic disease and still continuous to be a major public health problem. In this study, it was aimed to identify the Brucella strains to the species level isolated from blood cultures, and to determine the rate of antimicrobial susceptibility against eleven antibacterial agents. A total of 106 Brucella spp. strains were included in the study, which were isolated from blood cultures in University of Health Sciences, Konya Training and Research Hospital, Medical Microbiology Laboratory between January 2011 and June 2013. Identification of the isolated strains were mainly based on conventional methods. In vitro antibacterial susceptibilities of azithromycin, ciprofloxacin, doxycycline, gentamicin, levofloxacin, moxifloxacin, rifampicin, streptomycin, tetracycline, tigecycline, and trimethoprim/sulfamethoxazole, were evaluated by using the gradient (E-test, bioMerieux, France) strip method. The bacterial suspensions adjusted to 0.5 McFarland turbidity was inoculated to Mueller Hinton agar plates, supplemented with 5% sheep blood, and E-test strips of selected antibacterial were applied. The plates were incubated in ambient air 48 hours at 37\u00baC and Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 29213 were used as quality control strains for antimicrobial susceptibility testing. Minimum inhibitors concentration (MIC) values were interpreted according to Clinical and Laboratory Standards Institute (CLSI) guidelines for slow-growing bacteria such as Haemophilus spp. Of the 106 Brucella spp. strains included in to the study, 90 were identified as Brucella melitensis, and 16 were Brucella abortus. MIC90 values of azithromycin, ciprofloxacin, doxycycline, gentamicin, levofloxacin, moxifloxacin, rifampicin, streptomycin, tetracycline, tigecycline, and trimethoprim/sulfamethoxazole were determined as 1 \u00b5g/ml, 0.25 \u00b5g/ml, 0.19 \u00b5g/ml, 0.25 \u00b5g/ml, 0.19 \u00b5g/ml, 0.75 \u00b5g/ml, 0.25 \u00b5g/ml, 0.75 \u00b5g/ml, 0.38 \u00b5g/ml, 0.64 \u00b5g/ml, and 0\n[Computational prediction of secretion systems and secretomes of Brucella: identification of novel type IV effectors and their interaction with the host.](https://www.ncbi.nlm.nih.gov/pubmed/26575364)\nSankarasubramanian, Jagadesan; Vishnu, Udayakumar S; Dinakaran, Vasudevan; Sridhar, Jayavel; Gunasekaran, Paramasamy; Rajendhran, Jeyaprakash\n2016-01-01\nBrucella spp. are facultative intracellular pathogens that cause brucellosis in various mammals including humans. Brucella survive inside the host cells by forming vacuoles and subverting host defence systems. This study was aimed to predict the secretion systems and the secretomes of Brucella spp. from 39 complete genome sequences available in the databases. Furthermore, an attempt was made to identify the type IV secretion effectors and their interactions with host proteins. We predicted the secretion systems of Brucella by the KEGG pathway and SecReT4. Brucella secretomes and type IV effectors (T4SEs) were predicted through genome-wide screening using JVirGel and S4TE, respectively. Protein-protein interactions of Brucella T4SEs with their hosts were analyzed by HPIDB 2.0. Genes coding for Sec and Tat pathways of secretion and type I (T1SS), type IV (T4SS) and type V (T5SS) secretion systems were identified and they are conserved in all the species of Brucella. In addition to the well-known VirB operon coding for the type IV secretion system (T4SS), we have identified the presence of additional genes showing homology with T4SS of other organisms. On the whole, 10.26 to 14.94% of total proteomes were found to be either secreted (secretome) or membrane associated (membrane proteome). Approximately, 1.7 to 3.0% of total proteomes were identified as type IV secretion effectors (T4SEs). Prediction of protein-protein interactions showed 29 and 36 host-pathogen specific interactions between Bos taurus (cattle)-B. abortus and Ovis aries (sheep)-B. melitensis, respectively. Functional characterization of the predicted T4SEs and their interactions with their respective hosts may reveal the secrets of host specificity of Brucella.\n[Brucella Genetic Variability in Wildlife Marine Mammals Populations Relates to Host Preference and Ocean Distribution.](https://www.ncbi.nlm.nih.gov/pubmed/28854602)\nSu\u00e1rez-Esquivel, Marcela; Baker, Kate S; Ruiz-Villalobos, Nazareth; Hern\u00e1ndez-Mora, Gabriela; Barquero-Calvo, El\u00edas; Gonz\u00e1lez-Barrientos, Roc\u00edo; Castillo-Zeled\u00f3n, Amanda; Jim\u00e9nez-Rojas, C\u00e9sar; Chac\u00f3n-D\u00edaz, Carlos; Cloeckaert, Axel; Chaves-Olarte, Esteban; Thomson, Nicholas R; Moreno, Edgardo; Guzm\u00e1n-Verri, Caterina\n2017-07-01\nIntracellular bacterial pathogens probably arose when their ancestor adapted from a free-living environment to an intracellular one, leading to clonal bacteria with smaller genomes and less sources of genetic plasticity. Still, this plasticity is needed to respond to the challenges posed by the host. Members of the Brucella genus are facultative-extracellular intracellular bacteria responsible for causing brucellosis in a variety of mammals. The various species keep different host preferences, virulence, and zoonotic potential despite having 97-99% similarity at genome level. Here, we describe elements of genetic variation in Brucella ceti isolated from wildlife dolphins inhabiting the Pacific Ocean and the Mediterranean Sea. Comparison with isolates obtained from marine mammals from the Atlantic Ocean and the broader Brucella genus showed distinctive traits according to oceanic distribution and preferred host. Marine mammal isolates display genetic variability, represented by an important number of IS711 elements as well as specific IS711 and SNPs genomic distribution clustering patterns. Extensive pseudogenization was found among isolates from marine mammals as compared with terrestrial ones, causing degradation in pathways related to energy, transport of metabolites, and regulation/transcription. Brucella ceti isolates infecting particularly dolphin hosts, showed further degradation of metabolite transport pathways as well as pathways related to cell wall/membrane/envelope biogenesis and motility. Thus, gene loss through pseudogenization is a source of genetic variation in Brucella, which in turn, relates to adaptation to different hosts. This is relevant to understand the natural history of bacterial diseases, their zoonotic potential, and the impact of human interventions such as domestication. \u00a9 The Author 2017. Published by Oxford University Press on behalf of the Society for Molecular Biology and Evolution.\n[Clinical and Diagnostic Aspects of Brucellosis and Antimicrobial Susceptibility of Brucella Isolates in Hamedan, Iran.](https://www.ncbi.nlm.nih.gov/pubmed/27580575)\nTorkaman Asadi, Fatemeh; Hashemi, Seyyed Hamid; Alikhani, Mohammad Yousef; Moghimbeigi, Abbas; Naseri, Zahra\n2017-05-24\nCurrent drug regimens for brucellosis are associated with relatively high rates of therapeutic failure or relapse. Reduced antimicrobial susceptibility of Brucella spp. has been proposed recently as a potential cause of therapeutic failure. The aim of this study was to evaluate the antibiotic resistance pattern of Brucella melitensis clinical isolates by E-test method in Hamadan, west of Iran. In a 15-month period, all patients with suspected brucellosis were enrolled. Blood specimens were collected for diagnosis of brucellosis by BACTEC system and serological tests. Antimicrobial susceptibility of clinical isolates to 7 antibiotics was assessed by the E-test method. One hundred forty-nine patients with brucellosis were evaluated. 38.3% of cultures of clinical samples were positive for BACTEC system, of which 91.2% were associated with a positive serological test result. No significant associations were found between serology and the culture method. All Brucella isolates were susceptible to doxycycline, streptomycin, gentamicin, ciprofloxacin, and moxifloxacin. However, decreased sensitivity to rifampin and trimethoprim-sulfamethoxazole was found in 35.1% and 3.5% of isolates, respectively. Because of the high rates of intermediate sensitivity to rifampin among Brucella isolates, this drug should be prescribed with caution. We recommend restricting the use of rifampin for treatment of brucellosis except as an alternative drug for special situations.\n[Brucellosis caused by the wood rat pathogen Brucella neotomae: two case reports.](https://www.ncbi.nlm.nih.gov/pubmed/29254496)\nVillalobos-Vindas, Juan M; Amuy, Ernesto; Barquero-Calvo, El\u00edas; Rojas, Norman; Chac\u00f3n-D\u00edaz, Carlos; Chaves-Olarte, Esteban; Guzman-Verri, Caterina; Moreno, Edgardo\n2017-12-19\nBrucellosis is a chronic bacterial disease caused by members of the genus Brucella. Among the classical species stands Brucella neotomae, until now, a pathogen limited to wood rats. However, we have identified two brucellosis human cases caused by B. neotomae, demonstrating that this species has zoonotic potential. Within almost 4 years of each other, a 64-year-old Costa Rican white Hispanic man and a 51-year-old Costa Rican white Hispanic man required medical care at public hospitals of Costa Rica. Their hematological and biochemical parameters were within normal limits. No adenopathies or visceral abnormalities were found. Both patients showed intermittent fever, disorientation, and general malaise and a positive Rose Bengal test compatible with Brucella infection. Blood and cerebrospinal fluid cultures rendered Gram-negative coccobacilli identified by genomic analysis as B. neotomae. After antibiotic treatment, the patients recovered with normal mental activities. This is the first report describing in detail the clinical disease caused by B. neotomae in two unrelated patients. In spite of previous claims, this bacterium keeps zoonotic potential. Proposals to generate vaccines by using B. neotomae as an immunogen must be reexamined and countries housing the natural reservoir must consider the zoonotic risk.\n[A potent Brucella abortus 2308 \u0394ery live vaccine allows for the differentiation between natural and vaccinated infection.](https://www.ncbi.nlm.nih.gov/pubmed/24994009)\nZhang, Junbo; Yin, Shuanghong; Guo, Fei; Meng, Ren; Chen, Chuangfu; Zhang, Hui; Li, Zhiqiang; Fu, Qiang; Shi, Huijun; Hu, Shengwei; Ni, Wei; Li, Tiansen; Zhang, Ke\n2014-08-01\nBrucellosis is a globally distributed zoonotic disease that causes animal and human diseases. However, the current Brucella abortus vaccines (S19 and RB51) are deficient; they can cause abortion in pregnant animals. Moreover, when the vaccine S19 is used, tests cannot differentiate natural from vaccinated infection. Therefore, a safer and more potent vaccine is needed. A Brucella abortus 2308 ery promoter mutant (\u0394ery) was constructed to overcome these drawbacks. The growth of the \u0394ery mutant was significantly attenuated in macrophages and mice and induced high protective immunity in mice. Moreover, \u0394ery induced an anti-Brucella-specific IgG (immunoglobulin G) response and stimulated the expression of interferon-gamma (INF-\u03b3) and interleukin-4 (IL-4). Furthermore, the expression of EryA antigen allowed for the serological differentiation between natural and vaccinated infection in mice. These results indicate that the \u0394ery mutant is a potential attenuated live vaccine candidate against virulent Brucella abortus 2308 (S2308) infection.\n[Cloning and Expression of 31kDa Outer Membrane Protein of Brucella melitansis in E.coli](http://jarums.arums.ac.ir/browse.php?a_code=A-10-27-123&slc_lang=en&sid=1) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nSayeneh Khodadadi\n2012-04-01\nFull Text Available Background & Objectives: The identification of Brucella spp. antigens with the capacity to elicit a protective immune response is of the great interest for the researchers. So, characterization and assessment of diverse antigens of Brucella need to be evaluated. In this study, we report the cloning and expression of the gene coding for 31 KDa OMP (OMP31 of Brucella melitensis 16M. Methods: Brucella melitensis Omp31 gene was amplified with specific primers, cloned into pJET1/2 and subsequently subcloned in pET28a (+ vector. Both these recombinant plasmids were sequenced and then after, expression of recombinant protein was induced by 1mM IPTG. Western blot analysis was also performed by polyclonal rabbit antiserum. Results: Omp31 successfully was cloned in both plasmid vectors. The recombinant Omp31 was expressed in E.coli host and purified with significant yield. Western blot results along with those of sequencing ensured accurate production of recombinant omp31 and retaining of its partial epitopes. Conclusion: Our results show that, an expression host such as E. coli is suitable for omp31 production.\n[Brucella pinnipedialis hooded seal (Cystophora cristata) strain in the mouse model with concurrent exposure to PCB 153.](https://www.ncbi.nlm.nih.gov/pubmed/24534631)\nNymo, Ingebj\u00f8rg H; das Neves, Carlos G; Tryland, Morten; B\u00e5rdsen, B\u00e5rd-J\u00f8rgen; Santos, Renato Lima; Turchetti, Andreia Pereira; Janczak, Andrew M; Dj\u00f8nne, Berit; Lie, Elisabeth; Berg, Vidar; Godfroid, Jacques\n2014-05-01\nBrucellosis, a worldwide zoonosis, is linked to reproductive problems in primary hosts. A high proportion of Brucella-positive hooded seals (Cystophora cristata) have been detected in the declined Northeast Atlantic stock. High concentrations of polychlorinated biphenyls (PCBs) have also been discovered in top predators in the Arctic, including the hooded seal, PCB 153 being most abundant. The aim of this study was to assess the pathogenicity of Brucella pinnipedialis hooded seal strain in the mouse model and to evaluate the outcome of Brucella spp. infection after exposure of mice to PCB 153. BALB/c mice were infected with B. pinnipedialis hooded seal strain or Brucella suis 1330, and half from each group was exposed to PCB 153 through the diet. B. pinnipedialis showed a reduced pathogenicity in the mouse model as compared to B. suis 1330. Exposure to PCB 153 affected neither the immunological parameters, nor the outcome of the infection. Altogether this indicates that it is unlikely that B. pinnipedialis contribute to the decline of hooded seals in the Northeast Atlantic. Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.\n[Tiempo libre de enfermedad en infecciones urinarias recurrentes seg\u00fan profilaxis con antibi\u00f3tico o con vacuna bacteriana](https://www.openaire.eu/search/publication?articleId=dedup_wf_001::f118b21a924c80aa9ffde3c6916975f2)\nSanto Bueno, Pedro Jos\u00e9\n2014-01-01\n[ES]Estudio comparativo de dos tipos de tratamientos profilacticos, antibioterapia supresiva y vacuna bacteriana, en infecciones urinarias de repetici\u00f3n, para determinar el tiempo libre de enfermedad, entendida como el tiempo transcurrido entre la finalizaci\u00f3n de la profilaxis y la aparici\u00f3n de un episodio de infeccion urinario.\n[A study using an isotope probe comparing immunoassay with serology in detection of Brucella Abortus antibody](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=18036747) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nDevlin, J.G.; Redington, F.; Stephenson, M.\n1986-01-01\nWe report a comparison of radio-immunoassay with conventional serology in the detection of brucella abortus antibody from three laboratories. Overall agreement by Chi squared analysis is 5%. There are significant differences between laboratories and a significant number of sero negative suspect sera (from 20% - 60%) were positive by ratio-immunoassay test. We suspect that conventional serology under-reports the incidence of antibody to brucella abortus. (author)\n[Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996 Prevalencia de anticuerpos contra sarampi\u00f3n, paperas y rub\u00e9ola en ni\u00f1os en edad escolar antes y despu\u00e9s de la vacunaci\u00f3n con tres vacunas triples antivirales combinadas diferentes, Rio Grande do Sul, Brasil, 1996](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006001000002) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nBoaventura Ant\u00f4nio dos Santos\n2006-11-01\nvacunaci\u00f3n a ni\u00f1os de dos escuelas municipales de Rio Grande do Sul, Brasil, durante 1996. Se investig\u00f3 la seropositividad de anticuerpos de la clase IgG mediante un ensayo de inmunoadsorci\u00f3n enzim\u00e1tica tipo ELISA (sarampi\u00f3n y paperas con Enzygnost [Behring, Marburgo, Alemania] y rub\u00e9ola con Rubenostika [Organon Teknica, Boxtel, Pa\u00edses Bajos]. Las vacunas comparadas fueron: a E-Zagreb, L-Zagreb y Wistar RA 27/3 (Tresivac; b Moraten, J-Lynn y Wistar RA 27/3 (M-M-R II; y c Schwarz, Urabe AM-9 y Wistar RA 27/3 (Trimovax. RESULTADOS: Antes de la vacunaci\u00f3n, 79,2% (intervalo de confianza [IC] 95%: 76,0 a 82,2 de las muestras fueron positivas para sarampi\u00f3n, 69,4% (IC 95%: 65,8 a 72,8 para paperas y 55,4% (IC 95%: 51,6 a 59,2 para rub\u00e9ola. Despu\u00e9s de la vacunaci\u00f3n con las vacunas A, B y C, la seropositividad fue de 100%, 99,5% y 100%, respectivamente para sarampi\u00f3n; de 99,5%, 94,5% y 92,0% para paperas; y de 92,6%, 92,3% y 88,6% para rub\u00e9ola. CONCLUSIONES: Alrededor de un quinto (20,8% de los escolares que pudieron haber sido vacunados contra el sarampi\u00f3n a los 9 meses de edad ten\u00edan niveles de anticuerpos insuficientes para protegerlos. En la muestra de escolares sin vacunaci\u00f3n previa contra paperas y rub\u00e9ola se encontr\u00f3 una alta proporci\u00f3n de ni\u00f1os susceptibles. Todas las vacunas fueron inmunog\u00e9nicas, pero la vacuna A produjo una tasa de seroconversi\u00f3n de 99,5% para el componente de paperas, significativamente mayor que la de las otras dos vacunas (P < 0,01.\n[Detection of virulence-associated genes in Brucella melitensis ...](https://www.ajol.info/index.php/ovj/article/download/168985/158449) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nIbrahim Eldaghayes\n2018-03-20\nMar 20, 2018 ... isolated from goats. This discrepancies may indicate that B. melitensis field strains prevailing in Egypt are more virulent than the strains of B. melitensis isolated from caprines in Iran. As, it was emphasized that the. T4SS of Brucella encoded by the virB operon is a major virulence factor (Delrue et al., 2005).\n[Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5638537)\nMailybayeva, Aigerim; Yespembetov, Bolat; Ryskeldinova, Sholpan; Zinina, Nadezhda; Sansyzbay, Abylai; Renukaradhya, Gourapura J.; Petrovsky, Nikolai\n2017-01-01\nWe previously developed a potent candidate vaccine against bovine brucellosis caused by Brucella abortus using the influenza viral vector expressing Brucella Omp16 and L7/L12 proteins (Flu-BA). Our success in the Flu-BA vaccine trial in cattle and results of a pilot study in non-pregnant small ruminants prompted us in the current study to test its efficacy against B. melitensis infection in pregnant sheep and goats. In this study, we improved the Flu-BA vaccine formulation and immunization method to achieve maximum efficacy and safety. The Flu-BA vaccine formulation had two additional proteins Omp19 and SOD, and administered thrice with 20% Montanide Gel01 adjuvant, simultaneously by both subcutaneous and conjunctival routes at 21 days intervals in pregnant sheep and goats. At 42 days post-vaccination (DPV) we detected antigen-specific IgG antibodies predominantly of IgG2a isotype but also IgG1, and also detected a strong lymphocyte recall response with IFN-\u03b3 production. Importantly, our candidate vaccine prevented abortion in 66.7% and 77.8% of pregnant sheep and goats, respectively. Furthermore, complete protection (absence of live B. melitensis 16M) was observed in 55.6% and 66.7% of challenged sheep and goats, and 72.7% and 90.0% of their fetuses (lambs/yeanlings), respectively. The severity of B. melitensis 16M infection in vaccinated sheep and goats and their fetuses (index of infection and rates of Brucella colonization in tissues) was significantly lower than in control groups. None of the protection parameters after vaccination with Flu-BA vaccine were statistically inferior to protection seen with the commercial B. melitensis Rev.1 vaccine (protection against abortion and vaccination efficacy, alpha = 0.18\u20130.34, infection index, P = 0.37\u20130.77, Brucella colonization, P = 0.16 to P > 0.99). In conclusion, our improved Flu-BA vaccine formulation and delivery method were found safe and effective in protecting pregnant sheep and goats against adverse\n[Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.](https://www.ncbi.nlm.nih.gov/pubmed/26709638)\nTabynov, Kaissar; Yespembetov, Bolat; Ryskeldinova, Sholpan; Zinina, Nadezhda; Kydyrbayev, Zhailaubay; Kozhamkulov, Yerken; Inkarbekov, Dulat; Sansyzbay, Abylai\n2016-01-20\nThis study analyzed the duration of the antigen-specific humoral and T-cell immune responses and protectiveness of a recently-developed influenza viral vector Brucella abortus (Flu-BA) vaccine expressing Brucella proteins Omp16 and L7/L12 and containing the adjuvant Montadine Gel01 in cattle. At 1 month post-booster vaccination (BV), both humoral (up to 3 months post-BV; GMT IgG ELISA titer 214\u00b155 to 857\u00b1136, with a prevalence of IgG2a over IgG1 isotype antibodies) and T-cell immune responses were observed in vaccinated heifers (n=35) compared to control animals (n=35, injected with adjuvant/PBS only). A pronounced T-cell immune response was induced and maintained for 12 months post-BV, as indicated by the lymphocyte stimulation index (2.7\u00b10.4 to 10.1\u00b10.9 cpm) and production of IFN-\u03b3 (13.7\u00b11.7 to 40.0\u00b13.0 ng/ml) at 3, 6, 9, and 12 months post-BV. Prime-boost vaccination provided significant protection against B. abortus infection at 3, 6, 9 and 12 months (study duration) post-BV (7 heifers per time point; alpha=0.03-0.01 vs. control group). Between 57.1 and 71.4% of vaccinated animals showed no signs of B. abortus infection (or Brucella isolation) at 3, 6, 9 and 12 months post-BV; the severity of infection, as indicated by the index of infection (P=0.0003 to Brucella colonization (P=0.03 to abortus infection was also observed among pregnant vaccinated heifers (alpha=0.03), as well as their fetuses and calves (alpha=0.01), for 12 months post-BV. Additionally, 71.4% of vaccinated heifers calved successfully whereas all pregnant control animals aborted (alpha=0.01). Prime-boost vaccination of cattle with Flu-BA induces an antigen-specific humoral and pronounced T cell immune response and most importantly provides good protectiveness, even in pregnant heifers, for at least 12 months post-BV. Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.\n[Comparison of brucella and non-specific epididymorchitis: gray scale and color Doppler ultrasonographic features](http://dx.doi.org/10.1016/j.ejrad.2005.01.008) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nOzturk, Adil; Ozturk, Ebru; Zeyrek, Fadile; Onur, Kahraman; Sirmatel, Ocal; Kat, Nurcan\n2005-01-01\nObjective: The aim of this study is to find out if it is possible to differentiate between brucellar and non-specific epididymorchitis by comparing ultrasonography (US) and color Doppler ultrasonography (CDUS) findings. Material and methods: Fifty-six patients diagnosed to have epididymorchitis both clinically and ultrasonographically were included to study. All of the patients were investigated serologically for brucella. Twenty-eight of those patients were admitted brucella epididymorchitis because of high agglutinations titers for brucella. The other 28 patients were admitted non-specific epididymorchitis because of normal agglutinations titers for brucella. Testicular size, echogenicity, hydrocele, internal echoes and/or septations within hydrocele, and scrotal skin thickness of normal and involved testis were compared by ultrasonography. Besides, pick systolic velocity, end diastolic velocity, resistive index and pick systolic velocity ratio values were measured by bilateral testicular color Doppler ultrasonography in both groups. When the p-value is <0.05, the difference between groups is accepted as statistically significant. Results: Thickening of scrotal skin was seen in 17 of 28 patients with brucella epididymorchitis (BEPO) (67%) and in 25 of 28 patients with non-specific epididymorchitis (NEPO) (89.2%) (p < 0.01). There was no difference between groups regarding presence of hydrocele. However hydrocele seen in all patients was anechoic except for two patients (8.6%). Hydrocele seen in 18 of 22 patients with BEPO and hydrocele had internal echogenicity or septation (p < 0.001). Sizes of testes and epididymis were found to be increased in involved testis compared to normal testis. Testes of all patients with NEPO were homogenous with decreased echogenicity except for five patients (17.8%). However, 23 patients with BEPO (82%) found to have heterogenous testis (p < 0.001). Spectral measurements showed increased PSV and EDV values and decreased RI values in\n[Comparison of brucella and non-specific epididymorchitis: gray scale and color Doppler ultrasonographic features](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=20694750) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nOzturk, Adil [Department of Radiology, Harran University School of Medicine, Arastirma ve Uygulama Hastanesi, TR-63100 Sanliurfa (Turkey)]. E-mail: ozturka26@hotmail.com; Ozturk, Ebru [Department of Radiology, Harran University School of Medicine, Arastirma ve Uygulama Hastanesi, TR-63100 Sanliurfa (Turkey); Zeyrek, Fadile [Department of Microbiology, Harran University School of Medicine, Sanliurfa (Turkey); Onur, Kahraman [Department of Urology, SSK Sanliurfa Hastanesi, Sanliurfa (Turkey); Sirmatel, Ocal [Department of Radiology, Harran University School of Medicine, Arastirma ve Uygulama Hastanesi, TR-63100 Sanliurfa (Turkey); Kat, Nurcan [Department of Radiology, Harran University School of Medicine, Arastirma ve Uygulama Hastanesi, TR-63100 Sanliurfa (Turkey)\n2005-11-01\nObjective: The aim of this study is to find out if it is possible to differentiate between brucellar and non-specific epididymorchitis by comparing ultrasonography (US) and color Doppler ultrasonography (CDUS) findings. Material and methods: Fifty-six patients diagnosed to have epididymorchitis both clinically and ultrasonographically were included to study. All of the patients were investigated serologically for brucella. Twenty-eight of those patients were admitted brucella epididymorchitis because of high agglutinations titers for brucella. The other 28 patients were admitted non-specific epididymorchitis because of normal agglutinations titers for brucella. Testicular size, echogenicity, hydrocele, internal echoes and/or septations within hydrocele, and scrotal skin thickness of normal and involved testis were compared by ultrasonography. Besides, pick systolic velocity, end diastolic velocity, resistive index and pick systolic velocity ratio values were measured by bilateral testicular color Doppler ultrasonography in both groups. When the p-value is <0.05, the difference between groups is accepted as statistically significant. Results: Thickening of scrotal skin was seen in 17 of 28 patients with brucella epididymorchitis (BEPO) (67%) and in 25 of 28 patients with non-specific epididymorchitis (NEPO) (89.2%) (p < 0.01). There was no difference between groups regarding presence of hydrocele. However hydrocele seen in all patients was anechoic except for two patients (8.6%). Hydrocele seen in 18 of 22 patients with BEPO and hydrocele had internal echogenicity or septation (p < 0.001). Sizes of testes and epididymis were found to be increased in involved testis compared to normal testis. Testes of all patients with NEPO were homogenous with decreased echogenicity except for five patients (17.8%). However, 23 patients with BEPO (82%) found to have heterogenous testis (p < 0.001). Spectral measurements showed increased PSV and EDV values and decreased RI values in\n[Immunological characteristics of outer membrane protein omp31 of goat Brucella and its monoclonal antibody.](https://www.ncbi.nlm.nih.gov/pubmed/26505344)\nZheng, W Y; Wang, Y; Zhang, Z C; Yan, F\n2015-10-05\nWe examined the immunological characteristics of outer membrane protein omp31 of goat Brucella and its monoclonal antibody. Genomic DNA from the M5 strain of goat Brucella was amplified by polymerase chain reaction and cloned into the prokaryotic expression vector pGEX-4T-1. The expression and immunological characteristics of the fusion protein GST-omp31 were subjected to preliminary western blot detection with goat Brucella rabbit immune serum. The Brucella immunized BALB/c mouse serum was detected using purified protein. The high-potency mouse splenocytes and myeloma Sp2/0 cells were fused. Positive clones were screened by enzyme-linked immunosorbent assay to establish a hybridoma cell line. Mice were inoculated intraperitoneally with hybridoma cells to prepare ascites. The mAb was purified using the n-caprylic acid-ammonium sulfate method. The characteristics of mAb were examined using western blotting and enzyme-linked immunosorbent assay. A 680-base pair band was observed after polymerase chain reaction. Enzyme digestion identification and sequencing showed that the pGEX-4T-1-omp31 prokaryotic expression vector was successfully established; a target band of approximately 57 kDa with an apparent molecular weight consistent with the size of the target fusion protein. At 25\u00b0C, the expression of soluble expression increased significantly; the fusion protein GST-omp31 was detected by western blotting. Anti-omp31 protein mAb was obtained from 2 strains of Brucella. The antibody showed strong specificity and sensitivity and did not cross-react with Escherichia coli, Staphylococcus aureus, Bacillus subtilis, Mycobacterium tuberculosis, or Bacillus pyocyaneus. The pGEX-4T-1-omp31 prokaryotic expression vector was successfully established and showed good immunogenicity. The antibody also showed strong specificity and good sensitivity.\n[Limitaciones del ensayo de toxicidad espec\u00edfica para el componente pertussis de c\u00e9lulas completas](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2008000300002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMario Landys Chovel\n2008-12-01\nFull Text Available Las vacunas que contienen c\u00e9lulas inactivadas de Bordetella pertussis se han utilizado con efectividad en los Programas Nacionales de Inmunizaci\u00f3n de todo el mundo. Pese a su reconocida eficacia, ellas se caracterizan por su elevada reactogenicidad, atribuible a la presencia de componentes como toxina pertussis y endotoxinas. Para monitorear la seguridad de estas vacunas existe el ensayo de ganancia en peso en ratones, el cual ha sido criticado por su inespecificidad, poca sensibilidad y alta variabilidad. Basado en lo anterior, el Laboratorio Nacional de Biol\u00f3gicos del Centro Estatal para el Control de de la Calidad de los Medicamentos en Cuba, decidi\u00f3 evaluar la relevancia de esta prueba para la liberaci\u00f3n de los lotes de la vacuna DPT. Para ello se estim\u00f3 la sensibilidad del m\u00e9todo para detectar diferentes concentraciones de endotoxinas y toxina pertussis, as\u00ed como la variabilidad entre ensayos. Los resultados de este trabajo mostraron que s\u00f3lo altas concentraciones de endotoxinas y toxina pertussis, muy superiores a las habituales en las vacunas DPT, provocan una disminuci\u00f3n de la ganancia en peso promedio y un fallo en la especificaci\u00f3n de la prueba. Este elemento y la inherente variabilidad de este m\u00e9todo resultaron claves en la decisi\u00f3n de no utilizarlo para la liberaci\u00f3n nacional de lotes de la vacuna DPT.\n[Limitaciones del ensayo de toxicidad espec\u00edfica para el componente pertussis de c\u00e9lulas completas](http://www.finlay.bvv.cu/vaccimonitor/Vm2008/a11.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nVicente Perdomo\n2008-01-01\nFull Text Available Las vacunas que contienen c\u00e9lulas inactivadas de Bordetella pertussis se han utilizado con efectividad en los Programas Nacionales de Inmunizaci\u00f3n de todo el mundo. Pese a su reconocida eficacia, ellas se caracterizan por su elevada reactogenicidad, atribuible a la presencia de componentes como toxina pertussis y endotoxinas. Paramonitorear la seguridad de estas vacunas existe el ensayo de ganancia en peso en ratones, el cual ha sido criticado por su inespecificidad, poca sensibilidad y alta variabilidad. Basado en lo anterior, el Laboratorio Nacional de Biol\u00f3gicos del Centro Estatal para el Control de de la Calidad de los Medicamentos en Cuba, decidi\u00f3 evaluar la relevancia de esta prueba para la liberaci\u00f3n de los lotes de la vacuna DPT. Para ello se estim\u00f3 la sensibilidad del m\u00e9todo para detectar diferentes concentraciones de endotoxinas y toxina pertussis, as\u00ed como la variabilidad entre ensayos. Los resultados de este trabajo mostraron que s\u00f3lo altas concentraciones de endotoxinas y toxina pertussis, muy superiores a las habituales en las vacunas DPT, provocan una disminuci\u00f3n de la ganancia en peso promedio y un fallo en la especificaci\u00f3n de la prueba. Este elemento y la inherente variabilidad de este m\u00e9todo resultaron claves en la decisi\u00f3n de no utilizarlo para la liberaci\u00f3n nacional de lotes de la vacuna DPT.\n[The attenuation effect of UVc radiation doses in gram-negative bacteria (Brucella, Yersinia, Escherichia coli)](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=38019855) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nAl-Mariri, A.\n2007-01-01\nThe gram-negative bacteria Yersinia enterocolitica sero group O:3 and O:9, and Brucella (Melitensis and abortus) together with Escherichia coli (O:157, DH5alpha-pEt15b), were investigated to evaluate their susceptibility to UV radiation at 254 nm. If the dose of UVc was 18.7 mW/cm2, the time required for inactivation of Y. enterocolitica and E. coli DH5alpha-pEt15b and O:157 was 240s and 360s in the dark and light respectively. Where if the dose was 19.5 mW/cm2, the time required was 60s in the dark and 120s in light respectively. The time required for inactivation of Brucella strains (melitensis and abortus) if the dose was 18.7 mW/cm2 was 240s in both dark and light, whereas it was 120s (dark) and 240s (light) respectively, when the dose was 19.5 mW/cm2. Using E. coli O:157 as control, it appears that Y. enterocolitica sero group O:3 and O:9 and vaccinal strains of Brucella (Rev. 1 and S19) are more sensitive to UV than wild Brucella strains. No relation was found between the sensitivity of Y. enterocolitica to UV and the presence or absence of a pYV+ virulence plasmid. (author)\n[Colony-level assessment of Brucella and Leptospira in the Guadalupe fur seal, Isla Guadalupe, Mexico.](https://www.ncbi.nlm.nih.gov/pubmed/28117297)\nZiehl-Quir\u00f3s, E Carolina; Garc\u00eda-Aguilar, Mar\u00eda C; Mellink, Eric\n2017-01-24\nThe relatively small population size and restricted distribution of the Guadalupe fur seal Arctocephalus townsendi could make it highly vulnerable to infectious diseases. We performed a colony-level assessment in this species of the prevalence and presence of Brucella spp. and Leptospira spp., pathogenic bacteria that have been reported in several pinniped species worldwide. Forty-six serum samples were collected in 2014 from pups at Isla Guadalupe, the only place where the species effectively reproduces. Samples were tested for Brucella using 3 consecutive serological tests, and for Leptospira using the microscopic agglutination test. For each bacterium, a Bayesian approach was used to estimate prevalence to exposure, and an epidemiological model was used to test the null hypothesis that the bacterium was present in the colony. No serum sample tested positive for Brucella, and the statistical analyses concluded that the colony was bacterium-free with a 96.3% confidence level. However, a Brucella surveillance program would be highly recommendable. Twelve samples were positive (titers 1:50) to 1 or more serovars of Leptospira. The prevalence was calculated at 27.1% (95% credible interval: 15.6-40.3%), and the posterior analyses indicated that the colony was not Leptospira-free with a 100% confidence level. Serovars Icterohaemorrhagiae, Canicola, and Bratislava were detected, but only further research can unveil whether they affect the fur seal population.\n[The attenuation effect of UVc radiation doses in gram-negative bacteria (Brucella, Yersinia, Escherichia coli)](http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/37/112/37112789.pdf?r=1) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nAl-Mariri, A.\n2006-06-01\nThe gram-negative bacteria Yersinia enterocolitica sero group O:3 and O:9, and Brucella (Melitensis and abortus) together with Escherichia coli (O:157, DH5\u03b1-pEt15b), were investigated to evaluate their susceptibility to UV radiation at 254 nm. If the dose of UVc was 18.7 mW/cm 2 , the time required for inactivation of Y. enterocolitica and E. coli DH5\u03b1-pEt15b and O:157 was 240s and 360s in the dark and light respectively; where if the dose was 19.5 mW/cm 2 , the time required was 60s in the dark and 120s in light respectively. The time required for inactivation of Brucella strains (melitensis and abortus) if the dose was 18.7 mW/cm 2 was 240s in both dark and light, whereas it was 120s(dark) and 240s (light) respectively, when the dose was 19.5 mW/cm 2 . Using E. coli O:157 as control, it appears that Y. enterocolitica sero group O:3 and O:9 and vaccinal strains of Brucella (Rev. 1 and S19) are more sensitive to UV than wild Brucella strains. No relation was found between the sensitivity of Y. enterocolitica to UV and the presence or absence of a pYV + virulence plasmid. (author)\n[Relative Quantitative Proteomic Analysis of Brucella abortus Reveals Metabolic Adaptation to Multiple Environmental Stresses.](https://www.ncbi.nlm.nih.gov/pubmed/29238329)\nZai, Xiaodong; Yang, Qiaoling; Yin, Ying; Li, Ruihua; Qian, Mengying; Zhao, Taoran; Li, Yaohui; Zhang, Jun; Fu, Ling; Xu, Junjie; Chen, Wei\n2017-01-01\nBrucella spp. are facultative intracellular pathogens that cause chronic brucellosis in humans and animals. The virulence of Brucella primarily depends on its successful survival and replication in host cells. During invasion of the host tissue, Brucella is simultaneously subjected to a variety of harsh conditions, including nutrient limitation, low pH, antimicrobial defenses, and extreme levels of reactive oxygen species (ROS) via the host immune response. This suggests that Brucella may be able to regulate its metabolic adaptation in response to the distinct stresses encountered during its intracellular infection of the host. An investigation into the differential proteome expression patterns of Brucella grown under the relevant stress conditions may contribute toward a better understanding of its pathogenesis and adaptive response. Here, we utilized a mass spectrometry-based label-free relative quantitative proteomics approach to investigate and compare global proteomic changes in B. abortus in response to eight different stress treatments. The 3 h short-term in vitro single-stress and multi-stress conditions mimicked the in vivo conditions of B. abortus under intracellular infection, with survival rates ranging from 3.17 to 73.17%. The proteomic analysis identified and quantified a total of 2,272 proteins and 74% of the theoretical proteome, thereby providing wide coverage of the B. abortus proteome. By including eight distinct growth conditions and comparing these with a control condition, we identified a total of 1,221 differentially expressed proteins (DEPs) that were significantly changed under the stress treatments. Pathway analysis revealed that most of the proteins were involved in oxidative phosphorylation, ABC transporters, two-component systems, biosynthesis of secondary metabolites, the citrate cycle, thiamine metabolism, and nitrogen metabolism; constituting major response mechanisms toward the reconstruction of cellular homeostasis and metabolic\n[MOTIVOS DA N\u00c3O ADES\u00c3O DE M\u00c3ES AO ESQUEMA VACINAL DE FILHOS EXPOSTOS AO HIV](http://www.redalyc.org/articulo.oa?id=324027986012) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaria do Socorro Mendon\u00e7a Sherlock\n2013-01-01\nFull Text Available El objetivo fue describir el conocimiento de madre seropositiva al VIH sobre el calendario de vacunaci\u00f3n del hijo y conocer las razones de no adhesi\u00f3n al esquema de vacunas del hijo. Estudio descriptivo, cualitativo, llevado a cabo en ambulatorio de instituci\u00f3n p\u00fablica de Fortaleza-CE, Brasil. Participaron 16 madres/cuidadoras de ni\u00f1os con hasta dos a\u00f1os expuestos al VIH/SIDA. Los datos fueron recolectados a trav\u00e9s de entrevista semiestructurada, de enero a marzo/2012. Del an\u00e1lisis, emergieron dos categor\u00edas: desconocimiento de la madre acerca de las vacunas especiales en ni\u00f1os con VIH y razones de la no adherencia al programa de vacunaci\u00f3n especial. Las madres presentaron deficiencia de conocimiento, se\u00f1alaron miedo y desinter\u00e9s por informaciones sobre la enfermedad y las medidas preventivas, adem\u00e1s de dificultades enfrentadas. Los profesionales de salud deben promover acciones con estas madres para integraci\u00f3n, responsabilidad y atenci\u00f3n acerca de la importancia de las vacunas a la salud del hijo.\n[Brucella abortus agglutinins in dogs in Zaria, Nigeria | Osinubi ...](https://www.ajol.info/index.php/nvj/article/view/3464) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nSerum samples from dogs brought for routine physical examination, vaccination and other complaints at the Veterinary Teaching Hospital (VTH) of Ahmadu Bello University and other parts of Zaria were tested for Brucella abortus antibodies. Forty-three (21.5%) of the 200 dogs studied were positive for B. abortus agglutinins ...\n[Structural changes in \u03b3-irradiated Brucella strain chemical vaccine](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17058913) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nDranovskaya, E.A.; Kulikov, V.I.\n1986-01-01\nIt was shown that \u03b3-irradiation of Brucella strain chemical vaccine stimulated phospholipid peroxidation therein: the content of extractable total phospholipids in the exposed vaccine decreased mainly due to diminution of phosphatidynatidylcholines and phosphatidylethanolamines. A relative content of high- and low-molecular weight protein componets increase in the \u03b3-irradiated vaccine\n[Prevalence of Brucella Antibodies in Migratory Fulani Cattle Herds ...](https://www.ajol.info/index.php/nvj/article/view/68999) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nBrucellosis is a major cause of economic losses such as abortion, infertility, low conception rate and low survival rate of neonates in the livestock industry and zoonoses of great public health significance. The prevalence of Brucella antibodies in migratory Fulani cattle in Kaduna State was determined using the Milk Ring ...\n[JST Thesaurus Headwords and Synonyms: Brucella melitensis biovar abortus [MeCab user dictionary for science technology term[Archive](https://togodb.biosciencedbc.jp/mecab_thesaurus/show/1451#en) [Lifescience Database Archive (English)](http://biosciencedbc.jp/dbsearch/index.php?lang=en)\nFull Text Available MeCab user dictionary for science technology term Brucella melitensis biovar abortu...s \u540d\u8a5e \u4e00\u822c * * * * \u30a6\u30b7\u6d41\u7523\u83cc \u30a6\u30b7\u30ea\u30e5\u30a6\u30b6\u30f3\u30ad\u30f3 \u30a6\u30b7\u30ea\u30e5\u30fc\u30b6\u30f3\u30ad\u30f3 Thesaurus2015 200906011165481664 C LS07 UNKNOWN_2 Brucella melitensis biovar abortus\n[Detection of virulence-associated genes in Brucella melitensis ...](https://www.ajol.info/index.php/ovj/article/view/168985) [African Journals Online (AJOL)](http://www.ajol.info/index.php)\nThe current study involved detection of three virulence genes (bvfA, virB, ure) by PCR in 52 isolates of Brucella melitensis biovar 3, recovered from different animal species (28 sheep, 10 goats, 9 cattle and 5 buffaloes). Of the 52 B. melitensis strains; 48 (92.3%) isolates carried bvfA genes, 51 (98.1%) isolates had virB genes ...\n[Seroprevalence of Brucella antibodies in harbor seals in Alaska, USA, with age, regional, and reproductive comparisons.](https://www.ncbi.nlm.nih.gov/pubmed/28930080)\nHoover-Miller, A; Dunn, J L; Field, C L; Blundell, G; Atkinson, S\n2017-09-20\nPopulations of harbor seal Phoca vitulina in the Gulf of Alaska have dramatically declined during the past 4 decades. Numbers of seals in Glacier Bay, in southeast Alaska, USA, have also declined despite extensive protection. Causes of the declines and slow recovery are poorly understood. Brucellosis is a zoonotic disease that adversely affects reproduction in many domestic species. We measured the seroprevalence of Brucella antibodies in 554 harbor seals in 3 Alaska locations: Prince William Sound (PWS), Glacier Bay (GB), and Tracy Arm Fords Terror (TAFT) Wilderness Area. Objectives included testing for regional, sex, age, and female reproductive state differences in Brucella antibody seroprevalence, persistence in titers in recaptured seals, and differences in titers between mother seals and their pups. Overall, 52% of adults (AD), 53% of subadults (SA), 77% of yearlings (YRL), and 26% of Brucella. Results show higher seroprevalence (64%) for AD and SA seals in the depressed and declining populations in PWS and GB than in TAFT (29%). Lactating females were less likely to be seropositive than other AD females, including pregnant females. Further research is needed to seek evidence of Brucella infection in Alaskan harbor seals, identify effects on neonatal viability, and assess zoonotic implications for Alaska Natives who rely on harbor seals for food.\n[Characterization of Brucella abortus mutant strain \u039422915, a potential vaccine candidate.](https://www.ncbi.nlm.nih.gov/pubmed/28376905)\nBao, Yanqing; Tian, Mingxing; Li, Peng; Liu, Jiameng; Ding, Chan; Yu, Shengqing\n2017-04-04\nBrucellosis, caused by Brucella spp., is an important zoonosis worldwide. Vaccination is an effective strategy for protection against Brucella infection in livestock in developing countries and in wildlife in developed countries. However, current vaccine strains including S19 and RB51 are pathogenic to humans and pregnant animals, limiting their use. In this study, we constructed the Brucella abortus (B. abortus) S2308 mutant strain \u039422915, in which the putative lytic transglycosylase gene BAB_RS22915 was deleted. The biological properties of mutant strain \u039422915 were characterized and protection of mice against virulent S2308 challenge was evaluated. The mutant strain \u039422915 showed reduced survival within RAW264.7 cells and survival in vivo in mice. In addition, the mutant strain \u039422915 failed to escape fusion with lysosomes within host cells, and caused no observable pathological damage. RNA-seq analysis indicated that four genes associated with amino acid/nucleotide transport and metabolism were significantly upregulated in mutant strain \u039422915. Furthermore, inoculation of \u220622915 at 10 5 colony forming units induced effective host immune responses and long-term protection of BALB/c mice. Therefore, mutant strain \u220622915 could be used as a novel vaccine candidate in the future to protect animals against B. abortus infection.\n[Portadores de Neisseria meningitidis, caracterizaci\u00f3n de las cepas aisladas y respuesta inmune basal a VA-MENGOC-BC](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2008000200002&lng=es&nrm=iso&tlng=es) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda J. Vald\u00e9s\n2008-08-01\nFull Text Available Con el prop\u00f3sito de conocer la prevalencia de portadores de Neisseria meningitidis en un grupo de adolescentes, los marcadores epidemiol\u00f3gicos de las cepas aisladas, as\u00ed como los factores de riesgo asociados con el estado de portador y la respuesta inmune basal a VA-MENGOC-BC , se realiz\u00f3 un estudio transversal descriptivo de portadores en 189 estudiantes de 12-19 a\u00f1os de un polit\u00e9cnico de Ciego de \u00c1vila, siguiendo las Normas Bio\u00e9ticas establecidas. A los estudiantes se les realiz\u00f3 un exudado far\u00edngeo y una extracci\u00f3n de sangre para la obtenci\u00f3n de suero, as\u00ed como una encuesta relacionada con aspectos de la investigaci\u00f3n. La identificaci\u00f3n de N. meningitidis se hizo por el sistema API NH (bioM\u00e9rieux. Los serosubtipos e inmunotipos se clasificaron por ELISA de c\u00e9lulas enteras con anticuerpos monoclonales y la respuesta inmune basal se detect\u00f3 por el Ensayo Bactericida del Suero. Se determin\u00f3 la susceptibilidad antimicrobiana de las cepas frente a la penicilina, cloranfenicol, rifampicina, sulfadiacina s\u00f3dica, ceftriaxona y ciprofloxacina. La prevalencia de portadores de N. meningitidis fue del 17%. Predominaron las cepas no agrupables (84,7%, seguidas por los serogrupos B (12,5% y Z (3,1%, destac\u00e1ndose la ausencia del C. Prevaleci\u00f3 el fenotipo NA:NT:P1.NST:L3,7,9 (12,5%, las cepas resistentes a la sulfadiacina (78,2% y sensibles a penicilina (81,3%, aunque el 18,7% mostr\u00f3 sensibilidad intermedia a este f\u00e1rmaco. Al resto de los antimicrobianos todas fueron sensibles. Se constat\u00f3 una respuesta inmune de memoria a la vacuna antimeningoc\u00f3cica (VAMENGOC-BC\u00ae, 12 a\u00f1os despu\u00e9s de su aplicaci\u00f3n, con t\u00edtulos bactericidas anti C y B de 25 y 42%, respectivamente, resultados que pudieran estar influenciados por la inmunizaci\u00f3n sistem\u00e1tica que se realiza en Cuba con esta vacuna desde 1991.\n[Brucella abortus infection acquired in microbiology laboratories.](https://www.ncbi.nlm.nih.gov/pubmed/10790142)\nFiori, P L; Mastrandrea, S; Rappelli, P; Cappuccinelli, P\n2000-05-01\nWe report an outbreak of laboratory-acquired Brucella abortus infection originating in the accidental breakage of a centrifuge tube. A total of 12 laboratory workers were infected (attack rate of 31%), with an incubation time ranging from 6 weeks to 5 months. Antibody titers were evaluated weekly in all personnel exposed, allowing the diagnosis of the infection in most cases before the onset of clinical symptoms, so that specific therapy could be administrated.\n[Use of an indirect elisa for Brucella abortus diagnosis in Cuba](http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/29/067/29067680.pdf?r=1) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nPeraza, C.; Valdes, O.; Fonseca, N.; Garcia, M.; Alvarez, M.; Izquierdo, D.L.\n1998-01-01\nIntroducing immunoassays in Brucella diagnosis requires a comparative study with reference techniques such as the complement fixation reaction (CFR). Sensitivity and relative specificity studies allowed us to observe the behaviour of this immunoassay, using samples from free of disease, free by vaccination and affected areas. Sensitivity results for a cut-off point of 40PP and a confidence interval of 95% ranged from 94.8 to 99.5% and the specificity between 94.1 and 97.5%. For free of disease areas a cut-off point of 22 PP was calculated that reached a 99% specificity. This immunoassay for the detection of antibodies against Brucella abortus must be used with two different cut-off points, depending on the epidemiologic conditions of the country, with CFR in affected or vaccinated areas as a confirmative method. (author)\n[[Different aluminum adjuvants significantly enhances the effect of immunization on Brucella Omp31].](https://www.ncbi.nlm.nih.gov/pubmed/29673454)\nQing, Rui; Xiang, Qingke; Liu, Zhongqi; Xiao, Fei; Yang, Fan\n2018-02-01\nObjective To investigate the effect of aluminum phosphate (AP) and aluminum hydroxide (AH) as adjuvants on Brucella outer membrane protein 31 (Omp31) in inducing humoral and cellular immune responses and immune protection. Methods AP and AH adjuvants were prepared and separately mixed with Brucella Omp31 protein to measure the adsorption rates. The AP- and AH-absorbed Omp31 protein were intraperitoneally injected into BLAB/c mice at 0, 2, and 4 weeks, and meanwhile, unabsorbed Omp31 protein and PBS were used as controls. The levels of serum IgG, IgG1, IgG2a and genital tract secretion sIgA were determined by ELISA at 0, 2, 4 and 6 weeks. Spleen cells were collected for culture at 6 weeks, and the cells were stimulated by Omp31 for 48 hours followed by the analysis of IFN-\u03b3 and IL-10 levels in the supernatants by ELISA, and the determination of lymphocyte proliferation by CCK-8 assay. The mice were challenged with Brucella at 6 weeks, and bacterial content in spleen tissue was determined 1 and 2 weeks later. Results AP and AH could absorb over 70% and 85% of the Omp31 protein, respectively, for solutions at all the tested concentrations. ELISA suggested that serum IgG, IgG1, IgG2a and genital tract sIgA levels peaked 2 weeks after the last immunization for both AP and AH groups, and antibody level was higher in the AP and AH groups than the control groups, and higher in the AH group than in the AP group. CCK-8 assay showed that the proliferating rate of lymphocytes induced by the AH group was significantly higher than that by the AP group, and the AH group also showed significantly higher IFN-\u03b3 level in the supernatant than the AP group, but no significant difference in IL-10 level. The AH group had remarkably lower bacterial load in the spleen than the AP group 2 weeks after challenged by Brucella 16M strain. Conclusion Both AP and AH adjuvants effectively enhanced immunogenicity and immune protection of the Brucella Omp31 protein, and AH was superior to AP in\n[Multipronged diagnostic approaches for monitoring the treatment of Brucella abortus infected patient: a case report](http://oaji.net/articles/2016/3556-1469432265.pdf) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRajeswari Shome\n2015-07-01\nFull Text Available Brucellosis caused by Brucella species is readily transmissible to humans, causing acute febrile illness and undulant fever which may progress to a more chronic form and can also produce serious complications affecting the musculoskeletal, cardiovascular, and central nervous systems. A veterinary livestock inspector presented to the institute with symptoms of intermittent fever, pain involving muscles and joints, loss of weight, anxiety and weakness for about three months has been investigated. The isolation, serological tests and PCR were performed for diagnosis of brucellosis. Based on history of constant professional association with animals, characteristic symptoms, hematological and biochemical, multiple serological and PCR assay results, the patient was diagnosed as brucellosis. Detection of Brucella abortus directly in the clinical samples by gel based PCRs were highly useful for diagnosis and monitoring of treatment. This diagnostic protocol will facilitate in a simple way to map major Brucella species infecting humans in a geographical region.\n[Pesquisa de aglutininas anti Brucella canis em soros humanos na cidade de S\u00e3o Paulo, Brasil Research on agglutinins for Brucella canis in human sera in the city of S. Paulo, Brazil](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89101980000300011) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaria Helena Matiko Akao Larsson\n1980-09-01\nFull Text Available De 330 soros humanos examinados pela prova de soroaglutina\u00e7\u00e3o lenta em tubos, 4(1,21% apresentaram aglutininas anti Brucella canis em dilui\u00e7\u00e3o 1:100 (1 reagente com t\u00edtulo 100, 2 reagentes com t\u00edtulo 200 e 1 reagente com t\u00edtulo 400.Of the 330 human sera tested by tube agglutination test, 4 (1.21% were positive for Brucella canis antibodies with tilers 1:100 or higher (1 reagent with titer of 1:100, 2 reagents with titer of 1:200, and 1 reagent with tiler of 1:400.\n[Bison PRNP genotyping and potential association with Brucella spp. seroprevalence](http://pubs.er.usgs.gov/publication/70028766)\nSeabury, C.M.; Halbert, N.D.; Gogan, P.J.P.; Templeton, J.W.; Derr, J.N.\n2005-01-01\nThe implication that host cellular prion protein (PrPC) may function as a cell surface receptor and/or portal protein for Brucella abortus in mice prompted an evaluation of nucleotide and amino acid variation within exon 3 of the prion protein gene (PRNP) for six US bison populations. A non-synonymous single nucleotide polymorphism (T50C), resulting in the predicted amino acid replacement M17T (Met ??? Thr), was identified in each population. To date, no variation (T50: Met) has been detected at the corresponding exon 3 nucleotide and/or amino acid position for domestic cattle. Notably, 80% (20 of 25) of the Yellowstone National Park bison possessing the C/C genotype were Brucella spp. seropositive, representing a significant (P = 0.021) association between seropositivity and the C/C genotypic class. Moreover, significant differences in the distribution of PRNP exon 3 alleles and genotypes were detected between Yellowstone National Park bison and three bison populations that were either founded from seronegative stock or previously subjected to test-and-slaughter management to eradicate brucellosis. Unlike domestic cattle, no indel polymorphisms were detected within the corresponding regions of the putative bison PRNP promoter, intron 1, octapeptide repeat region or 3???-untranslated region for any population examined. This study provides the first evidence of a potential association between nucleotide variation within PRNP exon 3 and the presence of Brucella spp. antibodies in bison, implicating PrPC in the natural resistance of bison to brucellosis infection. ?? 2005 International Society for Animal Genetics.\n[Des-aprendizaje y p\u00e9rdida de capacidades locales. El calendario nacional de vacunaci\u00f3n en Argentina](http://www.redalyc.org/articulo.oa?id=14551170001) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDora Corval\u00e1n\n2017-01-01\nFull Text Available A comienzos del siglo xxi, el gobierno argentino modific\u00f3 su pol\u00edtica p\u00fablica vinculada al Calendario Nacional de Vacunaci\u00f3n (cnv, mediante la incorporaci\u00f3n de vacunas. La industria farmac\u00e9utica global incursiona en la producci\u00f3n de vacunas a partir de la adopci\u00f3n de t\u00e9cnicas biol\u00f3gicas, desde mediados de los 80. En este marco, la industria cambia su encuadre innovativo y surgen las vacunas modernas. Producto de este recorrido, la producci\u00f3n local sufri\u00f3 un desfasaje t\u00e9cnico y organizacional, una mayor p\u00e9rdida de capacidades productivas, y como consecuencia, perdi\u00f3 relevancia como proveedora de vacunas al cnv. Paralelamente, la provisi\u00f3n de vacunas en Argentina muestra un sesgo marcadamente importador. Este trabajo analiza estos cambios en los pa\u00edses centrales y su incidencia sobre la realidad local. Unas pocas empresas transnacionales controlan la producci\u00f3n de vacunas modernas a nivel global, as\u00ed como la provisi\u00f3n de vacunas en el pa\u00eds.\n[Brucella abortus Triggers a cGAS-Independent STING Pathway To Induce Host Protection That Involves Guanylate-Binding Proteins and Inflammasome Activation.](https://www.ncbi.nlm.nih.gov/pubmed/29203515)\nCosta Franco, Miriam M; Marim, Fernanda; Guimar\u00e3es, Erika S; Assis, Natan R G; Cerqueira, Daiane M; Alves-Silva, Juliana; Harms, Jerome; Splitter, Gary; Smith, Judith; Kanneganti, Thirumala-Devi; de Queiroz, Nina M G P; Gutman, Delia; Barber, Glen N; Oliveira, Sergio C\n2018-01-15\nImmunity against microbes depends on recognition of pathogen-associated molecular patterns by innate receptors. Signaling pathways triggered by Brucella abortus DNA involves TLR9, AIM2, and stimulator of IFN genes (STING). In this study, we observed by microarray analysis that several type I IFN-associated genes, such as IFN-\u03b2 and guanylate-binding proteins (GBPs), are downregulated in STING knockout (KO) macrophages infected with Brucella or transfected with DNA. Additionally, we determined that STING and cyclic GMP-AMP synthase (cGAS) are important to engage the type I IFN pathway, but only STING is required to induce IL-1\u03b2 secretion, caspase-1 activation, and GBP2 and GBP3 expression. Furthermore, we determined that STING but not cGAS is critical for host protection against Brucella infection in macrophages and in vivo. This study provides evidence of a cGAS-independent mechanism of STING-mediated protection against an intracellular bacterial infection. Additionally, infected IFN regulatory factor-1 and IFNAR KO macrophages had reduced GBP2 and GBP3 expression and these cells were more permissive to Brucella replication compared with wild-type control macrophages. Because GBPs are critical to target vacuolar bacteria, we determined whether GBP2 and GBP chr3 affect Brucella control in vivo. GBP chr3 but not GBP2 KO mice were more susceptible to bacterial infection, and small interfering RNA treated-macrophages showed reduction in IL-1\u03b2 secretion and caspase-1 activation. Finally, we also demonstrated that Brucella DNA colocalizes with AIM2, and AIM2 KO mice are less resistant to B. abortus infection. In conclusion, these findings suggest that the STING-dependent type I IFN pathway is critical for the GBP-mediated release of Brucella DNA into the cytosol and subsequent activation of AIM2. Copyright \u00a9 2018 by The American Association of Immunologists, Inc.\n[Real-time PCR detection of Brucella spp. DNA in lesions and viscera of bovine carcasses.](https://www.ncbi.nlm.nih.gov/pubmed/24978591)\nSola, Mar\u00edlia Cristina; da Veiga Jardim, Eurione A G; de Freitas, Marcius Ribeiro; de Mesquita, Albenones Jos\u00e9\n2014-09-01\nThis study reports a real-time PCR assay for the detection of Brucella spp. associated with the FTA\u00ae Elute method in lesions observed during sanitary inspections in beef slaughter. Of the total 276 samples, 78 (28.3%) tested positive and 198 (71.7%) negative for Brucella spp. The real-time PCR technique associated with the FTA\u00ae Elute method proved to be an important tool for the diagnosis, judgment about and disposal of carcasses and viscera of slaughtered animals. Copyright \u00a9 2014 Elsevier B.V. All rights reserved.\n[Economic impact of pneumococcal conjugate vaccination in Brazil, Chile, and Uruguay Impacto econ\u00f3mico de la vacuna antineumoc\u00f3cica conjugada en Brasil, Chile y Uruguay](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000800004) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nDagna O. Constenla\n2008-08-01\nFull Text Available OBJECTIVES: To evaluate the economic impact of vaccination with the pneumococcal 7-valent conjugate vaccine (PCV7 in Brazil, Chile, and Uruguay. METHODS: A decision analytic model was constructed to compare pneumococcal vaccination of children 0-5 years old with no vaccination in Brazil, Chile, and Uruguay. Costs and health outcomes were analyzed from the societal perspective. Vaccine, demographic, epidemiologic, and cost data were incorporated into this economic analysis. RESULTS: At the rate of diphtheria-tetanus-pertussis (DTP vaccine coverage and a vaccine price of US$ 53 per dose, PCV7 was projected to prevent 23 474 deaths per year in children under 5 years old in the three countries studied, thus averting 884 841 disability-adjusted life years (DALYs yearly. To vaccinate the entire birth cohort of the three countries, total vaccine costs would be US$ 613.9 million. At US$ 53 per dose, the cost per DALY averted from a societal perspective would range from US$ 664 (Brazil to US$ 2 019 (Chile. At a cost of US$ 10 per dose, vaccine cost is lower than the overall cost of illness averted (US$ 125 050 497 versus US$ 153 965 333, making it cost effective and cost-saving. CONCLUSIONS: The results of this study demonstrate that the incorporation of PCV7 vaccine at US$ 53 per dose confers health benefits at extra costs. It is unclear whether vaccination at the current price is affordable to these countries.OBJETIVOS: Evaluar el impacto econ\u00f3mico de la aplicaci\u00f3n de la vacuna antineumoc\u00f3cica conjugada heptavalente (PCV7 en Brasil, Chile y Uruguay. M\u00c9TODOS: Se elabor\u00f3 un modelo anal\u00edtico de decisiones para comparar la vacunaci\u00f3n antineumoc\u00f3cica de los ni\u00f1os de 0-5 a\u00f1os de edad con la no vacunaci\u00f3n, en Brasil, Chile y Uruguay. Los costos y los desenlaces para la salud se analizaron desde el punto de vista de la sociedad. Al an\u00e1lisis econ\u00f3mico se incorporaron los costos y los datos demogr\u00e1ficos, epidemiol\u00f3gicos y de la vacuna. RESULTADOS\n[MLVA genotyping of Brucella melitensis and Brucella abortus isolates from different animal species and humans and identification of Brucella suis vaccine strain S2 from cattle in China.](http://europepmc.org/articles/PMC3790686?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nHai Jiang\nFull Text Available In China, brucellosis is an endemic disease and the main sources of brucellosis in animals and humans are infected sheep, cattle and swine. Brucella melitensis (biovars 1 and 3 is the predominant species, associated with sporadic cases and outbreak in humans. Isolates of B. abortus, primarily biovars 1 and 3, and B. suis biovars 1 and 3 are also associated with sporadic human brucellosis. In this study, the genetic profiles of B. melitensis and B. abortus isolates from humans and animals were analyzed and compared by multi-locus variable-number tandem-repeat analysis (MLVA. Among the B. melitensis isolates, the majority (74/82 belonged to MLVA8 genotype 42, clustering in the 'East Mediterranean' group. Two B. melitensis biovar 1 genotype 47 isolates, belonging to the 'Americas' group, were recovered; both were from the Himalayan blue sheep (Pseudois nayaur, a wild animal. The majority of B. abortus isolates (51/70 were biovar 3, genotype 36. Ten B. suis biovar 1 field isolates, including seven outbreak isolates recovered from a cattle farm in Inner Mongolia, were genetically indistinguishable from the vaccine strain S2, based on MLVA cluster analysis. MLVA analysis provided important information for epidemiological trace-back. To the best of our knowledge, this is the first report to associate Brucella cross-infection with the vaccine strain S2 based on molecular comparison of recovered isolates to the vaccine strain. MLVA typing could be an essential assay to improve brucellosis surveillance and control programs.\n[Radiology changes in brucella spondylitis, experience with 26 cases](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=36048881) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nAbbassioun, K.; Amirjamshidi, A.; Taheri, B.\n2003-01-01\nBackground/objective: brucellosis is an endemic zoonosis in the Middle East and despite all public health efforts it has not yet been eradicated in Iran. We aimed to highlight and categorize the imaging features of Brucella spondylitis. Material and method: twenty six cases of Brucella spondylitis were treated by the authors from 1982 up to 2003. The available imaging studies of all the cases are reviewed and include X-ray films, conventional myelography, computerized tomographic (CT Scan) and magnetic resonance imaging. Results: there were 21 male and 5 female patients with an age range of 5 to 62 years and the majority (60 %) in the 4 Th and 5 Th decades of life. Wright hemagglutination tests were positive in all cases. Plain x-ray films typically showed lysis of the end plates with osteophyte formation involving affected vertebrae, followed by narrowing of the inter spaces and destruction or collapse of the vertebral bodies in 7 cases. Myelography demonstrated various types of epidural filling defects and obstruction to the flow of contrast material in 10 cases. CT scan, available in 3 cases, showed erosion and cauliflower-like proliferation at the bony edges of the vertebral bodies and end plates. MRI findings varied depending upon the acute or chronic stages of the illness with hypo- or hyper-intense changes on T1 sequences, and primarily hyper-intense changes of T2 sequences in 8 cases. Conclusion: The findings in this series of patients suggest that imaging findings of Brucella spondylitis are scarcely specific. However when considering the medical history, place of origin of the patients, clinical presentation and laboratory findings, the early diagnosis of the illness may be possible before proceeding to surgical intervention\n[Temporal Role for MyD88 in a Model of Brucella-Induced Arthritis and Musculoskeletal Inflammation.](https://www.ncbi.nlm.nih.gov/pubmed/28069819)\nLacey, Carolyn A; Mitchell, William J; Brown, Charles R; Skyberg, Jerod A\n2017-03-01\nBrucella spp. are facultative intracellular Gram-negative bacteria that cause the zoonotic disease brucellosis, one of the most common global zoonoses. Osteomyelitis, arthritis, and musculoskeletal inflammation are common focal complications of brucellosis in humans; however, wild-type (WT) mice infected systemically with conventional doses of Brucella do not develop these complications. Here we report C57BL/6 WT mice infected via the footpad with 10 3 to 10 6 CFU of Brucella spp. display neutrophil and monocyte infiltration of the joint space and surrounding musculoskeletal tissue. Joint inflammation is detectable as early as 1 day postinfection and peaks 1 to 2 weeks later, after which WT mice are able to slowly resolve inflammation. B and T cells were dispensable for the onset of swelling but required for resolution of joint inflammation and infection. At early time points, MyD88 -/- mice display decreased joint inflammation, swelling, and proinflammatory cytokine levels relative to WT mice. Subsequently, swelling of MyD88 -/- joints surpassed WT joint swelling, and resolution of joint inflammation was prolonged. Joint bacterial loads in MyD88 -/- mice were significantly greater than those in WT mice by day 3 postinfection and at all time points thereafter. In addition, MyD88 -/- joint inflammatory cytokine levels on day 3 and beyond were similar to WT levels. Collectively these data demonstrate MyD88 signaling mediates early inflammatory responses in the joint but also contributes to subsequent clearance of Brucella and resolution of inflammation. This work also establishes a mouse model for studying Brucella -induced arthritis, musculoskeletal complications, and systemic responses, which will lead to a better understanding of focal complications of brucellosis. Copyright \u00a9 2017 American Society for Microbiology.\n[Brucella microti sp. nov., isolated from the common vole Microtus arvalis](http://hdl.handle.net/11104/0159559) [Czech Academy of Sciences Publication Activity Database](https://www.library.sk/arl-cav/en/expanded-search/)\nScholz, H. C.; Hub\u00e1lek, Zden\u011bk; Sedl\u00e1\u010dek, I.; Vergnaud, G.; Tomaso, H.; Al Dahouk, S.; Melzer, F.; K\u00e4mpfer, P.; Neubauer, H.; Cloeckaert, A.; Maquart, M.; Zygmunt, M. S.; Whatmore, A. M.; Falsen, E.; Bahn, P.; G\u00f6llner, C.; Pfeffer, M.; Huber, B.; Busse, H.-J.; N\u00f6ckler, K.\n2008-01-01\nRo\u010d. 58, \u010d. 2 (2008), s. 375-382 ISSN 1466-5026 Institutional research plan: CEZ:AV0Z60930519 Keywords : common vole * Brucella microti * rodent brucellosis Subject RIV: EE - Microbiology, Virology Impact factor: 2.222, year: 2008\n[Brucella suis vaccine strain 2 induces endoplasmic reticulum stress that affects intracellular replication in goat trophoblast cells in vitro](http://journal.frontiersin.org/Journal/10.3389/fcimb.2016.00019/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nXiangguo eWang\n2016-02-01\nFull Text Available Brucella has been reported to impair placental trophoblasts, a cellular target where Brucella efficiently replicates in association with the endoplasmic reticulum (ER, and ultimately trigger abortion in pregnant animals. However, the precise effects of Brucella on trophoblast cells remain unclear. Here, we describe the infection and replication of Brucella suis vaccine strain 2 (B.suis.S2 in goat trophoblast cells (GTCs and the cellular and molecular responses induced in vitro. Our studies demonstrated that B.suis.S2 was able to infect and proliferate to high titers, hamper the proliferation of GTCs and induce apoptosis due to ER stress. Tunicamycin (Tm, a pharmacological chaperone that strongly mounts ER stress-induced apoptosis, inhibited B.suis.S2 replication in GTCs. In addition, 4 phenyl butyric acid (4-PBA, a pharmacological chaperone that alleviates ER stress-induced apoptosis, significantly enhanced B.suis.S2 replication in GTCs. The Unfolded Protein Response (UPR chaperone molecule GRP78 also promoted B.suis.S2 proliferation in GTCs by inhibiting ER stress-induced apoptosis. We also discovered that the IRE1 pathway, but not the PERK or ATF6 pathway, was activated in the process. However, decreasing the expression of phosphoIRE1\u03b1 and IRE1\u03b1 proteins with Irestatin 9389 (IRE1 antagonist in GTCs did not affect the proliferation of B.suis.S2. Although GTC implantation was not affected upon B.suis.S2 infection, progesterone secretion was suppressed, and prolactin and estrogen secretion increased; these effects were accompanied by changes in the expression of genes encoding key steroidogenic enzymes. This study systematically explored the mechanisms of abortion in Brucella infection from the viewpoint of pathogen invasion, ER stress and reproductive endocrinology. Our findings may provide new insight for understanding the mechanisms involved in goat abortions caused by Brucella infection.\n[Reconocimiento y prevenci\u00c3\u00b3n de la tosferina (Recognizing and Preventing Whooping Cough)](https://www2c.cdc.gov/podcasts/player.asp?f=3057384) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\n2015-04-13\nEste podcast proporciona informaci\u00c3\u00b3n acerca de los s\u00c3ntomas de la tosferina y la manera en que las vacunas pueden ayudar a prevenir esta grave enfermedad en personas de todas las edades. Es especialmente importante que las personas que tendr\u00c3\u00a1n contacto cercano con un beb\u00c3\u00a9 est\u00c3\u00a9n al d\u00c3a con la vacuna contra la tosferina. Created: 4/13/2015 by National Center for Immunization and Respiratory Diseases (NCIRD), Division of Bacterial Diseases (DBD), Meningitis and Vaccine Preventable Diseases Branch (MVPDB). Date Released: 4/13/2015.\n[Recomendaci\u00c3\u00b3n sobre la vacuna contra la tosferina para los preadolescentes y adolescentes(Whooping Cough Vaccine Recommendation for Preteens and Teens)](https://tools.cdc.gov/medialibrary/index.aspx#/media/id/303181) [Centers for Disease Control (CDC) Podcasts](http://www2c.cdc.gov/podcasts/search.asp)\nEste podcast proporciona informaci\u00c3\u00b3n acerca de la tosferina y la recomendaci\u00c3\u00b3n de que todos los preadolescentes reciban la vacuna Tdap a los 11 o 12 a\u00c3\u00b1os para ayudar a protegerlos contra esta grave enfermedad.\n[The effect of tigecycline and ertapenem against clinical isolates of Brucella melitensis detected by E-test on different media](http://www.ijmm.org/article.asp?issn=0255-0857;year=2010;volume=28;issue=4;spage=370;epage=371;aulast=Tanyel) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nTanyel E\n2010-01-01\nFull Text Available In this study, in vitro activity of tigecycline (TIG and ertapenem (ERT against clinical isolates of Brucella melitensis and the effect of different media on in vitro test results were investigated. The in vitro effects of TIG and ERT to 38 B. melitensis isolates were comparatively investigated in brucella agar and 5% sheep blood agar. MIC value of ERT was 0.032 \u03bcg/mL in 23 of 38 and 20 of 38 isolates on blood and brucella agar, respectively. Minimum inhibitory concentration values of TIG were substantially different ranging between 0.064-0.25 \u03bcg/mL on blood agar. However, MIC values of TIG were similar on brucella agar with 0.25 \u03bcg/mL in 15 of 38 isolates and 0.5 \u03bcg/mL in 10 of 38 isolates. In conclusion, although ERT and TIG were effective against B. melitensis isolates in vitro, further studies are needed in order to determine the use of these novel drugs in treatment of brucellosis.\n[Brucella TIR-like protein TcpB/Btp1 specifically targets the host adaptor protein MAL/TIRAP to promote infection.](https://www.ncbi.nlm.nih.gov/pubmed/27311859)\nLi, Wenna; Ke, Yuehua; Wang, Yufei; Yang, Mingjuan; Gao, Junguang; Zhan, Shaoxia; Xinying, Du; Huang, Liuyu; Li, Wenfeng; Chen, Zeliang; Li, Juan\n2016-08-26\nBrucella spp. are known to avoid host immune recognition and weaken the immune response to infection. Brucella like accomplish this by employing two clever strategies, called the stealth strategy and hijacking strategy. The TIR domain-containing protein (TcpB/Btp1) of Brucella melitensis is thought to be involved in inhibiting host NF-\u03baB activation by binding to adaptors downstream of Toll-like receptors. However, of the five TIR domain-containing adaptors conserved in mammals, whether MyD88 or MAL, even other three adaptors, are specifically targeted by TcpB has not been identified. Here, we confirmed the effect of TcpB on B.melitensis virulence in mice and found that TcpB selectively targets MAL. By using siRNA against MAL, we found that TcpB from B.melitensis is involved in intracellular survival and that MAL affects intracellular replication of B.melitensis. Our results confirm that TcpB specifically targets MAL/TIRAP to disrupt downstream signaling pathways and promote intra-host survival of Brucella spp. Copyright \u00a9 2016 Elsevier Inc. All rights reserved.\n[Virulence Effects and Signaling Partners Modulated by Brucella melitensis Light-sensing Histidine Kinase](http://adsabs.harvard.edu/abs/2012PhDT.......190G)\nGourley, Christopher R.\nThe facultative intracellular pathogen Brucella melitensis utilizes diverse virulence factors. A Brucella light sensing histidine kinase can influence in vitro virulence of the bacteria during intracellular infection. First, we demonstrated that the B. melitensis light sensing kinase (BM-LOV-HK) affects virulence in an IRF-1-/- mouse model of infection. Infection with a \u0394 BM-LOV-HK strain resulted in less bacterial colonization of IRF-1-/- spleens and extended survivorship compared to mice infected with wild type B. melitensis 16M. Second, using PCR arrays, we observed less expression of innate and adaptive immune system activation markers in \u0394BM-LOV-HK infected mouse spleens than wild type B. melitensis 16M infected mouse spleens 6 days after infection. Third, we demonstrated by microarray analysis of B. melitensis that deletion of BM-LOV-HK alters bacterial gene expression. Downregulation of genes involved in control of the general stress response system included the alternative sigma factor RpoE1 and its anti-anti sigma factor PhyR. Conversely, genes involved in flagella production, quorum sensing, and the type IV secretion system (VirB operon) were upregulated in the \u0394 BM-LOV-HK strain compared to the wild type B. melitensis 16M. Analysis of genes differentially regulated in \u0394 BM-LOV-HK versus the wild type strain indicated an overlap of 110 genes with data from previous quorum sensing regulator studies of \u0394 vjbR and/\u0394blxR(babR) strains. Also, several predicted RpoE1 binding sites located upstream of genes were differentially regulated in the \u0394BM-LOV-HK strain. Our results suggest BM-LOV-HK is important for in vivo Brucella virulence, and reveals that BM-LOV-HK directly or indirect regulates members of the Brucella quorum sensing, type IV secretion, and general stress systems.\n[Coinfection and vertical transmission of Brucella and Morbillivirus in a neonatal sperm whale (Physeter macrocephalus) in Hawaii, USA.](https://www.ncbi.nlm.nih.gov/pubmed/25390763)\nWest, Kristi L; Levine, Gregg; Jacob, Jessica; Jensen, Brenda; Sanchez, Susan; Colegrove, Kathleen; Rotstein, David\n2015-01-01\nThe viral genus Morbillivirus and the bacterial genus Brucella have emerged as important groups of pathogens that are known to affect cetacean health on a global scale, but neither pathogen has previously been reported from endangered sperm whales (Physeter macrocephalus). A female neonate sperm whale stranded alive and died near Laie on the island of Oahu, Hawaii, US, in May of 2011. Congestion of the cerebrum and enlarged lymph nodes were noted on the gross necropsy. Microscopic findings included lymphoid depletion, chronic meningitis, and pneumonia, suggesting an in utero infection. Cerebrum, lung, umbilicus, and select lymph nodes (tracheobronchial and mediastinal) were positive for Brucella by PCR. Brucella sp. was also cultured from the cerebrum and from mediastinal and tracheobronchial lymph nodes. Twelve different tissues were screened for Morbillivirus by reverse-transcriptase (RT)-PCR and select tissues by immunohistochemistry, but only the tracheobronchial lymph node and spleen were positive by RT-PCR. Pathologic findings observed were likely a result of Brucella, but Morbillivirus may have played a key role in immune suppression of the mother and calf. The in utero infection in this individual strongly supports vertical transmission of both pathogens.\n[Outer Membrane Protein 25 of Brucella Activates Mitogen-Activated Protein Kinase Signal Pathway in Human Trophoblast Cells](http://journal.frontiersin.org/article/10.3389/fvets.2017.00197/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nJing Zhang\n2017-12-01\nFull Text Available Outer membrane protein 25 (OMP25, a virulence factor from Brucella, plays an important role in maintaining the structural stability of Brucella. Mitogen-activated protein kinase (MAPK signal pathway widely exists in eukaryotic cells. In this study, human trophoblast cell line HPT-8 and BALB/c mice were infected with Brucella abortus 2308 strain (S2308 and 2308\u0394Omp25 mutant strain. The expression of cytokines and activation of MAPK signal pathway were detected. We found that the expressions of tumor necrosis factor-\u03b1, interleukin-1, and interleukin-10 (IL-10 were increased in HPT-8 cells infected with S2308 and 2308\u0394Omp25 mutant. S2308 also activated p38 phosphorylation protein, extracellular-regulated protein kinases (ERK, and Jun-N-terminal kinase (JNK from MAPK signal pathway. 2308\u0394Omp25 could not activate p38, ERK, and JNK branches. Immunohistochemistry experiments showed that S2308 was able to activate phosphorylation of p38 and ERK in BABL/c mice. However, 2308\u0394Omp25 could weakly activate phosphorylation of p38 and ERK. These results suggest that Omp25 played an important role in the process of Brucella activation of the MAPK signal pathway.\n[MicroRNA-125b-5p suppresses Brucella abortus intracellular survival via control of A20 expression.](https://www.ncbi.nlm.nih.gov/pubmed/27473222)\nLiu, Ning; Wang, Lin; Sun, Changjiang; Yang, Li; Sun, Wanchun; Peng, Qisheng\n2016-07-29\nBrucella may establish chronic infection by regulating the expression of miRNAs. However, the role of miRNAs in modulating the intracellular growth of Brucella remains unclear. In this study, we show that Brucella. abortus infection leads to downregulation of miR-125b-5p in macrophages. We establish that miR-125b-5p targets A20, an inhibitor of the NF-kB activation. Additionally, expression of miR-125b-5p decreases A20 expression in B. abortus-infected macrophages and leads to NF-kB activation and increased production of TNF\u03b1. Furthermore, B. abortus survival is attenuated in the presence of miR-125b-5p. These results uncover a role for miR-125b-5p in the regulation of B. abortus intracellular survival via the control of A20 expression.\n[Preventive vaccines for cervical cancer Vacunas para prevenir el c\u00e1ncer cervical](http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36341997000400006) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCOSETTE M WHEELER\n1997-07-01\nFull Text Available The potential use of vaccines for the human papillomavirus (HPV in the prevention and treatment of cervical cancer is a possibility in the near future. Close to 20 genotypes of HPV, of the 75 that have been identified, infect the femine genital tract, but four subtypes (16, 18, 31 and 45 have been associated in close to 80% of cervical cancers. this article proposes that in order to design an effective prophylactic vaccine against HPV infection, an adequate immune response should be guaranteed through four goals; a activation of antigens present in the cell; b overcoming the host response and viral genetic variability in the T cell response; c generation of high levels of T and B memory cells; and d persistence of antigens.El potencial uso de vacunas de virus del papiloma humano (VPH en la prevenci\u00f3n y tratamiento del c\u00e1ncer cervical posiblemente ser\u00e1 implementado durante los pr\u00f3ximos a\u00f1os. Cerca de los 20 genotipos de VPH de los 75 que se encuentran identificados infectan el tracto genital femenino, pero son cuatro subtipos: 16, 18, 31 y 45 los que se han asociado en cerca de 80% a c\u00e1ncer cervical. En este ensayo se plantea que para poder dise\u00f1ar una vacuna profil\u00e1ctica contra la infecci\u00f3n de VPH, efectiva, se debe garantizar una adecuada respuesta inmune a trav\u00e9s de cuatro metas: a activaci\u00f3n de ant\u00edgenos presentes en la c\u00e9lula; b superar la respuesta del hu\u00e9sped y la variabilidad gen\u00e9tica viral en la respuesta de c\u00e9lulas T; c generaci\u00f3n de altos niveles de c\u00e9lulas T y B de memoria, y d persistencia de ant\u00edgenos.\n[Efic\u00e1cia e seguran\u00e7a da vacina brasileira contra hepatite B em rec\u00e9m-nascidos Eficiencia y seguridad de la vacuna brasilera contra hepatitis B en reci\u00e9n-nacidos Efficacy and safety of the Brazilian vaccine against Hepatitis B in newborns](http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102009000600013) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nExpedito Jos\u00e9 de Albuquerque Luna\n2009-12-01\nFull Text Available OBJETIVO: Analisar a efic\u00e1cia e seguran\u00e7a de vacina recombinante contra hepatite B em rec\u00e9m-nascidos. M\u00c9TODOS: O estudo foi conduzido em hospital geral do munic\u00edpio de Guarulhos, SP, entre 2002 e 2005. A vacina recombinante contra hepatite B do Instituto Butantan (VrHB-IB foi analisada em dois ensaios cl\u00ednicos. Em ambos os ensaios, os rec\u00e9m-nascidos foram alocados aleatoriamente ao grupo experimental ou controle (vacina de refer\u00eancia. Os rec\u00e9m-nascidos receberam tr\u00eas doses das vacinas, uma em at\u00e9 24 h ap\u00f3s o nascimento e as subseq\u00fcentes 30 e 180 dias ap\u00f3s. No primeiro ensaio 538 rec\u00e9m-nascidos completaram o protocolo e no segundo ensaio, 486. Considerou-se crit\u00e9rio de equival\u00eancia a diferen\u00e7a na soroprote\u00e7\u00e3o inferior a 5%. RESULTADOS: A soroprote\u00e7\u00e3o no primeiro ensaio (anti HBs > 10mUI/ml foi de 92,5% (247/267 no grupo experimental, comparada a 98,5% (267/271 no grupo controle (p = 0,001. Com este resultado, a VrHB-IB n\u00e3o atingiu o crit\u00e9rio de equival\u00eancia estabelecido. Ap\u00f3s o aumento da concentra\u00e7\u00e3o de ant\u00edgeno na vacina para 25\u00bcg, a soroprote\u00e7\u00e3o no segundo ensaio foi de 100% no grupo experimental e 99,2% no grupo controle. Nenhum evento adverso grave foi registrado. CONCLUS\u00d5ES: A vacina VrHB-IB modificada foi considerada equivalente \u00e0 vacina de refer\u00eancia e seu uso recomendado \u00e0 vacina\u00e7\u00e3o de rec\u00e9m-nascidos.OBJETIVO: Analizar la eficiencia y seguridad de vacuna recombinante contra hepatitis B en reci\u00e9n-nacidos. M\u00c9TODOS: El estudio fue conducido en hospital general del municipio de Guarulhos, Sureste de Brasil, entre 2002 y 2005. La vacuna recombinante contra hepatitis B del Instituto Butantan (VrHB-IB fue analizada en dos ensayos cl\u00ednicos. En ambos ensayos, los reci\u00e9n-nacidos fueron distribuidos aleatoriamente en el grupo experimental o control (vacuna de referencia. Los reci\u00e9n-nacidos recibieron tres dosis de las vacunas, una en m\u00e1ximo 24 h posterior al nacimiento y las subsecuentes 30 y 180 d\n[Systems Biology Analysis of Temporal In vivo Brucella melitensis and Bovine Transcriptomes Predicts host:Pathogen Protein\u2013Protein Interactions](http://journal.frontiersin.org/article/10.3389/fmicb.2017.01275/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCarlos A. Rossetti\n2017-07-01\nFull Text Available To date, fewer than 200 gene-products have been identified as Brucella virulence factors, and most were characterized individually without considering how they are temporally and coordinately expressed or secreted during the infection process. Here, we describe and analyze the in vivo temporal transcriptional profile of Brucella melitensis during the initial 4 h interaction with cattle. Pathway analysis revealed an activation of the \u201cTwo component system\u201d providing evidence that the in vivo Brucella sense and actively regulate their metabolism through the transition to an intracellular lifestyle. Contrarily, other Brucella pathways involved in virulence such as \u201cABC transporters\u201d and \u201cT4SS system\u201d were repressed suggesting a silencing strategy to avoid stimulation of the host innate immune response very early in the infection process. Also, three flagellum-encoded loci (BMEII0150-0168, BMEII1080-1089, and BMEII1105-1114, the \u201cflagellar assembly\u201d pathway and the cell components \u201cbacterial-type flagellum hook\u201d and \u201cbacterial-type flagellum\u201d were repressed in the tissue-associated B. melitensis, while RopE1 sigma factor, a flagellar repressor, was activated throughout the experiment. These results support the idea that Brucella employ a stealthy strategy at the onset of the infection of susceptible hosts. Further, through systems-level in silico host:pathogen protein\u2013protein interactions simulation and correlation of pathogen gene expression with the host gene perturbations, we identified unanticipated interactions such as VirB11::MAPK8IP1; BtaE::NFKBIA, and 22 kDa OMP precursor::BAD and MAP2K3. These findings are suggestive of new virulence factors and mechanisms responsible for Brucella evasion of the host's protective immune response and the capability to maintain a dormant state. The predicted protein\u2013protein interactions and the points of disruption provide novel insights that will stimulate advanced hypothesis\n[Vectores recombinantes basados en el virus Vaccinia modificado de Ankara (MVA) como vacunas contra la leishmaniasis](https://www.openaire.eu/search/publication?articleId=od______1106::2d0994ebc04aca806f25b6ad7129d7d2)\nP\u00e9rez Jim\u00e9nez, Eva; Larraga, Vicente; Esteban, Mariano\n2005-01-01\nVectores recombinantes basados en el virus vaccinia modificado de Ankara (MVA) como vacunas contra la leishmaniasis. Los vectores de la invenci\u00f3n contienen secuencias codificantes de la prote\u00edna LACK, preferentemente insertadas en el locus de hemaglutinina del virus y bajo el control de un promotor que permite su expresi\u00f3n a lo largo del ciclo de infecci\u00f3n del virus. Son vectores seguros, estables, que dan lugar a una potente respuesta inmune que confiere protecci\u00f3n frente a la leishmaniasis,...\n[Evidence of Brucella strain ST27 in bottlenose dolphin (Tursiops truncatus) in Europe.](https://www.ncbi.nlm.nih.gov/pubmed/27939163)\nCvetni\u0107, \u017deljko; Duvnjak, Sanja; \u0110uras, Martina; Gomer\u010di\u0107, Tomislav; Reil, Irena; Zdelar-Tuk, Maja; \u0160pi\u010di\u0107, Silvio\n2016-11-30\nMarine mammal brucellosis has been known for more than 20 years, but recent work suggests it is more widespread than originally thought. Brucella (B.) pinnipedialis has been isolated from pinnipeds, while B. ceti strains have been associated with cetaceans. Here we report a Brucella strain isolated from multiple lymph nodes of one bottlenose dolphin (Tursiops truncatus) during routine examination of dolphin carcasses found in the Croatian part of the northern Adriatic Sea during the summer of 2015. Classical bacteriological biotyping, PCR-based techniques (single, multiplex, PCR-RFLP) and 16S rRNA DNA sequencing were used to identify Brucella spp. Multiple-locus variable number tandem repeat analysis of 16 loci and multilocus sequence typing of 9 loci were used for genotyping and species determination. The combination of bacteriological, molecular and genotyping techniques identified our strain as ST27, previously identified as a human pathogen. This report provides, to our knowledge, the first evidence of ST27 in the Adriatic Sea in particular and in European waters in general. The zoonotic nature of the strain and its presence in the Adriatic, which is inhabited by bottlenose dolphins, suggest that the strain may pose a significant threat to human health. Copyright \u00a9 2016 Elsevier B.V. All rights reserved.\n[Brucella serology in abattoir workers](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=41000868) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nMukhtar, F.; Kokab, F.\n2008-01-01\nBrucellosis is an occupational hazard with those particularly at risk either living in close proximity with animals or handling them. It is a public health problem in developing countries with adverse health implications both for animals and human beings as well as economic implications for individuals and communities. The Objectives were to estimate the seroprevalence of brucellosis among abattoir workers of Lahore District and to determine the association of brucellosis with nature of job of the workers. Data was collected in April 2008. It was a cross-sectional study in which four main slaughterhouses in Lahore were included. The slaughterhouse workers were divided into seven strata based on their nature of job: meat sellers, slaughterers, animal keepers, drivers, cleaners, loaders and vets/paravets. A total of 360 such workers were selected using stratified random sampling technique. Sampling frames for different strata were prepared and from each frame, proportionate numbers, were selected through simple random method using random number tables. Data was obtained using a questionnaire. Additionally blood samples were collected and analyzed for anti-Brucella Immunoglobulin G (IgG) using enzyme-linked immunosorbent assay (ELISA) technique. The seroprevalence of anti-Brucella IgG was found to be 21.7%. A statistically significant difference was observed between the immune status of the respondents and their nature of job (p=0.005), age groups (p=0.013), and duration of job (p=0.003). The disease is an important public health problem in Pakistan. The disease can be prevented in the slaughterhouse workers through the use of personal protective devices. Public health authorities should educate the general public regarding prevention of the disease with specific emphasis on people working in slaughterhouses. (author)\n[Relative Quantitative Proteomic Analysis of Brucella abortus Reveals Metabolic Adaptation to Multiple Environmental Stresses](http://journal.frontiersin.org/article/10.3389/fmicb.2017.02347/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nXiaodong Zai\n2017-11-01\nFull Text Available Brucella spp. are facultative intracellular pathogens that cause chronic brucellosis in humans and animals. The virulence of Brucella primarily depends on its successful survival and replication in host cells. During invasion of the host tissue, Brucella is simultaneously subjected to a variety of harsh conditions, including nutrient limitation, low pH, antimicrobial defenses, and extreme levels of reactive oxygen species (ROS via the host immune response. This suggests that Brucella may be able to regulate its metabolic adaptation in response to the distinct stresses encountered during its intracellular infection of the host. An investigation into the differential proteome expression patterns of Brucella grown under the relevant stress conditions may contribute toward a better understanding of its pathogenesis and adaptive response. Here, we utilized a mass spectrometry-based label-free relative quantitative proteomics approach to investigate and compare global proteomic changes in B. abortus in response to eight different stress treatments. The 3 h short-term in vitro single-stress and multi-stress conditions mimicked the in vivo conditions of B. abortus under intracellular infection, with survival rates ranging from 3.17 to 73.17%. The proteomic analysis identified and quantified a total of 2,272 proteins and 74% of the theoretical proteome, thereby providing wide coverage of the B. abortus proteome. By including eight distinct growth conditions and comparing these with a control condition, we identified a total of 1,221 differentially expressed proteins (DEPs that were significantly changed under the stress treatments. Pathway analysis revealed that most of the proteins were involved in oxidative phosphorylation, ABC transporters, two-component systems, biosynthesis of secondary metabolites, the citrate cycle, thiamine metabolism, and nitrogen metabolism; constituting major response mechanisms toward the reconstruction of cellular\n[Attenuated Bioluminescent Brucella melitensis Mutants GR019 (virB4), GR024 (galE), and GR026 (BMEI1090-BMEI1091) Confer Protection in Mice](https://www.openaire.eu/search/publication?articleId=od_______908::c3650ab32c4b3d31986ee0be8d7f3e9b)\nRajashekara, Gireesh; Glover, David A.; Banai, Menachem; O'Callaghan, David; Splitter, Gary A.\n2006-01-01\nIn vivo bioluminescence imaging is a persuasive approach to investigate a number of issues in microbial pathogenesis. Previously, we have applied bioluminescence imaging to gain greater insight into Brucella melitensis pathogenesis. Endowing Brucella with bioluminescence allowed direct visualization of bacterial dissemination, pattern of tissue localization, and the contribution of Brucella genes to virulence. In this report, we describe the pathogenicity of three attenuated bioluminescent B....\n[Effects of gamma radiation and azathioprine on Brucella abortus infection in BALB/c mice](http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5011391) [Energy Technology Data Exchange (ETDEWEB)](https://www.etde.org/etdeweb/fieldedsearch.jsp)\nElzer, P.H.; Rowe, G.E.; Enright, F.M.; Winter, A.J. (Department of Veterinary Microbiology, Immunology and Parasitology, College of Veterinary Medicine, Cornell University, Ithaca, NY (United States))\n1991-06-01\nSublethal irradiation of BALB/c mice 4 hours prior to inoculation with 5 {times} 10(4) virulent Brucella abortus, caused significant (P less than 0.01) reductions in bacterial numbers in comparison with numbers in unirradiated controls. Numbers of brucellae in the spleen were significantly lower by 5 days after inoculation and decreased thereafter, so that at 2 and 3 weeks after inoculation, there were up to 1,000-fold fewer organisms in the spleen of irradiated mice. The number of brucellae in the spleen increased in irradiated mice thereafter. The course of events in the liver was similar, but developed more slowly, and peak differences in bacterial numbers were about 1 log less. These phenomena were not attributable to differences in implantation of brucellae in the liver or spleen, nor to an abnormal distribution of organisms in other organs of irradiated mice. Irradiation of mice during the plateau phase of infection also resulted in significant (P less than 0.05) reductions in bacterial counts in the spleen during the succeeding 4 weeks. Macrophage activation in the spleen, measured by a Listeria monocytogenes-killing assay, was significantly (P less than 0.01) increased by irradiation alone at 1 week after inoculation and at that time was significantly (P less than 0.01) greater in B abortus-infected, irradiated mice than in B abortus-infected controls. Histologic, cytologic, and immunologic studies revealed that the decrease in numbers of organisms between 1 and 2 weeks after inoculation in irradiated mice occurred at a time when their immune response to B abortus was suppressed and when numbers of neutrophils and monocytes infiltrating the spleen were significantly (P less than 0.01) diminished.\n[Effects of gamma radiation and azathioprine on Brucella abortus infection in BALB/c mice](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23021805) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nElzer, P.H.; Rowe, G.E.; Enright, F.M.; Winter, A.J.\n1991-01-01\nSublethal irradiation of BALB/c mice 4 hours prior to inoculation with 5 x 10(4) virulent Brucella abortus, caused significant (P less than 0.01) reductions in bacterial numbers in comparison with numbers in unirradiated controls. Numbers of brucellae in the spleen were significantly lower by 5 days after inoculation and decreased thereafter, so that at 2 and 3 weeks after inoculation, there were up to 1,000-fold fewer organisms in the spleen of irradiated mice. The number of brucellae in the spleen increased in irradiated mice thereafter. The course of events in the liver was similar, but developed more slowly, and peak differences in bacterial numbers were about 1 log less. These phenomena were not attributable to differences in implantation of brucellae in the liver or spleen, nor to an abnormal distribution of organisms in other organs of irradiated mice. Irradiation of mice during the plateau phase of infection also resulted in significant (P less than 0.05) reductions in bacterial counts in the spleen during the succeeding 4 weeks. Macrophage activation in the spleen, measured by a Listeria monocytogenes-killing assay, was significantly (P less than 0.01) increased by irradiation alone at 1 week after inoculation and at that time was significantly (P less than 0.01) greater in B abortus-infected, irradiated mice than in B abortus-infected controls. Histologic, cytologic, and immunologic studies revealed that the decrease in numbers of organisms between 1 and 2 weeks after inoculation in irradiated mice occurred at a time when their immune response to B abortus was suppressed and when numbers of neutrophils and monocytes infiltrating the spleen were significantly (P less than 0.01) diminished\n[Variabilidad de las meningoencefalitis bacterianas en el Hospital Pedi\u00e1trico \"Pepe Portilla\" Variability of the bacterial meningoencephalitis at \"Pepe Portilla\" Paediatric Hospital](http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942009000100003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMaydelin Fern\u00e1ndez Gonz\u00e1lez\n2009-03-01\nFull Text Available Se realiz\u00f3 un estudio retrospectivo y prospectivo longitudinal de las Meningoencefalitis Bacterianas diagnosticadas en el Hospital Pedi\u00e1trico \"Pepe Portilla\" en el a\u00f1o 2006 y 2007, con el objetivo de determinar los g\u00e9rmenes que han aislado en dicha patolog\u00eda, compar\u00e1ndose con a\u00f1os anteriores desde 1992, analizando el impacto de la vacunaci\u00f3n contra Neisseria meningitidis y Haemophilus influenzae. Los estudios de l\u00edquido cefalorraqu\u00eddeo se realizaron como indican las normativas para estos casos. Se encontr\u00f3 que en el 2006 solo hubo un caso de meningitis a Neisseria meningitidis y en el 2007 dos casos de meningitis por Streptocuccus pneumoneae, y adem\u00e1s que la incidencia de Neisseria meningitidis y Haemophilus influenzae disminuy\u00f3 despu\u00e9s de la aplicaci\u00f3n de las vacunas VAMENGO BC y Hib de manera ostensible como lo hizo en el pa\u00eds en general, demostr\u00e1ndose la efectividad de dicha vacuna en nuestro medio.A retrospective-prospective and longitudinal study about Bacterial Meningoencephalitis diagnosed at \"Pepe Portilla\" Paediatric Hopital was carried out during 2006-2007 aimed at determining the isolated germs of this pathology comparing them with previous years (since 1992 and analyzing the impact of vaccination against Neisseria meningitidis y Haemophilus influenzae. The studies about cerebrospinal fluid were conducted as indicated by the rules towards these cases. Results showed that in 2006 only one case of meningitis a Neisseria meningitidis occurred and two cases of meningitis by Streptocuccus pneumoneae in 2007; besides the incidence of Neisseria meningitidis y Haemophilus influenza diminished after the vaccination with VAMENGON BC and Hib observed in all the country, showing the effectiveness of the vaccine in our environment.\n[Epidemiological investigation of the first human brucellosis case in Spain due to Brucella suis biovar 1 strain 1330.](https://www.ncbi.nlm.nih.gov/pubmed/27474211)\nComp\u00e9s Dea, Cecilia; Guimbao Besc\u00f3s, Joaqu\u00edn; Alonso P\u00e9rez de \u00c1greda, Juan Pablo; Mu\u00f1oz \u00c1lvaro, Pilar Mar\u00eda; Blasco Mart\u00ednez, Jos\u00e9 Mar\u00eda; Villuendas Us\u00f3n, Mar\u00eda Cruz\n2017-03-01\nNo cases of human brucellosis caused by Brucella suis has been reported in Spain. This study involved interviews with the case and his co-workers, inspection of their workplace, checking infection control measures, and typing the Brucella strain isolated in the blood culture. Brucella suis biovar 1 strain 1330 was isolated from a patient who worked in a waste treatment plant. Food borne transmission, contact with animals, and risk jobs were ruled out. An accidental inoculation with a contaminated needle from a research laboratory waste container was identified as the most probable mode of transmission. There should be controls to ensure that waste containers are sealed. Copyright \u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.\n[Advancement of knowledge of Brucella over the past 50 years](http://www.ars.usda.gov/research/publications/publication/?seqNo115=302753)\nFifty years ago, bacteria in the genus Brucella were known to cause infertility and reproductive losses. The genus was considered to contain only three species, B. abortus, B. melitensis and B. suis. Since the early 1960\u2019s, at least seven new species have been identified as belonging to the Brucell...\n[Rapid identification of Yersinia pestis and Brucella melitensis by chip-based continuous flow PCR](http://adsabs.harvard.edu/abs/2012SPIE.8367E..0FD)\nDietzsch, Michael; Hlawatsch, Nadine; Melzer, Falk; Tomaso, Herbert; G\u00e4rtner, Claudia; Neubauer, Heinrich\n2012-06-01\nTo combat the threat of biological agents like Yersinia pestis and Brucella melitensis in bioterroristic scenarios requires fast, easy-to-use and safe identification systems. In this study we describe a system for rapid amplification of specific genetic markers for the identification of Yersinia pestis and Brucella melitensis. Using chip based PCR and continuous flow technology we were able to amplify the targets simultaneously with a 2-step reaction profile within 20 minutes. The subsequent analysis of amplified fragments by standard gel electrophoresis requires another 45 minutes. We were able to detect both pathogens within 75 minutes being much faster than most other nucleic acid amplification technologies.\n[MEDICAL vs. MEDICAL AND SURGICAL TREATMENT FOR BRUCELLA ENDOCARDITIS: A REVIEW OF THE LITERATURE](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3508082)\nKeshtkar-Jahromi, Maryam; Razavi, Seyed-Mostafa; Gholamin, Sharareh; Keshtkar-Jahromi, Marzieh; Hossain, Mian; Sajadi, Mohammad\n2012-01-01\nThis review was undertaken to determine the role of surgery in the treatment of brucella endocarditis. All English and French articles reporting brucella endocarditis (1966\u20132011) in Pubmed, Google and Scopus were reviewed. 308 cases were identified and Linear and Logistic regression was performed. Surgery improved outcomes by decreasing mortality from 32.7% in the medical treatment only group to 6.7% in the combined surgical and medical treatment group (p<.001). This association was still significant while controlling for other contributing factors. In the absence of a controlled trial, we recommend the utmost vigilance and consideration of surgical management in treating such patients. PMID:23102495\n[Evoluci\u00f3n de las coberturas de vacunaci\u00f3n antineumoc\u00f3cica en la poblaci\u00f3n infantil de Tarragona, 2002-2011](http://www.redalyc.org/articulo.oa?id=17025099009) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\n\u00c1ngel Vila C\u00f3rcoles\n2012-01-01\nFull Text Available Fundamentos: En Catalu\u00f1a, como en la mayor\u00eda de Comunidades Aut\u00f3nomas de nuestro pa\u00eds, la vacuna antineumoc\u00f3cica conjugada (VNC no es financiada p\u00fablicamente, excepto para ni\u00f1os inmunocomprometidos y/o con condiciones de riesgo. Este estudio investig\u00f3 la cobertura de VNC en los ni\u00f1os atendidos a finales de 2011 en la regi\u00f3n de Tarragona y analiz\u00f3 la evoluci\u00f3n de las coberturas, seg\u00fan a\u00f1o de nacimiento, desde la comercializaci\u00f3n de la vacuna hasta la actualidad (2002-2011. M\u00e9todos: Estudio transversal multic\u00e9ntrico que incluy\u00f3 a todos los ni\u00f1os entre 6 meses y 10 a\u00f1os que acudieron durante los d\u00edas 1 y 2 de diciembre de 2011 a las consultas de pediatr\u00eda y/o enfermer\u00eda pedi\u00e1trica de 9 centros de Atenci\u00f3n Primaria en la comarca del Tarragon\u00e9s (n=521 ni\u00f1os. La situaci\u00f3n vacunal se determin\u00f3 mediante revisi\u00f3n del historial cl\u00ednico. Las coberturas vacunales fueron comparadas mediante test de chi cuadrad. Resultados: Del total de 521 ni\u00f1os estudiados el 45,1% (intervalo de confianza [IC] 95%: 40,8-49,5 hab\u00edan recibido la VNC. La cobertura fue del 18,5% (IC 95%: 9,3-31,4 para los ni\u00f1os nacidos en 2002-2003; del 38,6% (IC 95%: 27,2-51,0 en 2004-2005; del 62,5% (IC 95%: 51,0-73,0 en 2006-2007, del 50,8% (IC 95%: 41,7-59,8 entre 2008-2009, y 44,6% (IC 95%: 36,8-51,3 en 2010-2011 (p<0,001. Conclusiones: La cobertura vacunal alcanzada de VNC es intermedia/baja. Tras un r\u00e1pido incremento inicial de vacunaciones, las coberturas han retrocedido en el \u00faltimo cuatrienio, coincidiendo con la actual crisis econ\u00f3mica.\n[Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells.](https://www.ncbi.nlm.nih.gov/pubmed/27584799)\nCasanova, Alain; Low, Shyan H; Emmenlauer, Mario; Conde-Alvarez, Raquel; Salcedo, Suzana P; Gorvel, Jean-Pierre; Dehio, Christoph\n2016-08-05\nBrucella species are facultative intracellular pathogens that infect animals as their natural hosts. Transmission to humans is most commonly caused by direct contact with infected animals or by ingestion of contaminated food and can lead to severe chronic infections. Brucella can invade professional and non-professional phagocytic cells and replicates within endoplasmic reticulum (ER)-derived vacuoles. The host factors required for Brucella entry into host cells, avoidance of lysosomal degradation, and replication in the ER-like compartment remain largely unknown. Here we describe two assays to identify host factors involved in Brucella entry and replication in HeLa cells. The protocols describe the use of RNA interference, while alternative screening methods could be applied. The assays are based on the detection of fluorescently labeled bacteria in fluorescently labeled host cells using automated wide-field microscopy. The fluorescent images are analyzed using a standardized image analysis pipeline in CellProfiler which allows single cell-based infection scoring. In the endpoint assay, intracellular replication is measured two days after infection. This allows bacteria to traffic to their replicative niche where proliferation is initiated around 12 hr after bacterial entry. Brucella which have successfully established an intracellular niche will thus have strongly proliferated inside host cells. Since intracellular bacteria will greatly outnumber individual extracellular or intracellular non-replicative bacteria, a strain constitutively expressing GFP can be used. The strong GFP signal is then used to identify infected cells. In contrast, for the entry assay it is essential to differentiate between intracellular and extracellular bacteria. Here, a strain encoding for a tetracycline-inducible GFP is used. Induction of GFP with simultaneous inactivation of extracellular bacteria by gentamicin enables the differentiation between intracellular and extracellular\n[Serological survey for Brucella antibodies in donkeys of north-eastern Nigeria.](https://www.ncbi.nlm.nih.gov/pubmed/28616790)\nTijjani, A O; Junaidu, A U; Salihu, M D; Farouq, A A; Faleke, O O; Adamu, S G; Musa, H I; Hambali, I U\n2017-08-01\nA cross-sectional epidemiological study was conducted to determine seroprevalence and risk factors influencing the presence of Brucella antibodies in donkeys of Borno State, north-eastern Nigeria. The study aimed at providing baseline information that may be used in planning a control policy against equine brucellosis. Blood samples were collected from 601 donkeys, comprised of 374 males and 227 females from the six agricultural zones of the state between March 2013 and September 2014. The sera obtained were tested for Brucella antibodies using Rose Bengal plate test (RBPT) and competitive enzyme-linked immunosorbent assay (cELISA). Of the 601 donkeys tested, 43 (7.2%) and 40 (6.7%) were seropositive by RBPT and cELISA, respectively. A seroprevalence of 8.6% was obtained in male and 3.5% in female donkeys. According to age, the highest seroprevalence of 9.6% was obtained from donkeys of age group 4-6 years. With respect to pregnancy status, a higher seroprevalence (6.8%) was obtained from pregnant donkeys compared to 3.8% obtained from the non-pregnant ones. There were statistically significant associations between the presence of antibodies and sex (p donkeys. However, no statistically significant association (p > 0.05) was observed between the pregnancy status and presence of antibodies. The study concludes that Brucella infection is present in donkeys in all the agricultural zones of the state. The relatively high seroprevalence (7.2%) obtained is of public health concern because of the close interaction between donkeys, ruminants, and humans in the study area.\n[Outer membrane vesicles from Brucella abortus promote bacterial internalization by human monocytes and modulate their innate immune response.](http://europepmc.org/articles/PMC3506553?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nCora N Pollak\nFull Text Available Outer membrane vesicles (OMVs released by some gram-negative bacteria have been shown to exert immunomodulatory effects that favor the establishment of the infection. The aim of the present study was to assess the interaction of OMVs from Brucella abortus with human epithelial cells (HeLa and monocytes (THP-1, and the potential immunomodulatory effects they may exert. Using confocal microscopy and flow cytometry, FITC-labeled OMVs were shown to be internalized by both cell types. Internalization was shown to be partially mediated by clathrin-mediated endocytosis. Pretreatment of THP-1 cells with Brucella OMVs inhibited some cytokine responses (TNF-\u03b1 and IL-8 to E. coli LPS, Pam3Cys or flagellin (TLR4, TLR2 and TLR5 agonists, respectively. Similarly, pretreatment with Brucella OMVs inhibited the cytokine response of THP-1 cells to B. abortus infection. Treatment of THP-1 cells with OMVs during IFN-\u03b3 stimulation reduced significantly the inducing effect of this cytokine on MHC-II expression. OMVs induced a dose-dependent increase of ICAM-1 expression on THP-1 cells and an increased adhesion of these cells to human endothelial cells. The addition of OMVs to THP-1 cultures before the incubation with live B. abortus resulted in increased numbers of adhered and internalized bacteria as compared to cells not treated with OMVs. Overall, these results suggest that OMVs from B. abortus exert cellular effects that promote the internalization of these bacteria by human monocytes, but also downregulate the innate immune response of these cells to Brucella infection. These effects may favor the persistence of Brucella within host cells.\n[Efectividad de una vacuna antigripal en una poblaci\u00f3n laboral colombiana Effectiveness of an influenza vaccine in a working population in Colombia](http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892001001000003) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nStella Sof\u00eda Mesa Duque\n2001-10-01\nFull Text Available Objetivos. Determinar si una vacuna contra la influenza disminuye significativamente los episodios de infecci\u00f3n respiratoria superior aguda (IRSA y la incapacidad laboral por esta causa, en trabajadores adultos sanos de una entidad bancaria en la ciudad de Medell\u00edn. M\u00e9todos. Se realiz\u00f3 un estudio aleatorizado con doble enmascaramiento y placebo en 493 voluntarios. Mediante asignaci\u00f3n aleatoria se conformaron dos grupos, uno de estudio y otro de control, con 247 y 246 empleados, respectivamente. Se utilizaron por participante dosis de 0,5 mL de una vacuna contra la influenza que contiene ant\u00edgenos de superficie de las cepas recomendadas por la OMS para el per\u00edodo 1996-1997 con los subtipos A/Wahan/359/95 (H3N2, A/Texas/36/91 (H1N1 y B/Beijing/184/93. Se consider\u00f3 episodio de IRSA cuando alg\u00fan participante refer\u00eda dolor de garganta, fiebre y tos con m\u00e1s de 24 horas de duraci\u00f3n. La evaluaci\u00f3n se realiz\u00f3 quincenalmente durante seis meses; la gravedad de los episodios se estudi\u00f3 por el ausentismo laboral debido a IRSA, seg\u00fan la novena Clasificaci\u00f3n Internacional de Enfermedades (CIE-9, mediante la evaluaci\u00f3n mensual de las ausencias laborales por incapacidad certificada por la Seguridad Social en Salud, a lo largo de un a\u00f1o. Resultados. La descripci\u00f3n de los efectos colaterales asociados con la vacuna fueron el eritema (riesgo relativo (RR = 8,0; P = 0,02 y el edema local (RR = 4,5; P = 0,03. La incidencia acumulada anual de los episodios de IRSA fue 78,5% para los vacunados y 91,5% para el grupo placebo, con una reducci\u00f3n de 14%, observ\u00e1ndose valores entre 7 y 20% (RR = 0,86; IC95%: 0,80-0,93. La incidencia acumulada anual de IRSA con discapacidad fue de 15,8% en el grupo de vacunados, con una reducci\u00f3n de 31% respecto al grupo placebo (22,8%, con valores entre 0 y 52% (RR = 0,69; IC95%: 0,48-1,0. Estos niveles de protecci\u00f3n, tanto contra las formas menos sintom\u00e1ticas de IRSA como contra las causantes de incapacidad laboral\n[Assessment of Genetic Diversity of Zoonotic Brucella spp. Recovered from Livestock in Egypt Using Multiple Locus VNTR Analysis](http://dx.doi.org/10.1155/2014/353876) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nAhmed M. S. Menshawy\n2014-01-01\nFull Text Available Brucellosis is endemic in most parts of Egypt, where it is caused mainly by Brucella melitensis biovar 3, and affects cattle and small ruminants in spite of ongoing efforts devoted to its control. Knowledge of the predominant Brucella species/strains circulating in a region is a prerequisite of a brucellosis control strategy. For this reason a study aiming at the evaluation of the phenotypic and genetic heterogeneity of a panel of 17 Brucella spp. isolates recovered from domestic ruminants (cattle, buffalo, sheep, and goat from four governorates during a period of five years (2002\u20132007 was carried out using microbiological tests and molecular biology techniques (PCR, MLVA-15, and sequencing. Thirteen strains were identified as B. melitensis biovar 3 while all phenotypic and genetic techniques classified the remaining isolates as B. abortus (n=2 and B. suis biovar 1 (n=2. MLVA-15 yielded a high discriminatory power (h=0.801, indicating a high genetic diversity among the B. melitensis strains circulating among domestic ruminants in Egypt. This is the first report of the isolation of B. suis from cattle in Egypt which, coupled with the finding of B. abortus, suggests a potential role of livestock as reservoirs of several zoonotic Brucella species in the region.\n[The efficacy of the skin delayed-type hypersensitivity using a brucellin prepared from a mucoid strain of Brucella abortus to detect brucellosis](http://www.narcis.nl/publication/RecordID/oai%3Alibrary.wur.nl%3Awurpubs%2F308132/uquery/brucella%20AND%20abortus/id/8/Language/EN)\nBercovich, Z.; Muskens, J.A.M.\n1998-01-01\nEight-hundred-and-ninety-six cattle belonging to herds officially designated Brucella-free, and 190 cattle belonging to infected herds were tested with the skin delayed-type hypersensitivity (SDTH) test, using brucellin (273) prepared from a rnucoid strain of Brucella abortus. An increase in\n[The Prevalence of Brucella Biotypes Isolated From Sterile Body Fluids of Patients With Brucellosis in Kashan, Iran in 2013](+++++++++++++++++http://ajcmicrob.com/?page=article&article_id=33516+++++++++++++) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nErami\n2016-07-01\nFull Text Available Background Brucella species are classified based on their pathogenic and genetic properties and hosts. Considering the significance of identifying different biotypes of Brucella from the epidemiological point of view and lack of such information in the city of Kashan, Iran. Objectives This study was designed to determine the biotypes and strains of Brucella isolated from patients with brucellosis. Methods This was a descriptive study of 206 samples obtained from patients with suspected brucellosis in 2013 in Kashan. BACTEC 9050 culture media was employed to test the samples. Suspected colonies of Brucella were identified through morphology, staining, and biochemical tests. The biotypes were identified by the Razi Research Institute. Lysis tests with the Tbilisi (Tb phage were performed, the need for CO2, SH2 production, sensitivity to basic fuchsin and thionin stains, and the reaction of all the samples to specific antiserum A and M (monospecific were tested. Results Fifty (24.3% of the 206 samples were culture positive. SH3 production was not detected in any of the isolates, and none of the isolated strains required CO2. The results of the sensitivity test to basic fuchsin and thionin staining and specific agglutination and phage lysis (phage typing tests indicated that all the isolated strains were biotype 1 B. melitansis. Conclusions The cause of human brucellosis in Kashan and its suburbs was biotype 1 B. melitensis. The identification of various biotypes of Brucella is important. Similar studies should be performed to detect the presence of new biotypes originating from neighboring countries.\n[Circulating strains of Brucella abortus in cattle in the province of Santo Domingo de los Ts\u00e1chilas - Ecuador.](http://journal.frontiersin.org/Journal/10.3389/fpubh.2015.00045/full) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nRichar Ivan Rodr\u00edguez Hidalgo\n2015-03-01\nFull Text Available In Ecuador, the Province of Santo Domingo de los Ts\u00e1chilas represents the largest informal market of livestock due to its strategic position in the country; thus, given the high mobility of cattle in this region, the aim of this study was to determine the strain variation of Brucella sp.. Part of the study was the isolation, biotyping and genotyping of Brucella species isolated from milk and supra-mammary lymph nodes of sero-positive bovines. Protocols used for isolation, biotyping and genotyping of Brucella species were selective Farrell medium, biochemical assays and IS711-PCR, AMOS-PCR and HOOF-Prints techniques, respectively. In total, 656 animals from sero-positive dairy herds and from the slaughterhouse of the province were diagnosed by Rose Bengal and Wright\u2019s Slow Agglutination test with EDTA. From these animals, 50 animals were found sero-positive for brucellosis. Twenty-five lymph nodes and 25 milk samples from each group of positive reactors were cultured and growth. Isolation was possible in 4 (16% and 9 (36%, respectively; and of these, 10 isolates were diagnosed as Brucella sp. All 4 isolates of lymphatic tissue corresponded to Brucella abortus biotype 1, confirmed as field strains by molecular analysis. Milk isolations, biochemically showed a more dispersed pattern in which B. abortus biotypes 1 and 4 were found; yet four samples gave a pattern similar to B. abortus biotype 2; however, only biotypes 1 and 4 were confirmed by molecular analysis. The concordance between biochemical and molecular diagnostic tests reached 76.9%.\n[Brucella abortus choloylglycine hydrolase affects cell envelope composition and host cell internalization.](http://europepmc.org/articles/PMC3234258?pdf=render) [Directory of Open Access Journals (Sweden)](https://doaj.org/search#.V6PA8bgrK70)\nMar\u00eda In\u00e9s Marchesini\nFull Text Available Choloylglycine hydrolase (CGH, E.C. 3.5.1.24 is a conjugated bile salt hydrolase that catalyses the hydrolysis of the amide bond in conjugated bile acids. Bile salt hydrolases are expressed by gastrointestinal bacteria, and they presumably decrease the toxicity of host's conjugated bile salts. Brucella species are the causative agents of brucellosis, a disease affecting livestock and humans. CGH confers Brucella the ability to deconjugate and resist the antimicrobial action of bile salts, contributing to the establishment of a successful infection through the oral route in mice. Additionally, cgh-deletion mutant was also attenuated in intraperitoneally inoculated mice, which suggests that CGH may play a role during systemic infection other than hydrolyzing conjugated bile acids. To understand the role CGH plays in B. abortus virulence, we infected phagocytic and epithelial cells with a cgh-deletion mutant (\u0394cgh and found that it is defective in the internalization process. This defect along with the increased resistance of \u0394cgh to the antimicrobial action of polymyxin B, prompted an analysis of the cell envelope of this mutant. Two-dimensional electrophoretic profiles of \u0394cgh cell envelope-associated proteins showed an altered expression of Omp2b and different members of the Omp25/31 family. These results were confirmed by Western blot analysis with monoclonal antibodies. Altogether, the results indicate that Brucella CGH not only participates in deconjugation of bile salts but also affects overall membrane composition and host cell internalization.\n[Nocodazole treatment interrupted Brucella abortus invasion in RAW 264.7 cells, and successfully attenuated splenic proliferation with enhanced inflammatory response in mice.](https://www.ncbi.nlm.nih.gov/pubmed/28017899)\nReyes, Alisha Wehdnesday Bernardo; Hop, Huynh Tan; Arayan, Lauren Togonon; Huy, Tran Xuan Ngoc; Min, Wongi; Lee, Hu Jang; Chang, Hong Hee; Kim, Suk\n2017-02-01\nBrucellosis is one of the most important and widespread zoonosis worldwide responsible for serious economic losses and considerable public health burden. In this study, we investigated the modulatory effect of a microtubule-inhibitor, nocodazole, on B. abortus infection in murine macrophages and in a mouse model. Nocodazole activated macrophages and directly inhibited the growth of Brucella in a dose-dependent manner. Nocodazole increased adhesion but reduced invasion and intracellular growth of Brucella in macrophages although it did not affect co-localization of Brucella with LAMP-1. In addition, nocodazole negatively affected actin polymerization, and weakly activated ERK and p38\u03b1 but significantly activated JNK in non-infected cells. After subsequent infection, nocodazole weakly inhibited activation of ERK and p38\u03b1. For the in vivo tests, nocodazole -treated mice displayed elevated levels of IFN-\u03b3, MCP-1 and IL-10 while Brucella-infected nocodazole -treated mice showed high levels of TNF, IFN-\u03b3, MCP-1, IL-10 and IL-6 as compared to controls. Furthermore, nocodazole treatment reduced inflammation and Brucella proliferation in the spleens of mice. These findings highlight the potential use of nocodazole for the control of brucellosis although further investigations are encouraged to validate its therapeutic use in animal hosts. Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.\n[Immunization of Mice with Recombinant Brucella abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella abortus 544 Infection.](https://www.ncbi.nlm.nih.gov/pubmed/26464379)\nHop, Huynh Tan; Reyes, Alisha Wehdnesday Bernardo; Simborio, Hannah Leah Tadeja; Arayan, Lauren Togonon; Min, Won Gi; Lee, Hu Jang; Lee, Jin Ju; Chang, Hong Hee; Kim, Suk\n2016-01-01\nIn this study, the Brucella abortus ohr gene coding for an organic hydroperoxide resistance protein (Ohr) was cloned into a maltose fusion protein expression system (pMAL), inserted into Escherichia coli, and purified, and its immunogenicity was evaluated by western blot analysis using Brucella-positive mouse sera. The purified recombinant Ohr (rOhr) was treated with adjuvant and injected intraperitoneally into BALB/c mice. A protective immune response analysis revealed that rOhr induced a significant increase in both the IgG1 and IgG2a titers, and IgG2a reached a higher level than IgG1 after the second and third immunizations. Additionally, immunization with rOhr induced high production of IFN-\u03b3 as well as proinflammatory cytokines such as TNF, MCP-1, IL-12p70, and IL-6, but a lesser amount of IL-10, suggesting that rOhr predominantly elicited a cell-mediated immune response. In addition, immunization with rOhr caused a significantly higher degree of protection against a virulent B. abortus infection compared with a positive control group consisting of mice immunized with maltose-binding protein. These findings showed that B. abortus rOhr was able to induce both humoral and cell-mediated immunity in mice, which suggested that this recombinant protein could be a potential vaccine candidate for animal brucellosis.\n[Combinatorial control of adhesion of Brucella abortus 2308 to host cells by transcriptional rewiring of the trimeric autotransporter btaE gene.](https://www.ncbi.nlm.nih.gov/pubmed/27862467)\nSieira, Rodrigo; Bialer, Magal\u00ed G; Roset, Mara S; Ruiz-Ranwez, Ver\u00f3nica; Langer, Tom\u00e1s; Arocena, Gast\u00f3n M; Mancini, Estefan\u00eda; Zorreguieta, Angeles\n2017-02-01\nRegulatory network plasticity is a key attribute underlying changes in bacterial gene expression and a source of phenotypic diversity to interact with the surrounding environment. Here, we sought to study the transcriptional circuit of HutC, a regulator of both metabolic and virulence genes of the facultative intracellular pathogen Brucella. Using in silico and biochemical approaches, we identified a novel functional HutC-binding site upstream of btaE, a trimeric-autotransporter adhesin involved in the attachment of Brucella to host extracellular matrix components. Moreover, we identified two additional regulators, one of which, MdrA, acts in concert with HutC to exert a combinatorial control of both btaE promoter activity and attachment of Brucella to HeLa cells. Analysis of btaE promoter sequences of different species indicated that this HutC-binding site was generated de novo by a single point mutation in a virulent Brucella strain, indicative of a transcriptional rewiring event. In addition to major domain organization differences existing between BtaE proteins within the genus Brucella, our analyses revealed that sequences upstream of btaE display high variability probably associated to intrinsic promoter structural features, which may serve as a substrate for reciprocal selection during co-evolution between this pathogen and its mammalian host. \u00a9 2016 John Wiley & Sons Ltd.\n[Isolation & characterization of Brucella melitensis isolated from patients suspected for human brucellosis in India](https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4989840)\nBarua, Anita; Kumar, Ashu; Thavaselvam, Duraipandian; Mangalgi, Smita; Prakash, Archana; Tiwari, Sapana; Arora, Sonia; Sathyaseelan, Kannusamy\n2016-01-01\nBackground & objectives: Brucellosis is endemic in the southern part of India. A combination of biochemical, serological and molecular methods is required for identification and biotyping of Brucella. The present study describes the isolation and biochemical, molecular characterization of Brucella melitensis from patients suspected for human brucellosis. Methods: The blood samples were collected from febrile patients suspected to have brucellosis. A total of 18 isolates were obtained from 102 blood samples subjected to culture. The characterization of these 18 isolates was done by growth on Brucella specific medium, biochemical reactions, CO2 requirement, H2S production, agglutination with A and M mono-specific antiserum, dye sensitivity to basic fuchsin and thionin. Further, molecular characterization of the isolates was done by amplification of B. melitensis species specific IS711 repetitive DNA fragment and 16S (rRNA) sequence analysis. PCR-restriction fragment length polymorphism (RFLP) analysis of omp2 locus and IS711 gene was also done for molecular characterization. Results: All 102 suspected samples were subjected to bacteria isolation and of these, 18 isolates could be recovered on blood culture. The biochemical, PCR and PCR-RFLP and 16s rRNA sequencing revealed that all isolates were of B. melitensis and matched exactly with reference strain B. melitensis 16M. Interpretation & conclusions: The present study showed an overall isolation rate of 17.64 per cent for B. melitensis. There is a need to establish facilities for isolation and characterization of Brucella species for effective clinical management of the disease among patients as well as surveillance and control of infection in domestic animals. Further studies are needed from different geographical areas of the country with different level of endemicity to plan and execute control strategies against human brucellosis. PMID:27488010\n[Et tilf\u00e6lde af brucella spondylodiscitis efter rejse til Libanon](http://www.forskningsdatabasen.dk/en/catalog/2434076655) [DEFF Research Database (Denmark)](http://forskningsbasen.deff.dk/?lang=eng)\nNielsen, Stig L\u00f8nberg; Johansen, Isik Somuncu\n2012-01-01\nBrucellosis is a widespread endemic zoonotic infection affecting more than 500,000 people per year. The disease is very uncommon in Denmark and almost always imported. We present a case of a 57 year-old male with blood culture and magnetic resonance imaging verified brucella spondylodiscitis. Prior...\n[Typing and comparative genome analysis of Brucella melitensis isolated from Lebanon.](https://www.ncbi.nlm.nih.gov/pubmed/28961704)\nAbou Zaki, Natalia; Salloum, Tamara; Osman, Marwan; Rafei, Rayane; Hamze, Monzer; Tokajian, Sima\n2017-10-16\nBrucella melitensis is the main causative agent of the zoonotic disease brucellosis. This study aimed at typing and characterizing genetic variation in 33 Brucella isolates recovered from patients in Lebanon. Bruce-ladder multiplex PCR and PCR-RFLP of omp31, omp2a and omp2b were performed. Sixteen representative isolates were chosen for draft-genome sequencing and analyzed to determine variations in virulence, resistance, genomic islands, prophages and insertion sequences. Comparative whole-genome single nucleotide polymorphism analysis was also performed. The isolates were confirmed to be B. melitensis. Genome analysis revealed multiple virulence determinants and efflux pumps. Genome comparisons and single nucleotide polymorphisms divided the isolates based on geographical distribution but revealed high levels of similarity between the strains. Sequence divergence in B. melitensis was mainly due to lateral gene transfer of mobile elements. This is the first report of an in-depth genomic characterization of B. melitensis in Lebanon. \u00a9 FEMS 2017. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.\n[NLRP12 negatively regulates proinflammatory cytokine production and host defense against Brucella abortus.](https://www.ncbi.nlm.nih.gov/pubmed/27800616)\nSilveira, Tatiana N; Gomes, Marco T\u00falio R; Oliveira, Luciana S; Campos, Priscila C; Machado, Gabriela G; Oliveira, Sergio C\n2017-01-01\nBrucella abortus is the causative agent of brucellosis, which causes abortion in domestic animals and undulant fever in humans. This bacterium infects and proliferates mainly in macrophages and dendritic cells, where it is recognized by pattern recognition receptors (PRRs) including Nod-like receptors (NLRs). Our group recently demonstrated the role of AIM2 and NLRP3 in Brucella recognition. Here, we investigated the participation of NLRP12 in innate immune response to B. abortus. We show that NLRP12 inhibits the early production of IL-12 by bone marrow-derived macrophages upon B. abortus infection. We also observed that NLRP12 suppresses in vitro NF-\u03baB and MAPK signaling in response to Brucella. Moreover, we show that NLRP12 modulates caspase-1 activation and IL-1\u03b2 secretion in B. abortus infected-macrophages. Furthermore, we show that mice lacking NLRP12 are more resistant in the early stages of B. abortus infection: NLRP12 -/- infected-mice have reduced bacterial burdens in the spleens and increased production of IFN-\u03b3 and IL-1\u03b2 compared with wild-type controls. In addition, NLRP12 deficiency leads to reduction in granuloma number and size in mouse livers. Altogether, our findings suggest that NLRP12 plays an important role in negatively regulating the early inflammatory responses against B. abortus. \u00a9 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.\n[Seroprevalence of Brucella spp. in Cattle, Molecular Characterization in Milk, and the Analysis of Associated Risk Factors with Seroprevalence in Humans, Egypt.](https://www.ncbi.nlm.nih.gov/pubmed/27754795)\nEl-Diasty, Mohamed M; Ahmed, Heba A; Sayour, Ashraf E; El Hofy, Fatma I; Tahoun, Asmaa B M B; Shafik, Saleh M\n2016-12-01\nThe objective of the present study was to estimate the seroprevalence of Brucella spp. in humans and cattle at Sharkia Governorate, Egypt. In addition, identification of Brucella spp. in milk samples by PCR and culture with the evaluation of the risk factors associated with Brucella spp. seroprevalence in humans were carried out. Overall, the seroprevalence of Brucella antibodies in the examined cattle was 23.8%, while in human participants it was 21%. The examination of 205 milk samples using PCR revealed that 6.3% were positive for B. abortus biovar 1 and the results were confirmed by culture methods. Multivariate logistic regression revealed that consumption of unpasteurized dairy products, occupational contact with animals, and knowledge about the disease are risk factors associated with infection in humans. This study documented the endemic status of brucellosis in Egypt. Hygienic measures and increased awareness about the disease are recommended to minimize the spread of infection from animals to humans.\n[Ultraviolet C lethal effect on Brucella melitensis](https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=39120143) [International Nuclear Information System (INIS) ](http://inis.iaea.org/search/)\nAl-Mariri, A.\n2008-01-01\nThe gram-negative bacteria Brucella melitensis was investigated to evaluate its susceptibility to UVC radiation at 254 nm. At an intensity of 18.7 m W/cm 2 of UVC, the time required for in activation of B. melitensis was 240 seconds in both dark and light, whereas it was 120 seconds and 240 seconds in dark and light respectively; at an intensity of 19.5 m W/cm 2 . The results indicate that vaccinal strain of B. melitensis (Rev.1) is more sensitive to UVC than wild B. melitensis strain. (author)\n[Vaccination of elk (Cervus canadensis) with Brucella abortus strain RB51 overexpressing superoxide dismutase and glycosyltransferase genes does not induce adequate protection against experimental brucella abortus challenge](http://www.ars.usda.gov/research/publications/publication/?seqNo115=320632)\nIn recent years, elk (Cervus canadensis) have been implicated as the source of Brucella abortus infection for numerous cattle herds in the Greater Yellowstone Area (GYA). In the face of environmental and ecological changes on the landscape, the range of infected elk is expanding. Consequently, the d...\n[Gene Discovery through Genomic Sequencing of Brucella abortus](https://www.openaire.eu/search/publication?articleId=od_______908::f3726fc4479cb6e5776b349b2763659d)\nS\u00e1nchez, Daniel O.; Zandomeni, Ruben O.; Cravero, Silvio; Verd\u00fan, Ramiro E.; Pierrou, Ester; Faccio, Paula; Diaz, Gabriela; Lanzavecchia, Silvia; Ag\u00fcero, Fern\u00e1n; Frasch, Alberto C. C.; Andersson, Siv G. E.; Rossetti, Osvaldo L.; Grau, Oscar; Ugalde, Rodolfo A.\n2001-01-01\nBrucella abortus is the etiological agent of brucellosis, a disease that affects bovines and human. We generated DNA random sequences from the genome of B. abortus strain 2308 in order to characterize molecular targets that might be useful for developing immunological or chemotherapeutic strategies against this pathogen. The partial sequencing of 1,899 clones allowed the identification of 1,199 genomic sequence surveys (GSSs) with high homology (BLAST expect value < 10\u22125) to sequences deposit...\n[Des-aprendizaje y p\u00e9rdida de capacidades locales. El calendario nacional de vacunaci\u00f3n en Argentina](https://www.openaire.eu/search/publication?articleId=doajarticles::b043f1bb117279190c73f54ac4c4578c)\nDora Corval\u00e1n\n2017-01-01\nA comienzos del siglo xxi, el gobierno argentino modific\u00f3 su pol\u00edtica p\u00fablica vinculada al Calendario Nacional de Vacunaci\u00f3n (cnv), mediante la incorporaci\u00f3n de vacunas. La industria farmac\u00e9utica global incursiona en la producci\u00f3n de vacunas a partir de la adopci\u00f3n de t\u00e9cnicas biol\u00f3gicas, desde mediados de los 80. En este marco, la industria cambia su encuadre innovativo y surgen las vacunas modernas. Producto de este recorrido, la producci\u00f3n local sufri\u00f3 un desfasaje t\u00e9cnico y organizacional...", "language": null, "image": null, "pagetype": null, "links": ["#", "//worldwidescience.org/index.html", "//worldwidescience.org/about.html", "//worldwidescience.org/news.html", "//worldwidescience.org/wws", "//worldwidescience.org/contact.html", "//worldwidescience.org/sitemap.html", "//worldwidescience.org/help.html", "#", "#", "#", "#", "#", "#", "http://riiad.org/index.php/riiad/article/view/riiad.2017.2.05", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271999000400003", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892007000300011", "https://doaj.org/search#.V6PA8bgrK70", "https://www2c.cdc.gov/podcasts/player.asp?f=8630647", "http://www2c.cdc.gov/podcasts/search.asp", "http://asclepio.revistas.csic.es/index.php/asclepio/article/view/71/74", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17023106004", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::ece01fbd6d31d8575f7f4ae84e6b72a6", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od______1325::3699ed70c8821c924c79160abcf4fcaf", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832008000100006&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1404::4f4db4f9056e1f4cbb5edb2cfbec944e", "https://www.openaire.eu/search/advanced/publications", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______3272::e04c2a8ca070b76a97f8c299cefc6434", "https://www.openaire.eu/search/advanced/publications", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342013000200018&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::6f322a77ce0bd5fd88c95f861a1a0782", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200005&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412005000300002", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______3056::90581237738de503aa4b6681ae4c01e3", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46651991000100005", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=doajarticles::9f083d9cb2b9e06dbceeb1cf2c0fabe3", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od______3040::cc271e44d67bb301b8673ae704eb1321", "https://www.openaire.eu/search/advanced/publications", "http://www.revistas.usach.cl/ojs/index.php/historiasocial/article/view/319", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1404::05502ca26081377cb9ac9b967d7e66d8", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=doajarticles::4639710bd8874709386dd27339826e1d", "https://www.openaire.eu/search/advanced/publications", "http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/903", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000200006&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272002000400008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9f9342f04c4ecfc6206eb357ddd593ea", "https://www.openaire.eu/search/advanced/publications", "http://www.sciencedirect.com/science/article/pii/S0716864017300160", "https://doaj.org/search#.V6PA8bgrK70", "http://www.sciencedirect.com/science/article/pii/S0716864014700689", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891998001000001", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312014000200012&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::61ee14b25b56c72855596bb426219d56", "https://www.openaire.eu/search/advanced/publications", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49891997001200001&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17020115007", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1320", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::136a986051855d4bcd529e7bf176cfb3", "https://www.openaire.eu/search/advanced/publications", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::9c7220297c636745e06628ec37f2b47e", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/1056", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342015000300021&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1326::8fd162326a4cf806bef07884700a3945", "https://www.openaire.eu/search/advanced/publications", "https://revistas.unal.edu.co/index.php/revfacmed/article/view/22140", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900012", "https://doaj.org/search#.V6PA8bgrK70", "http://www.sciencedirect.com/science/article/pii/S0716864010706088", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0465-546X2007000400010", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2000000400004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://revistamedicina.net/ojsanm/index.php/Revistamedicina/article/view/92", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::d1c5d56abb3c55f6f0d140a1ec694442", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2010000300001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______617::72f63e3faddc26d37afb5bec15e160d2", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000300011&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2007000300004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=od______3056::b5aead9f580b681052141b2e3d723c77", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342006000100007&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832006000300009&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://revistabionatura.com/2017.02.01.7.html", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000500007", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=83743886006", "https://doaj.org/search#.V6PA8bgrK70", "https://www2c.cdc.gov/podcasts/player.asp?f=8630175", "http://www2c.cdc.gov/podcasts/search.asp", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1726-46342012000200017", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342003000200007&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17033372012", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17015304012", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/2011", "https://doaj.org/search#.V6PA8bgrK70", "https://revistas.unal.edu.co/index.php/actabiol/article/view/11338", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832011000300003&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://asclepio.revistas.csic.es/index.php/asclepio/article/view/546/568", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::0f1a7e9d964b5b4dd7e2026d0f5f7623", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000300014", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=od______1472::a09ac4cf255ae73a6b4363b1bbc0a6ad", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/28622869", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::6c224d812f75e411561938046626731c", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2004000100001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112005000600006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______935::d513a40dc09e50440853f4ad3258003a", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000100002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______3056::d4191acb1173d7dbea934cb8c961809f", "https://www.openaire.eu/search/advanced/publications", "http://dx.doi.org/10.1155/2009/354649", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27436438", "https://www.science.gov/", "http://www.biomedcentral.com/1471-2180/9/145", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1404::6574285bd1662fef225103ab5f2fa6f1", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342011000200010", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000300006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/24941369", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28443226", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57272002000400005", "https://doaj.org/search#.V6PA8bgrK70", "http://asclepio.revistas.csic.es/index.php/asclepio/article/view/62/64", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342010000300007", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892013001000002&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://apps.unicordoba.edu.co/revistas/revistamvz/mvz-122/122-7.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.gpo.gov/fdsys/pkg/CFR-2010-title9-vol1/pdf/CFR-2010-title9-vol1-sec113-65.pdf", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25471320", "https://www.science.gov/", "http://www.anfamed.edu.uy/index.php/rev/article/view/123", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000400005", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000900002", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=73138582007", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26778206", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24558120", "https://www.science.gov/", "https://ojs.unud.ac.id/index.php/jvet/article/view/9979", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26445639", "https://www.science.gov/", "http://rii.cujae.edu.cu/index.php/revistaind/article/view/80", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3146883", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______3056::5d7a8a9d35638166a4e7ccabd8678667", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/24981716", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27734009", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2014000100003&lng=es&nrm=iso", "https://doaj.org/search#.V6PA8bgrK70", "https://revistas.unal.edu.co/index.php/actabiol/article/view/27394", "https://doaj.org/search#.V6PA8bgrK70", "http://www.biomedcentral.com/1471-2148/11/200", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412009000200005", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=doajarticles::71daec30452063189f5b50ff40cbc04d", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/26626213", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/250070116", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.openaire.eu/search/publication?articleId=od______1326::8ba7ba7cedd44552d4d60ca52f50c9aa", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/26230118", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______1325::4966a7cc814137a440382bdf643c90d0", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802011000500015", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29173617", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=321362", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29727136", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382006000300011", "https://doaj.org/search#.V6PA8bgrK70", "http://rbmv.org/index.php/BJVM/article/view/434", "https://doaj.org/search#.V6PA8bgrK70", "https://www.gpo.gov/fdsys/pkg/CFR-2010-title21-vol8/pdf/CFR-2010-title21-vol8-sec866-3085.pdf", "https://www.science.gov/", "http://www.ars.usda.gov/research/publications/publication/?seqNo115=275280", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revista-socampar.com/images/articulos/ArticulosSeparadosNum6/Articulo%20especial.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://revistas.utadeo.edu.co/index.php/TyE/article/view/945/984", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-11042016000400009&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412010000100008", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=11562070", "http://inis.iaea.org/search/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352007000600036", "https://doaj.org/search#.V6PA8bgrK70", "http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/19745.pdf&manuscript_id=19745", "https://doaj.org/search#.V6PA8bgrK70", "https://www.gpo.gov/fdsys/pkg/CFR-2010-title9-vol1/pdf/CFR-2010-title9-vol1-sec113-32.pdf", "https://www.science.gov/", "https://www.ajol.info/index.php/bahpa/article/view/114719", "http://www.ajol.info/index.php", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002001000005", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F175b4943-cce5-4a49-8c81-e99e4eda87d2/uquery/Brucella/id/1/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/20875156", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1135-57271997000200003", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3161862", "https://www.science.gov/", "http://www.veterinaryresearch.org/content/42/1/93", "https://doaj.org/search#.V6PA8bgrK70", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=978721", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.openaire.eu/search/publication?articleId=doajarticles::022a82660015c5c135852a1b502182b6", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=od______1404::4dfcdb9afa501d98d59e07e37c0dec1f", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/21441188", "https://www.science.gov/", "http://www.dtic.mil/docs/citations/ADA552244", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25179110", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342009000900010", "https://doaj.org/search#.V6PA8bgrK70", "http://journal.frontiersin.org/Journal/10.3389/fcimb.2014.00023/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/24634889", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25242540", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1726-46342007000400013&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______2347::862e193bff7f2aed1ec83096ecbe1486", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352004000200021", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistas.usp.br/bjvras/article/view/34369", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/18218934", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28934239", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______908::f382cfe4b1f06bccb36e7dabdad3c112", "https://www.openaire.eu/search/advanced/publications", "https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2AwNtIz0EUrEyyT0sySzFOTLVLNUi1SzIySTYwS05KTzUwtU41NU41A-51DQ41dI0z8AkFbY2B7xKC1gC5iKAO8FCoR6fgkQwvQ3JVBXTDo2G1gcx-Y1lkdA13dArgZOPOKkiHqeRAlppsggzDiGlsFYFFeCmIIMTCl5okwxNok2YEDFRgHNvpJdgoeIUGOCgGgIxMy8xSAfXuFAGDDLD8dVA5lFlspoCt3Sc0pSYRoCgbf8VCskFisEJaYDJolLxZlUHdzDXH20IU7LB7qM8iZ1vFQz1QYiTGwAHv_qRKgPdVJxklpyRZJqUYGJqmmoOtZzFPN0kyTko2SjVKSTSUZFAiZJkVYiTQDF-RcVtDYggwDaxow7afKMrCnFefoJhWnAQAi_4sH", "http://science-libraries.canada.ca/eng/national-science-library/", "https://www.ncbi.nlm.nih.gov/pubmed/25320267", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342003000900019", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29634193", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28715292", "https://www.science.gov/", "http://tumj.tums.ac.ir/browse.php?a_code=A-10-25-5498&slc_lang=en&sid=1", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25011712", "https://www.science.gov/", "http://europepmc.org/articles/PMC5608248?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25892682", "https://www.science.gov/", "https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LS8NAEF7EIj4uPvEJc_MUDZtHUymFWBJ6Uaxt1VvJbndJQVJwm4Me_Ff-P2eSmIgIve1hGNid3dmZb_ebYczhV7b1xyd0hPZFW8lA-SqY-Vy6PNFS-l5HOZ7ixHeeTJzoxb0fEjXmhyNW3QJWA2UUX6GSX-WTMABxcVd-jqjsNob7uNdb4TCKH7bZZvYmS_mdxjPGu2y_aWML6MpzGuyxNZUdsK-SHqsrvAwWGkaUmGJO_w53efk6buA5ncsUoiwlywCm_IChIX1m_VCAcRuESwx481pFV_QKS6Fhu9eiB4PxY1hoy5bmBmr04F856xZvM9JPHSMMJAaeEklv7tAn3gvBAuaQXcbRuD-w6glPqxUra2VPq0Wy-RFbzxaZOiautnCEloFQ3HaVR21f2srXnpBc8pn0This0na6WuSMbZXcdcIszllL45lSF2xDm1dLGP0NOCqrIA", "http://science-libraries.canada.ca/eng/national-science-library/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692015000500919&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28506887", "https://www.science.gov/", "https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2AwNtIz0EUrEyyT0sySzFOTLVLNUi1SzIySTYwS05KTzUwtU41NU41A-51DQ41dI0z8AkFbY2B7xKC1gC5iKAO8FCoR6fgk0OZfCwPzumDQsdvA5j4wrbM6Brq6BXAzcOYVJUPU8yBKSDdBBmHENbYKwKK8FMQQYmBKzRNhiLFJsgMHKjAObPST7BQ8QoIcFQJARyZk5ikA-_YKAcCGWX46qBzKLLZSQFfukppTkgjU5KgQDL7ioVghsVghLDEZNEleLMqg7uYa4uyhC3dXPNRjkCOt46F-MTcSY2ABdv5TJUBbqpOMk9KSLZJSjQxMUk1Bt7OYp5qlmSYlGyUbpSSbSjIoEDJNirASaQYuyF470NCCDANrGjDpp8oysKcV5-gmFacBAGjOihQ", "http://science-libraries.canada.ca/eng/national-science-library/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/26579096", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4623201", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______3056::6f997afa8ad420371310199c381d7419", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412006000200007", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/20593515", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2897020", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______1404::024354d31010002918ddb339dc0408a6", "https://www.openaire.eu/search/advanced/publications", "http://apps.unicordoba.edu.co/revistas/revistamvz/mvz-133/v13n3a9.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25916795", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26523973", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26093199", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24026689", "https://www.science.gov/", "http://www.ars.usda.gov/research/publications/publication/?seqNo115=317634", "https://www.science.gov/", "https://www.ajol.info/index.php/ahs/article/view/111374", "http://www.ajol.info/index.php", "https://www.ncbi.nlm.nih.gov/pubmed/28715291", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::665616b0e79abcde2883f393f494e02c", "https://www.openaire.eu/search/advanced/publications", "http://journal.frontiersin.org/Journal/10.3389/fcimb.2015.00072/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26528442", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27785661", "https://www.science.gov/", "https://www.ejcrim.com/index.php/EJCRIM/article/view/808", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006000900001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25258171", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4791395", "https://www.science.gov/", "http://journal.frontiersin.org/Journal/10.3389/fcimb.2012.00002/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3417401", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29578063", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28255651", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2016000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000100003", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28437181", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28325071", "https://www.science.gov/", "http://dx.doi.org/10.1155/2010/124509", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______296::4dfda7f2f3e4339756541268672e7022", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3845367", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25505297", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89101984000100005", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26606688", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26160544", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=7186793", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=19092716", "http://inis.iaea.org/search/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/26851674", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/9407549", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/23862154", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29023001", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29644829", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::e53e6396d7036924ac4edb136005a9b2", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-21002010000600013", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26733136", "https://www.science.gov/", "http://www.biomedcentral.com/1471-2180/7/34", "https://doaj.org/search#.V6PA8bgrK70", "http://www.pagepressjournals.org/index.php/ijfs/article/view/5913", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=doajarticles::10bf287ae0007ca1c04dfbe102687a3b", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2010000500012", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2013/743509", "https://doaj.org/search#.V6PA8bgrK70", "http://www.revistabiomedica.org/index.php/biomedica/article/view/44", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100001&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28418765", "https://www.science.gov/", "http://www.onehealthjournal.org/Vol.4/5.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3445970", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27740712", "https://www.science.gov/", "http://www.archrazi.com/browse.php?a_id=544&sid=1&slc_lang=en", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/23868548", "https://www.science.gov/", "http://journal.frontiersin.org/article/10.3389/fvets.2017.00215/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/23999701", "https://www.science.gov/", "http://www.bjbms.org/ojs/index.php/bjbms/article/view/3203", "https://doaj.org/search#.V6PA8bgrK70", "http://www.biomedcentral.com/1471-2180/12/110", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25115787", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=17029171003", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=17078406", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26959235", "https://www.science.gov/", "http://europepmc.org/articles/PMC4784796?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/19369480", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27771184", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::1ea3de1bdf059dfdef615fb2bb624b84", "https://www.openaire.eu/search/advanced/publications", "https://revistas.unal.edu.co/index.php/revfacmed/article/view/27236", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000300002", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892004000100014", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::6ef7b58983f5b0ca0d0bcc5a7870b293", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/25641125", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2008000200004&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/7865557", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152010000300006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.redalyc.org/articulo.oa?id=203315187001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27072820", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/21660647", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3180695", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=17043728001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25381237", "https://www.science.gov/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=878626", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "http://journal.frontiersin.org/article/10.3389/fimmu.2017.00903/full", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0036-36341998000100006", "https://doaj.org/search#.V6PA8bgrK70", "https://togodb.biosciencedbc.jp/mecab_jstmesh/show/247#en", "http://biosciencedbc.jp/dbsearch/index.php?lang=en", "http://tumj.tums.ac.ir/browse.php?a_code=A-10-1245-2&slc_lang=en&sid=1", "https://doaj.org/search#.V6PA8bgrK70", "http://www.biomedcentral.com/1471-2180/10/269", "https://doaj.org/search#.V6PA8bgrK70", "http://www.ann-clinmicrob.com/content/5/1/24", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28068003", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______908::cacb64baa2ac1317d6c406c65df338fa", "https://www.openaire.eu/search/advanced/publications", "http://www.uel.br/revistas/uel/index.php/semagrarias/article/view/12582", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26724943", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28284850", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/28036367", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3553818", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::f3f4ecc159ebb48d37bb75cddc626a36", "https://www.openaire.eu/search/advanced/publications", "http://journal.frontiersin.org/article/10.3389/fvets.2018.00008/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26398680", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3738490", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3666581", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26928956", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352016000400853&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.jlponline.org/article.asp?issn=0974-2727;year=2017;volume=9;issue=4;spage=340;epage=342;aulast=Purwar", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412005000400002", "https://doaj.org/search#.V6PA8bgrK70", "http://hdl.handle.net/11104/0162961", "https://www.library.sk/arl-cav/en/expanded-search/", "https://www.ncbi.nlm.nih.gov/pubmed/28604602", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5490821", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::c580d41545043deca12d565f9de29d89", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100003&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.forskningsdatabasen.dk/en/catalog/78986016", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::e0bd92d25a74133eb0953454de67c655", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/29277251", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26990900", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/28151078", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25650208", "https://www.science.gov/", "http://orbit.dtu.dk/ws/files/9907332/289EDd01.pdf", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-08072013000200006&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000100009", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ajol.info/index.php/ahs/article/view/6901", "http://www.ajol.info/index.php", "http://www.mdpi.com/1999-4915/9/6/144", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000200004", "https://doaj.org/search#.V6PA8bgrK70", "http://www.biomedcentral.com/1471-2180/11/267", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28930081", "https://www.science.gov/", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102010000200020", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26253151", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25066000", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3639602", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24803576", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29361960", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::5a3d15d15f7f64f4480c15e8217237c8", "https://www.openaire.eu/search/advanced/publications", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412004000300002", "https://doaj.org/search#.V6PA8bgrK70", "http://www.aspajournal.it/index.php/ijas/article/view/1142", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/25563793", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75312003000400006", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1457::861141a5b3a1c81718b3bd8af3bb9c00", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/24632518", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=108437", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892002001000021", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412012000200004", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3655278", "https://www.science.gov/", "http://www.actavetscand.com/content/55/1/2", "https://doaj.org/search#.V6PA8bgrK70", "http://www.mdpi.com/2306-7381/4/4/65", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28262966", "https://www.science.gov/", "http://www.narcis.nl/publication/RecordID/oai%3Alibrary.wur.nl%3Awurpubs%2F303465/uquery/brucella%20AND%20abortus/id/14/Language/EN", "http://www.narcis.nl", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::fb3ccd9dfed07a473c165abd115b9a9a", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5367834", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28296882", "https://www.science.gov/", "http://europepmc.org/articles/PMC5367834?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://tools.cdc.gov/medialibrary/index.aspx#/media/id/302981", "http://www2c.cdc.gov/podcasts/search.asp", "https://www.ncbi.nlm.nih.gov/pubmed/26497941", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5839387", "https://www.science.gov/", "http://dx.doi.org/10.1155/2015/720413", "https://doaj.org/search#.V6PA8bgrK70", "https://fsl-bsf.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LSwMxEB7EIj4uPvEJc_O02mYf3UoprLKlF8XaVr2VTZqwgqRgugc9-IP8lWZ2110RobcchoFkksnMJN83AC67aDp_fEKHq4C3pQhlIMNZwITHEiVE4Hek60tGeOfJxI2fvbshQWN-MGLlLeDUpYz8K1Tyiz6pFRLfTOtzRLTbNty3e70RDeP-_Sas6zdRyG_VnrK_Dbt1G1u0rjyjwQ6sSL0HXwU8VpX1MpwrHFFianP6d7zNitdxg0_pi0gx1ilZBm3KjzY0pM-sHxJt3IbRwga8WaWiy3u5paxhu5e8h4PxQ5Rr0wtzhVX14F8559reZqSfOkYYTAw-JoLe3PfhvB-PbwZONctpuUwFQfa0XJmQHcCqnmt5SABt7nIlQi5Z05M-9Xppy0D5XDDBZsI_Alym7Xi5yAlsFOQGVKg4hYayB0mewZoyrw436htfKac9", "http://science-libraries.canada.ca/eng/national-science-library/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3633026", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27672085", "https://www.science.gov/", "http://www.biomedcentral.com/1756-0500/2/261", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-84782016000500847&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://www.ars.usda.gov/research/publications/publication/?seqNo115=335414", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/23645957", "https://www.science.gov/", "http://ijms.sums.ac.ir/index.php/ijms/article/view/835", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832007000300003&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Apure.rug.nl%3Apublications%2Ff7a9e3d1-4991-46ca-90fd-a78de1e3d079/uquery/Brucella/id/8/Language/EN", "http://www.narcis.nl", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36342001000400012", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/24781154", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152009000300004", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27031455", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27075847", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25691532", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152014000200009&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=97963", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29021973", "https://www.science.gov/", "http://journal.frontiersin.org/article/10.3389/fcimb.2017.00422/full", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC4077732?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/28518028", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/23209080", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=doajarticles::367390cf9b2dbf37007ca178aa36ab20", "https://www.openaire.eu/search/advanced/publications", "http://www.forskningsdatabasen.dk/en/catalog/1372964", "http://forskningsbasen.deff.dk/?lang=eng", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802010000600014", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0325-75412013000400003&lng=en&tlng=en", "https://doaj.org/search#.V6PA8bgrK70", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2005000100002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC2677664?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/23585050", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26626959", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28264909", "https://www.science.gov/", "http://journal.frontiersin.org/article/10.3389/fcimb.2018.00103/full", "https://doaj.org/search#.V6PA8bgrK70", "https://bibliotecavirtual.unl.edu.ar/publicaciones/index.php/CE/article/view/1109", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27405866", "https://www.science.gov/", "http://journal.frontiersin.org/article/10.3389/fmicb.2017.01232/full", "https://doaj.org/search#.V6PA8bgrK70", "http://orbit.dtu.dk/ws/files/137906590/Genome_Announc._2017_Duvnjak_.pdf", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/27001541", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26540335", "https://www.science.gov/", "http://journal.frontiersin.org/article/10.3389/fmicb.2017.02236/full", "https://doaj.org/search#.V6PA8bgrK70", "http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5067.pdf&manuscript_id=5067", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.openaire.eu/search/publication?articleId=od_______935::97010ba19bdb0882f040b83dc73c2b43", "https://www.openaire.eu/search/advanced/publications", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3719536", "https://www.science.gov/", "http://adsabs.harvard.edu/abs/2002cosp...34E...5H", "https://www.science.gov/", "http://www.biomedcentral.com/1471-2180/3/15", "https://doaj.org/search#.V6PA8bgrK70", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F55d90f9f-e2d0-488d-9a14-7c12c6b501cd/uquery/Brucella/id/16/Language/EN", "http://www.narcis.nl", "https://www.ncbi.nlm.nih.gov/pubmed/28456876", "https://www.science.gov/", "https://www.narcis.nl/publication/RecordID/oai%3Apure.amc.nl%3Apublications%2F0fe0791f-8b6e-402f-8bbb-bb7a2f7487db/uquery/Brucella/id/9/Language/EN", "http://www.narcis.nl", "http://www.biomedcentral.com/1471-2180/6/9", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.org.ar/scielo.php?script=sci_arttext&pid=S0025-76802007000400005", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______908::143d466e23900c306cb807c160920c8a", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/27012915", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26831160", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26851072", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/18528317", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::69504224a67a1db5cf7f4eafc85160f1", "https://www.openaire.eu/search/advanced/publications", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2017000300002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/24362435", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2006000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0103-05822012000200008", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29619446", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/16725834", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=457650040009", "https://doaj.org/search#.V6PA8bgrK70", "http://adsabs.harvard.edu/abs/2017NRL....12..179S", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od______3056::4ee0784225bd32bbddba79e8795b6f89", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/26438077", "https://www.science.gov/", "https://jsava.co.za/index.php/jsava/article/view/1087", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/26163135", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/25644010", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28929962", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26575364", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28854602", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27580575", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/29254496", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24994009", "https://www.science.gov/", "http://jarums.arums.ac.ir/browse.php?a_code=A-10-27-123&slc_lang=en&sid=1", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/24534631", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=dedup_wf_001::f118b21a924c80aa9ffde3c6916975f2", "https://www.openaire.eu/search/advanced/publications", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=18036747", "http://inis.iaea.org/search/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892006001000002", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ajol.info/index.php/ovj/article/download/168985/158449", "http://www.ajol.info/index.php", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=5638537", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26709638", "https://www.science.gov/", "http://dx.doi.org/10.1016/j.ejrad.2005.01.008", "http://inis.iaea.org/search/", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=20694750", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://www.ncbi.nlm.nih.gov/pubmed/26505344", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2008000300002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "http://www.finlay.bvv.cu/vaccimonitor/Vm2008/a11.pdf", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=38019855", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/28117297", "https://www.science.gov/", "http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/37/112/37112789.pdf?r=1", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/29238329", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=324027986012", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ajol.info/index.php/nvj/article/view/3464", "http://www.ajol.info/index.php", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=17058913", "http://inis.iaea.org/search/", "https://www.ajol.info/index.php/nvj/article/view/68999", "http://www.ajol.info/index.php", "https://togodb.biosciencedbc.jp/mecab_thesaurus/show/1451#en", "http://biosciencedbc.jp/dbsearch/index.php?lang=en", "https://www.ajol.info/index.php/ovj/article/view/168985", "http://www.ajol.info/index.php", "https://www.ncbi.nlm.nih.gov/pubmed/28930080", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/28376905", "https://www.science.gov/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1025-028X2008000200002&lng=es&nrm=iso&tlng=es", "https://doaj.org/search#.V6PA8bgrK70", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/10790142", "https://www.science.gov/", "http://www.iaea.org/inis/collection/NCLCollectionStore/_Public/29/067/29067680.pdf?r=1", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/29673454", "https://www.science.gov/", "http://oaji.net/articles/2016/3556-1469432265.pdf", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89101980000300011", "https://doaj.org/search#.V6PA8bgrK70", "http://pubs.er.usgs.gov/publication/70028766", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=14551170001", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/29203515", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/24978591", "https://www.science.gov/", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892008000800004", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC3790686?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=36048881", "http://inis.iaea.org/search/", "https://www.ncbi.nlm.nih.gov/pubmed/28069819", "https://www.science.gov/", "http://hdl.handle.net/11104/0159559", "https://www.library.sk/arl-cav/en/expanded-search/", "http://journal.frontiersin.org/Journal/10.3389/fcimb.2016.00019/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www2c.cdc.gov/podcasts/player.asp?f=3057384", "http://www2c.cdc.gov/podcasts/search.asp", "https://tools.cdc.gov/medialibrary/index.aspx#/media/id/303181", "http://www2c.cdc.gov/podcasts/search.asp", "http://www.ijmm.org/article.asp?issn=0255-0857;year=2010;volume=28;issue=4;spage=370;epage=371;aulast=Tanyel", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27311859", "https://www.science.gov/", "http://adsabs.harvard.edu/abs/2012PhDT.......190G", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/25390763", "https://www.science.gov/", "http://journal.frontiersin.org/article/10.3389/fvets.2017.00197/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27473222", "https://www.science.gov/", "http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0036-36341997000400006", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0034-89102009000600013", "https://doaj.org/search#.V6PA8bgrK70", "http://journal.frontiersin.org/article/10.3389/fmicb.2017.01275/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od______1106::2d0994ebc04aca806f25b6ad7129d7d2", "https://www.openaire.eu/search/advanced/publications", "https://www.ncbi.nlm.nih.gov/pubmed/27939163", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=41000868", "http://inis.iaea.org/search/", "http://journal.frontiersin.org/article/10.3389/fmicb.2017.02347/full", "https://doaj.org/search#.V6PA8bgrK70", "https://www.openaire.eu/search/publication?articleId=od_______908::c3650ab32c4b3d31986ee0be8d7f3e9b", "https://www.openaire.eu/search/advanced/publications", "http://www.etde.org/etdeweb/details.jsp?query_id=1&page=0&osti_id=5011391", "https://www.etde.org/etdeweb/fieldedsearch.jsp", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=23021805", "http://inis.iaea.org/search/", "http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-31942009000100003", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27474211", "https://www.science.gov/", "http://www.ars.usda.gov/research/publications/publication/?seqNo115=302753", "https://www.science.gov/", "http://adsabs.harvard.edu/abs/2012SPIE.8367E..0FD", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=3508082", "https://www.science.gov/", "http://www.redalyc.org/articulo.oa?id=17025099009", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/27584799", "https://www.science.gov/", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "#", "https://www.ncbi.nlm.nih.gov/pubmed/28616790", "https://www.science.gov/", "http://europepmc.org/articles/PMC3506553?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892001001000003", "https://doaj.org/search#.V6PA8bgrK70", "http://dx.doi.org/10.1155/2014/353876", "https://doaj.org/search#.V6PA8bgrK70", "http://www.narcis.nl/publication/RecordID/oai%3Alibrary.wur.nl%3Awurpubs%2F308132/uquery/brucella%20AND%20abortus/id/8/Language/EN", "http://www.narcis.nl", "+++++++++++++++++http://ajcmicrob.com/?page=article&article_id=33516+++++++++++++", "https://doaj.org/search#.V6PA8bgrK70", "http://journal.frontiersin.org/Journal/10.3389/fpubh.2015.00045/full", "https://doaj.org/search#.V6PA8bgrK70", "http://europepmc.org/articles/PMC3234258?pdf=render", "https://doaj.org/search#.V6PA8bgrK70", "https://www.ncbi.nlm.nih.gov/pubmed/28017899", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/26464379", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27862467", "https://www.science.gov/", "https://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=4989840", "https://www.science.gov/", "http://www.forskningsdatabasen.dk/en/catalog/2434076655", "http://forskningsbasen.deff.dk/?lang=eng", "https://www.ncbi.nlm.nih.gov/pubmed/28961704", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27800616", "https://www.science.gov/", "https://www.ncbi.nlm.nih.gov/pubmed/27754795", "https://www.science.gov/", "https://inis.iaea.orgsearchsinglerecord.aspx?recordsFor=SingleRecord&RN=39120143", "http://inis.iaea.org/search/", "http://www.ars.usda.gov/research/publications/publication/?seqNo115=320632", "https://www.science.gov/", "https://www.openaire.eu/search/publication?articleId=od_______908::f3726fc4479cb6e5776b349b2763659d", "https://www.openaire.eu/search/advanced/publications", "https://www.openaire.eu/search/publication?articleId=doajarticles::b043f1bb117279190c73f54ac4c4578c", "https://www.openaire.eu/search/advanced/publications", "#", "#", "#", "#", "#", "#", "http://worldwidescience.org/disclaimer.html", null, "http://www.science.gov", "http://worldwidescience.org"]}